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the corresponding methods section. 
 
 
Notes on the structure of the thesis 
Included in Appendix A is the transcript of a review paper written in the course of these 
studies and accepted for publication in PLoS Pathogens: "The KdpD/KdpE Two-
Component System: Integrating K+ Homeostasis and Virulence". The subject of this 
review paper is related to the results described in Chapter 5. 
Supplementary files are available on the DVD ‘e-Appendix’. 
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Abstract 
Burkholderia pseudomallei (Bp) is the causative agent of melioidosis, an opportunistic but 
serious human disease endemic to Southeast Asia and Northern Australia. The ‘Bp-group’ 
includes Bp and the closely-related organisms B. thailandensis (Bt) and B. oklahomensis 
(Bo), all of which are usually soil-dwelling saprophytes, and B. mallei (Bm) which is an 
equine-host-adapted pathogen.  
Bt is virulent in a number of invertebrate models but is generally non-pathogenic for 
mammals and is often used as a surrogate for the study of virulence mechanisms shared 
with Bp. Experiments to assess the potential of the Tobacco Hawkmoth Manduca sexta as 
a model host for Bp or Bt infection revealed surprising results. Bp, Bt and Bo were all 
lethal to M. sexta larvae. This is the first report of Bo virulence in an infection model. 
Additionally, the relative virulence of the three species was the reverse of that reported in 
humans and in larvae of the Greater Waxworm Galleria mellonella. Despite that, well-
known hallmarks of Bp-group pathogenesis in mammalian hosts – intracellular survival 
and multiplication, actin remodelling and acute sepsis – were observed in M. sexta 
infection during a fluorescent confocal microscopy time-course study. 
M. sexta feeding experiments with Bt and Bo indicated that cultures of these bacteria are 
also pathogenic via the oral route, which is likely to be relevant for natural insect-bacteria 
interactions. Cell-free supernatant of Bo was as harmful to larvae as complete culture, 
supporting previous suggestions that Bp-group bacteria produce toxins or paralytic agents 
that are active against invertebrates. 
Finally, Rapid Virulence Annotation (RVA) was performed as a genome-wide screen for 
virulence determinants of Bp strain K96423, using three invertebrate bioassays with a 
recombinant expression library. In response to problems with the reproducibility of 
biologically active clones, a new statistical approach was devised which enabled 
quantitative identification of the most convincing RVA hits.  
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List of Abbreviations 
ABC adenosine tri-phosphate (ATP)-
binding cassette 
A. polyphaga Acanthamoeba polphaga 
aGOT amoeba Gain of Toxicity 
AMP antimicrobial peptide 
Ara+/- arabinose positive/negative 
ATP adenosine tri-phosphate 
Bcc / B. cepacia complex Burkholderia cepacia complex 
Bm / B. mallei Burkholderia mallei 
Bo / B. oklahomensis Burkholderia oklahomensis 
Bp / B. pseudomallei Burkholderia pseudomallei 
Bt / B. thailandensis Burkholderia thailandensis 
BLAST Basic Local Alignment Search Tool 
BPF Burkholderia pseudomallei fosmid 
BSA bovine serum albumin 
C. elegans Caenorhabditis elegans 
CDS coding sequence 
CFU colony forming unit 
CHBP Cif homologue from B. pseudomallei 
chr chromosome 
CL2 / CL3 containment level 2/3 
CPS capsular polysaccharide 
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DAPI 4’,6-diamidino-2-phenylindole 
E. coli Escherichia coli 
g gram 
GIM Grace’s insect medium 
G. mellonella Galleria mellonella 
GFP green fluorescent protein 
GI genomic island 
GO gene ontology 
GOT Gain of Toxicity 
HC / HCs haemocyte(s) 
HK histidine kinase 
hr hour 
hrs_post_inj hours post-injection 




LD50 50% lethal dose 
LPS lipopolysaccharide 
M. sexta Manduca sexta 
Mb mega base pair 
mg milligram 
mGOT macrophage Gain of Toxicity 
ml millilitre 
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MLST multi-locus sequence typing 
MNGC multi-nucleated giant cells 
MTTD median time to death 
NGM nematode growth media 
nGOT nematode Gain of Toxicity 
NRPS non-ribosomal peptide synthetase 
Obs/Exp observed/expected 
OD600 optical density (600nm) 
PAMP pathogen-associated molecular 
pattern 
PAS Page's amoebal saline 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
Pfa paraformaldehyde 
PKS polyketide synthase 
PO phenoloxidase 
PRR pattern recognition receptor 
Ps. syringae Pseudomonas syringae 
PYG peptone-yeast-glucose 
RPM rotations per minute 
RR response regulator 
RT-PCR reverse-transcription polymerase 
chain reaction 
RVA rapid virulence annotation 
SD standard deviation 
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S.E./SE standard error 
SSR simple sequence repeat 
STM signature-tagged mutagenesis 
T3SS type three secretion system 
T6SS type six secretion system 
TAT twin-arginine translocation  
TraDIS sequencing transposon directed insertion-site 
sequencing 
TRITC tetramethylrhodamine B 
isothiocyanate 
w/v weight per volume 
w/w weight per weight 
μg microgram 
μl microlitre 
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Chapter 1. General Introduction 
The work described in this thesis investigates the use of invertebrates – amoebae, 
nematodes and, in particular, insects – as model hosts to study infection with bacterial 
species from the Burkholderia genus. This introductory chapter therefore discusses the 
Burkholderia, invertebrates as infection model hosts and finally background information 
with particular relevance to each of the three results chapters (Chapters 3-5). 
1.1. The Burkholderia genus 
Bacteria of the genus Burkholderia are motile Gram-negative bacilli and are members of 
the β-proteobacteria. They occupy diverse ecological niches with lifestyles ranging from 
obligate or opportunistic intracellular pathogens of animals (including humans) to plant-
associated pathogens and even symbionts with potential benefits for agriculture and 
bioremediation (Compant et al. 2008).  
The genus is best known for the human pathogens Burkholderia pseudomallei (Bp) and 
the Burkholderia cepacia complex (Bcc), which are phylogenetically distinct within the 
Burkholderia.  
The Bcc group are usually environmental organisms but can cause opportunistic 
infections. The group is comprised of 17 phenotypically similar  bacterial species that can 
exhibit pathogenic and beneficial effects on plants (Mahenthiralingam et al. 2008; 
Compant et al. 2008; Vial et al. 2011). In humans they can cause severe lung infections in 
immunodeficient patients, such as those with cystic fibrosis or chronic granulomatous 
disease. However, Bcc pathogens have been extensively studied elsewhere (for reviews 
see Mahenthiralingam et al. (2008) and Vial et al. (2011)). They do not fall within the 
scope of this work. 
This study stems from interest in Burkholderia pseudomallei (Bp), the causative agent of 
the serious human disease melioidosis. Bp is a containment level 3 pathogen requiring 
specialist facilities for laboratory work. This study focuses on Bp and its closest relatives; 
B. thailandensis (Bt) is higly relevant for the study of Bp – despite the fact it is non-virulent 
to humans – because it shares extensive genetic similarity to Bp. It has therefore been 
used in many studies as a safe surrogate to investigate their shared or divergent biology.   
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Burkholderia phylogeny 
The Burkholderia were originally classified as Pseudomonas species, as were several 
other bacterial species which have since been assigned to new genera (Tayeb et al. 
2008). A phylogenetic analysis which sought to define the relatedness of those species 
found that based on combining analyses from three genes (16S rRNA, rpoB and gyrB) the 
Burkholderia clade was divided into four sub-groups: a group including B. glathei and B. 
graminis; the B. plantarii-B. glumae-B. gladioli group; the B. cepacia complex (Bcc); and 
the B. pseudomallei-B. thailandensis group (Tayeb et al. 2008).  
Other phylogenetic analyses which include the species B. mallei and B. oklahomensis 
also group them into the same branch as Bp and Bt, as shown in Figure 1.1 (Glass, 
Steigerwalt, et al. 2006). In the absence of an established name for this group of four 
related species they will be referred to in this thesis as the ‘Bp-group’. 
Figure 1.1 Neighbour-joining phylogenetic tree of Burkholderia species. Based on 16S rRNA sequences, the 
tree shows the relationship between Bp-group species (B. oklahomensis, B. pseudomallei, B. thailandensis 
and B. mallei) and other Burkholderia. (Scale corresponds to 5% sequence dissimilarity). The abbreviations 
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1.1.1. The B. pseudomallei (Bp)-group 
The four member species of the Bp group show high genetic similarity but can be further 
divided by differences in lifestyle; B. mallei is an obligate intracellular pathogen whereas 
the three species studied in this thesis –  B. pseudomallei, B. thailandensis and B. 
oklahomensis –  are environmental saprophytes and opportunistic pathogens. 
B. mallei: an obligate intracellular pathogen 
B. mallei (Bm) is the causative agent of glanders, an equine disease which was first 
described by Aristotle over 2,000 years ago. Bm is a highly evolved obligate pathogen 
with a narrow natural reservoir limited to horses, donkeys and mules (Nierman et al. 
2004). Equine glanders presents as either an acute or chronic disease, with typical 
symptoms including an infectious and bloody nasal discharge, swelling of the lymph 
nodes, and ulcerated skin. The glanders infection can be transmitted to humans in contact 
with infected horses via ingestion or inhalation of infected material, although it is not 
reported to be transmissible from human-to-human. Bm has historically been used as a 
biological weapon (Galyov et al. 2010). Due to its high infectivity as an aerosol and the 
fact that glanders is incapacitating and often fatal in humans, it has been classed as a 
category B agent by the Centers for Disease Control and Prevention (Nierman et al. 
2004). It was also included in the recently created ‘Tier 1’ disease agents or toxins 
considered by the US Federal Select Agent Program to be exceptional threats to security 
(Butler 2012). 
B. pseudomallei, B. thailandensis and B. oklahomensis: environmental saprophytes 
Bp (previously known as Pseudomonas pseudomallei) is the causative agent of 
melioidosis, a ‘glanders-like’ disease of humans and other animals which was first 
described by Alfred Whitmore in Burma in 1911 (Whitmore 1913). Bp is also classed as a 
category B agent and a Tier 1 agent. B. thailandensis (Bt) and B. oklahomensis (Bo) were 
originally classed as non-virulent strains of Bp until they were recognised as separate 
species in 1998 and 2006 respectively (Brett et al. 1998; Glass, Steigerwalt et al. 2006). 
Unlike Bm, these three species are naturally soil-dwelling saprophytes, found in moist 
tropical soils and still waters such as rice paddies (Allwood et al. 2011).  
The virulence, phenotypes and genetics of Bp-group species will be discussed further, as 
will the mechanisms of Bp and Bt pathogenicity as understood so far. 
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1.1.2. Bp-group species virulence and disease 
Bp is well known to cause the potentially fatal human disease melioidosis which affects 
thousands of people in endemic areas each year, while Bt has been isolated from clinical 
infections in a small number of cases and Bo has been associated with human infection in 
just two documented cases. 
B. pseudomallei (Bp)-associated disease: melioidosis 
Melioidosis, the human disease caused by Bp, is primarily a disease of tropical regions. It 
is endemic to Southeast (SE) Asia and Northern Australia and is occasionally reported in 
travellers returning from such areas.  The potential that the disease is an emerging global 
problem has been recognised, with melioidosis being reported in the Indian sub-continent, 
the Caribbean, and less conclusively in South Africa, the Middle East, and Central and 
South America (Dance 2000; Cheng et al. 2005). In Northeast Thailand, melioidosis 
accounts for 40% of all deaths from community-acquired septicaemia (Felgner et al. 
2009). In 1996 it was estimated that 2,000-5,000 patients were presenting with melioidosis 
in Thailand alone (Dharakul & Songsivilai 1999).  
Figure 1.2. Some of the varied clinical features of melioidosis, which often contribute to its misdiagnosis. The 
disease may be acute (often associated with septicaemia and dissemination to sites such as the lungs, liver or 
spleen), or chronic (often involving lung disease). Melioidosis can also re-activate many years after apparently 
successful treatment. Alternatively, exposure may not lead to disease; many children in endemic areas test 
positive for antibodies to Bp but are asymptomatic. Based upon a diagram from Wiersinga et al (2006)  
  
Melioidosis is severe and often fatal and diagnosis is often complicated by a range of 
different presenting symptoms, as shown in Figure 1.2. So much so in fact, that it has 
been nick-named ‘The Great Mimicker’. Typically there is septicaemic illness with bacterial 
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dissemination to distant sites, which might include the lungs, spleen, kidneys or prostate 
(Holden et al. 2004). Other presentations include swelling of the parotid salivary gland 
(usually in children), soft tissue lesions, infections of the genito-urinary tract, and even 
involvement of the central nervous system (Wiersinga et al. 2006).  
Bp infection is opportunistic in nature. Infection is possible through inhalation of Bp-
contaminated dust or near-drowning in contaminated water, but the most common route of 
infection is thought to be through exposure to broken skin (Dance 2000). 
In a study in Northeast Thailand, 81% of melioidosis patients were rice farmers or their 
families (Suputtamongkol et al. 1994). Work in rice paddies is thought to pose a high risk 
of exposure to Bp via contaminated mud and water.  In Australia, cases most often occur 
after heavy rainfall in the wet season. In over 90% of cases studied in Thailand, no 
specific exposure incident was known (Suputtamongkol et al. 1994); the incident may 
even have occurred years earlier, as another trait of Bp is its ability to remain dormant at 
unknown sites in the body, becoming reactivated later in life. Asymptomatic exposure to 
Bp is thought to be common in Thailand, where up to two-thirds of children have 
antibodies to Bp by the age of fourteen years (Wuthiekanun et al. 2006). Disease most 
often occurs in adults with an underlying immune-suppressing illness, especially diabetes 
mellitus, chronic renal disease or alcoholism, although the precise nature of the 
predisposition is still not well understood (Dance 2000). Melioidosis can be cured if treated 
promptly with antibiotics but due to the variety of symptoms it can elicit it is easily 
misdiagnosed. Without appropriate antibiotic treatment, mortality from septicaemic 
melioidosis is close to 90% (Stone 2007). There is currently no vaccine (Cuccui et al. 
2007). 
Bp is also a facultative pathogen of a diverse range of non-human animal species. Just as 
in humans, the infection can exhibit latency and a wide range of clinical symptoms in 
many species (Choy et al. 2000). Sheep and goats are particularly susceptible. Natural 
infections also occur in: horses, camels, alpacas, kangaroos, koalas, deer, cats, dogs 
monkeys, gorillas, dolphins, birds, and reptiles including crocodiles (Lee et al. 2010; Choy 
et al. 2000). Interestingly, some species such as rats are only susceptible when 
immunocompromised (Choy et al. 2000). Bovine melioidosis is rare, and porcine 
melioidosis is often limited to asymptomatic organ abscesses (Choy et al. 2000). In 
experimental infection models, Syrian golden hamsters are exquisitely sensitive to Bp 
infection (Brett et al. 1997). A range of mammalian models of melioidosis have been 
developed; these are discussed further later in relation to Chapter 3. In laboratory 
experiments Bp has been shown to be virulent against insects (Schell et al. 2008; Fisher 
et al. 2012; Wand et al. 2011) and tomato plants Solanum lycopersicum (Lee et al. 2010).  
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B. thailandensis (Bt)-associated disease 
Bt is usually isolated in Southeast Asia, where a number of mammalian-avirulent ‘Bp’ 
strains were later confirmed by 16S sequencing and biochemical tests to be a distinct 
species (Brett et al. 1997; Brett et al. 1998; Smith et al. 1997). There are also two clinical 
isolates from the USA and one from a foal in France (Glass, Gee, et al. 2006). No strains 
have yet been isolated from the environment in the USA or France however.  
Bt is generally referred to in the literature as avirulent to humans and other mammals. 
Human clinical isolates of Bt are rare and are usually associated with extreme 
circumstances – serious injuries that had been heavily contaminated with soil or incidents 
of near-drowning (Glass, Gee, et al. 2006). Bt was cultured from an amputated knee 
following a motorcycle accident in Thailand which, it is thought, must have been due to a 
very heavy inoculation from the soil (Lertpatanasuwan et al. 1999). There is one other 
similar report from Thailand. Of the two American clinical isolates, one was associated 
with a near-drowning incident of a young infant and one from a pleural wound of an elderly 
man (Glass, Gee, et al. 2006). In a study of over 1,000 patients with melioidosis Bt was 
never isolated (Smith et al. 1997); Bt does not cause melioidosis. 
Bt exhibits greatly reduced virulence in the hamster model of infection that is so highly 
sensitive to Bp (Brett et al. 1997; Brett et al. 1998). In the BALB/c mouse the mean 50% 
lethal dose of Bt is 109 colony-forming units (CFU), versus 182 CFU of Bp (Smith et al. 
1997). In cell-based assays Bt exhibits cytotoxity to mammalian (HeLa) cells to a greater 
extent than Bp does (Brett et al. 1997). Interestingly, Bt is pathogenic for the tomato plant 
Solanum lycopersium and for Arabidopsis thaliana, but not for rice plants (Japonica 
nipponbare) (Lee et al. 2010). Yet Bp and Bt are frequently isolated from rice paddies, so 
this may suggest the bacteria co-exist alongside rice plants in a non-pathogenic 
relationship. Bt has recently been discovered to be virulent to three insect species: the 
caterpillar Galleria mellonella (Wand et al. 2011), the Madagascar Hissing cockroach 
(Fisher et al. 2012), and the fruit fly Drosophila melanogaster (Pilátová & Dionne 2012).  
B. oklahomensis (Bo)-associated disease 
Originally known as the Pseudomonas pseudomallei ‘Oklahoma strain’, Bo C6786 was 
isolated in 1973 from an infected deep leg wound of a patient after a farming accident in 
Oklahoma, USA (McCormick et al. 1977; Glass, Steigerwalt, et al. 2006). The wound had 
been heavily contaminated with soil. Two environmental isolates matching C6786 were 
also found at the location. Another clinical isolate (E0147) was recovered in Georgia in 
1977 from the wounded eye of a car accident victim, eight weeks after having been 
thrown into a clay embankment (Nussbaum et al. 1980). Both of these cases involved 
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extensive contamination of wound with soil and no other reports of Bo clinical infections 
exist. A guinea pig inoculated with Bo C6786 did not show any signs of infection 
(McCormick et al. 1977). The same was true for hamsters and mice inoculated with up to 
107 CFU of Bo (DeShazer 2007). Therefore Bo has been considered avirulent. 
1.1.3. Bp-group phenotypes and genomes 
Phenotypes 
The member speicies of the Bp-group share similar cellular morphologies and 
antigenicities (Lertpatanasuwan et al. 1999). The colony morphology differs however: on 
modified Ashdown's selective medium Bp colonies are ‘rough and wrinkled with a dark 
purple pigmentation’ and Bt colonies are ’smooth and glossy with a pink pigmentation’ 
(Brett et al. 1997). The most reliable biochemical test for differentiation between Bp and Bt 
is for assimilation of L-arabinose: Bt is capable (Ara+) whereas Bp is not (Ara-) (Smith et 
al. 1997). The two species also show broadly different profiles of exoproduct secretion 
(protease, lipase, lecithinase, and siderophore), although there is also variation within 
each species (Brett et al. 1997). Bo differs from either Bp or Bt in its ability to produce gas 
from nitrate, although that also varies (Glass, Steigerwalt, et al. 2006). PCR-based genetic 
tests are used to differentiate Bp-group species (Price et al. 2012). Multi-locus sequence 
typing (MLST) shows that the Bo isolates are divergent from Bp (Godoy et al. 2003). 
Phylogenetically Bp, Bm and Bt are very closely related and Bo lies on a separate branch 
within the Bp-group (Glass, Steigerwalt, et al. 2006). 
Genomes 
Bp genome 
The Bp sequence strain K96243 was isolated from a 34 year old female melioidosis 
patient in Thailand in 1996. The relatively large 7.2Mb genome consists of two circular 
chromosomes of 4.07Mb and 3.17Mb; chromosome 1 and 2, with 3,460 and 2,395 coding 
sequences (CDSs), respectively (Holden et al. 2004). As genes for central metabolism 
and essential functions are encoded on both replicons, they are both considered to be 
true chromosomes. Chromosome 1 encodes a higher proportion of core function CDSs for 
basic growth and survival whereas chromosome 2 encodes more accessory functions 
such as for adaptation, osmotic protection, iron acquisition, and secondary metabolism, 
suggesting it may be primarily responsible for the ability of Bp to survive in different 
niches. Chromosome 2 also has more CDSs which correspond to unknown “hypothetical” 
proteins or those with no database matches at all, i.e. there are currently many CDSs with 
no identified function (Holden et al. 2004).   
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However, a key feature of the Bp genome is that it is highly variable and dynamic 
(Wiersinga et al. 2012). 86% of the K96423 genome is present in all Bp strains but the 
remaining 14% varies among strain isolates (of which there are more than one hundred, 
with genome sequence data available for at least 19 strains). Horizontal acquisition of 
DNA has been intrinsic to the evolution of Bp. Genomic islands (GIs) are regions bearing 
unusual sequence hallmarks, such as atypical GC content or dinucleotide frequencies, 
which are likely to have been acquired horizontally. They are often associated with 
virulence- or survival-related genes (Sim et al. 2008). 6.1% of the Bp genome is found 
within 16 GIs (Nierman et al. 2004), and their distribution is highly variable between Bp 
strains (Holden et al. 2004). Bp sampled from different sites within the same melioidosis 
patient can even show considerable genetic diversity (Price et al. 2010). 
Sim et al (2008) used whole genome microarrays of 94 Southeast Asian Bp strains 
(clinical, animal, and environmental isolates) to define the common core genome and the 
variable accessory genome. 86% of the K96243 reference genome was common to all 
strains tested, and 14% was variably present. The core genome included many genes for 
basic functions such as amino acid metabolism and contained most of the genes which 
are conserved among other Burkholderia species. Well known virulence determinants 
from other bacteria such as secretion systems, capsular polysaccharides, adhesins, 
fimbriae and pili are encoded in the Bp core genome. The accessory genome includes 
multiple GIs. Interestingly the human clinical isolates of Bp cluster together in a 
phylogenetic tree based on accessory gene content and were significantly more likely to 
harbour certain GIs than environmental isolates (Sim et al. 2008).  
Bp can adapt to survive in diverse niches: soil, water and air, and in plants, mammals, 
invertebrates, birds and reptiles (Gan et al. 2002; Choy et al. 2000). In the environment 
the bacteria face changing biotic and abiotic challenges including temperature, humidity, 
and UV radiation, limited nutrients, predatory organisms, bacteriocides and phage 
infection (Sim et al. 2008). The large bipartite genome structure of Bp, with variable GIs 
and a repertoire of genes for diverse functions, is presumed to be what gives it the 
flexibility to cope with such pressures and to lead a dual existence as a soil coloniser and 
an effective pathogen of various species (Sim et al. 2008). It is thought that the 
adaptability of Bp is what enables it to cause multiple and variable disease manifestations 
in melioidosis, as well as chronic disease or relapse many years after treatment (Holden 
et al. 2004). 
Bm genome 
Bm diverged from a Bp-like ancestor and has undergone genomic deletions and 
rearrangements resulting in a  genome that is 1.31 Mb smaller, lacking 16% of the Bp 
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chromosome 1 and 31% of chromosome 2 (Nierman et al. 2004; Holden et al. 2004). 
These differences are consistent with genome reduction associated with the lifestyle of 
Bm as an obligate mammalian parasite (Moore et al. 2004). The Bm, Bp and Bt genomes 
contain notably high numbers of simple sequence repeats (SSRs) – over 12,000 in Bm 
(Nierman et al. 2004). SSRs are associated with frameshift mutations and phase variation 
due to slipped-strand mispairing. SSRs were found in over two-thirds of Bm CDSs and 
some promoter regions. Examination of SSR loci from surface-expressed and putative 
virulence genes in Bm and Bp revealed considerable variation both between and within 
strains, suggesting that phase variation may occur in genes critical for infection (Nierman 
et al. 2004).  
Bt genome 
The Bt sequence strain E264 is 0.5Mb smaller than Bp K96423, with chromosomes of 
3.8Mb and 2.9Mb (Yu et al. 2006). Unlike Bm, Bt shows extensive synteny with the gene 
order of Bp. Genomic comparisons between Bp K96423 and Bt E264  reveal that: Bp (and 
also Bm) has lost a gene cluster for arabinose assimilation which is suspected to play an 
anti-virulence regulatory role in Bt (Moore et al. 2004); Bt lacks a capsular polysaccharide 
(CPS) gene cluster which is present in Bp; there are some differences in presence of 
metabolic gene clusters; and virulence-related genes (especially type 3 secretion 
systems; T3SSs) are generally the most divergent at the amino acid level (Yu et al. 2006). 
Like Bp, Bt also contains multiple GIs which are variably present across different strains 
(Yu et al. 2006). 
Bo genome 
The Bo reference strain is C6786. Bo strains C6786 and E0147 have been draft-
sequenced and exist as contig assemblies (Mukhopadhyay et al. 2010). MLST and 16S 
gene sequencing have been described (Glass, Steigerwalt, et al. 2006; Godoy et al. 
2003). The relative DNA-DNA binding ratio of Bo C6786 to three other Bo isolates was 
over 90%, and to Bp ATCC 23343 or Bt E254 was less than 65% (Glass, Steigerwalt, et 
al. 2006). Nucleotide Basic Local Alignment Search Tool (BLASTN) searches of the two 
Bo strains did not identify loci with similarity to Bp gene clusters for CPS, T3SS-3 
(Stevens et al. 2002) or type 6 secretion system 5 (T6SS-5) (Shalom et al. 2007). No 
detailed analysis of the Bo genome has yet been published.  
1.1.4. The basis of Bp-group pathogenesis 
The majority of research into Bp-group pathogenesis has focused on melioidosis, and 
some has focused primarily on glanders. Some studies have used Bm or Bt to provide 
insights into Bp pathogenesis. The molecular and cellular basis of Bp pathogenesis in 
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melioidosis and strategies employed by Bp for intracellular survival have been 
comprehensively reviewed (Lazar Adler et al. 2009; Allwood et al. 2011). Another review 
discusses molecular insights into pathogenesis of both Bp and Bm (Galyov et al. 2010). 
Bp virulence factors will also be discussed further later in relation to Chapter 5. 
Bp bacteria possess many virulence factors that are common to other bacterial pathogens 
(Schell et al. 2008) including: three T3SSs (T3SS-1, T3SS-2, T3SS-3 / T3SSBsa) (Stevens 
et al. 2002); six T6SSs (T6SS-1 to T6SS-6); capsular polysaccharide (CPS) (Reckseidler-
Zenteno et al. 2010); lipopolysaccharide / O-antigen (LPS); flagella (Inglis et al. 2003; 
Chua et al. 2003); and type IV pili and adhesins (Essex-Lopresti et al. 2005; Balder et al. 
2010). There is conflicting evidence about the requirement of many of these factors 
(Allwood et al. 2011). Although many virulence factors are involved in Bp infection, there 
appears to be considerable redundancy as few have been identified as essential. The 
secretion systems (particularly T3SS-1, T3SS-3, T6SS-1 and T6SS-5) are thought to play 
critical roles in transporting effector molecules into target host cells (D’Cruze et al. 2011; 
Burtnick et al. 2011). A recently identified effector molecule (CHBP; Cif homologue from 
B. pseudomallei) is a potent inhibitor of eukaryotic ubiquitination, which ultimately leads to 
host cell cycle arrest (Cui et al. 2010).   
Secreted factors include proteases, haemolysins, lipases, lecithinases, catalases, and 
phospholipase C (Holden et al. 2004; Ashdown & Koehler 1990; Balaji et al. 2004; 
Hautbergue & Wilson 2012). Thermolabile toxins have been detected (Heckly & Nigg 
1958) and a lipid toxin complex has been suggested to exist, but not identified  (Balaji et 
al. 2004). Recently the first lethal toxin of Bp has been identified and characterised – 
BLF1 (Burkholderia lethal factor 1) is lethal to mice and to macrophage cells (Cruz-Migoni 
et al. 2011; Hautbergue & Wilson 2012). The toxin specifically deamidates a glycine 
residue of eIF4A (eukaryotic initiation factor 4A), which extensively inhibits protein 
synthesis in mammalian cells (Hautbergue & Wilson 2012).  
Intracellular survival allows bacteria to access nutrients while avoiding the host immune 
response, and is key to Bp virulence and pathogenicity (Allwood et al. 2011). The pattern 
of Bp pathogenesis, outlined in Figure 1.3, typically involves: bacterial attachment and 
uptake by phagocytes or invasion into non-phagocytic cells; phagosome vacuolar escape; 
intracellular survival and replication; and spread to other cells. Attachment to host cells 
involves pili (PilA) and the adhesins BoaA and BoaB (Essex-Lopresti et al. 2005). Entry 
into host cells includes the type 3 secretion system-3 (T3SS-3) and regulatory proteins 
IrlR and RpoS. T3SS-3 is also required for escape from endocytic vesicles, via membrane 
disruption (Allwood et al. 2011). Bp survives and replicates in the cytosol of the host cell, 
which appears to involve biosynthetic pathways for purines (PurM, PurN), histidine (HisF) 
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and paraminobenzoate (PabB) (Pilatz et al. 2006). Bp bacteria also leave the intracellular 
environment; in clinical and experimental melioidosis there is often a septicaemic infection 
of the blood in acute cases, or dissemination to other sites in the body in chronic infection.  
Figure 1.3. The intracellular infection cycle of B. pseudomallei. The bacteria (green): A - adhere to and are 
phagocytosed by epithelial or phagocytic host cells; B – are internalised in an endocytic/phagosomal vacuole; 
C – escape from vacuoles into the cytosol where they evade destruction, replicate, and may utilise actin-
mediated motility to move within or out of the host cell. D – Cell-cell fusion may occur, forming multi-nucleated 
giant cells (MNGCs); actin-mediated motility (represented by red filaments) may be involved in but is not 
essential for inter-cellular spread. Inter-cellular spread allows the bacteria to access more nutrients and to 
replicate while remaining inside the relatively protected intracellular niche. Finally, bacterial cellular escape 
follows host cell apoptosis or lysis. [Image based upon part of figure 1 from Allwood et al (2011)].  
 
 
Characteristic hallmarks of Bp pathogenesis are the formation of actin tails for intracellular 
motility and multi-nucleated giant cells (MNGCs) for intercellular spread; these are 
discussed further later in relation to Chapter 4. Actin tails were previously thought to be 
used primarily for cell-to-cell spread of Bp bacteria but cell-to-cell fusion is now considered 
to be the primary mechanism for intercellular spreading (French et al. 2011). Actin-based 
motility has also been described for other bacteria including Listeria and Shigella but the 
activation mechanism of Burkholderia actin-based motility is unique (Stevens et al. 2006; 
Allwood et al. 2011). The BimA protein is known to be required for formation of actin tails 
(Stevens et al. 2005), and it has been suggested that the remodelling process requires a 
concerted effort of multiple factors including type 6 secretion system-1 (T6SS-1) (Burtnick 
et al. 2011; Allwood et al. 2011). The T6SS-1 protein Hcp1, the sigma factor RpoS, and 
the T3SS-3 protein BipB all play a role in stimulating fusion with a neighbouring host cell 
and the subsequent formation of MNGCs. 
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1.2. Invertebrate models for Bp-group pathogens 
The majority of insights into Bp so far have come from clinical cases and mammalian 
infection models. In addition to mammalian infection models for the study of human 
pathogens, there are alternative models (also known as complementary, surrogate or 
mini-host models) (Casadevall  2005). These include invertebrate and plant infection 
models. They provide insights into comparative host responses, the evolution of 
pathogenicity, and bacterial virulence. Mechanisms of bacterial virulence and 
pathogenesis are often conserved across different hosts, so insights from invertebrate 
model hosts are often relevant to mammalian hosts (Casadevall 2005; Mahajan-Miklos et 
al. 2000). Invertebrate model hosts of microbial pathogens have been used widely since 
the discovery of an important parallel to mammalian immunity – that the Toll signalling 
pathway is essential for the Drosophila melanogaster (fruit fly) anti-microbial host 
response (Lemaitre et al. 1996).  
1.2.1. Benefits of invertebrate infection models  
Invertebrate model hosts provide a compelling alternative to mammalian infection models 
due to a number of advantages (Lionakis 2011). Invertebrates are ethically sound 
experimental models and an animal license is not required for their use. Under the 3Rs – 
the Replacement, Refinement and Reduction of ‘protected’ animals in research – 
invertebrates are considered a preferable replacement for vertebrates, which are 
protected under the Animals (Scientific Procedures) Act 1986 (Balls et al. 1995). In 
practical terms invertebrates are simple to work with, economical in terms of resources 
and space for their breeding or maintenance, and they also have rapid lifecycles 
compared to mammals. This means they are practical for undertaking high-throughput 
experiments that may not be feasible in mammalian hosts. As experimental tools many 
invertebrate host species have well-characterised physiologies and genomes, and 
relatively well-studied gene expression. Species including the fruit fly Drosophila 
melanogaster and the nematode worm Caenorhabditis elegans have tractable genetics 
and a considerable availability of characterised mutants (Lionakis 2011; Vlisidou et al. 
2009; Marsh & May 2012). Other popular host models of microbial infection include: the 
soil-dwelling amoebae Dictyostelium discoideum and Acanthamoeba species; the greater 
wax worm Galleria mellonella; the tobacco hornworm Manduca sexta; the silkworm 
Bombyx mori; and the mosquito Culex quinquefasciatus (Lionakis 2011; King & Hillyer 
2012; Waterfield et al. 2008; Harding et al. 2012; Vogel et al. 2011). 
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1.2.2. Basis for using invertebrate models for mammalian 
pathogens 
Importantly, there is also a sound biological basis for the use of invertebrates to 
investigate pathogens of mammals, owing to commonalities in the innate immune systems 
and ecological and evolutionary relevance. 
Innate immunity similarities 
The innate immune response is the primary defence against invading organisms. 
Invertebrates lack an adaptive immune system in the true sense, but the innate immune 
systems of invertebrates and mammals share many common features, both 
mechanistically and genetically (Khush & Bruno Lemaitre 2000; Sadd & Schmid-Hempel 
2006).  
The innate immune response consists of humoral and cellular elements, which are inter-
connected in their activities. In terms of humoral immunity, invertebrates produce a range 
of antimicrobial peptides (AMPs) which are analogous to vertebrate defensins (Kavanagh 
& Reeves 2004). Oxidative burst mechanisms and induction of lysozyme are also 
common to both. The insect phenoloxidase (PO) cascade leads to melanisation – the 
deposition of melanin to immobilise invading microbes – and it has been likened to the 
complement cascade of mammals; both are activated by pattern recognition receptors 
(PRRs) (Kavanagh & Reeves 2004). The cellular immune response includes 
phagocytosis, the process by which specialised cells engulf and kill invading microbes, 
which is common to both vertebrates and invertebrates. Mammalian phagocytes include 
neutrophils and macrophages, and invertebrate phagocytes are known as haemocytes. 
Haemocytes themselves include multiple sub-types, including plasmatocytes and 
granulocytes (Strand 2008). The mechanism of phagocytosis is the same in mammals 
and invertebrates – the phagocyte recognises and immobilises the invading microbe, 
which is then engulfed and sequestered within a phagosomal vacuole inside the cell. In 
mammalian macrophages, phago-lysosome fusion leads to increased acidity and a 
barrage of lytic enzymes and peptides which destroy the trapped microbes; similar 
effector molecules are found within insect-produced phagosomes (Strand 2008).  
Evolutionary and ecological relevance 
The evolutionary and ecological relevance relates to the fact that: (i) bacteria-invertebrate 
interactions are common in most environments (so experimental challenge has a natural 
basis); (ii) bacteria and invertebrates have co-evolved in a host-pathogen arms race over 
vast evolutionary timescales; and (iii) the commonalities between mammalian and 
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invertebrate immune systems means that the mechanisms bacteria have evolved to 
survive in invertebrates might confer an advantage in mammalian hosts. 
Amoebae are essentially free-living phagocytes, engulfing environmental bacteria for 
nutrition. It has been proposed that environmental bacteriovores may act as training 
grounds for the evolution of bacterial traits which confer ‘accidental’ virulence to other 
hosts (Molmeret et al. 2005). For example, Legionella pneumophila is able to evade 
predation by amoebae and to survive in a protected niche within them. It has been 
discovered that L. pneumophila uses similar strategies to subvert amoebae and 
macrophages, leading to Legionnaire’s disease in humans (Swanson & Hammer 2000). 
Both amoebae and nematodes consume large amounts of bacterial biomass. Insects too 
are likely to represent a natural environmental host for Burkholderia species. The extent to 
which Burkholderia associate with insects in natural environments, or what the typical 
outcomes of those associations are, has not been studied. The natural ecology of insects 
which feed on large quantities of plant material (including herbivorous caterpillars like M. 
sexta) means that they are highly likely to ingest environmental bacteria such as 
Burkholderia (Pauchet et al. 2010).  
1.2.3. Invertebrate studies with members of the Bp-group  
Bp-infection (experimental melioidosis) has been modelled in invertebrate hosts to varying 
extents. Over 60 years ago it was found that fleas and mosquitoes could transfer Bp 
infection from one guinea pig to another (Blanc & Baltazard 1949). Subsequent 
investigations of possible vectors of Bp included synanthropic flies (i.e. those that 
associate with or benefit from humans) in Malaysia (Sulaiman 2000), and two tick species 
(Kharbov et al. 1981). The collected flies were often found to harbour Bp, and after the tick 
species contracted Bp from infected rabbits the bacterium was culturable from the tick 
faeces. No further studies of natural Bp transmission vectors per se have been reported.  
Soil-dwelling organisms potentially represent a vast environmental reservoir of 
Burkholderia bacteria. Therefore numerous studies have looked at Bp in environmental 
bacteriovores, with the majority of work having been conducted with the C. elegans 
nematode model (Day & Sifri 2012; Inglis et al. 2003). 
Amoebae 
The interaction of Bp with three Acanthamoeba species was first described after amoebae 
were recovered from the vicinity of a melioidosis outbreak in Australia (Inglis et al. 1999; 
Inglis et al. 2000). Bp strain NCTC 10276 was co-cultured with the amoebae and bacterial 
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endocytosis was observed in all three species. Further experiments with A. astronyxis 
(Figure 1.4) showed that Bp cells were adhering by one bacterial pole to the amoeba.  
Figure 1.4. Acanthamoeba astronyxis  amoeba. Confocal laser scanning micrograph from Inglis et al (2000), 
depicting adhesion of polar end of bacillus to A. astronyxis surface (white arrow) leading to inclusion in 
vacuole (white arrowhead). 
 
Attached bacteria were observed to rotate for a few seconds before engulfment, in a style 
of coiling phagocytosis that is also characteristic of L. pneumophila entry into either 
amoebae or macrophages (Bozue & Johnson 1996; Horwitz 1984). Vacuoles packed with 
bacteria were seen adjacent to or protruding through the external plasma membrane, and 
some were in the process of releasing bacteria, forming an external tuft of cells. In a few 
cases, single bacilli moved throughout the amoeba cytoplasm, uncontained by vacuoles. 
Viable bacteria were recovered from amoebae one hour after endocytosis and motile 
intracellular bacilli were observed 72 hours after co-culture began (Inglis et al. 2000). A 
subsequent study indicated that the bacterial flagellum was involved in entry of Bp into A. 
astronyxis (Inglis et al. 2003). It has been suggested that amoebae might represent a 
natural reservoir of Bp in the environment (Dance 2000). No investigations testing this 
theory have yet been published. 
A recent study used the social amoeba Dictyostelium discoideum in two assays – one 
quantitative and one high-throughput (Hasselbring et al. 2011). The quantitative assay 
confirmed that levels of wild-type and mutant Bp and Bt resistance to D. discoideum 
predation (and survival within the amoeba) correlated well with results from other host 
models. 1,500 Bt strain DW503 transposon mutants were screened using the high-
throughput assay; 13 genes were identified as involved in resistance to amoeba predation 
and their orthologues were inactivated in Bp strain DD503. Ten mutants exhibited reduced 
resistance to predation; these are discussed further in Chapter 5. Of those, several also 
showed reduced intra-macrophage survival or cytotoxicity and finally tests in a murine 
model confirmed that some mutants were indeed attenuated for the mammalian host, 
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particularly the mutants in T3SS and a sensor kinase gene bpsl0127 (Hasselbring et al. 
2011).  
Nematodes 
Burkholderia species known to kill nematodes include multiple strains of Bp, Bt strain 
E264, and three Bm strains (O’Quinn et al. 2001). Over a decade of research into the 
effects of Bp on C. elegans has recently been reviewed (Day & Sifri 2012). Initial studies 
confirmed that Bp and Bt were pathogenic to the nematode by the feeding route and that 
locomotion, feeding and egg-laying were affected (O’Quinn et al. 2001). An unknown 
neurotoxin or paralytic agent was hypothesised to have been responsible. Subsequently, 
it was shown that a 12 hour and 24 hour exposure to Bp killed 55% and 100% of the 
nematode population respectively, indicating that maximal killing requires prolonged 
association with the live bacteria (Gan et al. 2002). It was suggested that Bp must 
continuously produce toxins to kill C. elegans, as Bp does not accumulate within the gut of 
wild-type worms (Lee et al. 2011; Ooi et al. 2012), and filtrate assays caused significantly 
less nematode mortality than direct killing assays (Lee et al. 2011). Figure 1.5 shows C. 
elegans nematodes following feeding on green fluorescent protein (GFP)-expressing Bp 
cells. 
Figure 1.5. C. elegans nematodes fed with GFP-expressing Bp, from Lee et al (2011). In the top image (wild-
type nematode) GFP fluorescence is confined to the anterior gut and is very faint. In the bottom image a 
grinder-defective mutant nematode is used to demonstrate the level of GFP fluorescence from a fully 
colonised gut. 
 
The rate of killing was also noted to be strain-specific and dependent on the type of 
growth media used in co-culture experiments (Lee et al. 2011). From the findings of 
O’Quinn (2001), Gan (2002) and Lee (2011) there is evidence both for and against the 
existence of a diffusible nematode-toxic factor from Bp. Recently Ooi et al (2012) looked 
at C. elegans gene expression during Bp infection. It was found that pgp-5, which 
encodes a toxin-exporting ATP-binding cassette (ABC) transporter, was highly induced in 
response to Bp exposure; a pgp-5 RNAi knock-down worm was also more susceptible to 
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infection (Ooi et al. 2012). The available evidence so far supports a theory that Bp killing 
of C. elegans involves both intoxication and unknown active processes which require the 
presence of live bacteria (O’Quinn et al. 2001; Day & Sifri 2012).  
Insects 
Insect species are often associated with soil and plants and are therefore likely to 
encounter Burkholderia in the environment. Four recent publications describe insect 
models of Bp-group infection (Schell et al. 2008; Fisher et al. 2012; Pilátová & Dionne 
2012; Wand et al. 2011). 
Schell et al (2008) first infected G. mellonella wax moth larvae with Bm, Bp and Bt. They 
found that Bp and Bm were highly pathogenic for G. mellonella: injection of just ten Bp 
K96423 cells led to over 80% mortality within two days; Bm virulence was lower, with the 
same dose taking up to six days to kill 90% of larvae. Bt virulence was lower still, with 105 
cells leading to 35% mortality in seven days, and no further work was conducted with Bt in 
that study. Both Bp and Bm caused insect paralysis around 12 hours prior to death, from 
which point the bacteria multiplied in number in the insect haemocoel by two logs, 
although there was no speculation as to whether this was due to intra- or extracellular 
replication. Four Bm mutants which are attenuated in mammalian models showed 
corresponding levels of attenuation in G. mellonella: a T3SS cluster mutant, a CPS 
mutant, a type II secretion mutant and an auxotrophic mutant (Schell et al. 2008). In silico 
genomic subtraction generated a set of 650 genes present in Bm ATCC 23344 and Bp, 
but absent from related non-pathogenic species (four environmental Burkholderia and one 
Ralstonia species). 70% of the virulome genes were also noted to be present in Bt. 
Inactivation of some of these ‘Bm-Bp virulome’ genes was followed by testing in G. 
mellonella infection assays. The most dramatic attenuation of Bm virulence was with a 
mutant of an AraC-type transcriptional regulator predicted to regulate a T6SS. Other 
attenuating mutants were in genes related to a putative insect-pathogenic toxin or 
secondary metabolite (with similarity to a Photorhabdus luminescens gene cluster), and a 
putative polyketide synthase (PKS). 
Wand et al (2011) reported that a macrophage cell culture model and the G. mellonella 
insect model both reflect the relative virulence levels of Bp, Bt and Bo strains as observed 
in murine models. These are the only published results of Bo infection in insects so far, 
and the conclusion was that Bo strains were the least virulent Burkholderia tested. The 
researchers challenged G. mellonella larvae with 100 CFU of bacteria and recorded 
survival at 24 hours post-challenge. Strain-dependent differences were evident; Bp 
K96423 and Bp 576 caused 100% mortality but Bp 708a caused no deaths. Bo C6786 
and Bo E0147 also caused no deaths. The American Bt strains CDC 272 and CDC 301 
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caused 100% mortality, the sequence strain E264 caused 50% mortality, and the Phuket 
strain caused 80% mortality. The number of bacteria in the haemocoel of some insects 
was enumerated at 20 hours post-challenge; bacterial numbers had increased since 
injection for all strains tested, although Bp 708a, Bt E264 and the Bo strains showed less 
of an increase relative to the others. Heat-killing rendered virulent Bt strains avirulent. At a 
challenge dose of 105 CFU Bo C6786 did cause 100% mortality within 24 hours, but Bo 
E0147 still did not (Wand et al. 2011).  
A Madagascar hissing cockroach (Gromphadorhina laevigata) infection model was 
recently used to test Bp, Bm and Bt (Fisher et al. 2012). The cockroaches were highly 
susceptible to all three species; all exhibited a 50% lethal dose (LD50) of less than 10 CFU 
per insect. This matches the Bp K96423 LD50 in the hamster model (Burtnick et al. 2011). 
Although the LD50 values were the same, Bm killed more slowly than either Bp or Bt, 
which is also the case in rodents (Galyov et al. 2010) and likely reflects the extent of Bm 
adaptation to the equine host. T6SS-1 (Δhcp1) mutants were attenuated in all three 
species, which is consistent with findings from mammalian models (Burtnick et al. 2011; 
Fisher et al. 2012). As insects lack adaptive immunity this result may indicate that the 
T6SS-1 plays a role in evading the innate immune response. Haemocytes sampled from 
Bp-infected cockroaches 48 hours post-infection contained numerous intracellular 
bacteria, indicating that Bp replicates within insect phagocytes. Some haemocytes had 
actually fused to form MNGCs; this is the first report of MNGC formation in a whole-
organism animal model, and means that infected haemocytes can fuse in the insect’s 
haemolymph (Fisher et al. 2012).   
The fruit fly D. melogaster has also been tested as a model host for Bt (Pilátová & Dionne 
2012). Bt E264 was highly virulent to D. melanogaster either by injection or by feeding; 
indeed this represents the first report of feeding Bp-group pathogens to an insect host. 
The study looked at fly survival and bacterial burden post-injection. 100% of flies injected 
with approximately 250 CFU died within 3.5 days post injection. Heat-killed bacteria did 
not cause any deaths. Bacterial burden in the fly rose slowly from 0-6 hours and then 
rapidly from 6-12 hours post-injection. Sterile Bt-conditioned medium was also lethal by 
injection, unless it was heat-treated, indicating that Bt secretes an exotoxin with activity 
against insects. Bt cells washed free of the conditioned medium were also lethal however. 
Bt mutants in T3SS-3 and T6SS-5, which are attenuated in murine models, did not show 
significantly different virulence compared to wild-type Bt in the fly model (Pilátová & 
Dionne 2012). After transfer onto Bt-laced food, at 24 hours the flies were apparently 
healthy but by 48 hours there was 50% mortality. Survivors at 48 hours which were 
transferred to control food still later died from the infection. Flies fed green fluorescent 
protein (GFP)-labelled Bt were dissected and imaged, and were observed to have 
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distended gut crops full of bacteria. Bacteria were not detected outside the gut (Pilátová & 
Dionne 2012).  
qRT-PCR was performed to analyse expression of host antimicrobial peptides (AMPs) 
(Pilátová & Dionne 2012). During the Bt infection all six of the tested AMPS were strongly 
induced. In addition, a rhodamine-based probe for phagocytosis was used and confirmed 
that haemocyte function was apparently normal at approximately 24 hours prior to fly 
death. Pilátová et al also reported a temperature effect on Bt infection in the fly, whereby 
median fly survival time increased from 2 days when maintained at 25°C to 20 days at 
18°C. At the lower temperature the bacterial numbers increased only slowly but shifting 
the temperature to 25°C caused host death within one or two days. 
1.3. Background to specific chapters of this study 
Invertebrate models including amoebae, nematodes and insects have been invaluable in 
the study of numerous bacterial pathogens. The Manduca sexta larva in particular is a 
well-characterised insect host which offers some beneficial differences compared to other 
invertebrate models of infection. Until recently there was negligible published evidence 
regarding the virulence of Bp-group pathogens in invertebrates; the publications 
discussed over the previous pages demonstrate a growing recognition of the potential 
value of these hosts for Burkholderia research.  
The aims of Chapter 3 were to confirm (or otherwise) the reported insect-virulence of Bt 
using the M. sexta host, and to place it in context by also comparing the virulence of Bp 
and Bo in M. sexta. 
The aim of Chapter 4 was to take advantage of the ease with which insect blood 
(haemolymph) samples can be collected from M. sexta to perform a time-course analysis 
of Bt infection in vivo. This would illuminate the progression of Burkholderia infection and 
help to characterise the M. sexta infection model, with a view to further development. 
Finally the aim of Chapter 5 was to screen a genome-wide Bp recombinant library against 
three invertebrate models (amoebae, nematodes and insects) in order to identify genomic 
regions containing putative virulence factors. This Rapid Virulence Annotation technique 
would allow the investigation of Bp virulence: (i) using an assumption-free approach; (ii) at 
containment level 2; and (iii) in practical, accessible and ethically sound host species. 
Putative virulence-related loci would then be confirmed and characterised further. 
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1.3.1. Chapter 3 - Burkholderia infection assays in Manduca 
sexta 
Host models of infection are an invaluable tool for the study of bacterial pathogens. 
Infection in a good model host mirrors that seen in the host of interest (e.g. humans) in 
terms of the level of virulence, the mechanisms of pathogenesis, and/or the similar 
attenuating effects of mutations in key genes. Therefore they provide a safe and suitable 
way to evaluate virulence of related species, potential attenuating mutations, or the 
protective effects of vaccine candidates.  
Model hosts of Burkholderia  
Mammalian models 
As discussed in the general introduction, Bp presents a considerable threat to human 
health. Several studies have used animal (mostly mammalian) infection models for Bp 
with a view to investigating melioidosis. Some data has come from guinea pig and goat 
models (Miller et al. 1948; Narita et al. 1982; Soffler et al. 2012), and recently a non-
human primate model of acute melioidosis via inhalational infection has been developed 
using the marmoset, Callithrix jacchus (Nelson et al. 2011). However by far the most-
established Bp models are mice, Syrian hamsters and infant diabetic rats, with the 
majority of recent work using BALB/c and C57BL6 mouse strains (Titball et al. 2008). 
Healthy rats are resistant to Bp infection but infant diabetic rats are susceptible, which 
mirrors the occurrence of human melioidosis, for which diabetes and other immune-
compromising conditions are a pre-disposing factor (Wiersinga et al. 2012). Bt and Bo 
infection have also been tested in the mouse and hamster models (DeShazer 2007). 
However, there is a high level of variability in the results from those three small mammal 
models: the susceptibility to infection and the pathogenesis of disease can vary greatly 
depending on the model used. Even within the same model, the route of infection, the 
dose, and the particular strain of Burkholderia can lead to varied results (Titball et al. 
2008). For example some Bp mutant strains that are attenuated in mice are fully virulent in 
the hamster model, indicating an unknown difference in the host-pathogen interaction 
between the two hosts (Chua et al. 2003; Titball et al. 2008). Certain characteristics in 
each model reflect particular aspects of human melioidosis, but it is not certain whether 
which (if any) of them reflects the human disease best. As such, the current thinking is 
that the best approach may be to use multiple different animals to model different aspects 
of melioidosis (Titball et al. 2008). Therefore there is still a need to investigate and 
characterise novel models of Burkholderia infection. Table 1.1 indicates the virulence of 
Bp-group pathogens in human clinical cases and in various experimental mammalian 
hosts. 
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Table 1.1 Virulence of Burkholderia species in human clinical cases and experimental mammalian models. Cell colour denotes virulence (red), attenuation or contrasting results 
(orange), reported avirulence (green), or no data (blank). Table continued overleaf. 
 Bp Bm Bt Bo 
Human 
Virulent: Environmental, can infect 
humans (usually immuno-
compromised, e.g. diabetic).  Mortality 
rate 40%  in Thailand, 14% in 
Australia (Wiersinga et al. 2012) 
Virulent: persists in equine hosts 
but can pass to humans. 50% 
mortality rate with antibiotic therapy 
(Balder et al. 2010) 
Generally avirulent: Environmental, 
some clinical isolates from soil-
contaminated wounds, one from 
near-drowning (Glass, Gee, et al. 
2006) 
Generally avirulent: Environmental, 
two clinical isolates from soil-
contaminated wounds (Glass, 
Steigerwalt, et al. 2006) 
Mouse 
BALB/c 
Virulent: Intraperitoneal median lethal 
doses (MLD) 14 - 5750 CFU. 
Intranasal MLD 5-20 CFU. Model for 
acute melioidosis (Titball et al. 2008; 
Smith et al. 1997) 
Virulent 
(Fritz et al. 2000; Lever et al. 2003; 
DeShazer et al. 2001) 
Highly attenuated or avirulent: 
intraperitoneal MLD >10^7 CFU. 
Intranasal MLD >10^4 CFU. Bt 
CDC 272 avirulent (Titball et al. 
2008; DeShazer 2007) 
Avirulent: intraperitoneal MLD 
>10^7 CFU (DeShazer 2007) 
C57BL6 
Virulent: host is much more resistant 
than BALB/c mice (intraperitoneal). 
Used to model chronic melioidosis 
(Titball et al. 2008; Ulett et al. 2005; 
Leakey et al. 1998; Conejero et al. 
2011) 
   
Rat 
Virulent: by intra-tracheal route. Only 
infant diabetic rats susceptible intra-
peritoneally (Van Schaik et al. 2008; 
DeShazer 2007; Woods et al. 1993; 
Brett & Woods 1996) 
Avirulent (Fritz et al. 2000) 
  
Hamster 
Virulent: host is highly susceptible. 
Used to model acute melioidosis 
(DeShazer 2007; Warawa & Woods 
2005; Tuanyok et al. 2006) 
Virulent (Galyov et al. 2010; Fritz et 
al. 1999; Ulrich & Deshazer 2004; 
DeShazer et al. 2001) 
Most strains virulent at >10^5 CFU. 
Bt CDC 272 avirulent (Brett et al. 
1997; DeShazer 2007) 
Avirulent (no data presented) 
(DeShazer 2007) 
Guinea pig 
Virulent: Used for many early 
experiments to characterise Bp (Miller 
et al. 1948; Whitmore 1913) 
 
Virulent: Used for many early 
experiments to characterise Bm. 
Variable host susceptibility (Miller 
et al. 1948; Whitmore 1913; Fritz et 
al. 2000) 
 
Avirulent (no data presented) 
(DeShazer 2007) 
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 Bp Bm Bt Bo 
Horse 
 
Virulent (Lopez et al. 2003) 
  
Pig 
Virulent at very high dosage, causing 
chronic infection (Najdenski et al. 
2004) 
   
Goat 
Virulent: model not used since 1982 





Virulent (Yeager et al. 2012; W. R. 










(Manzeniuk et al. 1999)    
Gorilla 
Virulent: host is highly susceptible 
(Yap et al. 1995) 
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Invertebrate models 
Invertebrate models of Bp and Bt have increasingly been developed and adopted, 
particularly within the last two years (Schell et al. 2008; Wand et al. 2011; Hasselbring et 
al. 2011; Ooi et al. 2012; Fisher et al. 2012; O’Quinn et al. 2001; Gan et al. 2002; Pilátová 
& Dionne 2012). Table 10 indicates the virulence of Bp-group pathogens in various 
experimental non-mammalian hosts. Amoebae including several Acanthamoeba species 
and the social amoeba Dictyostelium discoideum are susceptible to infection and 
intracellular replication by Bp (Inglis et al. 2000; Hasselbring et al. 2011). Similarly, the 
nematode C. elegans is susceptible to Burkholderia species including Bp, Bt, and Bm 
(O’Quinn et al. 2001). Some studies have probed the mechanisms by which Bp causes 
pathogenesis in the nematode (Ooi et al. 2012; Lee et al. 2011; O’Quinn et al. 2001; Gan 
et al. 2002). 
Insect species from the lepidopteran, coleopteran and dipteran orders are also susceptible 
to infection following injection with Burkholderia. Bp has been shown to be virulent in the 
wax worm (the larva of Galleria mellonella) and the Madagascar hissing cockroach 
Gromphadorhina laevigata (Schell et al. 2008; Wand et al. 2011). Bt was also tested and 
exhibited virulence in those models, as well as in the fruit fly Drosophila melanogaster 
(Pilátová & Dionne 2012). Bm is also virulent in G. mellonella and in the cockroach (Wand 
et al. 2011; Fisher et al. 2012). Bo has only been tested for insect virulence in G. 
mellonella, and was not found to be virulent (Wand et al. 2011).  
To date, the most widely used Burkholderia insect model has been the G. mellonella 
larva. As discussed in the main introduction, there are numerous reasons to support the 
use of insect models as a proxy for or in addition to mammalian infection models. These 
include mechanistic and genetic similarities in the insect and mammalian innate immune 
systems, and practical issues including reduced regulatory restrictions. In addition, there 
are fewer ethical issues surrounding the use of invertebrates and indeed their use 
represents a step towards the replacement, refinement and reduction (3Rs) of ‘protected’ 
animals in research (Balls et al. 1995). Table 1.2 indicates the virulence of Bp-group 
pathogens in various experimental non-mammalian hosts. 
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Table 1.2. Virulence of Burkholderia species in experimental non-mammalian models. Cell colour denotes virulence (red), attenuation or contrasting results (orange), avirulence 
(green), or no data (blank). Purple cells denote possible symbiosis or vector relationships. Table continued overleaf.  





A possible symbiotic 
relationship with limited 
damage to host or Bp (Inglis 
et al. 2000) 
      
Dictyostelium 
discoideum 
Resistant to predation, able 
to survive intracellularly 
(Hasselbring et al. 2011) 
Resistant to predation, able 
to survive intracellularly 
(Hasselbring et al. 2011) 
    
Nematode C. elegans 
Virulent  
(Ooi et al. 2012; Lee et al. 
2011; Gan et al. 2002; 
O’Quinn et al. 2001) 
Conflicting reports: virulent 
(Gan et al. 2002), avirulent 
(O’Quinn et al. 2001)  
Virulent (Gan et al. 2002; 
O’Quinn et al. 2001) 
  
Insect 
Fruit fly     
Virulent  




Virulent: except strain 708a 
(Schell et al. 2008; Wand et 
al. 2011) 
Virulent (Schell et al. 2008) 
Virulent: but attenuated 
compared to Bp. ~35% killed 
by >10^5 CFU (Schell et al. 
2008; Wand et al. 2011) 
Attenuated compared to Bt 
(Wand et al. 2011) 
Cockroach 
Virulent: 50% lethal dose 
(LD50) <10 CFU (Fisher et 
al. 2012) 
Virulent: LD50 <10 CFU. 
Killed more slowly than Bp or 
Bt (Fisher et al. 2012) 
Virulent: LD50 <10 CFU 
(Fisher et al. 2012) 
  
Flea 
Virulence unknown: but able 
to transmit Bp to guinea pigs 
(Blanc & Baltazard 1949) 
      
Mosquito 
Virulence unknown: but able 
to transmit Bp to guinea pigs 
(Blanc & Baltazard 1949) 
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 Bp Bm Bt Bo 
Arachnid Tick  
Virulence unknown: but able 
to contract Bp from infected 
rabbits (Kharbov et al. 1981) 
      
Plants and Fungi 
Plants 
Tomato plant Virulent (Lee et al. 2010)   Virulent (Lee et al. 2010)   
Rice Avirulent (Lee et al. 2010)   Avirulent (Lee et al. 2010)   
A. thaliana Avirulent (Lee et al. 2010)   Avirulent (Lee et al. 2010)   
Fungal spores G. decipiens 
Virulence unknown: 
colonises germinating 
spores (A. Levy et al. 2003) 
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Rationale behind Manduca sexta as a potential model host for 
Burkholderia 
A substantial body of work has successfully used lepidopteran larvae to model bacterial 
infections, and the lepidopteran immune system has been studied for over 50 years now 
(Stephens 1962). As discussed in the main introduction, data from these models cover all 
aspects of their biology including the host-pathogen response. This considerable existing 
knowledge complements the practical advantages offered by these hosts. 
Ecological relevance  
As Burkholderia are environmental bacteria occupying a range of habitats and lifestyles, 
there are also interesting evolutionary and ecological reasons to investigate the outcomes 
of their interactions with invertebrates, as discussed in the main introduction. Burkholderia 
are well known for their close associations with plants, as are invertebrates. Studies have 
revealed that Bp uses flagellum-mediated phagocytosis to enter amoebae (Inglis et al. 
2003), that Bp and Bt kill C. elegans probably via a combination of toxin release and 
active mechanisms (Day & Sifri 2012), and that Bp-group pathogens are virulent in 
several insect species (Fisher et al. 2012; Wand et al. 2011; Schell et al. 2008; Pilátová & 
Dionne 2012). 
Advantages over the Galleria mellonella infection model 
Despite the relatively wide use of the G. mellonella lepidopteran model, the Manduca 
sexta model offers some significant advantages. For a start, M. sexta is more 
physiologically tractable due to its larger overall size, numerous haemocytes, and greater 
volume of haemolymph. With last instar M. sexta larvae reaching weights of 10-12 g, 
haemolymph volumes up to or in excess of 1 ml can be collected from each larva, 
containing approximately one million haemocytes (Kanost et al. 2004). G. mellonella last 
instar larvae, by comparison, weigh around 250 mg and yield correspondingly lower blood 
volumes (Ramarao et al. 2012). Bacteria-infected M. sexta larvae often survive for longer 
than G. mellonella equivalents. Unpublished results (Waterfield lab) suggest that 
differences in virulence between various Bacillus cereus strains and also of different 
Staphylococcus aureus mutants can be masked in G. mellonella due to rapid 
“septicaemia” infection dynamics. These differences become apparent when using the 
larger and more resilient M. sexta host to compare the same strains. The slower infection 
kinetic probably reflects the larger size of the organism and its corresponding availability 
of resources. There could also be important differences between the immune systems of 
the two lepidopteran hosts which are as yet unknown.  
It should be noted that G. mellonella larvae are usually purchased from external suppliers 
(for fishing bait or reptile food) and as such their growth conditions and health are 
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unknown and cannot be controlled by the researcher. Conversely, at Bath a staged M. 
sexta colony is maintained in-house under tightly-controlled environmental and hygiene 
conditions. Light, heat and humidity are regulated, as is the artificial Manduca diet which is 
supplemented with antibiotics and formaldehyde to prevent unwanted microbial 
contamination of the colony. The M. sexta are monitored daily as they develop from 
hatchlings (neonates) through to later larval instars and finally pupae and moths. The 
ability to produce experimental cohorts all of the exactly the same age and developmental 
stage is also a distinct advantage for infection and immunity studies. Furthermore this 
colony has been in-bred and maintained since 1981 which means the individuals will be 
genetically highly homogenous.   
Another consideration is that G. mellonella are supplied at the wanderer stage of 
development, i.e. after they cease feeding. While that is convenient for short-term storage 
of the insects, a disadvantage is that in order to infect these larvae orally they must be 
force-fed – a process which is anecdotally unreliable. M. sexta larvae can be easily used 
for feeding assays by simply lacing the normal diet with bacteria or toxin samples. Young 
neonate stage larvae are thought to be best suited to use in feeding assays as even 
potent Photorhabdus insecticidal toxins exhibit little or no oral toxicity in older (e.g. fifth 
instar) larvae (Waterfield et al. 2001; Waterfield et al. 2005). This presumably relates to 
the immaturity of the neonate gut compared to later developmental stages, by which time 
the gut has become a frontline for antimicrobial defence (Pauchet et al. 2010).  
Finally, while a G. mellonella transcriptome has recently been published (Vogel et al. 
2011), there is currently a greater availability of research tools for M. sexta. These include 
transcriptomes relating to immunity (Zou et al. 2008), the antennae (Grosse-Wilde et al. 
2011), and the larval midgut which is critical for detoxification and defence mechanisms 
(Pauchet et al. 2010). There is a complete sequenced mitochondrial genome (Cameron & 
Whiting 2008). The genome of M. sexta itself has been fully sequenced by the Tobacco 
Hornworm Genome Project (https://www.hgsc.bcm.edu/content/tobacco-hornworm-
genome-project), available at: http://www.ncbi.nlm.nih.gov/assembly/382238/. 
Further background to Chapter 3 
To test the validity of the M. sexta model for Burkholderia infection, several strains were 
tested by injection and by feeding to larvae.  
Assessing Burkholderia virulence in Manduca sexta 
Bt E264 is the fully sequenced Bt type strain and was originally an environmental isolate 
(Brett et al. 1998). Bp K96423 is fully sequenced and is among the most studied of the Bp 
strains. It was a clinical isolate from Thailand (Holden et al. 2004). The Bt strains CDC 
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2721121 and CDC 3015869 (abbreviated elsewhere to CDC 272 and CDC 301) are 
atypical Bt strains in several regards (Glass, Gee, et al. 2006).  
Bt is usually described as avirulent in humans but CDC 272 and CDC 301 are rare clinical 
isolates from humans. Both were also isolated in the USA, whereas most Bt strains are 
isolated in Southeast Asia or Northern Australia. Bt CDC 301 is considered the most 
convincing case for human infection with Bt, isolated from an infant after a near-drowning 
incident. Bt CDC 272 was isolated from a pleural wound in an elderly man. Interestingly, a 
genomic approach using either multi-locus sequence typing (MLST) or array-based 
comparative genomic hybridisation (aCGH) clusters both these strains into a phylogenetic 
sub-group distinct from the ancestral Bt population. Although the two are phylogenetically 
very closely related, Bt CDC 301 encodes and expresses a Bp-like capsular 
polysaccharide (CPS) gene cluster which is absent from almost all characterised Bt 
strains including CDC 272 (Sim et al. 2010). One other strain in the Bt outlier group, Bt 
E555, also possesses this ‘Bp-likeCPS’ gene cluster. Experimental evidence from Bt E555 
with and without deletion of the Bp-likeCPS cluster indicated that the CPS is required for 
intracellular survival in RAW macrophages (Sim et al. 2010). This importance has not 
borne out in mammalian models though; relative to Bt E264, Bp-likeCPS strains did not 
display greater virulence in mouse or hamster models (Sim et al. 2010). In C. elegans Bt 
E555 was slower to kill than E264 was, but a CPS KO E555 strain was further attenuated, 
suggesting that the CPS cluster is somehow involved in nematode killing. It has therefore 
been proposed that the acquisition of the Bp-likeCPS by Bt strains may have conferred a 
selective advantage not in terms of mammalian infection but in terms of surviving 
environmental challenges (Sim et al. 2010). 
Bo was discovered following isolation from human clinical infections yet, like Bt, Bo is 
usually described as avirulent to humans and other tested mammals. Only two strains 
exist – Bo C6786 and Bo E0147 – which were both recovered from severe injuries that 
were extensively contaminated with soil (Glass, Steigerwalt, et al. 2006; McCormick et al. 
1977; Nussbaum et al. 1980).   
Testing attenuated Bt mutants in Manduca sexta 
Mutant Bt strains which have been demonstrated to be attenuated in other infection 
models can also be compared in the M. sexta model in order to confirm whether it shows 
the same attenuation effect. Two mutant strains were available: a surA mutant and a 
Twin-Arginine Transport (TAT) system mutant. 
In E. coli the SurA protein is a well characterised parvulin; that is, it exhibits peptidyl-prolyl 
isomerase (PPIase) activity (which catalyses the isomerisation of proline peptide bonds) 
and it is also a chaperone protein, aiding the correct folding and assembly of outer 
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membrane proteins such as OmpA (www.uniprot.org). It is also required for pilus 
construction (Watts & Hunstad 2008). SurA has recently also been implicated in the 
virulence of E. coli, Salmonella and Shigella species (Behrens-Kneip 2010). Homologues 
were identified in Bp K96423 and Bt E264 (Norville 2011). A non-polar deletion mutant of 
the Bt E264 surA gene (Bt ΔsurA) resulted in attenuated virulence in the G. mellonella 
model; challenge of 102 or 103 CFU resulted in a significantly increased time to death 
compared to wild-type (Norville 2011). Cell line assays with J774.A macrophages and 
A549 epithelial cells also showed significantly reduced intracellular growth at 24 hours 
post-infection. The reduction in virulence is believed to be due to pleiotropic effects on the 
outer membrane, reducing overall fitness and virulence under certain stresses (I. Norville, 
unpublished).  
The TAT pathway enables the transport of fully folded proteins across membranes. In 
bacteria TAT systems are prevalent in the cytoplasmic membrane and many proteins 
transported by them are involved in important homeostasis and pathogenesis functions 
(Sargent 2007; Stevenson et al. 2007). In Bp, factors transported via the TAT system 
include the haemolytic virulence factor phospholipase C. The enzyme is transported via 
TAT into the periplasm ready for export out of the cell via the type II secretion system 
(Vasil et al. 2012). A conditional mutant of the Bt E264 TAT system (Bt prhA:tatA) was 
reported to show attenuation in G. mellonella (S. Wagley, unpublished). In this conditional 
mutant the TAT system is under the control of a rhamnose-inducible promoter: when 
grown in the presence of rhamnose the system is active; when rhamnose is substituted 
with glucose the system is inactivated. It can therefore be used as an experimental tool.  
Feeding Burkholderia to Manduca sexta 
Finally, the effect of Burkholderia infection via the digestive route can be investigated, 
taking advantage of the ability to feed M. sexta. Until very recently the Burkholderia 
invertebrate infection models all used direct injection as the infection route. However, the 
most common natural route of Burkholderia infection is more likely to be via the digestive 
tract following ingestion of contaminated plants or detritus. Therefore it was of interest to 
investigate the effect of feeding Bt and Bo strains to M. sexta larvae. At the time that this 
work was conducted no results had been published regarding the effects of infecting 
insects with Burkholderia via the oral route. Very recently, a Drosophila melanogaster 
model has been used for this purpose (Pilátová & Dionne 2012) and the results will be 
compared in the discussion. 
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1.3.2. Chapter 4 - In vivo time-course of Burkholderia insect 
infection and pathogenesis 
Dose response virulence assays indicate which strains are more virulent relative to others 
in terms of how quickly (or whether) morbidity or mortality occurs, as judged by external 
signs. For more insight into mechanisms of bacterial pathogenesis, two types of 
experimental systems are typically used: in vitro cell culture models and in vivo infection of 
whole organisms.  
Monolayer cell cultures provide many useful insights, with fewer additional variables 
complicating the interpretation of results. Most discoveries regarding the cellular and 
molecular pathogenesis of Bp have come from such models, particularly RAW 264.7 cells 
(mouse leukaemic monocyte macrophages) or J774A.1 cells (BALB/c mouse monocyte 
macrophages). However, homogeneous cell culture models cannot reflect the full 
complexity of in vivo infection. The complete effects of the immune response and inter-
linked pathways are lost. Therefore whole organism models are an invaluable supplement 
to cell culture models, and vice versa.  
In whole-organism models, samples may be taken for analysis during the infection (e.g. 
blood samples) or post-mortem (e.g. dissection and examination of organs). Examining 
the location and number of bacteria, pathological effects on cells and tissues, or gene 
expression from bacteria or host all help to complete the picture of pathogenesis. For 
instance, as already discussed, Burkholderia pathogenesis hallmarks can include actin-
remodelling, multi-nucleated giant cell (MNGC) formation, and apoptosis of host cells. 
With cellular labelling or staining, these physical hallmarks are visible under the 
microscope. 
Case study: a murine Bp infection time-course  
Despite growing knowledge regarding Bp pathogenicity at the molecular level, it has been 
noted that there still remains a paucity of information about how Bp actually interacts with 
a host to elicit melioidosis symptoms (Chin et al. 2010). To address this need Chin et al 
examined the status of bacterial load and host leukocytes at time-points during a BALB/c 
mouse model of acute melioidosis. Parallel host gene expression profiling revealed that a 
range of innate immune mechanisms were activated within 24 hours of infection. At 16, 24 
and 42 hours after infection with Bp D286 (1.1x103 CFU) the bacterial load was evaluated 
in the spleen and liver, both of which contained increasingly high numbers of Bp (103-105 
CFU/organ). Viable Bp cells were also detected in the blood (102-103 CFU/ml), indicating 
acute septicaemic melioidosis. Changes in the proportions of different types of leukocytes 
were observed, with the ratio of neutrophils to lymphocytes increasing throughout the 
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infection. The increase in number of neutrophils indicated the involvement of the innate 
immune response (Chin et al. 2010).  
Case study: Bp pathogenesis in a cockroach model  
Invertebrates possess phagocytic cells known as haemocytes (HCs). A recent cockroach 
model of Bp infection used haemolymph samples taken at the point when the insects were 
judged to be near to death (up to a maximum of 48 hours post-infection) (Fisher et al. 
2012). For the first time, it was reported that HCs from the haemolymph of infected insects 
harboured numerous intracellular Bp bacteria and that some had formed MNGCs despite 
being non-adherent in the insect’s open circulatory system. Bacteria were also observed 
extracellularly in the haemolymph, though it was noted that it was unclear whether they 
were alive or dead, or just released from lysed cells. The authors suggested that Bp 
survives in an intracellular niche within the cockroach; infected HCs fuse with other HCs to 
enable continued bacterial replication, and eventually the bacterial load in the cells and 
haemolymph may overwhelm the insect (Fisher et al. 2012). 
Visible signs of Burkholderia cellular pathogenesis 
Actin remodelling 
Bp-group pathogens exhibit an ability to remodel the actin of a host cell (Stevens et al. 
2006). Actin-based motility is achieved when the bacterium recruits host actin monomers 
to build a ‘tail’-like projection; the bacterium remains at the extreme end of the actin tail 
(also known as comet tails), effectively being propelled within or out of a host cell (see 
panel B of Figure 1.6).  
Figure 1.6. Characteristic MNGCs and actin tails are visible in infected RAW 264.7 murine macrophage 
culture. Panel A: MNGCs are evident as multiple blue-stained nuclei within single large cells. Panel B: Many 
actin tails (red) propel B. pseudomallei bacteria (green) around macrophage cells (nuclei stained blue).  
Images reproduced from Galyov (2010).  
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Actin-based motility was believed to be the mechanism by which Bp primarily spreads 
from one host cell to another, until it was found that actin remodelling-defective mutants 
were able to spread to other cells (French et al. 2011). It is now accepted that optimal 
intercellular spread involves a combination of cell fusion and actin-based motility (Galyov 
et al. 2010). The T6SS-1 appears to be involved in that process, perhaps with unknown 
‘fusogenic’ factors (French et al. 2011). Motility within the cell increases the likelihood of 
contact between the bacteria and the host cell membrane, which can lead to cell-cell 
fusion. Studies in HEK293 human embryonic kidney cells revealed an interesting 
difference between the motility of Bp and Bt. Bp requires actin-based motility for 
intracellular propulsion but Bt has no absolute requirement for either actin polymerisation 
or membrane protrusion as it possesses a secondary flagellar system which enables rapid 
intracellular motility (French et al. 2011). Nonetheless, actin remodelling is a distinctive 
characteristic of Burkholderia infection and formation of actin tails is a sign of bacterial 
pathogenesis within the host.   
Multi-Nucleated Giant Cells (MNGCs) 
Cell fusion leads to the formation of MNGCs (also seen in Figure 1.6), which occur in 
clinical melioidosis infections and have been demonstrated to occur in vitro in phagocytic 
and non-phagocytic cell lines (Kespichayawattana et al. 2000). Bp, Bm and Bt are all able 
to induce MNGCs (Boddey et al. 2007; Burtnick et al. 2011; Harley et al. 1998; Pilatz et al. 
2006; Suparak et al. 2005; Utaisincharoen et al. 2001). The exact role of MNGCs in 
melioidosis or glanders is not fully understood but they must enable the bacteria to access 
more nutrients and space for replication without leaving the safety of the cell, and thereby 
avoiding the immune system (Galyov et al. 2010). 
MNGC formation by Bp has been discovered to be linked to a type VI secretion system 
(T6SS-1) – in particular to a surface-associated component, Hcp1 (Pilatz et al. 2006; 
Burtnick et al. 2011; French et al. 2011). A Bp hcp1 mutant strain was able to multiply to 
high numbers in the cytosol of RAW 264.7 cell monolayers but no fusion with adjacent 
cells occurred (Burtnick et al. 2011). Interestingly, Burtnick et al noted that no MNGCs 
were observed in their hamster model of melioidosis at 48 hours post-infection. They 
suggested that the rapidity of death in the hamster (an acute model of melioidosis) may 
limit the possibilities for identifying MNGCs in infected tissues (Burtnick et al. 2011), yet as 
described above, MNGCs have been reported within 48 hours post-infection in a 
cockroach model (Fisher et al. 2012).  
Apoptosis / cell death 
Apoptosis of host cells has been observed during Bp and Bt infection of either phagocytic 
or non-phagocytic cell lines – single cells and MNGCs both show condensed or 
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fragmented nuclei characteristic of apoptosis (Kespichayawattana et al. 2000; Burtnick et 
al. 2011). Kespichayawattana et al (2000) reported their findings for ‘virulent Ara-‘ and 
‘non-virulent Ara+’ strains, which are now known to be Bp and Bt species respectively 
(Smith et al. 1997; Brett et al. 1998; Kespichayawattana et al. 2000); Bp infection resulted 
in approximately double the proportion of apoptotic J774A.1 cells at six hours (43%) 
compared to Bt (23%). Figure 1.7 shows bright condensed nuclei in the remnants of a 
large MNGC (Burtnick et al. 2011). 
Figure 1.7. RAW 264.7 cells infected with Bp show signs of cell death: these multi-nucleated cells show 
extensive cell damage and some bright nuclei. Scale = 20 μm. Image reproduced from Burtnick et al (2010). 
 
In the first identification of a Bp factor that mediates apoptosis of host cells Suparak et al. 
(2005) found that MNGC formation and apoptosis are linked to a T3SS translocator 
protein, BipB. A polar deletion mutant of bipB was attenuated in a mouse model. It also 
resulted in reduced MNGC formation, cell-to-cell spreading and apoptosis in J774A.1 cells 
(Suparak et al. 2005). It is likely that a T3SS-secreted effector mediates the effects. In the 
bipB mutant the BopE T3SS effector was still secreted but other factors may have been 
affected by the polar mutation. For example a T3SS effector (CHBP: cycle inhibiting factor 
in Bp) was recently discovered to cause macrophage-specific apoptosis (Yao et al. 2012). 
Dowling et al (2010) reported that crude lysate from E. coli expressing 15kb of Bp genome 
caused MNGC formation and apoptosis in J774-2 macrophage-like cells (Dowling et al. 
2010). Within that region were putative toxin encoding genes (bpsl0590-91), although the 
effect was not confirmed to be due to those genes. 
Manduca sexta cellular immunity 
The cellular immune response of M. sexta to bacterial infection has been extensively 
studied. Cellular defences including phagocytosis, nodule formation and encapsulation 
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around invading organisms are mediated by HCs (Strand 2008). Insect HCs are 
heterogeneous populations; different subtypes exhibit different cell morphologies and 
functions. Two main populations most relevant for the immune response against microbial 
pathogens are plasmatocytes and granulocytes (or granular cells), which constitute up to 
95% of all HCs in lepidopteran larvae (Nardi et al. 2003). Granulocytes are the most 
abundant HC type in M. sexta and function as professional phagocytes, akin to 
mammalian neutrophils. Plasmatocytes are responsible for forming capsules around 
foreign bodies that are too large to be engulfed, such as nematodes (Strand 2008). M. 
sexta hyperphagocytic (HP) cells resemble large granulocytes and can each engulf up to 
500 bacteria (Dean et al. 2004). Although they only account for 1% of the circulating HC 
population, in experimental assays HP cells are reported to sequester the majority of heat-
killed bacteria (Strand 2008). In terms of morphology, granulocytes and plasmatocytes are 
rounded when circulating in the haemolymph and spread when bound to foreign surfaces 
(e.g. microscope slides). As shown in Figure 1.8, granulocytes and HP cells spread 
symmetrically (panel A) whereas plasmatocytes spread asymmetrically and more 
extensively (panel B). 
Figure 1.8. Confocal microscopic images of Manduca sexta haemocytes (Strand 2008). Panel A: Small 
granulocytes  and larger, spreading plasmatocytes (PL = plasmatocytes, GR = granulocytes ). Panel B: An 
aggregate of haemocytes including several hyperphagocytic cells (containing dense masses of E. coli, 
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1.3.3. Chapter 5 - Rapid Virulence Annotation of Burkholderia 
pseudomallei  
Rapid Virulence Annotation (RVA) is a technique developed by Waterfield et al (2008) to 
identify virulence factors of bacterial pathogens. The technique is an assumption-free 
approach; instead of targeting specific loci predicted to have an effect, RVA uses 
heterologous expression of relatively small genome fragments in an E. coli host strain. 
The cosmid- or fosmid-bearing E. coli clones are tested in a range of bioassays to look for 
any “gain of toxicity” (GOT) compared to the non-recombinant E. coli host strain. This 
means that quite subtle effects (or effects which are complemented by other genes in a 
complete genome) can be identified, whereas they may go unnoticed in approaches which 
mutate single genes (the effects of which may be masked by redundancy of virulence 
factors). In order to assess the whole genome, a large library of clones is used. The clone 
library is produced by shearing genomic DNA of the pathogen and ligating fragments of a 
certain size range into a fosmid vector. With a sufficiently large library the clones’ inserts 
overlap to cover the pathogen genome with several-fold redundancy.  
Rather than just one bioassay, RVA uses multiple model hosts from diverse taxa. The 
original RVA (of Photorhabdus asymbiotica) used four hosts: amoebae, nematodes, 
insects and a mammalian macrophage cell line, coining the terms aGOT, nGOT, iGOT 
and mGOT respectively. There are several reasons behind this selection of hosts. All are 
relatively inexpensive in terms of cost and space requirements, and have short life cycles. 
Three are whole organisms, which allows for effects to be studied in context with relevant 
host interactions in place. The fourth, although only a cell line, added a direct relevance to 
mammalian hosts. The different models give insights into different infection routes: direct 
inoculation and “blood”-borne infection in the insect; via the digestive route in the 
nematode; via engulfment by the amoebae (which has direct parallels to the engulfment of 
bacteria by professional phagocytes such as macrophages); and direct application of 
crude cellular lysates to the macrophage cell line. Finally, comparing positive ‘hits’ 
between the various GOT models gives insights into host-specific factors versus those 
with a less restricted general role in virulence.  
Previous RVA analyses 
Successful RVA screening results have previously been published for the insect pathogen 
and emerging human pathogen P. asymbiotica (Waterfield et al. 2008), and RVA-style 
analyses have also been applied to its close relative P. luminescens (unpublished). Both 
Photorhabdus species exist in symbiotic relationships with Heterorhabditid nematode 
hosts; the bacteria are vectored into an insect by the nematode whereupon they rapidly 
kill the insect by lethal septicaemia. Unlike P. luminescens, P. asymbiotica has 
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increasingly been recognised as a causative agent of invasive soft tissue infections and 
disseminated bacteraemia in humans (Gerrard et al 2006). As a result of the RVA study, 
21 discrete regions of the P. asymbiotica genome were identified as containing virulence 
determinants. These regions were identified by the clustering and overlapping of the 
inserts from GOT positive clones. Particular loci were narrowed down further based on the 
region of minimum genetic overlap between overlapping positives. The results 
successfully confirmed known virulence-related genes such as the toxin mcf1 (makes 
caterpillars floppy). Other factors included seven putative secretion systems, three 
operons for pili/fimbriae, TC (Toxin-Complex) insecticidal toxins, and ten polyketide 
synthases and non-ribosomal peptide synthetases (PKSs/NRPSs) (Waterfield et al. 2008). 
PKSs and NRPSs produce secondary metabolites including toxins, siderophores, 
pigments, antibiotics and immune-suppressants. Virulence-related genes encoding these 
types of small molecules are of particular interest as potential antibiotic or anti-virulence 
targets. Among RVA-style results from P. luminescens was the identification of a putative 
lipase pdl1 which was recently reported to enhance secretion of TC toxins (Yang et al. 
2012). Three Pseudomonas syringae pathovars were also probed with RVA using 
invertebrate hosts, leading to the identification of genes for a type 6 secretion system 
(T6SS), a TC toxin and flagellar proteins amongst others as being important for Ps. 
syringae virulence against invertebrates (Dorati 2011). 
The basis and methodology of RVA   
The rationale behind RVA is that E. coli laboratory strains such as K12 (from which the 
host strain for the clone library is derived) are harmless to the invertebrate hosts. In fact 
the amoebae and nematodes readily feed upon these E. coli. The insect immune system 
can efficiently cope with E. coli injected into the haemocoel, as is discussed in Chapter 4. 
Therefore if the addition of a small region of pathogen DNA causes an E. coli clone to 
have a harmful effect upon the insect or to resist predation by the amoebae or nematodes, 
then this gain of toxicity can be attributed to the effects of the insert DNA. End sequencing 
of the library allows knowledge of which genomic fragment is contained within the insert to 
be derived. A positive screening result can therefore be linked to a particular region of the 
pathogen’s genome.  
The fosmid library used for this Bp RVA was constructed at the Sanger Institute for Prof. 
Rick Titball (University of Exeter) and consists of E. coli bearing approximately 35-40 kb 
inserts from the Bp K96423 genome. The three invertebrate model hosts are the free-
living amoeba Acanthamoeba polyphaga, the nematode Caenorhabditis elegans and the 
larva of the lepidopteran insect Manduca sexta. How toxicity is assessed depends on the 
nature of the GOT screen. The insect (iGOT) screen involves direct injection of bacterial 
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culture into the haemocoel and larvae are subsequently assessed for signs of morbidity 
such as slow development, reduced feeding, melanisation or death. The amoeba (aGOT) 
and nematode (nGOT) assays present the bacterial mat as a food source to 
approximately one-thousand amoebae or ten adult nematodes, and the time taken for the 
mat to be consumed is monitored. A delay in feeding suggests the presence of toxic or 
repellent factors. RVA screens are relatively high-throughput so each clone is tested once 
initially. Positive-scoring clones are then re-tested with replicates. Finally the genomic loci 
corresponding to positive clones are calculated and loci found in multiple overlapping 
positive clones are shortlisted for further investigation. A typical next step is then to mutate 
a positive clone with transposon insertions across the full insert region and re-test the 
mutants to pin-point the precise gene(s) responsible for the GOT phenotype. 
Although the term ‘toxicity’ is used, a positive result from GOT assays could also be due 
to host reactions. For instance, in iGOT a strong immune reaction will give the 
appearance of insect illness (e.g. melanisation or slow development) but could be caused 
by an immunogenic factor which has no direct role in virulence. In aGOT and nGOT there 
can be multiple explanations for slow consumption of bacteria. True toxic factors could kill 
or paralyse the host or prevent their reproduction, or could have an “anti-predation” 
repellent effect which prevents consumption in the first place. In another scenario the 
hosts do consume the bacteria to some extent but a growth advantage has been 
conferred to the bacteria that allows them to out-grow the rate of consumption. 
Nonetheless, positive hits from any of these scenarios could give informative insights into 
bacterial virulence and the host-pathogen interaction. 
Why apply RVA to Bp? 
As already discussed, Bp is an opportunistic human pathogen of considerable clinical 
importance and represents a potential terrorist bio-threat. Much effort has gone into 
understanding its pathogenesis and numerous virulence factors have been identified. 
However, with researchers using different Bp strains and different model hosts, studies 
have often given contradictory results as to the importance of various factors. The picture 
of Bp virulence is therefore still confusing and further efforts are needed to improve our 
understanding of this important pathogen. The status of Bp as a containment level 3 (CL3) 
pathogen certainly limits the ease with which it can be investigated, and for that reason Bt 
is often used as a proxy for Bp. A major benefit of the recombinant fosmid library system 
is that it allows the genome of Bp strain K96243 to be investigated under CL2 laboratory 
conditions.  
Furthermore, the use of invertebrate models for Bp is appropriate due to the bacterium’s 
soil-dwelling saprophytic lifestyle. The extent to which Bp associates with organisms such 
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as amoebae and nematodes in the environment has not been thoroughly studied but they 
are certain to encounter one another frequently. It is highly likely that they are engaged in 
co-evolutionary arms races. These invertebrate models are also suited to the RVA 
analysis of Bp because they are all susceptible to infection by the bacterium; according to 
published findings (Inglis et al. 2000; Gan et al. 2002; Ooi et al. 2012) and as discussed in 
Chapter 3, M. sexta larvae, A. polyphaga and C. elegans are all killed by (or at least 
cannot predate) Bp. 
Previous invertebrate models for Bp virulence factor discovery 
Previous approaches for the identification of Bp virulence factors have taken advantage of 
invertebrate hosts. Genes of Bp strain KHW were mutated by transposon insertion and 
the mutants were tested in the C. elegans system (Gan et al. 2002). Of 3,400 mutants, 39 
exhibited reduced lethality towards the nematode; after eliminating mutants in which the 
reduced killing phenotype was due to debilitation of the bacteria, five attenuated mutants 
remained. The mutants had insertions in genes for hypothetical proteins, an amino acid 
transporter and a sugar ABC transporter. The virulence of those mutants was comparable 
between a BALB/c mouse model and the C. elegans killing assay, validating the clinical 
relevance of the nematode model as an alternative host for virulence factor discovery. The 
study reported that their transposon mutant screen did not reach genetic saturation of the 
Bp KHW genome and that therefore there may be more potential virulence genes to be 
discovered. Another approach used the G. mellonella insect model together with 
comparative genomics between Burkholderia species to identify novel virulence genes of 
Bm (Schell et al. 2008). In silico genomic subtraction identified a set of 650 genes (termed 
the ‘Bm-Bp virulome’) which were present in Bp and Bm (both opportunistic human 
pathogens) but absent from non-human-pathogenic Burkholderia species. Genes thought 
likely to encode novel virulence factors were selected, inactivated, tested in G. mellonella, 
and verified in a hamster model. 
Top-down approaches are often used for investigating microbial virulence, focusing on 
particular putative virulence factors based on gene homology and known roles in other 
species. The transposon insertion library method used by Gan et al (2002) for virulence 
factor discovery is similar to the RVA method in terms of using an assumption-free, 
bottom-up approach to reveal possibly unexpected determinants of virulence. Unlike that 
study, the RVA would use a different strain of Bp (K96243 versus KHW) and multiple 
invertebrate hosts. In addition it would not be possible to work with a Bp transposon 
mutant library in the laboratory facilities available at the University of Bath, but the 
recombinant fosmid library allows the investigation of this important pathogen at CL2.  
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Potential pitfalls of RVA  
Every experimental system also has its disadvantages. Although the recombinant 
expression system is advantageous in allowing subtle effects and the effects of discrete 
loci to be detected, it is potentially also a weakness. The biosynthesis and transport of 
proteins is exquisitely coordinated in native bacterial systems at all levels: regulation of 
transcription, translation, post-translational modification, and localisation to appropriate 
cellular compartments or secretion to the outside of the cell. Numerous inputs and genetic 
checkpoints influence the control of these processes and the recombinant expression 
system removes these normal levels of regulation. This could be either beneficial or 
detrimental to the discovery of virulence determinants.  Regulation of gene transcription in 
the recombinant system has a level of unpredictability, for example in the combined 
effects of native and fosmid promoters or the lack of transcriptional activator proteins. 
Problems may also occur at the level of protein translation if the E. coli host lacks tRNAs 
in adequate proportions to translate a transcript with a significantly different codon bias. 
Once translated, other important factors are whether the protein will be located in the 
appropriate cellular location, correctly folded, or successfully secreted. It should be noted 
however that RVA is not intended to model a pathogen’s virulence comprehensively or 
exactly, but rather to provide a ‘rough and ready’ shortlist of genomic regions for further 
study.  
What discoveries might be expected from Bp RVA? 
Despite the fact the approach is assumption-free, a few predictions can be made about 
what Bp RVA results might reveal. For a start, it is likely there will be some false-positives 
– due to larvae which were simply less healthy, or bacterial mats which were fed upon by 
more bacteriovores than average, for example. False-positives should be excluded during 
the re-testing round. True-positive hits – clones which make larvae less healthy or which 
somehow resist bacteriovore predation – can fall into several categories. Some may be 
true virulence factors, detrimental to the host either directly or by enabling the bacteria to 
evade host responses (which might be considered ‘offensive’ and ‘defensive’ virulence 
factors, respectively). These could include previously identified virulence factors or 
unexpected novel factors. Other GOT positives may be due to side-effects of aberrant 
gene expression in the recombinant system; over- or under-regulation of genes which 
usually play no role in virulence might have pleiotropic effects on the bacterium or host. 
Finally, clones may be detrimental to the host if they are particularly immunogenic; either 
the immune response itself (e.g. melanisation) will cause the clone to be scored positive, 
or the immune response may divert resources away from normal feeding and 
development, again leading to a false-positive identification. However, immunogenic 
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factors are integral in the host-pathogen interaction and can therefore be considered 
virulence determinants themselves.  
Considering the results of the P. asymbiotica RVA and the importance of expressing 
proteins and other molecules in the right locations, perhaps the types of factors most likely 
to be identified are those which: can export themselves (autotransporters); can be 
exported by E. coli secretion systems; or those encoded in close proximity to their 
transport genes so that a fosmid insert can include all necessary genes. Alternatively an 
accumulation of a toxin inside a bacterial cell could also allow for a large ‘dose’ to be 
delivered to the ingesting host or cell. Small ‘stand-alone’ exotoxin genes are more likely 
to be cloned intact within any one clone, while large genes such as many that encode 
NRPS systems are less likely to be cloned intact within the 40kb of a fosmid. Also, factors 
specific to other taxa – mammalian or plant hosts for example – should not be identified in 
the invertebrate screens, but general virulence factors (such as non-specific proteases or 
lipases) or those specific to the models used should be.  
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Chapter 2. Methods and Materials  
Invertebrate host organisms and Burkholderia and Escherichia coli bacteria were used 
throughout the study. Species, strains, and culture and maintenance details are listed in 
section 2.1. Details of methods and materials relating to specific results chapters are 
given in sections 2.2 – 2.4. 
2.1. General methods and materials 
2.1.1. Invertebrate species and maintenance 
Three distinct classes of invertebrates were used as model hosts for bacterial infection 
and Gain of Toxicity (GOT) experiments: insect larvae, amoebae and nematodes (Table 
2.1).  
Table 2.1 Invertebrate species used in this study 
Species  Notes Source 
Manduca sexta 
Kingdom: Animalia  
Family: Arthropoda 
Class: Insecta  
Order: Lepidoptera 
Tobacco Hawkmoth. Insect 
larva used at fifth-instar 
stage for injection assays. 







Kingdom: Animalia  
Family: Arthropoda  
Class: Insecta  
Order: Lepidoptera 
Greater Waxworm. Insect 
larva used at fifth-instar 




Kingdom: Amoebozoa  
Phylum: Amoebozoa 
Family: Acanthamoebidae  
Free-living amoeba. Used for 











Nematode worm. Bristol N2 
strain. Used for nematode 
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Insect maintenance 
A Manduca sexta colony was maintained in controlled conditions (25 °C, 80% humidity) 
and on an artificial diet as detailed in Table 2.2, according to Reynolds, Nottingham, & 
Stephens (1985). Galleria mellonella larvae were purchased in batches from Livefoods Ltd 
and stored at 4 °C with no requirement for feeding.  
Table 2.2. Details of Manduca sexta diet 
Media Uses Composition 
Manduca diet 
M. sexta maintenance and 
feeding and infection 
assays 
Per cake (Reynolds et al. 1985):  
99.1% (v/v) dH20,  
0.22 (v/v) corn oil,  
0.22% (v/v) linseed oil,  
0.45% (v/v) formaldehyde (final 6mM),  
18.81% (w/v) premix,   
1.26% (w/v) agar,  
0.01% (w/v) chlortetracycline (final 234mM),  
0.01% (w/v) Vandersant vitamins,  
0.45% (w/v) ascorbic acid (final 25mM).  
Store at 4 °C. 
 
Premix (w/w): 
43.99% wheatgerm,  
20.53% casein,  
17.60% sucrose,  
8.80% dried active yeast,  
5.87% Wesson’s salt,  
0.58% choline chloride,  
1.17% cholesterol,  
0.58% methyl paraben,  
0.88% sorbic acid  
Antibiotic-free 
Manduca diet 
M. sexta feeding assays  
Recipe as for complete diet (above) minus 
formaldehyde and chlortetracycline. 
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Amoeba maintenance 
Acanthamoeba polyphaga amoebae were maintained in 25cm2 tissue culture flasks of 
peptone–yeast–glucose (PYG) broth (Table 2.3) at 22-25°C, and sub-cultured twice 
weekly (Rowbotham, 1980).  
Table 2.3. Details of amoeba media 
Media Uses Composition 
Page’s Amoebal 
Saline (PAS) 
Minimal media, basis for 
PYG media 
PAS 1 stock: in dH2O, 410.66 mM NaCl, 3.25 
mM MgSO4.7H2O, 1.75mM CaCl2.6H2O, in dH2O 
PAS 2 stock: in dH2O, 200 mM Na2HPO4, 200 
mM KH2PO4 
PAS working solution: in dH2O, 0.5% (v/v) PAS 1 
stock, 0.5% (v/v) PAS 2 stock. Autoclave at 121 
°C. (Final: 2.05 mM NaCl, 0.016 mM 
MgSO4.7H2O, 0.009 mM CaCl2.6H2O, 1 mM 




Complete media for A. 
polyphaga maintenance 
and feeding 
In PAS working solution: 1.5% (w/v) proteose 
peptone (Oxoid L85), 100 mM D-glucose, 0.25% 
(w/v) yeast extract (Oxoid L21). Autoclave at 
110 °C. 
PYG agar Amoeba assays 
In PAS working solution: 0.75% (w/v) proteose 
peptone (Oxoid L85), 50 mM D-glucose, 0.125% 
(w/v) yeast extract (Oxoid L21), 1.5% (w/v) 
agar. Autoclave at 110 °C. Plus 25 μg/ml 
chloramphenicol for fosmid selection. 
 
Nematode maintenance 
Caenorhabditis elegans worms were maintained on Nematode Growth Medium (NGM) 
agar at room temperature, using E. coli OP50 as a feeding strain (200μl spread per plate) 
and transferred weekly to fresh plates (Table 2.4).  
Table 2.4. Details of nematode media 




C. elegans maintenance and 
feeding (with E. coli OP50 
bacteria), nematode 
feeding assays  
In dH2O: 50 mM NaCl, 0.25% (w/v) peptone, 
1.7% (w/v) agar. Autoclave at 121 °C for 15 
min. When approx. 50 °C, add: cholesterol 
(final 5 μg/ml), 25 mM KH2PO4, 1mM MgSO4, 
1mM CaCl2.  
For feeding: 200μl E. coli OP50 onto dry 
plates, incubated at 37 °C overnight. For 
nGOT assays, add 25 μg/ml chloramphenicol. 
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2.1.2. Bacterial strains and culture methods  
E. coli strains were used as host strains for expression of the B. pseudomallei fosmid 
library, as well as controls in infection experiments, and for cloning (Table 2.5).  
Table 2.5. Escherichia coli strains and associated plasmids used in this study 
E. coli 
strain 












ΔlacX74 recA1 endA1 
araD139 Δ(ara, 
leu)7697 galU galK λ- 













models and in RVA 




ΔlacX74 recA1 endA1 
araD139 Δ(ara, 
leu)7697 galU galK λ- 
rpsL (StrR) nupG. With 
pWEB plasmid. 
50 µg/ml 





Toxic control for 
M. sexta injections 
























Strain for feeding 
C. elegans  
Uracil-requiring E. coli 
mutant; grows thinly 
on nematode growth 
agar, therefore 













lacIqZΔM15] recA1 end 
A1 hsdR17 (rK12– 
mK12+) lac glnV44 thi-









hsdR17 (rk- mk+) λ pir  
- 
Biomedal 
(Grant et al. 1990) 
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E. coli 
strain 





TpR SmR recA thi pro 










kdpDE KO genes  
DH5α λpir strain 










University of Exeter 
(Wand et al. 2011) 
 
B. thailandensis and B. oklahomensis strains were handled at containment level 2 (CL2). 
On my behalf, B. pseudomallei was grown and manipulated by appropriately trained 
workers using containment level 3 (CL3) facilities at the University of Exeter. Burkholderia 
strains used in this study are listed in Table 2.6. 
Table 2.6. Burkholderia species and strains used in this study 
Burkholderia 
species / strain 
Comments Selection Source 
B. pseudomallei 
K96423 
Clinical isolate; type strain; GenR. 
The fosmid library consisted of Epi300 









Environmental isolate; type strain; 








Conditional mutant of the 
Twin Arginine Translocation system 
(prhAB::tatA). Supplement media with 
rhamnose to activate or glucose to 
inactivate TAT system 










Unmarked deletion mutant of Survival 








Enhanced Green Fluorescent Protein 
(eGFP)-expressing strain. Constitutive 










Clinical isolate from a human wound, 
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Burkholderia 
species / strain 
Comments Selection Source 
B. thailandensis 
CDC 3015869 
Clinical isolate from human blood 
following an automobile accident, USA. 







Clinical isolate from a human wound, 
identical to environmental isolates at 







Clinical isolate from human conjunctiva 





2.1.3. Bacterial culture media  
Bacteria were grown on Luria Bertani (LB) agar plates or shaking in LB broth (200-
250rpm) at 37 °C overnight, unless otherwise stated. Stocks were stored long-term in 20% 
glycerol at -80 °C. Culture media used in this study are listed in Table 2.7. Media was 
supplemented with antibiotic selection as necessary (refer to Tables 2.5-2.6). 
Table 2.7. Bacterial culture media used in the study 




In dH2O: 2% (w/v) pre-formulated LB powder 
mix (Sigma). Autoclave at 121 °C. 
(Final: 1% (w/v) tryptone peptone, 0.5% (w/v) 
yeast extract, 85.5 mM NaCl). 
LB agar 
Bacterial growth and 
isolation 
In dH2O: 2% (w/v) pre-formulated LB powder 
mix (Sigma, as above). 1.5% (w/v) agar. 
Autoclave at 121 °C. 
Skimmed milk 
agar (3% w/v) 
Testing for proteolysis 
Solution 1: In dH2O, 4% (w/v) LB powder, 3% 
(w/v) agar. Solution 2: In dH2O, 6% (w/v) 
skimmed milk powder.   
Autoclave both solutions at 110°C for 15 min, 
cool to approximately 50 °C then gently mix 
equal volumes together.  
(Final: 3% (w/v) skimmed milk, 2% (w/v) LB 
powder, 1.5% (w/v) agar) 
LB broth or agar 
with rhamnose 
(0.2% w/v) 
To maintain B. thailandensis 
conditional prhAB::tatA 
mutant with promoter on 
As for LB broth and LB agar compositions 
(above) plus 0.2% (w/v) rhamnose (12.18 mM). 
Autoclave at 110 °C. 
LB broth or agar 
with glucose 
(0.2% w/v) 
To maintain B. thailandensis 
conditional prhAB::tatA 
mutant with promoter off 
As for LB broth and LB agar compositions 
(above) plus 0.2% (w/v) glucose (11.10 mM). 
Autoclave at 110 °C. 
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2.2. Chapter 3 methods – Burkholderia infection 
assays in Manduca sexta 
2.2.1. Confirmation of Bt virulence against invertebrate hosts 
Caenorhabditis elegans infection assay 
A simple assay was used to confirm a lethal effect of our Bt E264 stock on nematodes. 
200μl of Bt E264 culture was spread into a rectangle on NGM agar plates (n = 3). The 
same was done using E. coli OP50, as for normal C. elegans maintenance. The bacterial 
lawns were grown overnight at 37°C. Adult C. elegans were washed in PBS to remove 
remaining OP50 cells and seeded onto the lawns, n = 10 nematodes per plate. The plates 
were assessed daily for one week to assess nematode activity. 
Acanthamoeba polyphaga dose response assay 
A simple dose response assay was used to confirm a lethal effect of our Bt E264 stock on 
A. polyphaga amoebae. Bt E264 and E. coli Epi300 were grown overnight and adjusted to 
OD600 0.5, then serially diluted 1:2. 10μl of cultures at OD600 0.5, 0.25, 0.125, 0.0625 and 
0.0313 was spotted onto PYG nutrient agar or PAS minimal media agar. Bacterial mats 
were grown overnight at 37°C. An A. polyphaga suspension was adjusted to 2x105 cells 
per ml and serially diluted 1:2 to 2.5x104 cells per ml. 10μl drops of the four amoeba 
dilutions (or 10μl PYG liquid media) were spotted into the corner of wells with bacterial 
mats at the centre. Mats were assessed daily for up to 13 days, noting the days at which 
mat consumption began and ended. 
Initial dose response assay in Manduca sexta 
M. sexta larvae were infected using a range of doses of different Burkholderia species, 
initially by injection directly into the haemocoel with subsequent assessment of larva 
health and mortality. Where mortalities reach 50% or greater, median time to death 
(MTTD) values were calculated, providing a simple comparative value between species, 
strains or doses. 
Dose response #1: First, to confirm a lethal effect of our Bt E264 stock on M. sexta high 
doses of Bt E264 based on OD600 values were tested (n = 3 larvae per condition). 
Bacterial liquid cultures were grown overnight (37 °C, 225-250 rpm) and adjusted to OD600 
0.5, followed by 1:2 serial dilutions to approximately OD600 0.0313. E. coli Epi300 was 
used as a non-pathogenic control (n = 3) and LB medium was also injected as a control. 
Bacterial inoculum samples were spread on LB plates and incubated at 37 C to 
enumerate CFUs.  
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Larvae were reared as described in section 2.1.1. Fresh fifth-instar larvae were 
anaesthetised on ice for 10 minutes, surface-sterilised with 70% ethanol, and injected 
using sterile insulin needles. 100 μl of bacterial culture was injected between the 2nd and 
3rd last segment on the side of each larva. Larvae were supplied with Manduca diet, 
incubated at 25 °C, and scored daily until they either died or reached the pre-pupation 
‘wanderer’ stage of development. At that point they were euthanised by freezing at -20 °C. 
Larva health was assessed by visual appearance and by response to physical stimulus 
(prodding or lifting up with tweezers). 
2.2.2. Manduca sexta as a Burkholderia infection model  
Burkholderia dose responses were subsequently carried out in M. sexta over four more 
experiments, using the same basic methodology with a greater serial dilution factor and 
more replicate larvae. 
Bacterial liquid cultures were grown overnight (37 °C, 225-250 rpm) and adjusted to OD600 
values as described for each experiment, then serially diluted in 0.9% (w/v) NaCl as 
appropriate. Estimated doses between 105 – 101 CFU were injected into M. sexta larvae 
(100 μl from cultures of 106-102 colony forming units (CFU) per ml). Five to ten replicate 
larvae were used per condition tested. Diluted samples were also spread on LB plates to 
enumerate CFUs. 
Dose response #2 tested a wider and lower range of Bt E264 doses compared to the 
initial dose response #1. Initial OD600 adjustment was to 0.25, followed by 1:10 serial 
dilutions to 105-101 CFU (n = 5). 
Dose response #3: Having confirmed a dose-responsive lethal effect of Bt E264 in M. 
sexta, dose response #3 tested Bp K96423 (105-101 CFU; n = 8). This work was carried 
out in CL3 facilities at the University of Exeter by appropriately trained personnel (Claudia 
Müller and Sariqa Wagley). Heat-killed Bp K96423 was used as a negative control, as 
was E. coli Epi300 (both equivalent to 105 CFU). 
Dose response #4 compared the effect of Bt E264 to that of two other Bt strains (CDC 272 
and CDC 301) and two Bo strains (C6786 and E0147) to investigate whether virulence in 
M. sexta would reflect the relative virulence levels seen in other model species. Initial 
OD600 adjustment was to between 0.20-0.25, followed by 1:10 serial dilutions to 10
4-102 
CFU (n = 10). 
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Dose response #5 repeated testing of the three Bt and two Bo strains at a 104 CFU 
intended dose; n = 10. Initial OD600 adjustment was to between 0.20-0.25, followed by 
1:10 serial dilution to 104 CFU (n = 10). 
Summaries of larva survival are shown in the results. Detailed notes on larva health are 
included in e-Appendix 3a.  
Statistical analysis: 
For statistical analyses the experimental data were grouped into log doses according to 
the actual CFU counts (rather than the estimated doses). The statistical package SPSS 
was used to perform Kaplan-Meier Survival Analysis. This produced survival curves, 
Median Time to Death (MTTD) values (also referred to as median survival times), and log-
rank (Mantel-Cox) significance values (which indicate whether two sets of survival data 
are significantly different). [Settings: Time = hours post-injection; Status = 0 if survived, 1 if 
died; Factor = different treatment groups; analysed pairwise over strata.] Complete SPSS 
outputs are available in e-Appendix 3b. 
2.2.3. Assessing attenuation of Bt E264 mutants 
Two mutant strains of Bt E264 were tested: a deletion mutant in the surA gene (ΔsurA), 
and a conditional mutant of the Twin Arginine Translocation (TAT) system. 
ΔsurA dose response: Bt E264 and the ΔsurA mutant were compared at 106-104 CFU 
doses (n = 10 larvae). Note that this initial ΔsurA test incubated the injected larvae at 
37°C to replicate the conditions which had been used for G. mellonella tests (at Dstl 
Porton Down; personal correspondence with I. Norville). This was followed up by more 
detailed tests at doses 103-101 CFU (n = 10 larvae), repeated in three independent 
experiments, and incubating larvae at 25°C as for all other tests. 
 
Conditional expression of the Bt TAT mutant: The Bt E264 TAT mutant (Bt E264 
prhA:tatA) was conditional upon sugar supplementation in the LB medium. To activate 
expression of the TAT system, as in wild-type E264, the strain was grown in LB with 0.5% 
(w/v) rhamnose. To inactivate it the strain was grown in LB with 0.5% (w/v) glucose. The 
mutant growth rate was known to be reduced when the TAT system was inactivated (S. 
Wagley, personal communication). 
TAT #1: A dose response from 105-102 CFU was tested using Bt E264 or the conditional 
mutant, each grown in LB with either rhamnose or glucose. Larvae were scored daily for 6 
days, n = 8. 
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TAT #2: A second TAT dose response was performed which also tested the wild-type and 
mutant strain grown in LB alone. Doses of 106, 104 and 102 CFU were tested. Larvae were 
scored daily for 7 days, n = 8. 
2.2.4. Virulence in Galleria mellonella at 25 °C versus 37 °C 
Temperature is known to greatly affect bacterial growth and even virulence. Most of the 
experiments in this study maintained infected larvae at 25 °C. This is the ideal 
temperature for M. sexta maintenance and is also comparable to soil temperature in 
tropical regions where Bp and Bt are endemic. However, human body temperature (37 °C) 
is relevant to human infection and was used by Wand et al (2011). To investigate the 
effect of the post-injection incubation temperature on virulence, G. mellonella larvae were 
injected with Burkholderia strains: Bt E264, Bt CDC 272, Bt CDC 301, Bo C6786 and Bo 
E0147. E. coli Epi300 and 0.9% (w/v) NaCl were used as controls. Bacterial cultures were 
prepared as described for M. sexta injections. Larvae were used straight from storage at 4 
°C, surface-sterilised with 70% ethanol, and injected with 10 μl of diluted culture to give 
doses of approximately 102 CFU. The larvae (n = 10) were subsequently maintained at 25 
°C or 37 °C for four days and assessed daily for movement and response to stimulus.  
2.2.5. Manduca sexta feeding assay 
Manduca diet was prepared without antibiotics (see Chapter 2 – Materials and Methods) 
to avoid detrimental effects on the bacteria which would be added. The food was cut into 
uniform sizes with a sterilised borer (15mm diameter by approximately 5mm high). Liquid 
samples (bacteria or controls) were added onto the food pieces and allowed to soak in 
before adding larvae and sealing into lidded pots. For fifth-instar feeding, one recently 
moulted fifth instar larva was added per food block. For neonate feeding, two M. sexta 
larvae hatched from eggs the same day (neonates) were added per food block. Neonates 
were weighed on day 7 or 8 and each condition used 10-20 replicate larvae. Neonates or 
fifth-instars were monitored daily for mortality. 
The samples applied to the food blocks were derived from Bt E264, Bo C6786, and E. coli 
Epi300. Bacterial liquid cultures were grown overnight (37 °C, 225-250 rpm) and applied 
directly to food blocks or treated to retrieve supernatant, to heat-kill supernatant or to 
wash cells, as described for each experiment below. LB was added to food blocks as a 
negative control; to confirm there was no contamination in the medium the LB was also 
incubated at 37 °C overnight with the bacterial cultures. No contamination was present.  
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Experiment #1: In the first instance, ten neonates were fed food laced with 100μl of either 
an overnight culture of Bt E264 or LB. Neonates were weighed on day 8. 
Experiment #2: In the following experiment the dosage volume was increased to 200μl per 
food block in order to cover all exposed surfaces of the food. An E. coli Epi300 control 
was also used. All bacteria were adjusted to OD600 0.1 before addition. Ten neonates 
were used per condition. Weights were not recorded. 
Experiment #3: Using undiluted overnight cultures again, with 200μl volumes. ‘Cell-
reduced culture’ samples were included (see Table 2.8); this sample was mostly 
supernatant but some cells were still present as it was not filtered. Samples were spread 
on LB plates and incubated at 37 °C; the cell-reduced culture did exhibit bacterial growth, 
although to a lesser extent than the whole-culture lawn (colonies were not separated 
enough to enumerate CFUs). Twenty neonates were used per condition. Day 8 weights 
were recorded. Fifth instar larvae were also tested: food blocks were 20x10x10mm, 400μl 
samples were added per block, five larvae per condition. Fifth instar larvae were 
euthanised (-20°C) on day 5 when they reached the wanderer stage of development. 
Table 2.8. Conditions for feeding assay #3. Epi300 = E. coli Epi300  
Condition 
(Bt E264, Epi300) Undiluted overnight culture treated as 
follows: 
Culture 200μl directly added per block 
Cell-reduced culture 
Centrifuged (5 minutes at 10,000G) to pellet cells, supernatant 
carefully retrieved. Spin repeated and supernatant carefully 
retrieved. 200μl added to blocks 
 
Experiment #4: See Table 2.9 for sample preparation. Bo C6786 was added as an extra 
sample. In this experiment supernatant samples were filtered (0.2 μm) to achieve cell-free 
supernatant; this was confirmed by spreading samples on LB plates and incubating at 37 
°C. Washed cells and heat-treated supernatant were also tested. This experiment was set 
up on two sequential days so that bacteria could be tested which had been incubated: (i) 
for 16 hours as before (‘1 night’), and (ii) for 40 hours (‘2 nights’). This was because some 
Photorhabdus toxins are known to be produced more strongly after extended incubation 
(Yang et al. 2012). Another improvement was to decrease the supernatant addition 
volumes to reflect the removal of the cellular component. Twenty neonates were used per 
condition. Day 7 weights were recorded. The neonates which were available to use in the 
first batch (for 1-night-incubated samples) appeared to be less healthy than usual (pale 
colour and less movement). The 2nd batch (used for 2-night-incubated samples) showed 
normal health.  
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Table 2.9. Conditions for feeding assay #4. Epi300 = E. coli Epi300 
Condition 
(Bt E264, Bo C6786, Epi300) Undiluted overnight culture treated 
as follows: 
Culture 200μl directly added per block 
Cell-free supernatant 
200μl per block centrifuged (5 minutes at 7,000G) to pellet cells 
for washing (below). Supernatant retrieved and centrifuged (15 
minutes at 20,000G), then filtered (0.2 μm). Cell-free volumes 
(equivalent to cell-replete 200μl) were calculated and added to 
blocks 
Heat-killed supernatant 
As for supernatant: after filtration step, 10 minutes in an 80 °C 
heat block. Cell-free volumes (equivalent to cell-replete 200μl) 
added to blocks 
Washed cells 
Cells pelleted from the supernatant (above) were washed in LB, 
centrifuged again (5 minutes at 7,000G), and re-suspended in LB 
to the original volumes. 200μl added to blocks 
 
Statistical analysis: The significance of average weight differences between groups was 
calculated using the two-tailed T-test statistic for unequal variances. (The data were first 
assessed for equality of variances). 
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2.3. Chapter 4 methods – In vivo time-course of 
Burkholderia insect infection and pathogenesis 
These experiments investigated the progression of infection within the insect model after 
injection. Haemolymph samples taken from infected larvae were viewed using fluorescent 
confocal microscopy. Images were assessed for bacterial and haemocyte cell numbers 
and cellular hallmarks of Burkholderia infection. Haemolymph samples were also 
assessed for haemocyte number and viability using a kit for flow cytometry. 
2.3.1. Comparative virulence of Bt E264 wild-type and GFP 
strains 
Green fluorescent protein (GFP)-labelled strains of Bt E264 and E. coli Ec100 were to be 
used for microscopy. Therefore the relative virulence of labelled and wild-type strains was 
investigated using injections into M. sexta fifth-instar larvae.  
Bacteria and larvae were prepared and larvae were injected with bacteria as described for 
dose responses #4 and #5 in Chapter 3: initial OD600 adjustment was to between 0.20-
0.25, followed by 1:10 serial dilutions. First, estimated doses of 102-104 CFU were tested 
(n = 10). Estimated doses of 104 CFU were repeated in a second experiment (n = 10). 
Statistical analysis: 
The statistical package SPSS was used to perform Kaplan-Meier Survival Analysis on the 
data from each dose. This produced survival curves, Median Time to Death (MTTD) 
values (referred to in the software output as median survival times), and log-rank (Mantel-
Cox) significance values (which indicate whether two sets of survival data are significantly 
different). [SPSS settings: Time = hours post-injection; Status = 0 if survived, 1 if died; 
Factor = different treatment groups; analyse pairwise over strata.] Analysis for the 
estimated 104 CFU dose was performed for each set of data (each n = 10) and for the 
combined data (n = 20). Complete SPSS output is available in e-Appendix 4a. 
2.3.2. Visualisation of haemocytes and bacteria 
Injections and haemolymph collection at time-points 
GFP-labelled Bt E264 or GFP-labelled E. coli Ec100 were used. Overnight cultures of 
bacteria were adjusted to OD600 0.20-0.25 and injected into fifth-instar M. sexta larvae as 
described in Chapter 3. Larvae were injected with 50μl doses, equating to approximately 
106 CFU. A batch of six replicate larvae was used per condition. 
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Injected larvae (or un-injected control larvae) were bled at certain time-points to collect 
haemocytes and bacteria. After chilling on ice for 10 minutes, the larvae were surface 
sterilised with 70% ethanol and the dorsal horn was cut at its mid-point with sterilised 
dissection scissors. Larvae were gently squeezed and haemolymph was collected into 
ice-cold micro-centrifuge tubes. Sample dilutions were plated onto LB agar plates and 
incubated at 37 °C for enumeration of bacterial colony forming units (CFU). 
Experiment #1: Initial assessment of infection  
Initial images were captured from samples collected at 5, 24, 30, 36 and 48 hours post-
injection with Bt E264 GFP or E. coli Ec100 GFP. Samples were also used from an un-
injected batch of six insects at 24 hours ‘post-injection’. Filamentous actin was stained 
with TRITC-phalloidin. Staining (without DAPI) and microscopy were performed as 
described below.  
Experiment #2: Time-course microscopy  
For the time-course study the time-points were altered to provide more data from within 
the first 24 hours and triplicate batches of insects were used per time-point, with ten 
images captured per batch. The solutions used are detailed in Chapter 2. Haemocytes 
were double-stained with TRITC-phalloidin (filamentous actin) and DAPI (nuclei) as 
described. The time-points were at 0 hours (within 45 minutes of injection), and 3, 6, 12, 
18, 24 and 30 hours post-injection. The images were all studied manually in order to 
assess bacterial and haemocyte numbers and health, and to look for hallmarks of 
Burkholderia pathogenesis such as actin tail formation or MNGCs. 
In summary: 
Haemolymph of six larvae pooled per microscope slide 
Ten fields of view imaged and analysed per microscope slide 
Three independent replicate slides produced per time-point 
= 30 fields of view imaged and analysed per time-point 
Staining and microscopy 
Collection of haemolymph 
Haemolymph samples were centrifuged for 5 minutes at 1200 rpm to a fluffy pellet. Very 
loose pellets were spun for a further 2 minutes. As much supernatant was removed as 
possible without disturbing the pellet and tubes were topped up to 500µl with ice-cold 
Grace’s Insect Medium (GIM) to wash. Following centrifugation for 5 minutes at 1000-
1500 rpm, supernatant was again gently removed and tubes were topped up to 1ml with 
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ice-cold GIM. For each set of 6 larvae, the contents were gently re-suspended and 
pooled.   
Cells were allowed to attach to 13 mm cover slips in wells of a 24-well plate: 500µl of the 
cell suspension was added per cover slip and left to attach for 30-45 minutes at room 
temperature, protected from light. Liquid was then aspirated and wells were washed 
gently with 500µl of room temperature GIM. In a fume hood, GIM was removed and 
replaced with fixative (500µl 4% (w/v) paraformaldehyde (Pfa) in PBS). Plates were stored 
at 4 °C for 1-16 hours.  
Fluorescent staining and mounting 
Solutions used in fluorescent confocal microscopy to analyse M. sexta haemocytes are 
described in Table 2.10. 
Table 2.10. Reagents used for microscopy procedures 
Reagent Preparation Source 
Grace’s Insect Medium 
(GIM) 
With L-glutamine and sodium bicarbonate, liquid, sterile-
filtered, suitable for insect cell culture 
Sigma 
1X Phosphate buffered 
saline (PBS) 
Pre-formulated tablets dissolved 1 per 100ml as per 





100mls PBS heated to 40-50°C, 4g Pfa, one drop NaOH. 
Stored at -20°C. Aliquots thawed on day of use 
Sigma 
0.1% (v/v) Triton X-100 
in PBS 
100μl Triton X-100 added to 100ml PBS, mixed well. 
Sterile-filtered 
Sigma 
0.5% (w/v) Bovine 
Serum Albumin (BSA) 
in PBS 
0.5g BSA dissolved in 100ml PBS. Sterile-filtered Sigma 
1μg/ml TRITC-
phalloidin solution in 
PBS 
Stock solution: 1mg dissolved in 1ml DMSO 






Stock solution: 2mg dissolved in 1ml dH2O 




6g glycerol plus 2.4g Mowiol 4-88, stirred. Add 6ml dH2O, 
incubate at room temperature for 2 hrs. Add 12ml 0.2M 
Tris (pH 8.5), heat to 53 °C until dissolved. Centrifuge at 
5000 rpm for 20 mins. Store aliquots at -20°C.   
Sigma 
 
See the materials and methods section for complete details of solutions used. The 
following solutions were freshly prepared: 0.1% (v/v) Triton X-100, 0.5% (w/v) Bovine 
Serum Albumin (BSA), 1 μg/ml 4',6-diamidino-2-phenylindole (DAPI) in PBS, and 
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tetramethylrhodamine B isothiocyanate (TRITC)-phalloidin in PBS. TRITC-phalloidin final 
concentrations ranged from 0.5-5.0 μg/ml (conditions were optimised for different dye 
batches). 
Samples and fluorescent dyes were protected from light as far as possible at all steps. 
Care was taken to wash cells gently. Wells were washed 3 times with PBS in the fume 
hood. Cells were permeabilised with Triton X-100 in PBS for 5 minutes, and washed a 
further 3 times with PBS. Non-specific binding sites were blocked with BSA in PBS for 30 
mins, and wells were washed 2 times with PBS. Cellular filamentous (F)-actin was then 
stained with TRITC-phalloidin diluted in PBS (from 40 minutes to 4 hours; conditions were 
optimised for different dye batches). Wells were washed 3 times with PBS and then 
stained with DAPI (final concentration) for 15-20 minutes. Finally wells were washed 5 
times with PBS. 
Small drops of Mowiol mounting medium were prepared on clean slides. Coverslips were 
dipped once into dH2O and their edges carefully blotted onto tissue, before being placed 
cell-side down onto the Mowiol. Slides were incubated in the dark at room temperature 
overnight to dry, and then stored at 4 °C. 
Microscopy and analysis 
A Zeiss LSM 510 META confocal microscope was used, with a Plan-Apochromat 63X/1.4 
Oil Ph3 lens. Red, green and blue (543nm, 405nm, and 488nm) channels were used, as 
well as white light.  
For the initial assessment (experiment #1): dependent on the required image quality, scan 
number was 1 or 2, frame size was 512 or 1024, and zoom was typically 1X – 3X. Z-
stacks were captured in order to be able to visualise bacteria at all planes: on the surface 
of the slide, or within or on top of haemocytes. Some single-plane images were also 
captured. 
For the time-course (experiment #2): scan number was 1, frame size was 512, and zoom 
was 2X. Z-stacks were captured. Single-plane images were only used if all bacteria were 
verified as visible in one focal plane (i.e. on the surface of the slide) and no amoebae 
were in the field of view. 
Images were processed using LSM Image Browser (Carl Zeiss Ltd.). For the time-course 
images Z-stacks were each made into 3D projections and assessed by eye to count: 
Number of extracellular bacteria 
Number of intracellular bacteria 
Number of bacteria associated with the surface of a haemocyte 
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Total number of haemocytes 
And to qualitatively assess: 
Whether cell debris was present 
If actin remodelling was apparent 
If multinuclear giant cells (MNGCs) were present 
Statistical analyses 
The data were used to calculate average values and standard errors of the following 
parameters: 
Number of haemocytes 
Total number of bacteria 
Number and proportion of extracellular bacteria (excluding surface-attached) 
Number and proportion of intracellular bacteria 
n = 30 for each time-point with ten images from each of the three replicate batches. 
Significance of the data from Bt-infected samples compared to the equivalent data from E. 
coli -infected samples was tested using T-tests for unequal variances. 
Whether the following signs of pathogenesis were observed in any images from each 
time-point was noted: evidence of cell death or cellular debris; actin remodelling; or 
MNGCs. 
2.3.3. ViaCount haemocyte quantification 
Cytometry was used to assess the number and viability of M. sexta haemocytes, using 
Guava ViaCount Reagent (Millipore). Insects were injected as described for the 
microscopy with Bt E264, Bt E264 GFP, E. coli Ec100, or E. coli Ec100 GFP. Control 
insects were injected with saline (0.9% w/v NaCl) or were not injected at all. 
At 24 hours post-injection the larvae were bled into ice-cold micro-centrifuge tubes as 
described for the microscopy method. Samples were diluted 1:2 with ice-cold GIM to 
reduce cell clumping or melanisation, then treated with ViaCount reagent according to 
manufacturer’s guidelines (1:20 sample-to-reagent mixed gently, five minutes incubation 
at room temperature). Readings were taken using a Guava EasyCyte™ cytometer 
(Millipore) and the ViaCount Assay program. Following the readings, the software’s 
analysis gates were set using equivalent samples from non-injected larvae as a baseline 
control to identify healthy cell populations. 
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Haemolymph was pooled from a batch of six replicate larvae for each condition. Each 
reading measured 1,000 events (insect cells). Bacteria are too small to be counted as 
cells and instead they should register as debris. Three readings were taken per condition 
per experiment. Two independent replicate experiments were performed. 
Statistical analyses 
The ViaCount data (n = 6) were plotted as averages (± standard error): for percentage of 
cells live, dead or apoptotic; and for cell concentration. Data for the viable percentage of 
cells and for cell concentration were tested for significant differences between conditions 
using two-tailed T-tests for unequal variances. 
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2.4. Chapter 5 methods – Rapid Virulence Annotation 
of Burkholderia pseudomallei 
A library of E. coli clones bearing fosmids with inserts from the Bp K96243 genome had 
been prepared by the Sanger Centre for genome sequencing purposes. The library was 
subsequently used for RVA, i.e. parallel screening of the clones against the invertebrates 
M. sexta, A. polyphaga and C. elegans. 
2.4.1. Analysis of the B. pseudomallei fosmid (BPF) library 
The B. pseudomallei K96243 genomic library was constructed by the Sanger Centre using 
the CopyControl™ Fosmid Library Production Kit by Epicentre. Epi300™-T1R E. coli was 
the host strain for the pCC1FOS™ fosmid vector. 3,552 individual fosmid-containing 
clones were arrayed into 37 96-well plates (referred to as BPF (Bp Fosmid) plates) and 
stored at -80°C. End-sequencing of the BPF library clones was also performed at the 
Sanger Centre. 
Assessing coverage 
Using the end-sequences, fosmid sizes and locations were determined by Batch-BLASTN 
comparison of each end against the published B. pseudomallei K96243 genome. Where 
multiple best matches were returned for an end-sequence, these were curated manually 
to select the most likely locations. Where only one end could be located, the average 
fosmid insert size was used to predict an estimated location for the opposite end. In 
instances where the location of only one end was known, corresponding ends were 
calculated at 38,878 bp away. This conservative value is based on the mean plus 1 
standard deviation; while it may underestimate the true length of some inserts, in theory 
this value should be equal to or greater than the length of 68.2% of the inserts (based on 
a normal distribution). 
Using all clones with coordinates, a coverage map was generated using Microsoft Excel: 
the mid-point base pair coordinate of each clone was plotted along the x-axis, each with 
horizontal error bars representing the average insert length.     
Testing for protein expression from RVA clones 
As Bp has an unusual codon bias it was important to discern whether the BPF clones (E. 
coli clones containing fosmids with Bp DNA) were able to express Bp proteins. In the first 
instance, expression was assessed using fosmid clones bearing a protein which would 
produce a visually identifiable phenotype. The Bp metalloprotease MprA, encoded by 
bpss1993, has previously been transgenically expressed in E. coli from 2-4kb inserts (Lee 
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and Liu, 2000). BPF clones containing bpss1993 were identified based on their insert end-
sequences; eight were grown up in LB with or without CopyControl™ Auto-Induction 
solution (Epicentre) to up-regulate copy number. These were streaked onto 3% (w/v) milk 
agar plates with 25 μg/ml chloramphenicol. Plates were incubated at 37 °C. Epi300 E. coli 
and Bt E264 were used (without antibiotic) as negative and positive controls for 
proteolysis, respectively. 
2.4.2. RVA assays and re-testing 
RVA GOT assays were based on methods previously published by Waterfield et al (2008), 
as described below. Bacterial and invertebrate maintenance methods and media are 
described in the Methods and Materials chapter. 
Amoeba Gain of Toxicity (aGOT) screen 
aGOT screens were performed on Peptone Yeast Glucose (PYG) agar in 25-well plates 
with 1ml of agar per well. To prepare the bacterial clones, BPF library plates stored at -80 
°C were sub-cultured into 96-well plates of LB broth with 25 μg/ml chloramphenicol and 
incubated at 37 °C overnight shaking at 225-250rpm. 10 μl drops of grown bacteria were 
added to the centres of the agar wells, allowed to dry, and incubated at 37 °C overnight to 
form bacterial mats. Epi300 E. coli (the fosmid strain) was not initially available so Ec100 
E. coli with plasmid pWEB (a closely related expression strain from the same supplier) 
was used as a control.  
To prepare the amoebae, stationary phase (approximately 10-day-old) cultures of A. 
polyphaga were adjusted to 2x105 cells per ml using a haemocytometer, and a 10 μl drop 
was applied to one corner of each agar well (Figure 2.1). Drops were allowed to dry and 
plates were sealed with parafilm to prevent dessication. Assay plates were incubated at 
22-25 °C and scored daily until bacterial mats were consumed, up to a maximum of 2 
weeks. Mats of Ec100 were used as a comparative control.  
Figure 2.1. Illustration of the aGOT or iGOT assay well. In the centre of each well is the bacterial mat. 
Amoebae or nematodes are added to the top right corner (shown in the left-most well). The progression from 
left to right shows the typical pattern of consumption by amoebae. 
 
 
 Methods and Materials pg. 81 
Toxicity was assessed qualitatively according to any delay in consumption of the bacterial 
mat. Amoeba screens were scored from 0-5 according to the extent to which the bacterial 
mat was consumed, whereby:  
5 = mat intact 
4 = one-quarter eaten 
3 = half eaten 
2 = one-quarter remaining 
1 = less than one-quarter remaining 
0 = totally consumed  
Examples of scores 1-4 are shown in Figure 2.2. Fosmids which were consumed slowly 
(relative to the majority from the same batch) were counted as positive GOT hits. Positive 
hits were to be re-tested in the same manner with 10 replicate mats. 
Figure 2.2. Photo showing examples of scores for amoeba (aGOT) or nematode (nGOT) feeding assays. 
Bacterial mats in the centre of each well are scored qualitatively according to how much of the mat remains 
each day, from 0 (totally consumed) to 5 (mat intact). 
 
 
Nematode Gain of Toxicity (nGOT) screen 
nGOT screens were performed on nematode growth media (NGM) agar in 25-well plates 
with 1ml of agar per well. BPF clones were prepared as described for aGOT.  
To prepare the nematodes, adult worms were washed off maintenance plates with 
phosphate buffered saline (PBS) and the suspension was adjusted to 10 adult nematodes 
per 10µl drop. Drops were allowed to dry and plates were sealed with parafilm to prevent 
dessication. 
As for aGOT, assay plates were incubated at 22-25°C and scored daily until bacterial 
mats were consumed, up to a maximum of 2 weeks. Mats of E. coli Ec100 were used as a 
comparative control. Toxicity was assessed qualitatively according to delay in 
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consumption of the bacterial mat. The same scoring system was used as that for aGOT. 
Fosmids which were consumed slowly (relative to the majority from the same batch) were 
counted as positive GOT hits. Positive hits were to be re-tested in the same manner with 
10 replicate mats. 
Insect Gain of Toxicity (iGOT) screen 
iGOT screens were performed by injection of clones into M. sexta caterpillars (Figure 2.3). 
BPF library plates stored at -80 °C were sub-cultured into plates or universal tubes with 5 
mL tubes of LB broth plus 25 μg/ml chloramphenicol. These were incubated overnight at 
37 °C, shaking at 225-250rpm. The grown bacterial culture was used directly in iGOT 
assays. 
Figure 2.3. A healthy Manduca sexta larva at the fifth-instar stage of development 
 
Larvae were reared as described in the Methods and Materials chapter (Chapter 2). Fresh 
fifth-instar larvae were anaesthetised on ice for 10 minutes, surface-sterilised with 70% 
ethanol, and injected using sterile insulin needles. A 100 μl dose of bacterial culture was 
injected into the haemocoel between the 2nd and 3rd last segment on each larva’s side 
(one clone injected per larva). Larvae were then supplied with Manduca diet, incubated at 
25 °C, and scored daily for signs of morbidity or mortality. E. coli Ec100 negative controls 
were also set up for each batch of fosmids tested. The health of caterpillars injected with 
this was used as a comparative negative control. As a positive control, larvae were 
injected with an E. coli Ec100 strain expressing the lethal Mcf1 (Makes Caterpillars 
Floppy) toxin from Photorhabdus asymbiotica (‘Ec100 Mcf’) (Waterfield et al. 2003). 
Larvae were maintained and scored daily until they either died or reached the pre-
pupation ‘wanderer’ stage of development, at which point they were euthanised by 
freezing at -20 °C. 
Larvae were assessed by visual appearance and by response to physical stimulus 
(prodding or lifting with blunt tweezers). Notes were recorded regarding the amount of 
food eaten and the condition of faeces, if unusual. Scores were judged relative to the 
Ec100-injected controls, and ranged from 0 to 4 including half-scores (e.g. 2.5, 3.5 etc): 
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0 =  No greater effect than that seen in typical negative controls 
1 =  A slight effect which could be temporary or perhaps not due to the injection, 
e.g. a slightly smaller size, a pale colour but otherwise active, slow response, little 
eating on day 1 
2 =  The larva was relatively healthy but there was a noticeable effect on 
development, or development was normal but there are indications of illness, e.g. 
a small size, not eating after day 1, some diarrhoea, melanisation, extremely pale 
or with a pinkish colouration, slightly shrunken appearance 
3 =  The larva was alive but obviously unwell or moribund, e.g. obviously 
shrunken / very small, severe diarrhoea, floppy, severe melanisation 
4 =  Dead. Notes were taken on the appearance/phenotypes of any dead 
larvae. 
Fosmids which scored 4 were ‘best’ positives. Scores of 3 or 3.5 were ‘higher possible’ 
positives, scores of 2.5 were ‘lower possible’ positives, and some lower-scoring fosmids 
with interesting phenotypes such as unusual colouration were ‘phenotype’ positives. All 
fosmids scoring 2.5 or above were re-tested in 10 replicate larvae, and some phenotype 
positives were also retested. 
Non-statistical analysis of RVA results 
A genome coverage map plotting only ‘hit’ fosmids (according to their end-sequences) 
was created to assess visually whether the GOT positives clustered to any genomic 
regions in particular.  
2.4.3. Statistical analysis of RVA results 
Subsequently a statistical method was devised to determine whether the distribution of 
hits was any different to that expected by chance, taking into consideration the coverage 
of the genome in the fosmid library. Gene coding sequences (CDSs) were used as the 
data units: if a clone was a positive hit then every CDS within its insert would acquire one 
hit. A script was used to calculate which CDSs are located within each fosmid (written by 
A. Topham using C# and Visual C#2010). The input was a file containing all fosmid start 
and stop coordinates (from end-sequencing results) and a file containing all B. 
pseudomallei K96243 CDS start and stop base pair coordinates (from published 
annotations available via www.sanger.ac.uk). 
The action of the script is outlined briefly: 
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Look at each row of a list of fosmids, one at a time; 
For each fosmid, look at each row in a list of all the Bp CDSs; 
 For each CDS, if its chromosome matches the fosmid’s chromosome, 
  AND its Stop bp >= the fosmid’s Start bp,  
AND its Start bp <= the fosmid’s Stop bp, 
 Then that CDS is recorded as present within that fosmid;  
Look at next CDS, and repeat. 
The output recorded all CDSs within each fosmid. CDSs which straddled fosmid 
coordinate boundaries were included to compensate for the fact that some fosmids had 
only estimated coordinates at one end, and therefore to risk including false-positives 
rather than risk excluding true ones.  
Re-determining library coverage 
The script outputs were entered into a Microsoft Access database, and the data were 
interrogated to return counts of how many times each particular CDS was represented in 
fosmids, using data only from clones which had successfully grown and been tested in 
GOT screens. (961 clones could not be tested in one or more screens. In total 57,228 
CDS representations were tested in aGOT and nGOT, and 57,170 in iGOT.) This formed 
the ‘Coverage’ data, i.e. the number of times each CDS was represented in testing.  
Determining ‘expected’ hit values 
GOT assay results were also interrogated to determine how many times each CDS had 
been hit in each screen. This formed the ‘Observed Hit’ data. The total number of hits and 
the total number of tested CDS representations was noted for each GOT screen and used 
to calculate average ‘Hit Rates’ (total hits / total representations). ‘Expected Hit’ values 
were calculated by multiplying each CDS’s Coverage value by the average Hit Rate for 
that GOT screen.  
Descriptive statistics of the data 
The statistical analysis software SPSS was used to analyse the RVA data. First the GOT 
Coverage data and Observed Hit data were tested for their fit to the normal distribution, 
using a One-Sample Kolmogorov-Smirnov test. None of the distributions were normal, so 
non-parametric statistics were used for subsequent analyses. Correlation analyses were 
performed using Spearman’s rho statistic.  
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Determining observed-to-expected hit values 
Observed-to-Expected (Obs/Exp) Hit Ratios were calculated for the CDSs (using 
Observed Hit values divided by Expected Hit values). These values were used to identify 
CDSs which had been hit significantly more than the average (median) ratio among hits. 
This should highlight the most statistically convincing positives. To identify significantly 
‘over-hit’ CDSs, the distribution of the ratios was analysed. CDSs which had received no 
actual hits were excluded from this analysis because they skewed the distribution towards 
zero and were not relevant for the purpose.  
Obs/Exp Hit Ratios were calculated. iGOT hits were analysed as a whole (all hits) but also 
by progressively eliminating hit types (best, higher-possible, lower-possible, and 
phenotype). The qualitatively weakest hit categories were removed one at a time so that 
from one analysis the 'phenotype hits' were excluded, from the next both the phenotype 
and lower-possible hits were excluded, and finally only the 'best hits' remained. This was 
performed in order to assess whether similar results were seen among the different hit 
types. 
Identifying a refined subset of hit CDSs 
The data were analysed using SPSS’s ‘Ratio Statistic’ to find the median values (with 95% 
or 99.9% confidence intervals) for each GOT screen’s hits. [Despite its name the Ratio 
Statistic does not compute the desired output simply by entering Observed Hits as 
numerator and Expected Hits as denominator. Instead the calculated Obs/Exp Ratios 
must be entered as the numerator with the integer 1 as denominator].  
Mapping refined hit regions 
Using the upper-boundary values of the confidence intervals, CDSs with below average 
ratios were eliminated and the remainder were identified and mapped. In cases where two 
refined-hit CDSs flanked a relatively small ‘non-significant’ region (<10 kb between the 
start coordinates of the two CDSs), the entire region was included for the purposes of 
mapping. This was done in order to simplify visualising the significant regions, and was 
considered appropriate on the basis that: (i) around 30 CDSs are simultaneously counted 
as hit when a fosmid is positive, and there was uncertainty of some end-sequence data, 
so the results may not be accurate enough to specify single genes; and (ii) effects are 
likely to often be due to the activity of multiple genes in concert. 
Summarising functional annotations of hits 
Gene Ontology (GO) information was used to look for patterns in the functions of the 
refined hit genes. Biological Process GO data was originally downloaded from JCVI 
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[http://pathema.jcvi.org]. Many CDSs lacked GO annotations, so annotations from the Bp 
genome files (for the Artemis genome browser) were also used. The Artemis annotations 
include some additional functions and many similarities to known genes. 
2.4.4. Relation to known and putative Bp virulence factors 
The published literature was searched in order to collate a list of known and putative 
genes linked to Bp virulence. The Access database was used to cross-reference the list 
with the RVA refined hit genes. Genomic island data was cross-referenced in the same 
way (Holden et al. 2004). Particular attention was paid to genes that were also identified 
by the ‘mGOT’-style macrophage assay using the same BPF library (and BAC clones) 
(Dowling et al. 2010). 
2.4.5. Follow-up 1: Final re-resting of key positive hits 
A selection of positive GOT hits were re-tested in insect larvae to determine if the effects 
were reproducible. Fosmids were selected on the basis of their hits in GOT screens and 
relevance to virulence factors cited in Burkholderia literature (Table 2.11). Some aGOT or 
nGOT hits were also re-tested in insect larvae, on the basis that: their published links to 
virulence could be relevant in the insect host; and the aGOT or nGOT assays showed 
problems with consistency between replicates during the earlier re-testing. 
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aGOT hit.  
KdpDE has links to virulence in many 
bacteria as reviewed in Appendix A (review 
article in press).  
Comparing 29d10 to 32e10 may reveal 
whether presence of the ATPase structural 











iGOT hit.  
CHBP is involved in host ubiquitination 
interference and immune evasion (Cui et 
al. 2010; Felgner et al. 2009; Jubelin et al. 
2009; Yao et al. 2009). The fosmid also 
encodes a phospholipase D. 
02e09 T6SS-6 operon bpsl3096-3108 
iGOT hit. 
Encodes a complete T6SS-6 operon 
33e06 





iGOT and nGOT hits. 
Contains the Invasion-related locus 
regulatory genes (IrlRS) and adjacent ABC 
sugar transport operon which is up-
regulated in macrophages (Chieng et al. 
2012; Jones et al. 1997) 
 
Both M. sexta and G. mellonella larvae were used as hosts. M. sexta injections were as 
described for iGOT. G. mellonella were injected with 10 μl, as described for chapter 4. For 
each fosmid clone, cultures were tested following growth either with or without auto-
induction solution. 10 replicates were used in each case and the larvae were assessed 
daily for four days. 
2.4.6. Follow-up 2: Preliminary fosmid RT-PCR results 
RT-PCR was used to assess whether transcription of particular Burkholderia genes was 
occurring (and could be detected) in BPF fosmid clones. Genes selected for RT-PCR 
(shown in Table 2.12) were chosen on the basis of RVA results, known roles in virulence 
and non-virulence housekeeping roles. 
Bp gene targets were in an E. coli background (Bp fosmids), so all primer pairs were 
checked for similarity to E. coli genomes and only the best pairs were used (those 
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predicted to have no E. coli matches or if unavoidable, where possible non-specific 
products would be of very different sizes to the expected Bp amplicon). BPF fosmid 
clones were prepared by culturing in LB overnight, plus or minus CopyControl™ Auto-
Induction solution to increase copy number. 
Table 2.12. Targets for RT-PCR (RVA targets in Bp/Ec fosmids) 
Target Bp CDS BPF clone GOT hit Notes 
MprA bpss1993 05b11 nGOT 
Evidence suggests this protein is 
expressed in fosmids 
KdpD bpsl 1174 29d10 aGOT 
Sensor kinase of two-component 
system with links to virulence in 
many species 
TC toxin bpsl 0590 08d10  
An ‘mGOT’-style macrophage hit. 
TC toxins are known for links to 
invertebrate virulence 
BylA bpss1269 01d07 nGOT 
Also an ‘mGOT’-style macrophage 
hit. NRPS/PKS secondary 
metabolism 
BimA bpss1492 19b08 aGOT 
Involved in actin mobility. Usually 
expressed intracellularly 
BipD bpss1529 08h02 nGOT 
Part of the T3SS, involved in 




bpsl 1777 14d04 nGOT 




bpss1385 19e10 iGOT 
Up-regulated in macrophages, role 
in host actin and ubiquitination 
processes 
 
Samples were taken from overnight grown bacterial cultures: RNA was preserved using 
RNAlater and stored at -20 °C. RNA was purified using the RNeasy Mini Kit (Qiagen) 
following the protocol for Animal Cells Using Spin Technology (for cells grown in 
suspension). Homogenisation with a blunt needle was not required as re-suspension by 
pipetting was sufficient. The optional on-column DNase digestion step was included 
(RNase-free DNase I; NEB). After problems with DNA contamination, samples were 
DNase digested a second time following Appendix C of the Qiagen MinElute Cleanup 
handbook but extending the incubation time to 1 hour:   
≤87.5 μl RNA solution (contaminated with genomic DNA) 
10 μl Buffer RDD 
2.5 μl DNase I stock solution 
Volume made up to 100 μl with RNase-free water  
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Purified samples were quantified using a Qubit® RNA BR Assay Kit (Invitrogen) and 
stored at -20 °C (-70 °C for longer term). RT-PCR was performed using the Access RT-
PCR Kit (Promega). This method completes both the RT and PCR reactions in one tube; 
one target is amplified (i.e. with one set of specific PCR primers) per tube. The reaction 
mix was as follows: 
Nuclease-free water (to final 50 μl) 
10 μl reaction buffer (5X) 
1 μl dNTP mix (10mM each dNTP) 
Forward primer (50 pmol) 
Reverse primer (50 pmol) 
2 μl MgSO4 (25 mM) 
1 μl AMV reverse transcriptase* (5u / μl) 
1 μl Tfl DNA polymerase (5u / μl) 
RNA template (25 ng) 
Total 50 μl 
*Control reactions omitting the reverse transcriptase enzyme were included to detect any 
DNA contamination. Reaction samples were visualised by gel electrophoresis (1.5% TAE 
agarose gels).  
Thermo-cycling conditions: 
45 °C  45 min  reverse transcription 
94 °C  2 min  RT inactivation, denaturation 
94 °C  30 sec  denaturation 
** °C  1 min  annealing  40 cycles 
68 °C  2 min  extension 
68 °C  7 min  final extension 
  4 °C  ∞  soak 
**Annealing temperatures are shown in Table 2.13. The first seven cycles used touch-
down annealing temperatures, decreasing 1 °C per cycle until the calculated annealing 
temperature, which was used for the remaining 33 cycles.  
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Table 2.13. Primers for fosmid RT-PCR 
Target 






















59 – 53, 








































47.2 53 - 46 183 
 
2.4.7. Follow-up 3: Investigating Burkholderia kdpD 
Attempts to construct a knock out (KO) strain 
Several attempts were made to construct vectors for the generation of deletion mutations 
in the kdpDE operon of Bt E264, Bt CDC 272 or Bt CDC 301. Techniques used in the KO 
attempts and the strategies used are described below. 
Genomic DNA extractions: Bacterial genomic DNA (gDNA) extraction was performed 
using the DNeasy® Blood & Tissue Handbook (Qiagen) according to manufacturer’s 
instructions. From overnight cultures of the Bt strains, 500 μl was pelleted and processed 
according to the “cultured cells” sub-section of the kit protocol. A proteinase K step was 
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incubated for 3 hours. Purified gDNA samples were run on a 0.8% TAE gel and quantified 
using Qubit® BR DNA Assay (Invitrogen).  
Polymerase Chain Reaction (PCR): For approach #1 Pfu high-fidelity polymerase was 
used (Promega). A typical reaction mixture was: 
5 µl Pfu polymerase buffer (10X) 
1 µl forward primer (25 pmol/µl) 
1 µl reverse primer (25 pmol/µl) 
1 µl dNTPs mix (10 mM) 
1 µl genomic DNA (100 ng) 
0.5 µl Pfu polymerase (2-3 units/µl) 
40.5 µl distilled water  
50 μl total 
Typical thermo-cycling conditions for Pfu polymerase: 
95°C   1 min  denaturation 
95°C   1 min  denaturation 
X °C   30 sec  annealing    30 cycles        
72°C   2 min per kb extension 
72°C   10 min  final extension 
4°C   ∞  soak 
For approaches based on #2 Phusion™ proof-reading polymerase was used (New 
England Biolabs). A typical reaction mixture was: 
 
4 µl GC polymerase buffer (5X) 
1 µl forward primer (25 pmol/µl) 
1 µl reverse primer (25 pmol/µl) 
0.4 µl dNTPs mix (10 mM) 
0.4 µl DMSO 
0.5 µl genomic DNA (100 ng) 
0.2 µl Pfu polymerase (2-3 units/µl) 
12.5 µl distilled water  
20 μl total 
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Typical thermo-cycling conditions for Phusion polymerase: 
98°C   30 sec  denaturation 
98°C   10 sec  denaturation 
X °C    25 sec  annealing   35 cycles        
72°C   20 sec per kb  extension 
72°C   10 min  final extension 
4°C   ∞  soak 
Agarose gel electrophoresis: For gel electrophoresis of PCR products gels were 
prepared with 1% or 1.5% (w/v) agarose in 1X TAE buffer, with ethidium bromide. Gels 
were typically run at 100V for 30-60 minutes.  
Restriction digestions: Restriction enzymes (New England BioLabs) were used 
according to the manufacturer’s guidelines, typically in total reaction volumes of 20-45 μl. 
Vector DNA was digested for 2-3 hours and insert (PCR product) DNA was digested for 3-
6 hours. Cut DNA was purified after each digestion reaction.  
DNA purification methods: 
Different DNA purification methods are detailed in Table 2.14. 
Table 2.14. Methods used for DNA purification 
DNA type / source Method 
Bacterial genomic DNA 
DNeasy Blood and Tissue Kit (QIAGEN); according to 
manufacturer’s instructions 
Plasmid DNA 
Plasmid Spin Mini-prep Kit (QIAGEN); according to 
manufacturer’s instructions 
PCR reactions 
PCR Purification Kit (QIAGEN); according to 
manufacturer’s instructions 
DNA of particular sizes 
Gel electrophoresis followed by gel extraction kit 
(QIAGEN); according to manufacturer’s instructions 
 
KO approach #1: Based on a method successfully used at Dstl Porton Down (Norville 
2011) to KO genes in Bt, whereby the two flanking regions of the gene to be knocked out 
are amplified by PCR and each cloned into separate cloning vectors. Each flank is then 
digested, the two flanks are ligated together, and the joined construct is re-ligated back 
into a vector, which is transformed into electrocompetent E. coli. This allows multiple steps 
where the PCR or ligation products can be confirmed by PCR or sequencing. 
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 Primer design: Primers were designed to amplify ~500bp regions upstream and 
downstream of the target gene, including the start (left flank) and stop (right flank) 
codons, with appropriate restriction sites designed into the primers (See Table 
2.15 for sequences). 
 Generation of an unmarked deletion construct: Each flank was amplified by PCR 
and cleaned up. PCR products were quantified using Qubit® dsDNA assays 
(Invitrogen). 
This approach was not completed past this point but the next steps would have been to: 
 Add A-overhangs and clone each product into separate pDrive cloning vectors. 
Transform each into EZ competent E. coli (Qiagen), pick colonies and confirm 
sequences of each. Digest each flank and clean-up. Ligate cut flanks together. 
Ligate the joined construct into pDrive vector. Transform into EZ competent cells. 
Confirm by PCR and sequencing. 
 Create pDM4-LFRF deletion construct  
 Transform the construct into DH5α cells 
 Transform into S17-1 λpir cells (conjugation strain) 
 Conjugate pDM4 into Bt E264 
 Sucrose counter-selection for loss of suicide plasmid 
Table 2.15. Primers for kdpD KO in Bt: approach #1 
Primer Sequence (5’-3’) 
Annealing 




KdpD LF_F: ACTAGTACTCAATCTCGCGCTCGAC 64.6 SpeI 
KdpD LF_R: ATAGATCTTCTTGTCGAGAAGCTGGTCA 63.7 BglII 
KdpD RF_F:  TAAGATCTCCGTATCCAACGAACATCC 63.4 BglII 
KdpD RF_R:  ACTAGTACTTCACGACCGGCGATTC 64.6 SpeI 
 
 
KO approach #2: Based on a method successfully used at the University of Exeter, this 
approach is simplified in terms of cloning and ligation steps. Instead of putting each PCR 
flank into a separate vector (as with approach #1) the two purified PCR products resemble 
each other at the 3’ end and are used as a mixed template for a crossover PCR. The 
crossover product is cloned into the pDM4 plasmid. Additional Bt strains (CDC 272 and 
CDC 301) were also used as those strains reportedly have a higher KO success rate 
(unpublished; personal correspondence). All three Bt strains were 100% identical in the 
nucleotide region relevant for the KO primers.  
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 Primer design: Primers were designed to give 600bp flanking fragments (including 
the start and stop codon of kdpD, respectively) which would complement each 
other. A hexameric restriction site was included in the overlapping region (which 
can be used for restriction analysis) and two different sites at the ends were 
suitable for cloning into the pDM4 vector. One site used (XbaI) is dam-methylation 
sensitive but the methylation sequence was confirmed as absent. See Table 2.16 
for sequences. 
Table 2.16. Primers for kdpD KO in Bt: approach #2 











GTC GGT TCA TCT AGA CAT GCG AGG CCG 
AAG TCT CCG G 
XbaI 
Bt_D#3-fw: 
CCT CGC ATG TCT AGA TGA ACC GAC CGT 








 PCR amplification: See Figure 2.4. Upstream and downstream fragments were 
amplified by PCR using primers 1&2 and 3&4, respectively, and genomic DNA of 
target organism as template. The crossover PCR used ten-fold-diluted PCR 
products from the 1st PCR as a template and the outside primers 1&4, which 
should give a 1.2 kb PCR fragment. 
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Figure 2.4. PCR approach for gene deletion (image courtesy of C. Müller, University of Exeter) 
 
This approach was not completed past this point but the next steps would have been to: 
 Digest the pDM4 plasmid and recombinant PCR product with appropriate enzymes 
(SpeI and XmaI) and ligate the fragments together using T4 DNA ligase. 
Transform E. coli DH5α λpir with the ligation mix and select for CmR clones. Check 
the resulting plasmids by PCR and restriction digest pattern or sequencing, and 
transfer correct plasmids into E. coli S17 λpir by electroporation. 
 Conjugation to integrate suicide plasmid construct into chromosome 
 Sucrose counter-selection for loss of suicide plasmid 
 Confirm mutant by PCR and sequencing 
KO approach #2.1: This used the same approach as #2 but with new primers. The left 
flank primers were re-designed to lower the annealing temperature (Table 2.17). The right 
flank XmaI site (GGGCCC) was replaced with a SacI site (GAGCTC) to attempt to reduce 
perceived difficulties with primer structures and to lower the annealing temperature closer 











PCR1 (primers 1&2 or 3&4, Bt gDNA as template): 
SpeI XbaI 
XbaI XmaI 
PCR2 (primers 1&4, PCR1-products as template): 
SpeI 
XbaI 
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Table 2.17. Primers for kdpD KO in Bt: approach #2.1 















ATG CTG TCT AGA  GTA TCC AAC GAA CAT 
CC 72 
XbaI 
Bt_D#4-rv: G GAG CTC TCA GAT GCA CGA CCT C SacI 
 
KO approach #2.2: This used the same approach as #2 but with new primers again 
(Table 2.18). The size of the flanking regions was increased to ~800bp following advice 
that 600bp would not be long enough either side of the deletion to easily allow double 
cross-over into the chromosome. 
Table 2.18. Primers for kdpD KO in Bt: approach #2.2 







BtD_LF1:  CC ACT AGT CAT CGA GAA GGA CGG CAAG 66 SpeI 
BtD_LF2: 




CTG CTC TCT AGA CCC GTA TCC AAC GAA 
CAT CC 
66 XbaI 
BtD_RF4:  G GAG CTC ATG ACG AGC GGA AAT TGG AG 66 SacI 
 
Attempts to over-express kdpDE 
In order to try a different molecular approach, attempts were also made to over-express 
kdpDE using a groS promoter. The plasmid pBHR4-groS-RFP expresses RFP (red 
fluorescent protein) under the control of the groS promoter. The RFP gene would be 
replaced with the Bt kdpDE genes and the plasmid would be transformed into E. coli 
DH5α.  
 Primer design: Primers were designed to amplify both the kdpD and kdpE genes 
from Bt in case proximity of the two proteins is necessary for kdpE activation 
(Table 2.19). A SpeI site was engineered adjacent to the start of kdpD in the 
forward primer so that the insert would be close to the groS promoter. (The primer 
was particularly long because a second site was also included which may have 
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been used for a TOPO cloning method, which was not used). The reverse primer 
was 154-173 bp downstream of the kdpE stop site. 
Table 2.19. Primers for kdpDE over-expression construct 












BtDE comp Rv: AATAGGATCCGAATGACGACGAACGACGAT 65 BamHI 
 
 PCR of kdpDE from Bt: Phusion polymerase was used as described above to 
amplify the 3.97kb region from Bt gDNA. For the annealing step a gradient from 62 
– 72 °C was used. Reactions were analysed on 1.5% TAE gels; 71.8°C was 
selected as the optimal annealing temperature and PCR was repeated. The 
corresponding band was excised and cleaned up using a gel extraction kit 
(Qiagen). 
 Digestion of vector and insert: pBHR4-groS-RFP DNA was purified using a 
Plasmid Spin Mini-prep Kit (Qiagen). The purified vector and kdpDE insert were 
digested with SpeI-HF and BamHI-HF enzymes (NEB) at 37 °C for 2 hours and 6 
hours respectively. The cut insert was purified on a PCR purification column 
(Qiagen). The cut vector was run on a gel to confirm two separate fragments were 
seen and to excise and gel-extract the 5.65 kb band. Samples of purified vector 
and insert were run on a gel to compare DNA concentration.  
 Ligation and transformation: T4 DNA ligase (NEB) was used for ligation of 
sticky-ended DNA fragments, with a vector (μg) : insert (μg) ratio of approximately 
1:3 in a total reaction volume of 20 μl. Following manufacturer’s instructions, 
reaction components were assembled on ice, mixed well prior to ligase addition, 
and then mixed gently. Alongside vector-insert ligation reactions, a control reaction 
lacking insert DNA was also set up to check for re-ligation of the vector backbone. 
Reactions were incubated at room temperature for 2 hours, and immediately 
transformed into competent cells. EZ Competent Cells (Qiagen) were used for 
heat-shock transformation of ligated cloning constructs. One 50 μl aliquot of cells 
was thawed on ice per transformation, and 1 μl of ligation reaction was added. 
Cells were gently mixed by flicking, and incubated for 5 minutes on ice, then 30 
seconds in a 42 °C water bath, and then back on ice for 2 minutes. 250μl SOC 
media was added per tube, and tubes were incubated shaking at 37 °C for 30 
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minutes. 100 μl and 200 μl samples were spread onto LB plates with 50 mg/mL 
chloramphenicol (or no selection for a control), and incubated at 37 °C overnight.  
No transformants were seen but the next step would have been to prepare plasmid DNA 
from transformants and confirm by restriction mapping or sequencing. 
Preliminary RT-PCR of fosmid kdpD in response to host 
RT-PCR of the kdpD gene was performed on two fosmids: fosmid 29d10 which contains 
the two complete operons for the Kdp potassium ATPase (kdpFABC and kdpDE), and 
fosmid 32e10 which is incomplete in the structural operon (lacking kdpFA).  
To discover whether the kdpD/kdpE genes were differentially transcribed after injection 
into the insect host, RT-PCR of the kdpD target was performed using RNA samples 
collected before and after exposure. The same cultures from which the RNA samples 
were prepared (inoculum samples) were also used to inject M. sexta larvae (4 larvae per 
condition). 30 minutes post-injection the larvae were bled and RNA was prepared from the 
pooled haemolymph. RNA samples were processed and DNase digested twice as 
described earlier. RT-PCR of the kdpD gene was performed as described earlier. 
 
 Burkholderia infection assays in Manduca sexta pg. 99 
Chapter 3. Burkholderia infection 
assays in Manduca sexta 
3.1. Chapter summary 
The major aim of the work described in this chapter was to investigate the virulence of 
several Burkholderia species and strains in M. sexta by injection directly into the 
haemocoel or by feeding. It was observed that B. pseudomallei (Bp) and B. thailandensis 
(Bt) were virulent by injection, which agrees with reported virulence in Galleria mellonella. 
Unexpectedly, B. oklahomensis (Bo) strains were also virulent, which has not been 
reported from any animal infection models so far. In fact the relative virulence of Bp, Bt 
and Bo was reversed in M. sexta compared to reports from mammalian or other insect 
models, with Bo strains being amongst the most virulent. Infections were repeated in G. 
mellonella maintained at both 37 °C and 25 °C to determine whether that observation 
reflects differences in the host systems or is primarily related to temperature. The results 
indicated that there may be host-specific differences, but were not conclusive and further 
investigation will be required.  
No previous publications have reported feeding Bp, Bt or Bo to lepidopteran hosts. Bt and 
Bo were virulent to M. sexta neonates via the oral route of infection, although variability 
was observed between experiments with Bt. Based on the ability of cell-free Bo 
supernatant to kill the larvae or prevent normal growth our findings support previous 
suggestions that Burkholderia secrete diffusible toxic or paralytic agents which are active 
against invertebrates.  
3.2. Introduction 
Until recently there was negligible published evidence regarding the virulence of Bp-group 
pathogens in invertebrates. Host models of infection are an invaluable tool for the study of 
bacterial pathogens. Infection in a good model host mirrors that seen in the host of 
interest (e.g. humans) in terms of the level of virulence, the mechanisms of pathogenesis, 
and/or the similar attenuating effects of mutations in key genes. Therefore they provide a 
safe and suitable way to evaluate virulence of related species, potential attenuating 
mutations, or the protective effects of vaccine candidates. 
The aims of the work described in this chapter were to: (i) investigate the virulence of 
several Burkholderia species and strains in M. sexta; (ii) test the virulence of mutant 
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strains which display attenuation in other hosts; and (iii) challenge M. sexta with 
Burkholderia orally to investigate a more ecologically plausible route of infection. 
Aim: Assessing Burkholderia virulence in Manduca sexta 
Following preliminary tests in M. sexta with the Bt type strain E264, dose response 
injection assays were also performed with Bp K96423, two other Bt strains and two Bo 
strains. These same strains of Bp, Bt, Bo have previously been tested in G. mellonella 
and the results were reported to generally compare well in that model with the virulence 
observed in BALB/c mouse models, as shown in Table 3.1 (Wand et al. 2011; Titball et al. 
2008; DeShazer 2007). In those models Bp was the most virulent species and Bo was the 
least. These results will be compared to those from M. sexta regarding the relative 
virulence of these same species and strains. 
Table 3.1. Comparative virulence of Burkholderia strains in the G. mellonella model versus the mouse. Median 
Lethal Dose (MLD) or % survivors were reported from BALB/c mice after intra-peritoneal injections (Titball et 
al. 2008; DeShazer 2007). G. mellonella were injected with 10
2
 colony forming units (CFU; 10μl at 10
4
 CFU 
/ml); % survivors and growth of bacteria in the insects are shown (Wand et al. 2011). Strains are ranked in 









Virulence in G. mellonella  
(10
2
 CFU dose: 10
4
 CFU /ml)  
(Wand 2011) Ranked 
virulence in 
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Aim: Testing attenuated Bt mutants in Manduca sexta 
Mutant Bt strains which have been demonstrated to be attenuated in other infection 
models were also tested in the M. sexta model in order to confirm whether the same 
attenuating effects were seen. Two mutant strains were available: a surA mutant and a 
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Twin-Arginine Transport (TAT) system mutant, which are both discussed in the main 
introduction. Briefly, both mutants had been seen to be attenuated in the Galleria 
mellonella model (I. Norville and S. Wagley respectively, unpublished results).  
Aim: Feeding Burkholderia to Manduca sexta 
Finally, the effect of Burkholderia infection via the digestive route will be investigated, as 
ingestion of contaminated plant material is likely to be the most common route of insect 
infection with Burkholderia in the natural environment. Bt E264 and Bo C6786 were fed to 
M. sexta larvae and the results were compared to the effects of feeding Epi300 E. coli or 
LB controls.  
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3.3. Results 
3.3.1. Confirmation of Burkholderia pathogenicity to 
invertebrate hosts 
The first step was to confirm that Bt E264 (and by extrapolation, Bp K96423) was 
pathogenic to the invertebrate model hosts used in Rapid Virulence Annotation (RVA; the 
subject of Chapter 5). RVA detects an increase in toxicity/pathogenicity/virulence (or 
repellent factors) in otherwise harmless E. coli clones expressing portions of the genome 
of a pathogenic bacterium. Therefore, pathogenicity of the whole bacterium in M. sexta, 
and the ability to survive or avoid predation by Caenorhabdus elegans and Acanthamoeba 
polyphaga, is a pre-requisite for RVA testing. Bp K96423 was to be the subject of RVA but 
on the basis of their genetic similarity and the lower containment requirement Bt E264 was 
used for these preliminary tests instead. 
Caenorhabditis elegans pathogenicity / predation avoidance 
As expected (based on published results, discussed in the introduction), Bt E264 was 
lethal to C. elegans. Plates were maintained at room temperature. Control plates with E. 
coli OP50 were fully consumed by 3 days after seeding with nematodes, and the worms 
were seen to be active on every day assessed. However, on plates with Bt E264 no 
nematode activity was seen even 1 day after seeding. The Bt lawn was thick and not all 
nematodes were visible; those that were visible were motionless. By day 7 the mats had 
still not been consumed and no nematode movement (or tracks across the plates) had 
been observed. Therefore the nematodes were not consuming or were not surviving 
consumption of Bt E264.  
Acanthamoeba polyphaga pathogenicity / predation avoidance 
Plates were maintained at room temperature. Control plates seeded with E. coli were 
readily fed upon by the amoebae: on PAS minimal medium all the E. coli mats were fully 
consumed by the amoebae by day 4; on PYG nutrient medium there was a very slight E. 
coli dose response effect (see Table 3.2), with the most amoebae (2x105 per ml) eating 
the least bacteria (OD600 0.0313) by day 5, and the least amoebae eating the most 
bacteria by day 6. However, the Bt E264 mats were not consumed at all on either agar 
type or with any amoeba concentration, even by day 13. Therefore the amoebae were not 
consuming or were not surviving consumption of Bt E264. 
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Table 3.2. Rate of A. polyphaga feeding upon E. coli Epi300 mats on PYG agar (showing ‘day started’-‘day 
completed’). The amoebae fed readily upon the E. coli controls. Results for Bt E264 are not shown as the 
mats were not consumed within 13 days’ testing, indicating that Bt E264 is not consumed or is harmful to A. 
polyphaga. 
  E. coli  Epi300 (OD600) 
  
0.5 0.25 0.125 0.0625 0.0313 
A. polyphaga 
(cells per ml) 
2.0x10
5
 Day 5-6 Day 5-6 Day 4-5 Day 4-6 Day 4-5 
1.0x10
5
 Day 5-6 Day 4-5 Day 4-5 Day 4-5 Day 4-5 
5.0x10
4
 Day 5-6 Day 5-5 Day 5-5 Day 4-6 Day 4-5 
2.5x10
4
 Day 5-6 Day 5-6 Day 5-6 Day 5-6 Day 5-5 
PYG only Not eaten Not eaten Not eaten Not eaten Not eaten 
 
 
Manduca sexta pathogenicity (experiment #1) 
Initial experiments to look at the pathogenicity of Bt E264 in M. sexta used low numbers of 
insects (n = 3) simply to determine whether the bacterium was pathogenic and, if so, to 
roughly gauge the dynamics of the infection. Insects were maintained at 25 °C pre- and 
post-injection. A series of OD600 cell densities was initially tested as inoculum. Table 3.3 
shows the results. 
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Table 3.3. Results of initial Bt E264 injections in Manduca sexta. Epi300 = E. coli Epi300. O/n culture = 
overnight culture. P = paralysis. D = death. Bt E264 was lethal at all doses tested, with a dose responsive 
effect. A paralysis phase preceded death. 
 
OD600  CFU Replicate 20 hr 24 hr 48 hr 120 hr 
Bt E264 
O/n culture 
 1 P D     
1.53x108 2 P D     
 3 P D     
0.250 
 1 OK P D   
1.46x107 2 OK P D   
 3 OK P D   
0.125 
 1 OK P D   
8.40x106 2 OK P D   
 3 OK P D   
0.063 
 1 OK P D   
4.95x106 2 OK P D   
 3 OK OK D   
0.031 
 1 OK OK D   
1.90x106 2 OK OK D   
 3 OK OK D   
Epi300  0.250 
 1 OK OK OK OK 
3.59x107 2 OK OK OK OK 
 3 OK OK OK OK 
LB only    1 OK OK OK OK 
White cell = insect alive and well. Light grey, P = alive and paralysed. Dark grey, D = dead. 
 
All E. coli and LB-injected controls remained healthy at 120 hours post-injection. Undiluted 
overnight culture of Bt E264 killed all three larvae by 24 hours and the diluted samples all 
killed by 48 hours. The progression from an outwardly healthy appearance to death 
included a paralysis phase where movement was extremely limited or involved 
uncoordinated spasms. With the undiluted overnight culture the progression from 
paralysis to death was rapid (<4 hours). In summary, Bt E264 was lethal to M. sexta at all 
doses tested, with a dose responsive effect. A paralysis phase preceded death. 
3.3.2. Manduca sexta as a Burkholderia infection model  
Unless otherwise stated, all Manduca sexta were maintained at 25 °C before and after 
injection with bacteria (which was incubated overnight at 37 °C). 
Dose response #2: Bt E264 
Having established that Bt E264 was pathogenic to M. sexta, a wider and lower range of 
doses was tested.  
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Table 3.4 shows the survival of insects injected with different doses, over six days. The 
dose responsive effect was more apparent with this wider range of doses compared to 
dose response #1. Subsequent Bt injections used greater numbers of insects, and 
replicates, for improved reliability and statistical significance. 
Table 3.4. Numbers of larvae surviving Bt E264 infection (n = 5) over six days.Epi300 = E. coli Epi300. 

















2.30x101 5 5 5 5 
 
1 
2.20x102 5 5 5 0 
  
1.90x103 5 5 3 1 
 
0 
2.20x104 5 5 0 
   
2.00x105 5 0 
    
Epi300 3.80x105 5 5 5 5 
 
5 
Hatched cells indicate no data available. Light grey = <100% alive. Dark grey = 0% alive. 
 
Figure 3.1 depicts the calculated median times to death (MTTDs) for the different doses. 
The 103 CFU dose shows a standard error (SE) of the median because the point at which 
half of the insects died (2.5 insects) lies between 72-96 hours; at the other doses the SE 
was zero because ≥2.5 of the insects had died by the same day. The dose responsive 
effect is evident. MTTDs ranged from 48-144 hours post-injection. 
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Figure 3.2 is a Kaplan-Meier survival curve for the Bt E264 doses; the curves start at 1.0 
and drop down the y-axis (cumulative survival) as the insects die; the point at which the 
curve ends indicates the number of surviving insects at the end of the assessment. In 
cases where insects survive the Kaplan-Meier survival curve line displays a small cross, 
which is described in the key as a ‘censored’ case. Confirming what was shown in figure 
10, Bt E264 shows a dose-responsive lethal effect; the curves drop off sooner at higher 
doses and at the lowest dose the cumulative survival is 0.2 (one insect survived).  
Figure 3.2. Kaplan-Meier survival curve for Bt E264 doses injected into M. sexta. The curves start at 1.0 (all 
alive) and drop down the y-axis (cumulative survival) as the insects die. The point at which the curve ends 
indicates the number of surviving insects at the end of the assessment. In cases where insects survive, the 
curve line displays a small cross which is described in the key as a ‘censored’ case. Survival curves drop 
quickly to zero at high doses of Bt E264. At 10
1
 CFU Bt E264 one insect (0.2 of the total) survives to 140 
hours post-injection.  
 
 
As shown in Table 3.5 log-rank (Mantel-Cox) tests performed as part of the Kaplan-Meier 
analysis revealed that the 103 CFU dose gave a statistically similar larva-survival profile to 
the 102 CFU dose (p = 0.649) but the differences between all other combinations of doses 
were significant (p ≤ 0.05). 
  
 Burkholderia infection assays in Manduca sexta pg. 107 
Table 3.5. Log-rank (Mantel-Cox) pairwise comparisons between Bt E264 doses. NS = not significantly 
different, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
Bt E264 dose Bt E+01 Bt E+02 Bt E+03 Bt E+04 Bt E+05 
Bt E+01  ** * ** ** 
Bt E+02 **  NS ** ** 
Bt E+03 * NS  * ** 
Bt E+04 ** ** *  ** 
Bt E+05 ** ** ** **  
 
 
Dose response #3: Bp K96423 
Following the initial Bt E264 experiments, M. sexta larvae were injected with Bp K96423 in 
appropriate containment facilities. This served to confirm whether Bp K96423 was in fact 
virulent to M. sexta and therefore suitable for RVA testing (in chapter 5), rather than 
relying on extrapolation based on the virulence of Bt E264. 
Figures 3.3-3.5 show representative photographs of Bp-infected larvae or controls. 
Figure 3.3. Representative larvae injected with controls, on day 6 post-injection. Both are healthy wanderer 
stage larvae. 
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Figure 3.4. M. sexta larvae injected with Bp K96423 (various doses or heat-killed cells), on day 3 post-
injection. These larvae were representative of those that succumbed to Bp infection, which was not the case 
for all larvae. A positively-correlated dose-responsive effect on insect morbidity is evident. With 20 live CFU or 
200,000 heat-killed CFU the larva is healthy. With 20,000 live CFU the larva is small and slightly shrunken 
larva. With 200,000 live CFU the larvae is dead, with a shrunken appearance, discolouration, and little 
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Figure 3.5. M. sexta larvae injected with Bp K96423 did not all succumb to infection. At day 6 post-injection 
these larvae show examples of differing states of health from the same dose of Bp. 20 CFU: (left) dead larva, 
developed to approximately wanderer stage; (right) healthy wanderer larva. 200 CFU: (left) dead wanderer 
larva; (right) healthy wanderer larva. 2,000 CFU: (left) healthy larva showing signs of melanocytic nodulation 
immune response (black spots visible in the enlarged image); (right) dead larva. 
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Table 3.6 shows the survival of insects injected with different doses, over seven days.  
Table 3.6. Numbers of larvae surviving Bp K96423 infection  (n = 8) over seven days.Epi300 = E. coli Epi300. 
Various doses were tested and a dose responsive effect seemed to occur, although data was missing on two 


















168 hrs (in 100μl) 
Bp 
K96423 
2.00x101 8 8 8 8     6 5 
2.00x102 8 8 8 8     6 6 
2.00x103 8 7 7 7     4 4 
2.00x104 8 8 8 8     0 0 
2.00x105 8 8 8 1     0 0 
Heat 
killed Bp  
2.00x105 8 8 8 8     8 8 
Epi300  2.00x105 8 8 8 8     8 8 
PBS   8 8 8 8     8 8 
Hatched cells indicate no data available. Light grey = <100% alive. Dark grey = 0% alive. 
 
A dose responsive lethality was evident, as it had been with Bt E264, although the time to 
death was noticeably longer. The median time to death (MTTD) for larvae injected with Bp 
was 72 hours at a 105 CFU dose. The MTTD was calculated as 144 hours at a 104 or 103 
CFU dose; however, those MTTDs are not reliably useful because the deaths may have 
occurred during day 4 or 5 when no data was collected. MTTDs could not be calculated 
for the lower doses because more than half of the larvae survived beyond the seven days. 
Figure 3.6 is a Kaplan-Meier survival curve for the Bp K96423 doses, confirming the dose-
responsive lethal effect.  
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Figure 3.6. Kaplan-Meier survival curve for Bp K96423 doses. The curves start at 1.0 (all alive) and drop down 
the y-axis (cumulative survival) as the insects die. The point at which the curve ends indicates the number of 
surviving insects at the end of the assessment. In cases where insects survive, the curve line displays a small 
cross which is described in the key as a ‘censored’ case. Survival curves fell to zero at the two highest doses 
of Bp K96423. Several insects survived at the lower doses and with the controls. H.K. = heat-killed Bp 
K96423. Epi300 = E. coli Epi300.  
 
Shown in Table 3.7, log-rank (Mantel-Cox) tests performed as part of the Kaplan-Meier 
analysis of Bp K96423 injections revealed that: the highest dose generated a survival 
curve significantly different from all the other doses; the lower doses were significantly 
different from the higher doses; yet there were similar profiles between some doses that 
were only one log different.  
Table 3.7. Log-rank (Mantel-Cox) pairwise comparisons between Bp K96423 doses. NS = not significantly 
different, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
Bp K96243 dose Bp E+01 Bp E+02 Bp E+03 Bp E+04 Bp E+05 
Bp E+01  NS NS ** *** 
Bp E+02 NS  NS ** *** 
Bp E+03 NS NS  NS ** 
Bp E+04 ** ** NS  *** 
Bp E+05 *** *** ** ***  
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Like Bt E264, Bp K96423 showed a dose-responsive lethal effect: at 105 CFU the MTTD 
was 72 hours. At 104 or 103 CFU doses the MTTD was not reliable but was between 96-
144 hours. At the lower doses more than half of the larvae survived beyond the seven 
days. The controls all showed 100% survival throughout the experiment, including the 
heat-killed Bp cells at the highest concentration tested (equivalent to 105 CFU). 
Importantly, the Bp K96423 appeared to be less virulent than Bt E264 to M. sexta.  
In summary, Bp strain K96423 was less virulent than Bt strain E264 in Manduca sexta. 
Table 3.8 compares the M. sexta MTTD values calculated for Bp K96423 and Bt E264 at 
equivalent doses. As well as having longer MTTDs, fewer larvae succumbed to disease 
with Bp: up to 50% of the larvae given doses below 104 CFU remained healthy throughout 
the seven days. With Bt only one larva (20%) survived throughout the six days, and only 
at the lowest dose tested (101 CFU). 
Table 3.8. Median Times to Death for M. sexta larvae injected with equivalent doses of Bt E246 (n = 5) or Bp 




 CFU doses of Bp because more than half the 




 CFU Bp were calculated as 144 hours but data 
were missing; the true MTTD values are in the range of 96-144 hours. 
Dose (CFU) 
MTTD (hours) 
Bt E264 Bp K96423 
101 144 * 
102 96 * 
103 96 96-144* 
104 72 96-144* 
105 48 72 
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Dose response #4 and repeat #5:  Bt and Bo strains 
For greater reliability and statistical significance, further experiments were conducted with 
Bt E264 with more replicates. Out of interest, a selection of other containment level 2 
Burkholderia strains were also assessed in parallel – two other Bt strains (Bt CDC 272 
and Bt CDC 301) and two B. oklahomensis (Bo) strains (Bo C6786 and Bo E0147). These 
strains were all previously tested in mice and Galleria mellonella (Wand et al. 2011) and 
are therefore useful for comparison in the M. sexta model. The natural history of the 
strains is discussed in the introductory chapter.  
M. sexta injections were performed with Bt and Bo strains. Dose response #4 tested a 
range of doses, as shown in Table 3.9.  










No. alive (/10) at timepoints 
Day: 1 2 3 4 5 6 7 
Hour: 18 24 28 42 48 52 66 72 76 90 96 100 114 120 124 138 144 148 162 168 172 
Bt E264 
0.43x10^4   10 10 10 10 10 10 9 5 3 0 
           
0.43x10^3   10 10 10 10 10 10 10 9 8 2 1 
 
0 
        
0.43x10^2   10 10 10 10 10 10 10 10 10 10 10 
 
6 6 4 0 
     
Bt CDC 272 
1.50x10^4   10 10 10 10 10 10 10 10 10 10 10 
 
10 10 10 10 W 
    
1.50x10^3   10 10 10 10 10 10 10 10 10 10 10 
 
10 10 10 10 W 
    
1.50x10^2   10 10 10 10 10 10 10 10 10 10 10 
 
10 10 10 10 10 10 10 W 
 
Bt CDC 301 
0.69x10^4   10 10 10 10 10 10 0 
              
0.69x10^3   10 10 10 10 10 10 1 0 
             
0.69x10^2   10 10 10 10 10 10 9 3 1 0 
           
Bo C6786 
1.41x10^4   10 10 10 7 0 
                
1.41x10^3   10 10 10 10 10 10 0 
              
1.41x10^2   10 10 10 10 10 10 9 6 2 0 
           
Bo E0147 
0.33x10^4   10 10 10 10 10 7 0 
              
0.33x10^3   10 10 10 10 10 10 2 0 
             
0.33x10^2   10 10 10 10 10 10 10 9 7 1 0 
          
Epi300 0.77x10^4   10 10 10 10 10 10 10 10 10 10 10 
 
10 10 10 10 W 
    
Hatched cells indicate no data available. Light grey = <100% alive. Dark grey = 0% alive. W = wanderer stage, euthanised 
 
The experiment showed a dose-responsive lethal effect for Bt CDC 301, Bo C6786, Bo 
E0147, and Bt E264 as before. However, Bt CDC 272 did not show any effect on the 
larvae, which all developed to the wanderer stage. 
Dose repeat #5 focused on and repeated the 104 CFU dose, as shown in Table 3.10. 
When the ~104 dose of each strain was repeated in dose repeat #5, Bt CDC 272 did kill all 
larvae, yet at a considerably slower rate than the other strains. 
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No. alive (/10) at timepoints 
 
Day: 1 2 3 4 5 6 7 
Hour: 18 24 28 42 48 52 66 72 76 90 96 100 114 120 124 138 144 148 162 168 172 
Bt E264 0.49x10^4 
 
10 10 10 10 10 10 3 2 1 0 
           
Bt CDC 272 0.71x10^4 
 
10 10 10 10 10 10 10 10 10 9 9 9 5 4 4 0 
     
Bt CDC 301 1.44x10^4 
 
10 10 10 10 10 3 0 
              
Bo C6786 0.77x10^4 
 
10 10 10 9 1 0 
               
Bo E0147 0.24x10^4 
 
10 10 10 10 10 9 0 
              
Epi300 1.10x10^4 
 
10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 w 
    
Light grey = <100% alive. Dark grey = 0% alive. W = wanderer stage, euthanised 
 
For statistical analyses the data from dose response #4 and dose repeat #5 were 
combined and grouped into log doses according to the actual CFU counts. Bp K96423 
data was also compared. Bo E0147 CFU numbers were nearly one log lower than 
expected, so no data was available for the 104 dose (i.e. they were used for 103). The 
same was the case for the Bt E264 data; data from dose response experiment #2 were 
analysed for the Bt E264 104 dose. Bt CDC 301 had slightly low CFU numbers but they 
were closer to 104 than 103, so were retained in the 104 data set.   
Therefore the 103 and 102 dose comparisons were the most reliable and complete data 
sets for between-species comparison of virulence, but the 104 dose comparison is still 
informative. These data are analysed below, by dose. 
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102 CFU dose 
MTTDs for the 102 CFU doses are shown in Figure 3.7, with standard errors of the 
median.  
Figure 3.7. Median Time to Death (MTTD) for Bt, Bo and Bp strains at 10
2
 CFU doses. Error bars show SE of 
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Figure 3.8. Kaplan-Meier survival curve for 10
2
 doses. ‘CDC 2’ = CDC 272, ‘CDC 3’ = CDC 301, ‘K96’ = 
K96423. The curves start at 1.0 (all alive) and drop down the y-axis (cumulative survival) as the insects die. 
The point at which the curve ends indicates the number of surviving insects at the end of the assessment. In 
cases where insects survive, the curve line displays a small cross which is described in the key as a 
‘censored’ case. Several insects survived with Bp K96423 and all survived with Bt CDC 272. The other strains 
killed all larvae. 
 
Log-rank (Mantel-Cox) pairwise comparisons performed as part of the Kaplan-Meier 
analysis of Bp/Bt/Bo 102 CFU injections revealed that: 
 Bo C6786 was significantly different from all other strains (p ≤ 0.007)  
 Bt E264 was significantly different from all other strains (p ≤ 0.007) 
 Bo E0147 and Bt CDC 301 were similar (p = 0.542) but different from all other 
strains (p ≤ 0.001) 
 Bp K96423 and Bt CDC 272 were similar (p = 0.103) but different from all other 
strains (p = 0.000) 
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103 CFU dose 
At a 103 CFU dose, in one experiment Bt CDC 272 killed no larvae. In the second it killed 
all 10. Therefore it was possible to calculate an overall MTTD, although this value should 
be used with caution. This value (MTTD = 138 hours) places Bt CDC 272 slightly ahead of 
Bp K96423 in terms of virulence (Bp MTTD = 144 hours). 103 CFU MTTDs are shown in 
Figure 3.9, with standard errors of the median.  
Figure 3.9. Median Time to Death (MTTD) for Bt, Bo and Bp strains at 10
3
 CFU doses. Error bars show SE of 
the median.  
 
 










































 Burkholderia infection assays in Manduca sexta pg. 118 
Figure 3.10. Kaplan-Meier survival curve for 10
3
 doses. ‘CDC 2’ = CDC 272, ‘CDC 3’ = CDC 301, ‘K96’ = 
K96423. The curves start at 1.0 (all alive) and drop down the y-axis (cumulative survival) as the insects die. 
The point at which the curve ends indicates the number of surviving insects at the end of the assessment. In 
cases where insects survive, the curve line displays a small cross which is described in the key as a 
‘censored’ case. Several insects survived with Bp K96423 and Bt CDC 272, and all survived with the E. coli 
control. The other strains killed all larvae. 
 
 
Log-rank (Mantel-Cox) pairwise comparisons performed as part of the Kaplan-Meier 
analysis of Bp/Bt/Bo 103 CFU injections revealed that: 
 The two Bo strains were similar to each other (p = 0.860) but significantly different 
from all other strains (p ≤ 0.008) 
 Bp K96423 was similar to Bt CDC 272 (p = 0.757) but significantly different from all 
other strains (p ≤ 0.014) 
 Bt CDC 301, Bt E264 and E. coli Epi300 were all significantly different from other 
strains (p ≤ 0.014). 
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104 CFU dose 
104 CFU dose MTTDs are shown in Figure 3.11, with standard errors of the median. No 
data was available for Bo E0147 at 104 CFU doses. More than half of the Bt CDC 272 
larvae survived so no MTTD could be calculated. 
Figure 3.11. Median Time to Death (MTTD) for Bt, Bo and Bp strains at 10
4
 CFU doses. Error bars show SE of 
the median. No data was available for Bo E0147 at 104 CFU doses. All of the Bt CDC 272 larvae survived at 
this dose so no MTTD could be calculated. 
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Figure 3.12. Kaplan-Meier survival curve for 10
4
 doses. ‘CDC 2’ = CDC 272, ‘CDC 3’ = CDC 301, ‘K96’ = 
K96423. The curves start at 1.0 (all alive) and drop down the y-axis (cumulative survival) as the insects die. 
The point at which the curve ends indicates the number of surviving insects at the end of the assessment. In 
cases where insects survive, the curve line displays a small cross which is described in the key as a 
‘censored’ case. All insects survived with Bt CDC 272 and with the E. coli control. The other strains killed all 
larvae, although Bp K96423 was considerably slower to kill. 
 
 
Log-rank (Mantel-Cox) pairwise comparisons performed as part of the Kaplan-Meier 
analysis of Bp/Bt/Bo injections revealed that at 104 CFU the survival curve of every 
Burkholderia strain tested was significantly different from every other (p ≤ 0.001). 
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Table 3.11 summarises the MTTD values for Bt and Bo in the dose response #4 and dose 
repeat #5 experiments. 
Table 3.11. Median Time to Death (MTTD) values for Bt and Bo strains. n = 10.  
Strain 
Calculated dose  
(CFU per 100μl) 
MTTD (hrs) 
Dose response #4 
Dose  
repeat #5 
Bt E264  
2.2x104*  72 
4.3x103 4.9x103 72 
4.3x102  90 
Bt CDC 272  
1.5x104 0.71x104 - 
1.5x103  138** 
1.5x102  - 
Bt CDC 301  
0.69x104 1.44x104 52 
0.69x103  66 
0.69x102  66 
Bo C6786  
1.41x104 0.77x104 48 
1.41x103  52 
1.41x102  76 
Bo E0147  
NT  NT 
3.3x103 2.4x103 60 
3.3x102  66 
A dash denotes cases where death was not observed. NT = not tested 
*Bt E264 10
4
 dose data is based on dose response #2 
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Combined with the data from Bp K96423, Table 3.12 summarises the relative virulence at 
different doses of all the Bp-group bacteria tested in M. sexta.  
Table 3.12. Relative virulence in M. sexta of Bp, Bt and Bo strains, based on MTTD values. n = 10 except for 
Bp K96423 where n = 8  
 
Doses and strain MTTDs 










Bo C6786 48hrs Bo C6786 52hrs = Bt CDC 301 66hrs 
Bt CDC 301 52hrs Bo E0147 60hrs = Bo E0147 66hrs 
*  Bt CDC 301 66hrs Bo C6786 76hrs 
Bt E264 72hrs Bt E264 72hrs Bt E264 90hrs 
Bp K96423 96-144hrs Bt CDC 272 138hrs Bp K96423 ** 
Bt CDC 272 ** Bp K96423 96-144hrs Bt CDC 272 ** 
= denotes tied places 
*No data for Bo E0147 at 10
4
 CFU 
**No MTTD value 
  
 
In summary, differences were observed in the virulence of different Burkholderia strains, 
both within and between species. In general the pattern of virulence was the same at the 
different doses tested, with Bp K96423 and Bt CDC 272 being the least virulent in the 
insect host, and most virulent strains being the Bo strains and Bt CDC 301. These results 
were in contrast to those published from the G. mellonella larva model, where Bp K96423 
was the most virulent strain and Bt CDC 272 was also highly virulent (Wand et al. 2011).  
3.3.3. Virulence in Galleria mellonella at 25 °C versus 37 °C 
In addressing the differences seen in the results of Burkholderia insect infection compared 
to those of Wand et al. (2011), it was apparent that a major difference in methodology was 
the temperature at which the larvae were maintained post-injection. Therefore in this 
experiment larvae were injected with the same strains (at 102 CFU doses) and maintained 
at either 25 °C (as before) or 37 °C (as by Wand et al).  
It was decided to use G. mellonella larvae for this purpose, as previous experience of 
keeping infected M. sexta at 37 °C had resulted in even E. coli control-injected larvae 
dying in considerable numbers (although other authors have reported success using M. 
sexta at 37 °C (Fleming et al. 2006)).  
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Table 3.13 shows the results of Bt and Bo infections in G. mellonella larvae maintained at 
25 °C (top) and 37 °C (bottom). 





 CFU doses. Showing results of larvae incubated at 25 °C (top) and 37 °C (bottom). Median Time to 
Death (MTTD) values were calculated by Kaplan-Meier survival analysis. Epi300 = E. coli Epi300. Infection 








No. alive (/10) at time-points 
MTTD 
(hrs) 
Day: 0 1 2 3 4 
Hour: 0 24 48 72 96 
Bt E264 0.49x10^2 
 
10 10 10 1 0 72 
Bt CDC 272 0.71x10^2 
 
10 10 9 9 6 * 
Bt CDC 301 1.44x10^2 
 
10 10 9 0  72 
Bo C6786 0.77x10^2 
 
10 9 9 0  72 
Bo E0147 0.24x10^2 
 
10 10 10 0  72 
Epi300 1.10x10^2 
 
10 10 10 10 10 * 
NaCl 
  









No. alive (/10) at time-points 
MTTD 
(hrs) 
Day: 0 1 2 3 4 
Hour: 0 24 48 72 96 
Bt E264 0.49x10^2 
 
10 10 0 
 
 48 
Bt CDC 272 0.71x10^2 
 
10 8 7 7 7 * 
Bt CDC 301 1.44x10^2 
 
10 3 0 
 
 24 
Bo C6786 0.77x10^2 
 
10 10 0 
 
 48 
Bo E0147 0.24x10^2 
 





10 8 7 7 7 * 
NaCl 
  
10 10 10 10 10 * 
Light grey = <100% alive. Dark grey = 0% alive. * No MTTD values as >50% survived 
 
Bt CDC 272 failed to kill all G. mellonella larvae at either temperature, just as was 
observed in the M. sexta model at 25 °C. This supports the results from this study instead 
of the results of Wand et al (2011).  
At 25 °C all the other Burkholderia strains had MTTD values of 72 hours post-injection. At 
37 °C most MTTD values were reduced to 48 hours and Bt CDC 301 was reduced to just 
24 hours; however, it should be noted that the calculated dose was the highest for that 
strain. At 37 °C some E. coli -injected control larvae also died.   
Raising the maintenance temperature to 37 °C increased the rate of disease progression 
but the overall pattern of relative virulence in G. mellonella was not changed. This 
suggests that the relative virulence of these strains is not temperature-dependent.  Wand 
et al (2011) reported that in G. mellonella at 37 °C Bt CDC 272 was the most virulent Bt or 
Bo strain tested; yet in the same conditions it was found here to be the least virulent. 
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Wand et al (2011) also reported that the Bo strains were less virulent than Bt strains. With 
the exception of Bt CDC 272, this was found to be the same in this G. mellonella study, at 
either temperature. This general pattern which was conserved in the G. mellonella results 
is in contrast to that seen in the M. sexta results, wherein the Bo strains were generally 
the most virulent. 
In summary, Bt CDC 272 showed strikingly different results between Wand et al (2011) 
and this study. With that exception, in G. mellonella Bt strains were generally more 
virulent than Bo strains regardless of maintenance temperature. In M. sexta however, Bo 
strains were generally the most virulent. Therefore the relative virulence of these Bt and 
Bo strains appeared to be host-species-dependent.  
3.3.4. Attenuation of Bt E264 mutants in Manduca sexta 
To further investigate the suitability of M. sexta as a model host for Burkholderia infection, 
mutants were also tested which were reported to be attenuated in the established model 
G. mellonella. The ΔsurA deletion mutant and TAT (prhA:tatA) conditional mutant are 
discussed in the introductory chapter.   
Bt E264 ΔsurA 
The ΔsurA deletion mutant was reported to be attenuated in the G. mellonella insect 
model (I. Norville, unpublished results) and was therefore compared for attenuation in the 
M. sexta model. High doses of wild-type Bt E264 or the ΔsurA mutant were tested first 
(106-104 CFU), with larvae maintained at 37°C post-injection to match the method used at 
Dstl for G. mellonella (I. Norville, unpublished results). Results are shown in Table 3.14.  





 CFU doses. Note that larvae were incubated at 37°C. Epi300 = E. coli Epi300 
Strain  
Calculated dose (CFU 
per 100μl): 
No. Alive (/10) at time-points 
Day: Day 0 Day 1 Day 2 
Hour: 0 24 48 
NaCl 
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10 1 0 
Light grey = <100% alive. Dark grey = 0% alive. 
 Burkholderia infection assays in Manduca sexta pg. 125 
E. coli -injected controls all survived as expected. At 106 CFU no difference was evident 
between the wild-type Bt E264 and the mutant. At 105 and 104 CFU 10% of the larvae 
injected with the mutant strain survived for longer.  
To reveal greater differentiation this was followed up by tests at lower doses (101-103 
CFU), with larvae incubated at 25°C as for the other M. sexta dose responses. This low 
dose test (n = 10, 25°C incubation) was repeated in three independent experiments; 
combined results are shown in Table 3.15.  
Table 3.15. Numbers of M. sexta surviving infection with wild-type or ΔsurA Bt E264 (n = 30) over two days; 




 CFU doses. Larvae incubated at 25°C as usual. 
Epi300 = E. coli Epi300. WT = wild-type. Larvae injected with the mutant strain survived slightly longer than 




(CFU per 100μl, 
across replicate 
experiments) 
No. alive (/30) at time-points 
Days: Day 0 Day 1 Day 2 
Ave. Hours: 0 18 24 32 42 48 
NaCl    
30 30 30 30 30 30 
Epi300 3.50 x103   30 30 30 30 30 30 
Bt E264 WT 
1.93 x10
3
   30 30 27 0   
1.93 x10
2
   30 30 30 4 0  
1.93 x10
1




   30 30 30 5 0  
2.63 x10
2
   30 30 30 28 0  
2.63 x10
1
   30 30 30 30 8 1 
Light grey = <100% alive. Dark grey = 0% alive. 
 
Figure 3.13 shows MTTD values for larvae injected with different doses of wild-type and 
ΔsurA mutant Bt E264, with standard errors of the median. The mutant strain was 
attenuated in terms of MTTD at the 102 CFU dose. 
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Figure 3.13. Median Time to Death (MTTD) for wild-type or ΔsurA Bt E264 at different doses  (n = 30 over 






Although median time-to-death (MTTD) values have been used for comparing the strain 
virulence, the mean time-to-death values (Figure 3.14) shows a little more variation 
between strains, which may be informative in this case.   
Figure 3.14. Mean time to death for wild-type or ΔsurA Bt E264 at different doses. Error bars show SE of the 
mean. At each dose mean time to death is greater for the mutant strain, indicating attenuation of virulence. At 
the 10
3
 CFU dose the difference is slight.  
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Figure 3.15. Kaplan-Meier survival curve for wild-type or ΔsurA Bt E264 doses. BtE = Bt E264 wild-type. surA 
= Bt E264 ΔsurA. The curves start at 1.0 (all alive) and drop down the y-axis (cumulative survival) as the 
insects die. The point at which the curve ends indicates the number of surviving insects at the end of the 
assessment. In cases where insects survive, the curve line displays a small cross which is described in the 
key as a ‘censored’ case. 
  
 
According to log rank (Mantel-Cox) pairwise significance calculations shown in Table 3.16, 
the difference between wild-type and ΔsurA virulence was significant at equivalent doses 
(p ≤ 0.005).  
Table 3.16. Log-rank (Mantel-Cox) pairwise comparisons between M. sexta survival profiles when injected 
with wild-type or ΔsurA Bt E264. NS = not significantly different, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. The 
survival was significantly different at each equivalent dose. 
Dose ΔsurA10^1 ΔsurA10^2 ΔsurA10^3 
BtE 10^1 ** NS *** 
BtE 10^2 *** *** NS 
BtE 10^3 *** *** ** 
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Bt E264 ΔsurA was also tested alongside the other Bt and Bo strains in dose response #4 
and dose repeat #5 (n = 10 in each case) so that data could be used for direct 
comparisons (i.e. using larvae from the same batch and including a 104 CFU dose). MTTD 
values are summarised in Table 3.17. This time the MTTD values were considerably 
greater; all larvae still died but survived for a longer time period. 
Table 3.17. MTTD values for M. sexta injected with Bt E264 ΔsurA compared to values for the Bt and Bo 
strains  already discussed. Data is combined from dose response #4 and dose repeat #5. 
Strain 
Calculated dose  
(CFU per 100μl) 
MTTD (hrs) 
Dose response #4 
Dose  
repeat #5 
Bt E264  
2.2x104*  72 
4.3x103 4.9x103 72 
4.3x102  90 
Bt CDC 272  
1.5x104 0.71x104 - 
1.5x103  138** 
1.5x102  - 
Bt CDC 301  
0.69x104 1.44x104 52 
0.69x103  66 
0.69x102  66 
Bo C6786  
1.41x104 0.77x104 48 
1.41x103  52 
1.41x102  76 
Bo E0147  
NT  NT 
3.3x103 2.4x103 60 
3.3x102  66 
Bt E264 ΔsurA 
1.09x104 0.89 x104 72 
1.09x103  76 
1.09x102  124 
A dash denotes cases where death was not observed. NT = not tested 
* Bt E264 104 dose data is based on dose response #2 
** Bt CDC 272 MTTD is based on 100% death in one experiment and 0% death in another, so 
should be used with caution 
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Table 3.18 summarises the relative virulence of the Bp-group bacteria, as previously 
shown in Table 3.12, now including the Bt E264 ΔsurA mutant. 
Table 3.18. Bt E264 ΔsurA relative virulence compared to other strains, based on MTTD values 
 
Doses and strain MTTDs 










Bo C6786 48hrs Bo C6786 52hrs 
= Bt CDC 
301 
66hrs 
*  Bo E0147 60hrs = Bo E0147 66hrs 
Bt CDC 301 52hrs Bt CDC 301 66hrs Bo C6786 76hrs 
= Bt E264 72hrs Bt E264 72hrs Bt E264 90hrs 









Bp K96423 96-144hrs Bt CDC 272 138hrs Bp K96423 ** 
Bt CDC 272 ** Bp K96423 96-144hrs Bt CDC 272 ** 
= denotes tied places 
*Bo E0147 not tested at 10
4
 CFU 
**No MTTD values as >50% survived 
  
 
In summary, the Bt E264 ΔsurA mutant which was reported to be attenuated in the 
established G. mellonella host model (I. Norville, unpublished results) was also seen to be 
attenuated in M. sexta, most notably at a 102 CFU dose. According to MTTD values the 
strain is less virulent than the Bt E264 wild-type strain but still more virulent than Bt CDC 
272 or Bp K96423.  
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Bt E264 TAT (prhA:tatA) mutant  
The second mutant strain tested was a Bt E264 twin-arginine transport (TAT) system 
conditional mutant which was also attenuated in G. mellonella (S. Wagley, unpublished 
results). Larvae were maintained at 25 °C. Table 3.19 shows the results of M. sexta 
injection with the Bt E264 TAT system mutant in a TAT-active state (media supplemented 
with rhamnose) or a TAT-deficient state (media supplemented with glucose).  





 CFU doses. LB medium was supplemented with rhamnose to give normal TAT system 
expression or glucose to inactivate the system in the mutant strain. Wild-type Bt E264 was grown in identical 
conditions to the mutant strain for comparison. Epi300 = E. coli Epi300 






Number alive (/8) at timepoints 
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 
24 hr 48 hr 72 hr 96 hr 120 hr 144 hr 
Bt E264 rhamnose 
1.14x10
6
 8 8 0 
   
1.14x10
5












 8 8 8 7 3 0 
Bt E264 glucose 
0.80x10
6
 8 8 0 
   
0.80x10
5








 8 8 8 1 1 0 
0.80x10
2
 8 8 8 6 2 1 
Bt TAT rhamnose 
1.31x10
6
 8 8 0 
   
1.31x10
5




 8 8 8 4 1 1 
1.31x10
3
 8 8 8 8 7 6 
1.31x10
2
 8 8 8 8 8 8 
Bt TAT glucose 
10
6
 / / / / / / 
1.50x10
5
 8 8 0 
   
1.50x10
4








 8 8 8 2 1 1 
1.50x10
1
 8 8 8 8 5 3 
Epi300 0.86x10
6
 8 8 8 8 8 8 
PBS  8 8 8 8 8 8 
Light grey = <100% alive. Dark grey = 0% alive. / = no data. 
 
Figure 3.16 shows TAT #1 MTTD values for larvae injected with different doses of wild-
type and TAT mutant Bt E264 grown in the presence of rhamnose or glucose, with 
standard errors of the median.   
 Burkholderia infection assays in Manduca sexta pg. 131 
Figure 3.16. TAT #1: Median Time to Death (MTTD) for wild-type or TAT-mutant Bt E264 at different doses  (n 
= 8). Error bars show SE of the median. The TAT mutant should have wild-type-like (‘WT-like’) TAT 
expression when grown in the presence of rhamnose and an inactive TAT system when grown in the 
presence of glucose. The different sugars were not expected to affect the virulence of wild-type Bt E264. No 




 CFU because more than half of the larvae 
survived. It appears that the condition in which the TAT system should be inactive has amongst the shortest 
MTTD values, suggesting it was actually more virulent. 
 
Figure 3.17 shows representative photos of M. sexta larvae at three days post-injection 
with the Bt E264 TAT conditional mutant. The two sugar-supplemented conditions are 
shown, at two dosages. 
Figure 3.17. Representative larvae at 3 days post-injection with two doses of the Bt E264 TAT conditional 
mutant. With rhamnose the TAT system is active, as in wild-type Bt E264. The inactive TAT (with glucose) 












































Bt E264 rhamnose Bt E264 glucose TAT rhamnose ('WT-like') TAT glucose (inactive)
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Figure 3.18 shows the Kaplan-Meier survival curve for the TAT #1 injections at 104 CFU. 
Figure 3.18. TAT #1: Kaplan-Meier survival curve for wild-type or TAT conditional mutant Bt E264 at 10
4
 CFU 
doses. Growth with rhamnose (‘rh’) should give the mutant a wild-type TAT phenotype. Growth with glucose 
(‘gl’) inactivates the TAT system. The curves start at 1.0 (all alive) and drop down the y-axis (cumulative 
survival) as the insects die. The point at which the curve ends indicates the number of surviving insects at the 
end of the assessment. In cases where insects survive, the curve line displays a small cross and is described 
in the key as a ‘censored’ case. 
 
Log-rank (Mantel-Cox) pairwise comparisons performed as part of the Kaplan-Meier 
analysis revealed that: 
 None of the pairwise comparisons between wild-type Bt E264 grown with 
rhamnose or with glucose were significant, i.e. there was no significant difference 
in Bt E264 virulence as a result of the media used (p-values = 0.143 – 0.962).   
 Most of the p-values comparing actual wild-type Bt E264 and the ‘wild-type-like’ 
TAT phenotype were significant, meaning that there was a significant difference in 
virulence between them (102-104 CFU dose: p-values = 0.000 – 0.025). Therefore 
the rhamnose-induced expression of the TAT system did not appear to fully match 
wild-type; some larvae injected with TAT (rhamnose) did not die whereas all Bt 
E264-injected larvae did.  
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 Comparing the active (rhamnose-induced) and inactive (glucose) states of the TAT 
mutant showed that there was a significant difference in virulence, as all p-values 
were highly significant. However, the observed effect was the opposite of the 
expected effect; at 105, 104 and 102 CFU the TAT-inactive mutant killed more 
rapidly than the wild-type E264 or ‘wild-type’-like TAT.  
As the results were unexpected, a second TAT dose response was performed (TAT #2) 
this time also using the wild-type and mutant strains grown in LB alone to better 
understand whether the presence of sugar in the inoculum was affecting the bacteria-host 
interaction (Table 3.20). A greater range of doses was used in order to differentiate effects 
more clearly; 102, 104 and 106 CFU. 
Table 3.20. Numbers of larvae surviving infection with wild-type or conditional TAT mutant E264 (n = 8) over 






 CFU doses. LB medium was supplemented with rhamnose to give normal 
TAT system expression or glucose to inactivate the system in the mutant strain. As a control un-supplemented 
LB was also used. Wild-type Bt E264 was grown in identical conditions to the mutant strain for comparison. 




(CFU per 100μl) 
Number alive (/8) at timepoints 
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
24 hr 48 hr 72 hr 96 hr 120 hr 144 hr 168 hr 
Bt E264 LB 
1.16x10
6
 8 8 0     
1.16x10
4
 8 8 5 0    
1.16x10
2
 8 8 8 3 2 0  
Bt E264 rhamnose 
0.74x10
6
 8 8 0     
0.74x10
4
 8 8 5 2 0   
0.74x10
2
 8 8 8 6 4 2 0 
Bt E264 glucose 
0.99x10
6
 8 8 0     
0.99x10
4
 8 8 1 0    
0.99x10
2
 8 8 8 3 0   
Bt TAT LB 
est: 0.61x10
6
 8 8 8 7 0   
est: 0.61x10
4
 8 8 8 8 8 8 4 
est: 0.61x10
2
 8 8 8 8 8 8 8 
Bt TAT rhamnose 
est: 0.61x10
6
 8 8 0     
est: 0.61x10
4
 8 8 8 5 2 2 1 
est: 0.61x10
2
 8 8 8 8 6 5 3 
Bt TAT glucose 
0.61x10
6
 8 8 0     
0.61x10
4
 8 8 5 1 0   
0.61x10
2
 8 8 8 7 5 1 1 
Light grey = <100% alive. Dark grey = 0% alive. ‘est’ = CFUs could not be calculated; estimates are based on 
Bt TAT glucose figure and similar OD600 values 
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Figure 3.19 shows TAT #2 MTTD values for larvae injected with different doses of wild-
type and TAT mutant Bt E264 grown in the presence or absence of rhamnose or glucose, 
with standard errors of the median. 
Figure 3.19. TAT #2: Median Time to Death (MTTD) for wild-type or TAT mutant Bt E264 at different doses  (n 
= 8). Error bars show SE of the median. The TAT mutant should have wild-type-like TAT expression when 
grown in the presence of rhamnose and an inactive TAT system when grown in the presence of glucose. Both 
strains were also grown in LB without sugar supplements as a control. No MTTD value was calculable for 
‘TAT LB’ at 10
6
 CFU because more than half of the larvae survived. In the absence of sugar supplement the 
mutant strain was attenuated, probably due to lowered bacterial fitness. However, once again the mutant with 
glucose (inactive TAT) was more virulent than that with glucose (supposedly wild-type-like). 
 
Once again the TAT mutant with rhamnose was attenuated compared to an inactive TAT 
system with glucose (at 104 and 106 CFU doses). Another surprising result was that when 
the TAT mutant was grown with LB alone its virulence was even more attenuated. This 
suggests that the mutant has a lower fitness and that the presence of the different sugars 
in the inoculum may have complicated the outcome of the infections, for example by 
providing an extra energy source. 
In summary, the TAT-inactivated mutant did not show the same attenuating effect in the 
M. sexta model as in the G. mellonella model (S. Wagley, unpublished results). An 
additional level of complication is involved when conditional mutants are controlled by 
supplementation of the media with metabolites such as sugars. Fortunately the 
chromosomal ΔsurA mutant had shown attenuation, supporting the validity of the M. sexta 




















































Bt E264 LB Bt E264 rhamnose Bt E264 glucose
TAT LB TAT rhamnose ('WT-like') TAT glucose (inactive)
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3.3.5. Burkholderia exhibit oral pathogenicity or toxicity to 
Manduca sexta 
Another aspect of Burkholderia virulence which was of interest to study was the possibility 
that they may be pathogenic to M. sexta larvae via the oral route. This follows from the 
fact that Burkholderia are predominantly environmental organisms and saprophytes in 
particular, and that insects ingest a large amount of plant material and detritus. 
Experiments #1-3 were initial assessments of the effect on M. sexta neonates of ingesting 
Bt E264, with ingestion of LB or Epi300 E. coli as controls. In assessing the effect on 
larvae, two measurements were informative: the proportion and the weight of surviving 
insects, as either death or reduced weight may be indicative of a pathogenic or toxic 
effect. 
Experiment #1: There was a clear difference in mortality between LB and Bt E264-fed 
neonates; by day eight of the feeding assay 9 out of 10 control neonates were alive, 
compared to 3 out of 10 Bt E264-fed neonates (Table 3.21). However, the average weight 
of the surviving larvae was 0.139g for the LB control group and 0.135g for the Bt E264 
group (Figure 3.20 and Table 3.21); there was no significant difference (T-test for unequal 
variances, p = 0.833).  
Figure 3.20. Average day 8 weights of surviving 
neonates (experiment #1). Error bars = SE 
 




Bt E264  
culture 
Survival to Day 
8 
90 % 30 % 
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Table 3.21 shows the complete results for experiment #1. 
Table 3.21. Day 8 weights of surviving neonates (experiment #1). D = neonate died 
Neonate 
LB control  
(g) 
Bt E264 culture 
(g) 
1. 0.129 0.146 
2. 0.126 0.152 
3. 0.085 0.106 
4. 0.163 D 
5. 0.140 D 
6. 0.139 D 
7. 0.187 D 
8. 0.128 D 
9. 0.150 D 
10. D D 
AVERAGE 0.139 0.135 
SE 0.009 0.014 
 
Experiment #2: As a considerable number of neonates that had been fed Bt E264 had 
died, experiment #2 used diluted cultures. However, when the bacteria were adjusted to 
OD600 0.1 all of the neonates survived to day eight and no differences were seen between 
Bt E264, E. coli Epi300 and LB (data not shown). Therefore further experiments reverted 
to using undiluted overnight culture samples. The 200 μl addition volume was kept. 
Experiment #3: Reverting back to undiluted overnight cultures, this experiment tested the 
effect of feeding on both fifth istar and neonate larvae. In a crude attempt to produce a 
supernatant-only sample, cells were centrifuged to pellets and the supernatant was 
harvested; however, as the samples were not filtered a small amount of viable bacterial 
cells remained. Therefore these are referred to as ‘reduced-cell’ cultures. 
Fith instars: From the fifth-instar group all the larvae remained healthy. By day 2 they had 
consumed the bacteria-laced food blocks and were given normal antibiotic-free food. By 
day 5 none had died and all seemed healthy. In summary, Bt E264 had no harmful effect 
on fifth-instar stage M. sexta  
Neonates: The neonate results were quite different, as summarised in Table 3.22. The Bt-
fed neonates (fed either complete or reduced-cell Bt E264 culture) showed increased 
mortality compared to the E. coli controls.  
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n 10  20 20 16 17 
% 100 % 100 % 100 % 80 % 85 % 
 
The Bt-fed survivors also showed reduced weight in comparison to the controls, as shown 
in Figure 3.21. Interestingly, the weight of surviving larvae which were fed reduced-cell Bt 
culture was considerably lower than those fed complete Bt culture. 
Figure 3.21. Average day 8 weights of surviving neonates (experiment #3). In this experiment the ‘reduced-
cell’ culture samples contained relatively few bacteria (not quantified). Error bars = SE. 
 
This effect may perhaps be explained if: a low number of cells allows the Bt to achieve a 
‘stealthy’ infection and avoid immune detection before establishing an acute ‘attack’; or if a 
loosely surface-attached toxin is released into the medium (and thereby made 
available/active) during the centrifugation step to remove cells. Table 3.23 shows the 
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Table 3.23. Day 8 weights of surviving neonates (experiment #3). Epi300 = E. coli Epi300. In this experiment 
reduced-cell culture samples contained fewer bacteria (not quantified). 




cell culture (g) 





1. 0.205 0.166 0.158 0.124 0.022 
2. 0.171 0.145 0.14 0.135 0.021 
3. 0.154 0.144 0.188 0.087 0.025 
4. 0.162 0.193 0.198 0.083 0.02 
5. 0.17 0.141 0.183 0.189 0.022 
6. 0.178 0.106 0.135 0.067 0.028 
7. 0.151 0.172 0.202 0.081 0.052 
8. 0.136 0.187 0.173 0.082 0.036 
9. 0.229 0.156 0.114 0.098 0.023 
10. 0.177 0.161 0.171 0.113 0.072 
11.   0.134 0.123 0.093 0.021 
12.   0.154 0.202 0.085 0.048 
13.   0.157 0.149 0.126 0.023 
14.   0.158 0.135 0.085 0.024 
15.   0.123 0.144 0.079 0.067 
16.   0.144 0.126 0.091 0.047 
17.   0.041 0.082 D 0.023 
18.   0.178 0.074 D D 
19.   0.109 0.135 D D 
20.   0.08 0.139 D D 
AVERAGE 0.173 0.142 0.149 0.101 0.032 
SIG.  
0.015 * 0.047 * 0.000 *** 0.000 *** 
n 10 20 20 16 17 
SE 0.009 0.008 0.008 0.008 0.004 
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Figure 3.22 depicts neonate larvae from experiment #3, eight days after beginning to feed 
on the bacteria-laced diet. The size differences are apparent: LB and Epi300-fed controls 
are healthy and relatively large; Bt E264-fed larvae are somewhat smaller when fed 
complete culture or considerably smaller when fed centrifuged culture with low numbers of 
cells. 
Figure 3.22. Day 8 neonates after feeding on bacteria or LB control (experiment #3). In this experiment the 
reduced-cell culture samples (labelled ‘supernatant’) contained fewer bacteria (not quantified). 
 
 
Reduced-cell culture samples were intended as a crude supernatant but they were not 
truly sterile, so a filtration step was added for the next experiment. 
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Experiment 4: Experiment #4 was performed in order to repeat experiment #3 but with a 
properly sterile supernatant and a heat-treated supernatant. Additonally, the experiments 
were performed over two days so that exponential phase (16 hour) and stationary phase 
(40 hour) cultures could be compared, and a Bo strain (Bo C6786) was tested in parallel. 
A number of food blocks dried out during the course of this experiment due to poor seals 
on the container pots: those larvae were removed from the data set. Table 3.24 and 
Figures 3.23-3.24 summarise the survival of neonates fed bacteria and controls which had 
been incubated for 1 or 2 nights. 
Table 3.24. Survival of fed neonates to day 7 (experiment #4). Epi300 = E. coli Epi300. 1-night = 16 hours, 2-
night = 40 hours. All larvae fed 1-night incubated cultures  
 
Survival to Day 7 
1-night incubation 2-night incubation 
n % n % 
LB control 17 / 18 94.4 16 / 16 100 
Epi300 
Culture 14 / 14 100 12 / 12 100 
Washed cells 15 / 18 83.3 18 / 18 100 
Supernatant 18 / 18 100 13 / 14 92.3 
Heat-treated 
supernatant 
16 / 16 100 18 / 18 100 
Bt E264 
Culture 11 / 14 78.6 13 / 16 81.3 
Washed cells 13 / 16 81.3 17 / 18 94.4 
Supernatant 13 / 14 92.3 12 / 13 92.3 
Heat-treated 
supernatant 
16 / 16 100 14 / 16 87.5 
Bo C6876 
Culture 16 / 20 80.0 14 / 19 73.7 
Washed cells 13 / 14 92.3 8 / 16 50.0 
Supernatant 14 / 18 77.8 20 / 20 100 
Heat-treated 
supernatant 
10 / 10 100 16 / 17 94.1 
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Figure 3.23. Experiment #4: Survival of neonate larvae fed upon 1-night-incubated samples. The larvae fed Bt 
and Bo whole culture or cell-free supernatant showed lower survival than equivalent E. coli controls. 
 
Figure 3.24. Experiment #4: Survival of neonate larvae fed upon 2-night-incubated samples. The larvae fed 
with each Bt sample showed lower survival than their E. coli couterparts. The most striking result is the 
reduction in survival when fed Bo washed (supernatant-free) cells. 
 
In terms of survival rates, most samples were similar at between 70-100%. The larvae fed 
Bt and Bo whole culture or cell-free supernatant showed lower survival than equivalent E. 
coli controls. When fed the 2-night incubated (stationary phase) samples, the most striking 
result was the reduction in survival when fed Bo washed (supernatant-free) cells. This 
suggests that removal of supernatant also removes a protective factor for the insect host; 
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over-reaction, or perhaps factors in the supernatant prime the insect immune system and 
allow it to cope better. 
Turning to weight instead of survival, the effectsof Bt E264 and Bo C6786 samples on 
neonate growth are evident in the photos in Figure 3.25. 
Figure 3.25. Day 7 neonates after feeding on bacteria or LB control: 2-night-incubated (experiment #4) 
 
 
The following Figures 3.26-3.27 summarise the weights of surviving neonates which had 
been fed bacteria and controls which had been incubated for 1 or 2 nights. Compared to 
experiment #3, the effects of Bt on neonate weight were less apparent. Bo however 
showed striking results. Surviving larvae which had been fed Bo whole culture or Bo cell-
free supernatant showed greatly reduced weight compared to their counterparts including 
Bt. The fact that neonates fed heat-treated Bo supernatant were a ‘normal’ weight implies 
that the factor responsible for the toxic or pathogenic effect is proteinaceous and is 
released into the supernatant, either naturally or as a result of centrifugation.  
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Figure 3.26. Experiment #4: Average day 7 weights of surviving neonates fed 1-night (16 hour)-incubated 
cultures. Error bars = SE. Surviving larvae fed Bo culture or Bo cell-free supernatant showed greatly reduced 
weight compared to their counterparts, including Bt.  
 
Figure 3.27. Experiment #4: Average day 7 weights of surviving neonates fed 2-night (40 hour)-incubated 
cultures.Error bars = SE. Surviving larvae fed Bo culture or Bo cell-free supernatant showed greatly reduced 
weight compared to their counterparts, including Bt. 
 
Tables 3.25 and 3.26 contain the data and calculated p-values for the 1-night and 2-night- 
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1. 0.111 0.182 0.098 0.068 0.193 0.092 0.137 0.098 0.135 0.013 0.136 0.022 0.058 
2. 0.121 0.132 0.159 0.046 0.196 0.078 0.137 0.103 0.136 0.015 0.150 0.022 0.155 
3. 0.110 0.135 0.088 0.101 0.218 0.064 0.117 0.095 0.086 0.021 0.159 0.022 0.122 
4. 0.074 0.190 0.086 0.125 0.144 0.070 0.122 0.154 0.144 0.022 0.106 0.020 0.065 
5. 0.177 0.145 0.153 0.062 0.202 0.085 0.124 0.137 0.095 0.012 0.119 0.024 0.151 
6. 0.150 0.185 0.228 0.054 0.190 0.088 0.107 0.193 0.088 0.021 0.133 0.022 0.154 
7. 0.133 0.116 0.130 0.111 0.211 0.077 0.065 0.158 0.169 0.018 0.138 0.021 0.099 
8. 0.124 0.124 0.093 0.128 0.141 0.072 0.209 0.179 0.149 0.026 0.201 0.021 0.112 
9. 0.081 0.154 0.118 0.113 0.176 0.092 0.114 0.146 0.144 0.022 0.150 0.016 0.121 
10. 0.114 0.159 0.190 0.117 0.130 0.096 0.165 0.122 0.167 0.017 0.173 0.025 0.163 
11. 0.146 0.169 0.210 0.193 0.166 0.101 0.179 0.098 0.154 0.020 0.171 0.015 F 
12. 0.106 0.185 0.192 0.185 0.157 D 0.099 0.050 0.058 0.017 0.162 0.018 F 
13. 0.081 0.135 0.141 0.166 0.137 D 0.109 0.026 0.113 0.026 0.172 0.018 F 
14. 0.189 0.097 0.081 0.107 0.147 D D D 0.130 0.024 D 0.020 F 
15. 0.208 F 0.088 0.205 0.087 F D F 0.163 0.019 F D F 
16. 0.123 F D 0.138 0.068 F D F 0.101 0.024 F D F 
17. 0.119 F D 0.089 F F F F F D F D F 
18. D F D 0.122 F F F F F D F D F 
19. F F F F F F F F F D F F F 
20. F F F F F F F F F D F F F 
MEAN 
(g) 


















    0.000 
*** 
















n 17 14 15 18 16 11 17 13 16 16 13 14 10 
SE. 0.009 0.008 0.012 0.011 0.011 0.004 0.009 0.013 0.008 0.001 0.008 0.001 0.012 
D = neonate died. F = food dried out, excluded from data. SIG. = significance of difference compared to LB average, 
equivalent Epi300 average, or equivalent Bt E264 average (T-test, unequal variances) *p≤0.05, **p≤0.01, ***p≤0.001. 
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1. 0.134 0.159 0.047 0.054 0.149 0.112 0.138 0.166 0.092 0.023 0.190 0.024 0.225 
2. 0.122 0.197 0.050 0.174 0.195 0.092 0.157 0.130 0.073 0.022 0.077 0.022 0.182 
3. 0.208 0.182 0.150 0.146 0.098 0.059 0.052 0.166 0.144 0.020 0.097 0.018 0.182 
4. 0.147 0.191 0.174 0.083 0.157 0.088 0.171 0.160 0.098 0.017 0.116 0.013 0.178 
5. 0.075 0.209 0.078 0.028 0.146 0.081 0.163 0.074 0.105 0.014 0.168 0.017 0.071 
6. 0.138 0.185 0.035 0.023 0.151 0.052 0.168 0.020 0.081 0.015 0.110 0.020 0.077 
7. 0.174 0.175 0.174 0.062 0.131 0.149 0.111 0.084 0.146 0.014 0.128 0.011 0.183 
8. 0.172 0.187 0.164 0.059 0.119 0.140 0.174 0.130 0.111 0.016 0.106 0.010 0.055 
9. 0.148 0.120 0.151 0.102 0.140 0.087 0.155 0.084 0.113 0.013 D 0.019 0.058 
10. 0.114 0.122 0.138 0.110 0.149 0.159 0.182 0.099 0.133 0.018 D 0.019 0.011 
11. 0.161 0.191 0.098 0.051 0.173 0.091 0.184 0.052 0.034 0.032 D 0.013 0.109 
12. 0.185 0.178 0.120 0.045 0.137 0.006 0.117 0.059 0.033 0.013 D 0.020 0.083 
13. 0.110 F 0.189 0.054 0.158 0.078 0.020 D 0.174 0.018 D 0.013 0.150 
14. 0.132 F 0.048 D 0.164 D 0.195 F 0.151 0.014 D 0.012 0.140 
15. 0.112 F 0.060 F 0.072 D 0.085 F D D D 0.015 0.141 
16. 0.126 F 0.022 F 0.073 D 0.038 F D D D 0.015 0.146 
17. F F 0.022 F 0.169 F 0.042 F F D F 0.016 D 
18. F F 0.042 F 0.147 F D F F D F 0.015 F 
19. F F F F F F F F F D F 0.018 F 
20. F F F F F F F F F F F 0.017 F 
MEAN 
(g) 
























    0.000 
*** 















n 16 12 18 13 18 13 17 12 14 14 8 20 16 
SE. 0.008 0.008 0.014 0.013 0.006 0.012 0.014 0.014 0.007 0.001 0.013 0.001 0.019 
D = neonate died. F = food dried out, excluded from data. SIG. = significance of difference compared to LB average, 
equivalent Epi300 average, or equivalent Bt E264 average (T-test, unequal variances) *p≤0.05, **p≤0.01, ***p≤0.001. 
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The p-values from the 1-night exponential phase samples (Table 3.25) indicate that: 
Epi300 samples had little effect on the neonates’ growth compared to LB except that heat-
treated supernatant seemed to confer some nutrition; Bt E264 culture resulted in 
significantly reduced weight gain compared to LB or Epi300; and Bo C6786 samples 
resulted in weight gain that was significantly even less than Bt E264 culture or 
supernatant.  
The p-values from the 2-night stationary phase samples (Table 3.26) indicate that: Epi300 
culture was nutritious whereas Epi300 washed cells or supernatant led to reduced weight; 
Bt E264 culture again resulted in significantly reduced weight gain compared to LB or 
Epi300; and Bo C6786 samples again resulted in weight gain that was significantly less 
than even Bt E264 culture or supernatant. 
Table 3.27 summarises the percentage difference in mean neonate weight after feeding 
with 1-night-incubated versus 2-night-incubated bacteria. As noted in the method details, 
the neonates which were used for the first batch (1-night-incubated samples) appeared to 
be less healthy than usual, so it is unsurprising that the 2nd batch showed a 10.7% greater 
weight even in the LB control group.  
Table 3.27. Comparison of Day 7 weights of surviving neonates fed 2-night incubated (stationary phase) 
versus 1-night incubated (exponential phase) bacterial or control samples. Epi300 = E. coli Epi300. Control 
larvae weighed 10.7% more in the 2
nd
 batch, indicating the difference in general health of the larvae used on 
the two consecutive days. 
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Figure 3.28 therefore shows the percentage differences after accounting for the difference 
in the LB control. 
Figure 3.28. Chart showing the % difference in average Day 7 weights of surviving neonates (fed 2-night 
incubated versus 1-night incubated samples) minus the % difference seen in the LB control group. A negative 
change indicates that neonates fed 2-night incubated samples weighed less, i.e. were less healthy, than those 
fed the equivalent 1-night incubated samples.  
 
For most samples the stationary-phase samples were more harmful or less nutritious to 
neonates compared to exponential-phase samples. However, that effect was no greater 
for the Bt and Bo samples than the Epi300 E. coli samples, which indicates that unlike 
some Photorhabdus toxins the harmful factors produced by Bt or Bo are not up-regulated 
in stationary phase compared to exponential phase. 
Several points summarise the feeding experiments. When fed Bt E264 cultures, M. sexta 
neonates were variably killed or their growth was reduced. When fed Bo C6786 culture or 
cell-free supernatant, neonates showed greatly reduced growth. Mortality and morbidity 
(indicated by reduced growth) can be caused by infection or by toxic factors, or both. Bo 
washed cells led to 50% mortality. Infection may play a role but the fact that Bo cell-free 
supernatant caused morbidity indicates that a toxic factor is involved. The Bt results varied 
in the different experiments; in experiment #3 the reduced-cell culture (non-sterile 
supernatant) resulted in greatly reduced weight, but in experiment #4 the effect of cell-free 
supernatant was no greater than that of Epi300 E. coli. In both cases however, Bt E264 
whole culture caused significantly greater morbidity than Epi300.  
The results overall show that Bt and Bo are pathogenic to M. sexta neonates by the oral 
route, and indicate that a soluble toxic factor(s) are involved to some extent.  
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3.4. Discussion 
3.4.1. Burkholderia virulence in Manduca sexta 
The initial experiments with C. elegans and A. polyphaga confirmed that our stock of Bt 
E264 was indeed pathogenic to these invertebrates or able to evade predation as other 
studies have reported it to be (Ooi et al. 2012; Inglis et al. 2000). Neither host organism 
succeeded in consuming the bacterial mats. C. elegans were motionless and no offspring 
were hatched. Injecting Bt E264 into M. sexta larvae for the first time confirmed that, like 
G. mellonella, M. sexta is susceptible to Bt infection. In fact, effects of pathogenesis were 
seen rapidly; with a direct injection of overnight culture the larvae exhibited signs of 
paralysis by 20 hours and were dead by 24 hours post-injection. Paralysis prior to death 
has previously been reported for Bp or Bt infection in nematodes and G. mellonella 
(O’Quinn et al. 2001; Kim et al. 2005; Gan et al. 2002; Schell et al. 2008; Wand et al. 
2011). 
Bt E264 shows a dose-responsive lethal effect 
Further tests with Bt E264 confirmed that the rate of disease progression was positively 
correlated with bacterial dose, with median times to death (MTTDs) ranging from 48 hours 
at a dose of 105 CFU to 144 hours at 10 CFU.  
In Manduca sexta Bp K96423 is less virulent than Bt E264 
Surprisingly, when the Bp type strain K96423 was tested in M. sexta it was clearly less 
virulent than Bt E264. At 105 CFU the MTTD was 72 hours and at 10 CFU more than half 
of the larvae survived the course of the experiment (7 days post-injection). It was not 
feasible to maintain larvae beyond that time; beyond wanderer stage they begin to pupate 
and it could be hazardous and impractical to keep infected moths. As was the case with Bt 
E264, the larvae showed signs of paralysis prior to death. It is not clear whether the 
paralysis (judged by larvae showing an extremely limited response to stimuli) is due to a 
direct effect on the motor system or is a side-effect of limited resources and energy while 
fighting the bacterial infection. The fact that melanocytic spots were visible on several 
larvae (infected with either Bt or Bp) indicated that their immune systems had actively 
defended against bacteria.  
Reversal of relative Bp-group virulence in M. sexta  
When including Bt strains and the two Bo strains, it seems that in general the degree of 
Burkholderia virulence in M. sexta is inversely related to the degree of virulence in 
mammals. Both the Bo strains were more virulent than Bt E263, and Bp was less so. It 
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can be reasoned that greater virulence in a mammalian host comes at the expense of 
virulence in un-related host taxa such as insects, or in the environment, and vice versa. 
Thereby, although Bp is highly virulent in mammals it is much less so in M. sexta, and the 
mammalian-avirulent Bo strains display dramatic virulence in this insect. Indeed, in C. 
elegans Bt E264 was more virulent than Bp strains were (O’Quinn et al. 2001). However, 
this theory is not supported by contrasting results reported for the G. mellonella model. As 
illustrated in Figure 3.29, in most respects the G. mellonella findings from Wand et al 
correlated well with virulence in mammalians (Wand et al. 2011). 
Figure 3.29. The relative virulence of several Burkholderia strains in the mouse Mus musculus (Titball et al. 
2008; DeShazer 2007), in G. mellonella (Wand et al. 2011), and in M. sexta (this study). Bp = B. 
pseudomallei, Bt = B. thailandensis, Bo = B. oklahomensis. In the mouse Bp is highly virulent, most Bt strains 
are virulent, Bt CDC 272 and Bo strains are avirulent. In G. mellonella according to Wand et al Bp and Bt 
strains are virulent and Bo is avirulent. In M. sexta results (this study) Bo strains and Bt CDC 301 were the 
most virulent followed by Bt E264, and Bt CDC 272 and Bp exhibited relatively low virulence. 
 
One notable exception relates to the virulence of Bt CDC 272. In hamsters and mice most 
Bt strains (including Bt E264 and Bt CDC 301) exhibit some virulence, but the Bt strain 
CDC 272 is avirulent (DeShazer 2007; Wand et al. 2011). Wand et al reported that in G. 
mellonella Bt CDC 272 was more virulent than E264. In M. sexta however, Bt CDC 272 
showed low virulence, either killing as slowly as Bp K96423 or not at all. In this case the 
M. sexta results reflect observations from mammalian models; the variant strain CDC 272 
is attenuated compared to most Bt strains.  
Bt CDC 272 and CDC 301 are phylogenetically closely related but CDC 301 expresses a 
Bp-like CPS which is absent from CDC 272. As CDC 272 was at least as virulent as CDC 
301 in the G. mellonella model Wand et al (2011) reasoned that the CPS cluster is not 
required for virulence in insects. Our findings show that those results were not necessarily 
representative of all insects. Although the CPS cluster is not required for virulence of Bt 
E264 and other Asian strains, it may well be important for the virulence of the American 
variant strains. Its presence might explain the greatly increased virulence of CDC 301 
compared to its close relative CDC 272, in M. sexta at least.  
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Virulence in Galleria mellonella at 25 °C versus 37 °C 
It was apparent that the results from G. mellonella (Wand et al. 2011) and M. sexta (this 
study) were quite different, and one crucial difference between the models was the 
temperature at which the larvae were maintained post-injection: G. mellonella at 37 °C 
and M. sexta at 25 °C. In order to assess whether the reversal of Burkholderia virulence is 
a consequence of the incubation temperature it would be ideal to repeat the M. sexta 
virulence assay with larvae maintained at both temperatures after injection. One limitation 
of the M. sexta model is that the health of the larvae may be compromised when 
maintained at 37°C; although other authors have reported success using M. sexta for 
infection studies at 37 °C (Fleming et al. 2006), in a previous study in this laboratory larva 
mortality at 37 °C was 30% when injected with PBS alone and 60% when injected with E. 
coli Epi300 (unpublished, Waterfield lab). For that reason, the comparative virulence of 
the same strains at 25°C and 37°C was investigated in this study using G. mellonella 
larvae only (summarised in Figure 3.30).  
Figure 3.30. The relative virulence of several Burkholderia strains in G. mellonella maintained at 37 °C in a 
previous study (Wand et al. 2011) and at 37 °C and 25 °C in this study. The M. sexta results at 25 °C from this 
study are also compared. Bt = B. thailandensis, Bo = B. oklahomensis. 
 
Our findings at 37°C again differed from those of Wand et al; Bt CDC 272 was still found 
to be attenuated (less than half the larvae died), and the Bo strains were as virulent as Bt 
E264 (MTTD = 48 hours). Bt CDC 301 was the most virulent strain (MTTD = 24 hours).  
At 25°C our G. mellonella results were broadly the same as at 37°C. Bt CDC 272 was 
attenuated and the Bo strains were virulent. However, all four virulent strains had the 
same MTTD values (72 hours); shorter intervals between scoring would help to resolve 
whether there is any difference in virulence. Nonetheless, the difference must have been 
only slight. Notably the Bo strains and Bt E264 were found to have comparable virulence 
in G. mellonella at either temperature. In M. sexta the Bo strains were considerably more 
virulent than Bt E264, with MTTD values being 20-24 hours shorter. 
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The strains used came from the same source as those used by Wand et al (Titball lab, 
University of Exeter). It is not clear why the Bo strains were avirulent in their G. mellonella 
assay and virulent in ours, and why the opposite was true for Bt CDC 272. The further 
differences observed in M. sexta could related to: (i) unknown differences in the precise 
host-pathogen interactions; (ii) a longer time required to overcome the larger host which 
enables differences in MTTD to be resolved more accurately; (iii) a combination of both.  
G. mellonella belongs to the Pyralidae family which is considered to be an ancient clade 
within the Lepidoptera. Therefore its immune system is thought to be basal and perhaps 
more relevant to mammalian innate immunity than the more evolved and specialised 
system of M. sexta (Vogel et al. 2011). The fact remains that there is still a lot to learn 
from these models in order to fully characterise and understand their immune 
mechanisms, differences and similarities. Additionally, our G. mellonella 37 °C and 25 °C 
MTTD values did not show a great deal of resolution between the virulence of the different 
strains as they were based on 24 hour intervals, so further investigation would be 
warranted to confirm to what extent temperature plays a part. The higher incubation 
temperature clearly affects the rate of disease progression, probably due to increased 
bacterial growth, reduced M. sexta health, or both. 
3.4.2. Assessment of Bt E264 mutants in Manduca sexta 
Two E264 mutants were tested that had been constructed by other research groups and 
found by them to be attenuated in the G. mellonella model (Norville 2011; Wagley, 
unpublished results). 
ΔsurA mutant 
In the first assay the ΔsurA -infected M. sexta larvae were incubated at 37°C to replicate 
the conditions of the G. mellonella assay performed at Dstl. A slight attenuation was 
observed. To make the work comparable to the rest of our Burkholderia dose response 
assays, the next experiment, with lower doses, was incubated at 25°C. It was performed 
in triplicate experiments, giving n = 30 for each condition tested. At 102 CFU there was a 
10 hour difference in MTTD, with the ΔsurA strain being slower to kill. The calculated p-
values indicated that survival curves were significantly different but for E264 and ΔsurA at 
both 103 and 10 CFU doses the MTTD values were the same. Although the MTTD statistic 
has been used throughout this study to compare virulence, it is interesting to note that 
when the mean (as opposed to median) time to death is calculated there is a more 
pronounced attenuation of ΔsurA, especially at the 103 CFU dose. When ΔsurA was 
tested once again, this time alongside the other Burkholderia strains at doses 102-104, the 
MTTD values were considerably greater, with 103 CFU now having MTTD 76 hours (as 
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opposed to 36 hours in the triplicate experiment). This variation may be due to using 
different ‘batches’ of larvae; the health of the colony may naturally fluctuate slightly and 
the experiments were separated by several weeks. Combining all the results, Bt E264 
ΔsurA ranks just below the wild-type E264 strain in terms of Burkholderia virulence in M. 
sexta. Therefore, even this attenuated Bt strain was still more virulent to M. sexta than Bp 
K96423 or the Bt variant strain CDC 272.   
TAT mutant 
The E264 TAT mutant (prhA:tatA) yielded less straightforward results. The first 
experiment used the mutant and the E264 wild-type strain grown in LB containing either 
rhamnose (to maintain TAT activity) or glucose (to inactivate TAT in the conditional 
mutant). Results from three of the conditions looked fairly similar but surprisingly the 
mutant grown in rhamnose, reported to have wild-type-like activity in G. mellonella, was 
significantly less virulent. It was known that the mutant grows more slowly in LB with 
glucose but that was not the case for LB with rhamnose, suggesting that the general 
health of the bacterium was probably not the cause of this unexpected effect. It was also 
noticed that several of the larvae in the TAT experiments exhibited a dark blue tinge, 
which was unusual. Although they would be at a low concentration after diluting the 
inoculum to e.g. 103 CFU per ml, the presence of sugars may have affected the host 
physiology and response.  
In order to investigate this theory the next experiment also tested the two strains after 
growth in LB alone. The TAT mutant grew slowly in LB without sugar, indicating that the 
system was probably inactive (although confirmation of this would require further 
experimental investigation). Bt E264 killed within 72-96 hours (MTTD) after growth in LB 
alone or with glucose; with rhamnose there was a slightly longer MTTD (72-120 hours). 
Directly compared to the E264 strain in LB, the MTTDs of the TAT mutant grown in LB 
were much longer (120-168 hours, and less than 50% dead at 102 CFU). This suggests 
that the TAT mutant is indeed attenuated. Whether that is due to a direct effect on 
virulence or simply reduced growth is not clear but seeing as growth in complete media 
was reduced it is reasonable to assume that growth in the host is also reduced. When 
either glucose or rhamnose was present in the LB the TAT mutant still killed more slowly 
at 102 CFU than wild-type, but more quickly than the mutant without any sugar. It is 
conceivable that the sugar helps the weakened bacterial mutant during the infection, as 
an energy source for example. Rhamnose is a pathogen-associated molecular pattern 
(PAMP) – for example, it forms part of the mycobacterial cell membrane (Ma et al. 2001). 
It may therefore ‘distract’ the M. sexta immune system from the Bt cells, acting as a 
competitive inhibitor to some degree. Importantly, glucose has been observed to enhance 
 Burkholderia infection assays in Manduca sexta pg. 153 
Bp biofilm formation, which is likely to aid survival within a host (Ramli et al. 2012). 
Nutrients including sugars are also known to affect Burkholderia secondary metabolite 
production and quorum signals (Keum et al. 2009). The effects only seemed to be 
beneficial to the weakened TAT mutant strain; the wild-type E264 showed little difference 
in overall virulence with or without the different sugars present.  
The sugar-related effect with the Bt E264 TAT mutant was apparently not observed in the 
wax worm model: G. mellonella challenged with 104 CFU Bt E264 or TAT mutant grown in 
rhamnose (active TAT) all died by 18 hours post-challenge, whereas those injected with 
TAT mutant grown in glucose (inactive TAT) all survived beyond 20 hours with 85% dead 
by 24 hours (S. Wagley, unpublished). The TAT mutant has since been assessed in 
zebrafish (Danio rerio) embryos as well; fish challenged with active TAT strains (Bt E264 
or TAT mutant grown in rhamnose) showed 40% and 30% survival, whereas fish 
challenged with inactive TAT (mutant grown in glucose) showed 80% survival (S. Wagley, 
unpublished). 
The aim behind testing known attenuated mutants in M. sexta was to discover whether 
this host is potentially useful for evaluating mutants in the future. Three conclusions can 
be drawn: (i) the ΔsurA mutant did show attenuation, therefore supporting the potential 
use of the M. sexta model for mutant characterisation; (ii) conditional mutants controlled 
by sugar concentration are not suitable for testing in this model as sugar-control cannot be 
sustained inside the host and sugar appears to affect the outcome of host-pathogen 
interactions; and (iii) as seen earlier with Bo strains, attenuation in G. mellonella is not 
necessarily a predictor of attenuation in M. sexta. 
3.4.3. Burkholderia exhibit oral pathogenicity or toxicity to 
Manduca sexta 
Bt E264 was fed to M. sexta neonates in four experiments. In the first, only three of ten 
neonates survived to day eight, compared to nine of ten from the control group fed LB-
laced food. Of the three survivors the day 8 weight was not significantly different from the 
control group. Therefore in that experiment the outcome of ingestion of Bt was ‘all or 
nothing’ – either the neonates died or they showed no ill effects. In most cases the dead 
larvae were found away from the food block, and they were very small. They may have 
starved as a result of a ‘choice’ not to consume Bt, or perhaps due to an inability to 
continue eating caused by consumption of the bacteria (e.g. paralysis).  
As so many Bt-fed neonates had died, the next experiment used bacterial cultures diluted 
to OD600 0.1, but then no difference was seen in terms of mortality or size compared to the 
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control group. Either the effect was not potent enough or the appropriate bacterial genes 
were not expressed at lower cell density.  
Returning to undiluted overnight cultures, Bt was also fed to older fifth-instar larvae. The 
fifth-instars fully consumed the whole bacteria-laced food blocks by day two, which were 
then replaced with fresh bacteria-free and antibiotic-free diet. None of the larvae showed 
any signs of illness. It would be interesting to test whether, had they continued to be fed 
only on Bt-laced diet, a detrimental effect would eventually be observed; nematode 
studies show that prolonged contact with the bacteria is required for full pathogenesis of 
C. elegans (Ooi et al. 2012; Day & Sifri 2012). But the lack of effect on fifth-instar M. sexta 
was not unexpected, as feeding experiments within the Waterfield lab using Photorhabdus 
and Yersinia Toxin Complex (TC) toxins have shown that neonates are more susceptible 
to oral toxicity than the later developmental stages. This could relate to the immaturity of 
the neonate gut immune barriers or to the greater dose received relative to the size of the 
larva.  
The neonate results did show again that Bt had a detrimental effect. This time however 
the mortality was less severe (80% survival as opposed to 30%) but the weight of 
surviving larvae was significantly reduced compared to LB-fed controls. This is in contrast 
to the previous ‘all or nothing’ result. The Bt was fed either as whole culture (as before) or 
as a ‘reduced-cell culture’ (non-sterile supernatant). The neonates fed reduced-cell culture 
were significantly smaller than the whole-culture-fed group, indicating that the 
centrifugation process used to remove cells had increased the toxicity of the sample. 
Perhaps loosely attached proteins or polysaccharides could be sheared off into the 
supernatant during centrifugation steps. For example, lipopolysaccharide (LPS) and 
lipooligosaccharide (LOS) endotoxins are important for virulence of many Gram negative 
bacteria and are associated with the outside of the cell. Furthermore, insecticidal TC 
toxins are variably cell-surface attached or secreted away from the cell, and homologues 
do exist in Burkholderia (Yang et al. 2012; Waterfield et al. 2001). Alternatively, perhaps 
the presence of fewer Bt cells may have led to a less vigorous host immune response or 
toxin excretory response, while a component of the conditioned medium still exerted an 
effect which ceased neonate feeding. 
The final experiment separated different components of the cultures more carefully. As 
well as whole culture, the neonates were fed: cells which had been washed free of 
supernatant; cell-free filtered supernatant; and heat-denatured cell-free filtered 
supernatant. An additional variable that was tested was the effect of incubating the 
bacterial cultures for an extra 24 hours prior to the treatments. This was in order to 
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discover whether any effect might be more potent after stationary phase, as Photorhabdus 
TC toxins are expressed at stationary phase (Yang et al. 2012). 
Out of interest this last experiment also compared the effects of a Bo strain (C6786), 
which exhibited striking effects. Comparing the day seven weights of surviving neonates 
revealed that this time Bt E264 culture and supernatant did not show the detrimental 
effects seen previously, but Bo C6786 did. Bo whole culture and supernatant were 
significantly toxic to the neonates, while washed cells and heat-denatured supernatant 
were not. This indicates that Bo supernatant can show a deleterious effect on M. sexta 
neonate health and the orally toxic factor was heat-inactivated, suggesting it is likely to be 
proteinaceous.  
As discussed in the main introduction, Bp and Bt have been suggested to kill C. elegans 
nematodes in part through the activity of an unknown toxin or paralytic agent (O’Quinn et 
al. 2001), which may be soluble and heat labile (Gan et al. 2002). In contrast, one 
publication argued that a diffusible toxin was not present or at least was not effective (Lee 
et al. 2011), on the basis of the fact that nematode killing required prolonged contact with 
the bacteria. More recently, a comprehensive study has demonstrated that upon exposure 
to Bp: nematode pharyngeal pumping and defecation rates are reduced (which may be 
mediated by either the nematode or by bacterial factors); and a nematode detoxification 
transporter is up-regulated (Ooi et al. 2012). The M. sexta feeding results indicate that a 
diffusible toxic factor is produced by Bo. The Bt results from the last experiment (with cell-
free supernatant) do not support the same conclusion but this would certainly warrant 
repeating. 
As discussed earlier in this chapter and in the main introduction (Chapter 1), Bp-group 
species are known to produce several toxic factors. The BLF1 toxin of Bp is the only 
confirmed lethal toxin so far (Cruz-Migoni et al. 2011; Hautbergue & Wilson 2012). 
Unknown toxic factors from Bp and Bt are reportedly active against C. elegans  (O’Quinn 
et al. 2001; Ooi et al. 2012; Balaji et al. 2004; Day & Sifri 2012), and D. melanogaster 
(Pilátová & Dionne 2012). The activity of Bo supernatant against M. sexta could 
conceivably be due to a related factor. Alternatively, Bp-group bacteria possess several 
polyketide synthases and non-ribosomal peptide synthetases (PKS/NRPSs), which may  
synthesise cytotoxic peptides (Biggins et al. 2012; Schell et al. 2008). T6SS Hcp proteins 
are also suggested to be toxic (Burtnick et al. 2011). CPS, LPS and other surface O-
polysaccharides are additional putative virulence factors (Sim et al. 2008); it is possible 
that endotoxins such as these could have been sheared off during sample centrifugation. 
Comparing results from Burkholderia samples which had been incubated before feeding 
for 40 hours (‘two nights’) versus 16 hours (‘one night’) did not show any particular 
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changes in the patterns of day seven weights. This confirms that the orally toxic factor 
produced by Bo was neither over-expressed at stationary phase nor any more active over 
time. The average weights for each group with the one-night and two-night incubated 
bacteria could not be directly compared in a T-test because the neonates used on the two 
subsequent days were of quite different sizes to begin with, simply due to variation in day-
to-day health of the colony. Ideally every neonate would be weighed before feeding as 
well as after, but the precision of the scales is problematic at such low weights. One 
solution might be to calculate the average weight of a group before feeding by weighing all 
(e.g. twenty) neonates together. Accounting for the percentage weight change seen in the 
control groups between day one and day two, the largest negative changes were in E. coli 
Epi300 constituents, so the effect is probably due to a general toxicity from dead bacterial 
cells and lysates rather than a Burkholderia specific toxic effect. Interestingly the E. coli 
Epi300 whole culture (cells and supernatant together) gave the neonates a slight growth 
advantage compared to its 1-night grown culture. Bt E264 culture grown for 2 nights 
showed no different effect from the 1-night grown culture. 
One important observation from the feeding assays is that the effect of Bt E264 culture 
varies from one experiment to another. Sometimes the result was high mortality but with 
survivors showing general good health. Sometimes most neonates survived but with very 
poor weight gain due to very little feeding activity. In some cases the toxic effect was 
observed from supernatant more than from whole culture, and in others it was only seen 
with whole culture (and to a lesser extent). What was consistent was that some 
detrimental effect was always seen from undiluted Bt E264 culture. In the experiment 
where the effect of Bt was limited to the whole culture only, Bo C6786 showed the same 
results that Bt E264 had shown previously; a highly deleterious effect on weight gain 
associated with the whole culture or the supernatant. It is noteworthy that a similarly 
variable result of a Burkholderia strain was observed in the dose response injections, 
where Bt CDC 272 failed to kill any larvae in one experiment and then killed all (but 
slowly) in a subsequent one. Some Bp-infected larvae died while others survived, 
apparently unharmed. Additionally, the MTTD value for ΔsurA varied from 36 hours in one 
experiment to 76 hours in another, and the results of Bt CDC 272 and Bo virulence assays 
in G. mellonella were different in this study compared to that by Wand et al (Wand et al. 
2011). The observed variability is likely to be due to subtle differences in individual host-
pathogen interactions and/or natural variation within populations of Burkholderia cells, for 
example due to phase variation effects. Phase variation has been demonstrated to play a 
role in Bcc niche adaptation, with stable variants arising spontaneously and demonstrating 
differential expression of virulence factors (Vial et al. 2010). It has been suggested that 
this process enables the Bcc strain B. ambifaria to adapt to the very different 
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environments of the rhizosphere or the immunosuppressed lung of cystic fibrosis patients. 
Simple sequence repeats (SSRs) are often sites of slipped-strand mispairing, a 
mechanism which is linked to phase variation (Torres-Cruz & Van der Woude 2003) and 
the genomes of Bp and Bm (and most likely other Burkholderia)  contain many thousands 
of SSRs, particularly in genes for surface- or secreted proteins (Song et al. 2009).  
Toxin-antitoxin (TA) modules have been identified in Bp and Bt strains (and may exist in 
Bo strains): their function in Burkholderia is being investigated but in E. coli TA modules 
are linked to formation of persister cells (Butt et al. 2012). Persister cells are phenotypic 
variants within a population which are in a dormant state. As melioidosis is able to take 
the form of chronic or latent infections, it has been reasoned that these TA modules may 
lead to Burkholderia persister cell formation. Some Bp TA toxins expressed in E. coli did 
cause growth to cease, and their cognate antitoxins successfully restored growth. 
Therefore natural variation can occur within Burkholderia populations, and this probably 
contributes to the contrasting results which are quite often reported from different studies 
using the same strains.  
3.4.4. Potential value of Manduca sexta as a model host for 
Burkholderia 
The virulence of Burkholderia species in the wax worm G. mellonella apparently reflects 
their virulence in the mouse model quite well (Wand et al. 2011). This suggests that G. 
mellonella is potentially a good surrogate host for further study of Burkholderia 
pathogenesis, virulence factors, or vaccine candidates. Surprisingly, compared to this 
other lepidopteran host, M. sexta showed distinctly different results with a reversal of 
relative virulence. On one level this is discouraging in terms of the usefulness of M. sexta 
for the long-term aim of modelling melioidosis. However, even between different 
mammalian models there is considerable variability in the relative pathogenicity of 
different Bp strains. A review of mammalian models of Bp infection (Titball et al. 2008) 
emphasised that the disease pathogenesis differs between mice, hamsters and diabetic 
infant rat models. All reflect human melioidosis in different ways, so it is currently 
accepted that it may be necessary to use multiple different animal hosts to effectively 
model different aspects of melioidosis infection (Titball et al. 2008). M. sexta still has 
numerous practical advantages over G. mellonella as described earlier and therefore its 
usefulness for studying Bp should not be discounted. Although Bp was less virulent than 
Bt or Bo strains: (i) it was still virulent, killing up to half of the infected larvae; (ii) the fact 
that the larvae survived for at least three days (and in some cases beyond seven days) 
could be useful for investigating mechanisms relating to host defence or chronic or latent 
infection; (iii) only Bp K96423 was tested and as Bp strains are known to vary 
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considerably in their virulence in mammals it would be interesting to assess more strains 
in M. sexta.  
The recent release of the M. sexta genome will undoubtedly lead to more genetic and 
molecular tools and an increased understanding of this insect; with this in mind it could be 
highly informative to examine the difference between Bp K96423 infection in M. sexta 
versus G. mellonella. Discovering what aspects of the bacteria-host interaction greatly 
reduce the virulence of this formidable pathogen in one insect compared to another could 
hold the key to developing effective anti-virulence therapeutics or identifying ways to 
bolster the host immune defences.   
An interesting and unexpected finding of this study is that Bo strains which were 
considered avirulent in animals did show virulence in G. mellonella (contrary to a previous 
report) and indeed showed greater virulence in M. sexta than Bt or Bp strains. This 
reversal of Burkholderia virulence is very interesting from an ecological and evolutionary 
perspective, for example in terms of understanding generalism versus specialism and 
niche adaptation within the Burkholderia. Additionally the extent and relevance of 
Burkholderia-insect interactions in nature has not been studied and would be interesting 
from either a purely entomological standpoint or applied to the epidemiology of 
Burkholderia. Comparative genomic studies could be used to identify genetic regions 
involved in insect versus mammalian infection, with confirmation of mutation effects in the 
M. sexta model host. Alternatively, transposon mutant libraries in Bt or Bo strains could be 
tested for attenuation.  
Bt is often used as a surrogate for investigating the pathogenicity of Bp, as it is so closely 
genetically related and is pathogenic in some mammals. To investigate Burkholderia 
infection in M. sexta further and to investigate the validity of the host as a model, the 
studies carried out in Chapter 4 aimed to characterise aspects of Bt infection over a 30 
hour time-course and to reveal whether melioidosis-like mechanisms of pathogenesis are 
employed. 
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Chapter 4. In vivo time-course of 
Burkholderia insect infection and 
pathogenesis  
4.1. Chapter summary 
To investigate the Manduca sexta model of Burkholderia virulence further this chapter 
describes the use of haemolymph extraction and fluorescent confocal microscopy to 
characterise aspects of Bt infection over a 30 hour time-course. Bt bacterial cell numbers 
increased by four logs during the infection (whereas E. coli controls almost entirely 
cleared) and Bt cells appeared to survive within haemocytes. Signs of haemocyte (HC) 
cell death increased over time. Although formation of multi-nucleated giant cells (MNGCs) 
was not conclusively seen, another hallmark of Burkholderia infection in mammals – actin 
tails – were observed in a separate experiment at 24 and 36 hours post-injection. To the 
best of our knowledge this represents the first observation of Burkholderia-induced actin 
tails in invertebrate cells either in vivo or in vitro. The result correlates well with 
observations from mammalian studies and lends support to the validity of the M. sexta 
surrogate model of Burkholderia infection. Finally, preliminary results indicate that with 
further optimisation a flow cytometry-based assay could be a useful tool to rapidly quantify 
M. sexta haemocytes and their viability from haemolymph samples. 
4.2. Introduction 
In Chapter 3, dose response virulence assays allowed the median times to death 
(MTTDs) to be calculated for various Burkholderia strains in the M. sexta larva model of 
infection. This indicated which strains were more virulent in terms of how quickly they kill 
the host. However, externally visible signs such as melanisation, paralysis or death shed 
only limited light on the nature of the host-pathogen interaction. In other species, 
Burkholderia cellular pathogenesis hallmarks can include actin-remodelling, multi-
nucleated giant cell (MNGC) formation, and apoptosis of host cells. As discussed in the 
main introduction, in a BALB/c mouse model of acute melioidosis Chin et al (2010) 
examined the status of bacterial load and host leukocytes at time-points during infection, 
and in a cockroach model Fisher et al (2012) reported that HCs harboured intracellular Bp 
bacteria and that some had formed MNGCs. 
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The aims of this chapter were to investigate the pathogenesis of a Bp-group species (Bt) 
in the M. sexta infection model, characterising the bacterial load and looking for cellular 
characteristics of Burkholderia infection that have been observed in mammalian hosts 
and, in the case of MNGCs, in the cockroach model. A secondary aim was to evaluate 
numbers of HCs, one aspect of the host response during the course of infection. 
Aim: Investigating Bt pathogenesis in the M. sexta infection model  
As described in Chapter 3 Bp, Bt and Bo are all virulent in M. sexta to varying degrees. Bt 
was the organism investigated in this chapter for several reasons: (i) although Bp is the 
causative agent of melioidosis its use would require CL3 facilities; (ii) Bt is often used as a 
surrogate for Bp due to extensive shared similarities; and (iii) Bt was actually more virulent 
in M. sexta than Bp. There were no reports of MNGCs observed in insects until very 
recently (Fisher et al. 2012), and it appears that actin tails have yet to be observed in 
insect hosts. If these same pathogenesis mechanisms occur in M. sexta infection then the 
M. sexta model could potentially be used to test mutants or anti-virulence therapeutics 
involved in those pathways.  
Larvae were infected with GFP-labelled Bt E264 or an E. coli control, and haemolymph 
was collected at selected time-points post injection. Other studies have observed actin 
tails and MNGCs in cell cultures at 12 hours post-infection with Burkholderia. M. sexta 
virulence studies in Chapter 3 showed that a 106 CFU dose of Bt E264 kills by 48 hours 
post-injection. Initial microscopy was used to briefly assess the condition of HCs and 
bacteria at up to 48 hours post-injection so that an appropriate time-course could be 
planned. For confocal microscopy, to minimise the effects of variation between individual 
larvae batches of replicate larvae were bled and their haemolymph was pooled to produce 
slides. To minimise the effects of variation across the slide itself, ten images were 
captured per slide to generate averages. The time-course was performed in triplicate on 
different days. 
Aim: Evaluating M. sexta haemocyte number and health over the course of infection 
Finally, flow-cytometry and Guava ViaCount Reagent were used to measure M. sexta HC 
number and viability more quantitatively, towards an aim of establishing a reproducible 
semi-automated assay for future use. Replicate haemolymph samples were tested from 
Bt-infected and control larvae.  
 In vivo time-course of Burkholderia insect infection and pathogenesis pg. 161 
4.3. Results 
4.3.1. Comparative virulence of Bt E264 wild-type and GFP 
strains 
Assessing Bt infection using confocal microscopy would require the use of fluorescently-
labelled bacteria, so it was necessary to confirm whether a GFP-expressing strain of Bt 
was similarly pathogenic to M. sexta compared to the wild-type Bt E264 strain. 
Table 4.1 shows the survival of larvae after injection with different doses of wild-type or 
GFP-labelled Bt E264. Larvae injected with either E. coli Ec100 or Epi300 all survived the 
course of the assay and reached wanderer stage at day 6 (144 hours). Larvae injected 
with NaCl alone also reached wanderer stage at day 6 (138 hours). 
Table 4.1. Numbers of larvae surviving infection with wild-type (WT) or GFP-labelled Bt E264 over seven days  
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Table 4.2 shows MTTD values and the significance of the survival curves for the different 
strains. Kaplan-Meier survival curves are shown in Figure 4.1. Both strains were virulent in 
M. sexta. The survival curves were significantly different for the wild-type and GFP strains. 
The GFP strain took longer than the wild-type to kill larvae in this experiment, although the 
difference between MTTD values did decrease as the dosage increased. The difference 
was 40 hours at a 102 CFU dose, and 6-8 hours at a 104 CFU dose. At the 104 CFU dose 
both strains killed all larvae by 72-90 hours post-injection. 
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Table 4.2. Median Time to Death (MTTD) values for larvae injected with either wild-type (WT) or GFP-labelled 
Bt E264. Error bars show SE of the median. Values for the 10
4
 CFU dose were calculated from the combined 
data from experiment 1 and 2 (from experiment 1 the MTTDs were 72 hours for WT and 90 hours for GFP; 
from experiment 2 they were 66 hours for WT and 72 hours for GFP). The MTTD with the GFP strain is longer 
which suggests attenuation in virulene. However, the difference is less apparent as the dosage increases. At 
10
4
 CFU, the MTTDs are just 18 hours apart.  
 
Figure 4.1. Kaplan-Meier survival curve for wild-type or GFP-labelled Bt E264. Data for the 10
4
 CFU dose 
(denoted ^4) is combined from the two experiments. The curves start at 1.0 (all alive) and drop down the y-
axis (cumulative survival) as the insects die. The point at which the curve ends indicates the number of 
surviving insects at the end of the assessment. In cases where insects survive, the curve line displays a small 
cross which is described in the key as a ‘censored’ case. Half of the larvae with 10
2
 CFU GFP Bt survived to 
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According to log rank (Mantel-Cox) pairwise significance calculations shown in Table 4.3, 
the difference between wild-type and GFP Bt E264 virulence was statistically significant 
as each dosage tested. 
Table 4.3. Log-rank (Mantel-Cox) pairwise comparisons between M. sexta survival profiles when injected with 
wild-type or GFP Bt E264. NS = not significantly different, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. The survival 
was significantly different at each equivalent dose. 

















Although the MTTDs were significantly different with the GFP-expressing strain of Bt E264 
showing a longer time to kill M. sexta larvae, the GFP strain was still deemed useful for 
learning more about the dynamics of Bt infection. This was because: the strain was still 
lethal; as the dosage increased the difference was less noticeable, and the timecourse 
experiment could use a higher dose still; and the attenuation was thought to probably be a 
pleiotropic effect of GFP expression rather than due to loss of an important virulence 
mechanism.   
4.3.2. Initial visualisation of infection  
Before embarking upon the time-course itself, initial experiments were performed to 
confirm that slide preparation and actin staining were successful, and to gauge what time 
frame to sample within. Initial images were captured from samples collected at 5, 24, 30, 
36 and 48 hours post-injection. 
In the initial samples the TRITC-phalloidin staining of filamentous actin worked well. 
Haemocytes of various morphologies and sizes were apparent in all the samples and 
cellular projections had been well preserved (Figure 4.2). Beyond 5 hours post-injection 
there were clear differences in bacterial presence (Figure 4.3). 
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Figure 4.2. TRITC-phalloidin-stained (red) haemocytes from M. sexta larvae. Left: cells of different sizes and 
morphologies from un-infected larvae at 24 hours. Right: GFP-expressing (green) Bt E264 cells are visible on 
the surface of a haemocyte at 5 hours post-injection. The bottom-most bacterium appears to be partially inside 
the haemocyte.  
 
Figure 4.3. Cells from 48 hours post-injection. White light images (included in the left-hand panels) show 
healthy cells (Ec100, top left) and some dead cells and debris (Bt E264, bottom left). Top right: stained actin 
(red) reveals the extensive projections of healthy plasmatocytes. At 48 hours post-injection very few E. coli 
Ec100 cells remained (green; top panels), but many Bt bacteria remained (green; lower panels). Dozens of Bt 
E264 cells were clustered amongst disrupted host cells. 
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Figure 4.4 shows the presence of actin tails in the Bt-infected haemocytes at 24 and 36 
hours post-injection.  
Figure 4.4. Actin remodelling was evident in the 24hr and 36hr Bt E264 samples. Panel A: White arrows 
denote a host haemocyte cell with several actin tails (green GFP bacteria; red stained actin; composite 
image).  Panel B: An orthogonal view shows that these particular actin tails are inside the haemocyte cell. 
Panels C-D: In each of these cases actin tails are visible protruding from a haemocyte. 
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4.3.3. Time-course microscopy results 
For the time-course itself, time-points were set up to collect data within the first 30 hours, 
especially within the first 24 hours; after 30 hours the majority of insect cells were lysed. 
DAPI dye was also used to stain nuclei, as this would enable easier counting of individual 
insect cells and assessment of cellular health (e.g. apoptotic cells or MNGC formation). 
Control (no injection) 
Haemocytes (HCs) were counted from the un-injected controls, with an average of 15.9 
HCs per view (SE = 1.35). Cellular debris was observed in 10% of the images. 
Bt E264 versus E. coli Ec100 over time-course 
Figure 4.5 shows a representative sample of images from 0-30 hours post-injection with 
the GFP Bt or E. coli strains. The calculated means and standard errors (SE) of the 
replicates are shown for Bt E264 GFP (Table 4.4) and E. coli Ec100 GFP (Table 4.5), and 
those data are described in subsequent graphs and tables. Complete detailed results for 
each image are included in the supplementary DVD e-Appendix 4b. 
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Figure 4.5. Representative images from 3D-projections of Bt E264 GFP-infected (left) and E. coli Ec100 GFP-
infected (right) haemolymph. GFP bacteria are green. In Ec100 images the few bacteria are indicated by white 
arrows. At 0 hours (within 45 minutes post-injection) very few bacteria of either species were present per view, 
and most were intracellular. By 18 hours there were still very few Ec100 and most were intracellular, but there 
were many Bt cells. Bt cells were both intracellular and extracellular, and were often associated with clusters 
of haemocytes or cell debris (red actin, blue nuclei). By 30 hours post-injection barely any Ec100 cells were 
observed but there were many extracellular Bt cells. Many haemocytes in the Bt samples were dead or dying 
and there was abundant cell debris.  
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Table 4.4. Data from a time-course of Bt E264 GFP infection in M. sexta. Averages and standard errors (SE) 
from ten fields of view per slide, three slides per time-point. The data are described further in the chapter.  
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Table 4.5. Data from a time-course of E. coli Ec100 GFP infection in M. sexta. Averages and standard errors 
(SE) from ten fields of view per slide, three slides per time-point. The data are described further in the chapter.  
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The number of intact HCs per view varies over the time-course (Figure 4.6). The numbers 
and the trend over time are similar between the two bacterial strains: 5-15 cells per view 
immediately following infection until 6 hours, then a peak of 30-40 cells at 12 hours, which 
tails off to below 10 cells at 30 hours. Figure 4.6 also shows the corresponding numbers 
of bacteria over time. The observed numbers of Bt E264 GFP and Ec100 GFP bacteria 
were similar from 0 hours until 6 hours post-injection – below 10 bacteria per field of view. 
After that, however, Ec100 numbers dropped to almost zero, and Bt E264 numbers 
steadily increased to around 80-100 bacteria per view at 30 hours. 
Figure 4.6 Numbers of bacteria and intact M. sexta haemocytes per field of view at different time-points post-
injection with GFP Bt E264 or E. coli Ec100 (mean and SE, n = 30 per time-point). HC numbers increase after 
injection in both cases, as a host response to infection. For Ec100 the numbers drop off again because the 
infection has been cleared. For Bt E264 they drop off again because the extracellular bacteria have been 
internalised and/or later because of host cell death. E. coli Ec100 numbers fell to almost zero per view. 
Conversely, Bt E264 numberssteadily increased over time. 
 
In addition to counting bacteria from the microscopy images, CFUs were enumerated from 
the samples bled from the insects and plated out onto agar. As shown in Table 4.6 and 
Figure 4.7, enumerated CFUs from the bacterial inoculum and from bled haemolymph 
samples reflect the results from Figure 4.6; Ec100 GFP numbers reduced over the time-









































Time point (hours post-infection) 
Numbers of bacteria and haemocytes over 
time 
Bt E264 bacteria Ec100 bacteria Bt E264: HCs Ec100: HCs
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Table 4.6. Average bacterial CFU per ml in inoculum and in haemolymph extracted from larvae at time-points 
post infection. In cases where n = 1, no SE applies (labelled N/A = not applicable). Ave. = average. SE = 
standard error. ND = not determined. These data are visualised in Figure 4.8. 
   Inoculum 
Hours post-injection 






































































Figure 4.7. Bacterial CFU per ml in haemolymph extracted from larvae at time-points post infection (mean and 
SE); data and n values are shown in Table 4.6. Bt E264 numbers increase by several logs over the 30 hour 
time-course, while E. coli Ec100 numbers fell. These data indicate that E. coli cells were still present after 30 
hours in the insect but, as seen from the microscopy images, these were relatively very rare. 
 
 
Figures 4.8 - 4.9 break down the total numbers of bacteria per field of view in terms of 
their location relative to haemocytes, for E. coli Ec100 GFP and for Bt E264 GFP. Note 
the different y-axis scales. For Ec100 the majority of cells were always intracellular and 
those numbers did not exceed 9 cells per field of view, with the greatest numbers seen at 
3 hours post-injection. For Bt E264 most cells were intracellular up to 18 hours post-
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hours and particularly at 30 hours the majority of Bt E264 bacteria were extracellular and 
the number of intracellular bacteria had decreased. 
Figure 4.8. Numbers of E. coli Ec100 GFP bacteria intracellular, attached to haemocyte surfaces, or 
extracellular per field of view at time-points post-injection (mean and SE, n = 30 per time-point) 
 
Figure 4.9. Numbers of Bt E264 GFP bacteria intracellular, attached to haemocyte surfaces, or extracellular 
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In Figure 4.10 the intra- or extracellular location of Bt E264 cells is also displayed as 
proportions of all the observed bacteria at each time-point. The proportion of intracellular 
Bt E264 increased from 0-12 hours as bacteria either entered HCs or reproduced inside 
them. It then reduced again as bacteria either escaped from HCs or were released as 
HCs were destroyed. 
Figure 4.10. Proportions of Bt E264 GFP bacteria intracellular, attached to haemocyte surfaces, or 
extracellular per field of view at time-points post-injection (mean and SE, n = 30 per time-point). The 
intracellular proportion increases until 12 hours as bacteria either entered HCs or reproduced inside them. It 
then falls again as bacteria escaped or were released from HCs  
 
Data values from the Ec100 GFP-infected and Bt E264 GFP-infected samples were tested 
for significant differences using two-tailed T-tests for unequal variances (Table 4.7).  
Table 4.7. Significance of differences in time-course data for M. sexta larvae injected with Ec100 GFP versus 
Bt E264 GFP. p-values were calculated by two-tailed T-test for unequal variances. * p ≤ 0.05, ** = p ≤ 0.01, *** 












0 0.170   NS 0.000 *** 0.000 *** 0.002   ** 
3 0.027     * 0.000 *** 0.000 *** 0.000 *** 
6 0.003   ** 0.053   NS 0.000 *** 0.000 *** 
12 0.395   NS 0.000 *** 0.000 *** 0.000 *** 
18 0.033     * 0.000 *** 0.000 *** 0.000 *** 
24 0.000 *** 0.000 *** 0.000 *** 0.000 *** 
30 0.000 *** 0.000 *** 0.000 *** 0.000 *** 
In nearly all respects the data were significantly different. The exceptions were: the total 
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because equivalent numbers were injected) or at 12 hours post-injection; the total 
numbers of bacteria per view were (marginally) not significantly different at 6 hours post-
injection (when falling Ec100 numbers and rising Bt numbers were similar). 
Other observations 
Other observations were made non-quantitatively, regarding haemocyte health and 
possible hallmarks of Burkholderia pathogenesis. 
Evidence of haemocyte cell death  
Some evidence of damaged HCs was observed at all time-points and for both bacteria 
(Table 4.8). This included amorphous actin debris as well as nuclei stripped of actin, and 
condensed nuclei which were indicative of apoptosis. Examples of these ‘stripped nuclei’ 
are shown in Figure 4.11. In the E. coli Ec100 GFP time-course the most evidence of HC 
death was observed from 12 to 24 hours post-injection. This correlates with the 
observation that HC numbers peaked at 12 hours and then reduced. Levels of debris and 
stripped nuclei in the Bt time-course were increasingly high from 18 to 30 hours post-
injection. 
Table 4.8. Qualitative assessment of evidence of haemocyte cell death during Ec100 and Bt E264 infection 
time-courses from low (+) to high (++++). Based on observations from n =30 replicate images per time-point. 
Hours post-injection Bt E264 Ec100 
0 + + 
3 + + 
6 ++ + 
12 + ++ 
18 ++ ++ 
24 +++ ++ 
30 ++++ + 
Figure 4.11. Haemocyte cell death. Left panel: examples of haemocyte nuclei stripped of actin (white arrow). 
Right panel: condensed apoptotic nuclei (bright blue) amid cellular debris (actin components stained red) and 
extracellular Bt E264 GFP bacteria (green) 
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Evidence of actin remodelling and possible cell fusion 
Ec100 and Bt E264 injected samples both showed clusters of HCs and a few unusual 
actin shapes at all time-points. However, these actin structures did not resemble 
characteristic shapes such as actin tails. Suspected actin-remodelled structures were 
examined closely using 3D projections and orthogonal views. No real actin tails were seen 
with Ec100 samples. The most convincing Bt tail-like structure was seen at 12 hours post-
infection, as shown in Figure 4.12. It appears to form a ‘bridge’ between two HCs, each of 
which contains bacteria. 3D viewing revealed that the actin bridge is in contact with both 
cells. In this case propulsion by actin remodelling may have transferred a bacterium from 
one HC into another.  
Figure 4.12. Possible actin re-modelling. An actin structure links two haemocytes, 12 hours post-injection with 
Bt E264 GFP. Each haemocyte contains bacteria. Panels show TRITC-phalloidin staining of actin (red), DAPI 
staining of nuclei (blue), GFP-labelled Bt E264 (green), and a composite image. 
 
 
Figure 4.13 shows an example from six hours post-injection. The bacterium-containing HC 
appears to be making or breaking a link to the adjacent cell, but the join is not well stained 
and also looks less like a typical Burkholderia actin tail. This could be an example of cell-
to-cell fusion, which leads to MNGC formation: when a peripheral projection containing 
bacteria makes contact and fuses with another cell. 
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Figure 4.13. Membrane protrusion. A physical link between haemocytes at 6 hours post-injection with Bt E264 
GFP. A bacterium (green) -containing haemocyte (red with blue nucleus) is in contact with another cell, which 
itself is in close contact with a third. This image might depict cell-to-cell fusion, which leads to MNGC 
formation. 
 
Evidence of MNGCs 
The lower resolution of actin detail was also problematic for distinguishing true MNGCs 
from clusters of separate overlapping cells. 3D projections and orthogonal views 
confirmed that most suspected MNGCs were simply clusters of cells. Examples of clusters 
from Bt E264 samples and Ec100 samples are shown in Figure 4.14.  
Figure 4.14. Examples of M. sexta haemocyte clusters. Panels A and B: examples of haemocyte clusters from 
Bt E264 GFP-infected larvae. Panels C and D: examples from E. coli Ec100 GFP-infected larvae. All samples 
pictured were from 24 hours post-injection. The fact these types of clusters were observed in the E. coli 
samples means that this is not a specifically Burkholderia-induced phenomenon  
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Some potential MNGCs were observed at 6, 12 and 18 hours post-injection with Bt E264 
GFP, as shown in Figure 4.15.  
Figure 4.15. Possible examples of mutli-nucleated giant cells (MNGCs) from Bt E264 GFP-infected larvae. 
Panel A: At 12 hours post-injection, with TRITC-phalloidin staining of actin (red), DAPI staining of nuclei (blue), 
GFP-labelled Bt E264 (green), white light, and a composite image. The white arrow indicates the position of a 
potential MNGC (with two nuclei). Panel B: The same image is presented in orthogonal view. Panel C: At 18 
hours post-injection many bacteria are seen around a potential MNGC (white arrow). 
 
The image in Figure 4.15 panel C looks the most ‘MNGC-like’ but no 3D projection could 
be made of this image to verify its nature. Therefore it is not possible to say with certainty 
whether MNGCs or just clustered cells were observed in this time-course study.   
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4.3.4. ViaCount haemocyte quantification results  
Cytometry was used to attempt to assess the number and viability of M. sexta 
haemocytes using Guava ViaCount Reagent and a Guava EasyCyte cytometer. Insect 
injections were set up in the same way as for the time-course experiment, with additional 
saline-injected or non-injected controls. All readings were made immediately following 
bleeding (and pooling and staining) at 24 hours post-injection.  
In flow cytometry, a beam of light (a single wavelength) is directed onto a stream of liquid 
sample as it passes through the cytometer. A forward scatter (FSC) detector in line with 
the beam aims at the point where the light meets the passing sample. When suspended 
particles (0.2 – 150 μm in size) pass through the beam, the ray is scattered. Fluorescent 
entities within or on the particle may also be excited and detected by fluorescent 
detectors. The combination of scattered and fluorescent light is analysed in terms of 
fluctuations in brightness, revealing information about the particles. Each particle (or 
‘event’) is plotted against the measurement parameters, producing a visualisation of the 
particle population. Subset regions on cytometry plots can be defined using ‘gates’. 
The ViaCount method measures FSC and two fluorescent wavelengths corresponding to 
(unspecified) dyes in the proprietary ViaCount reagent. FSC correlates with 
the cell volume (i.e. cell size); larger cells generate more scatter. The two fluorescent 
readings correspond to ‘nucleated cells’ (i.e. a nuclear dye which, in this case, stains 
insect cells) and ‘viability’ (i.e. a nucleic acid-binding dye which can only stain dead or 
dying cells). Figure 4.16 explains a representative ViaCount cytometry plot. Each sample 
shows two plots: the plot on the left shows ‘Nucleated Cells’ against ‘Viability’, while the 
right shows ‘Viability’ against ‘FSC’ (forward scatter). On the left-hand plot there are two 
almost-vertical ‘gate’ lines splitting the plot into three sections – the left-most section is the 
live cells, the middle section is the dying (mid-apoptotic) cells, and the right-most section 
is the dead cells. The plot is also bisected horizontally – this gate separates nucleated 
cells (top) from non-nucleated particles such as debris and bacteria (bottom). On the right-
hand plot one gate bisects the plot vertically – this separates small debris (left) from larger 
cells (right), based on size (forward scatter).  
 
Figure 4.16. An explanation of the 
sections of a  ViaCount cytometry plot.  
Mid-apop = mid-apoptotic.  
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Figure 4.17 shows representative ViaCount plots for each of the samples tested. 
Figure 4.17. Representative cytometry plots of haemocytes in ViaCount assays. Six separate sets of plots 
were produced per condition. Left: nucleated cell reading vs. viability reading. Right: viability reading vs. 
forward scatter. In the controls, most insect cells were live and large. When-infected with bacteria, more insect 
cells became apoptotic. When infected with Bt E264 strains, more ‘cells’ were small – these may actually have 
been apoptotic stripped nuclei as seen in Figure 4.12. 
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The complete ViaCount results are included in DVD e-Appendix 4c. Refering to Figure 
4.17, in the ‘no injection’ sample haemolymph from healthy larvae contains mostly live 
cells, a few apoptotic cells and some dead cells. The majority of cells are large with a 
small subset of smaller cells. Injection of saline (NaCl) shows a very similar plot. Injection 
with any of the bacteria results in more insect cells falling within the mid-apoptotic gate. 
Injection with Bt E264 (either WT or GFP) results in more ‘small’ cells; these could be 
stripped nuclei as seen in Figure 4.11 (hence staining as nucleated and mid-apoptotic but 
generating little forward scatter).  
Six sets of readings were taken per condition, except for NaCl which had three sets of 
readings. The average results are summarised in Table 4.9, and shown in Figures 4.18 – 
4.19. 
Table 4.9. Average ViaCount values for the concentration of insect cells per ml haemolymph, and the 
percentages of haemocytes which were viable, mid-apoptotic or dead  
Condition 








No injection 3.76 x106 95.53 1.68 2.78 
NaCl 4.69 x106 97.83 0.80 1.37 
Ec100 4.11 x106 84.20 14.68 1.12 
Bt E264 6.09 x106 78.62 17.48 3.90 
Ec100 GFP 3.61 x106 82.48 16.22 1.30 
Bt E264 GFP 7.54 x106 44.68 50.25 5.07 
 
Haemocyte concentration 
All HC concentrations were in the order of 106 cells per ml of haemolymph; the differences 
are visualised in Figure 4.18. The Bt E264-injected larvae had the highest number of HCs, 
with the GFP strain apparently being associated with more HCs than the wild-type strain 
in injected larvae. 
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Figure 4.18. Insect cell concentrations calculated by ViaCount assay  (mean and SE). Using haemolymph 
samples bled at 24 hours post-injection with wild-type or GFP-labelled Ec100 or Bt E264 or controls 
 
The significance of different HC concentrations between samples is shown in Table 4.10.  
Table 4.10. Significance of differences in HC cell concentrations. Comparing ViaCount data from larvae 24 
hours post-injection with controls or wild-type- or GFP-labelled E. coli Ec100 or Bt E264. p-values calculated 
by two-tailed T-test for unequal variances. NS = not significant, * p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001. 
T-test:   Haemocyte concentration (cells/ml) 
 
No injection NaCl Ec100 Ec100 GFP Bt E264 Bt E264 GFP 
No injection  0.002 ** 0.472 NS 0.551 NS 0.003 ** 0.000 *** 
NaCl 0.002 ** 
 
0.244 NS 0.002 ** 0.028 * 0.000 *** 
Ec100 0.472 NS 0.244 NS 
 
0.325 NS 0.011 * 0.000 *** 
Ec100 GFP 0.551 NS 0.002 ** 0.325 NS 
 
0.002  ** 0.000 *** 
Bt E264 0.003 * 0.028 * 0.011 * 0.002 * 
 
0.023 * 
Bt E264 GFP 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.023 * 
 
HC concentration was not significantly different between un-injected controls, E. coli 
Ec100-injected, or E. coli Ec100-GFP injected larvae. NaCl-injected controls had a higher 
cell concentration compared to un-injected larvae (p = 0.002), which was not significantly 
different from the Ec100 value. The concentration for Bt E264 was significantly greater (p 

























 Haemocyte cell concentration in M. sexta 
injected with bacteria or controls 
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Haemocyte viability 
HC viabilities were broadly similar between samples, except for the Bt GFP injected 
larvae. The data are visualised in Figure 4.19. Cells from NaCl-injected larvae had the 
greatest viability (97.8%), followed by non-injected larvae (95.5%). 
Figure 4.19. Viability of insect cells calculated by ViaCount assay, displayed as the proportion of total cells 
which were live, apoptotic or dead  (mean and SE). Haemolymph samples were bled at 24 hours post-
injection with wild-type or GFP-labelled Ec100 or Bt E264, or controls  
 
The significance of differences in HC viability between samples is shown in Table 4.11.  
Table 4.11. Significance of differences in the percentage of viable insect cells. Comparing data from larvae 24 
hours post-injection with controls or wild-type- or GFP-labelled E. coli Ec100 or Bt E264. p-values calculated 
by two-tailed T-test for unequal variances. NS = not significant, * p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001. 
T-test:    Haemocyte viability (%) 
 No injection NaCl Ec100 Ec100 GFP Bt E264 Bt E264 GFP 
No injection  0.002 ** 0.000 *** 0.000 *** 0.000 *** 0.000 *** 
NaCl 0.002 * 
 
0.000 *** 0.000 *** 0.000 *** 0.000 *** 
Ec100 0.000 *** 0.000 *** 
 
0.275 NS 0.037 * 0.000 *** 
Ec100 GFP 0.000 *** 0.000 *** 0.275 NS 
 
0.106 NS 0.000 *** 
Bt E264 0.000 *** 0.000 *** 0.037 * 0.106 NS 
 
0.000 *** 







































Condition of haemocytes in M. sexta injected 
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The saline- and non-injected control values were significantly different from each other (p 
= 0.002) and from all the other samples (p < 0.001). Cells from larvae injected with wild-
type versus GFP-labelled Ec100 did not have significantly different viabilities (84.2% and 
82.5%), indicating that the expression of GFP did not make Ec100 noticeably more or less 
pathogenic for M. sexta haemocytes.  
Cells from larvae injected with wild-type Bt E264 were not significantly different in viability 
from those with Ec100 GFP (78.6%). Cells from larvae injected with Bt E264 GFP, 
however, had viability readings of just 44.7% (p < 0.001). 
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4.4. Discussion 
4.4.1. Comparative virulence of Bt E264 wild-type and GFP 
strains 
The virulence of GFP-labelled Bt E264 was compared to that of the wild-type strain for 
reference because GFP Bt E264 would be used in the microscopy experiments. The 
results showed that both strains were indeed virulent, with the GFP strain exhibiting a 
MTTD that was 38 hours longer at the 102 CFU dose. This implies reduced virulence. As 
the dosage increased the difference between the MTTDs decreased such that at a 104 
CFU dose the difference was 6-8 hours. Injections for the microscopy analyses were of 
estimated 106 CFU doses, so it is likely that in those experiments the MTTD of the GFP 
strain would approximately match that of the wild-type. Overall the GFP strain was 
considered fit for purpose for imaging Bt infection in M. sexta. 
4.4.2. Preliminary visualisation of infection  
Preliminary injections and slide preparation were used to confirm that the method for 
TRITC-phalloidin staining of filamentous actin was successful and that bacterial GFP 
fluorescence was visible. Early infection (5 hours post-injection) and late infection (24, 36 
and 48 hours post injection) time-points were sampled and imaged, as were un-injected 
controls. These images revealed that the staining and fluorescence were successful, with 
the actin staining showing a fine level of detail.  
Actin-remodelling occurs during Bt infection of Manduca sexta  
Crucially, actin tail formations were observed in the Bt-infected samples at 24 and 36 
hours. These are believed to be the first recorded observations of Burkholderia-induced 
actin remodelling in an invertebrate host or even from an in vivo model as opposed to in 
cell cultures. Actin tails were observed both within HCs and projecting outwards from 
them, indicating that actin-remodelling in the M. sexta model enables intracellular 
movement and cellular escape, and the potential to spread directly from cell-to-cell.  
4.4.3. Time-course microscopy results 
So that nuclei could be visualised, DAPI staining was included in the triplicate time-course 
experiments. This would enable us to identify multi-nucleated giant cells (MNGCs). 
Unfortunately, in the time-course images although nuclei were stained well the actin 
staining did not show as much detail as in the initial experiments. This coincided with 
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using a new stock of TRITC-phalloidin dye. A range of concentrations and incubation 
times had been tested and this was the optimal condition. Regardless, the time-course did 
generate useful data. 
Bt E264 GFP bacterial burden increases in Manduca sexta over thirty hours 
Unlike the avirulent E. coli infection, Bt numbers increased steadily throughout the 30 hour 
infection in M. sexta from 105-106 CFU at 0 hours up to >109 CFU at 30 hours post-
injection. These figures came from the enumeration of inoculum and haemolymph 
samples. The trend reflects the ‘bacteria per field of view’ figures obtained from counting 
cells in each microscopy image (under 10 Bt cells per view at zero hours up to 
approximately 90 cells per view at 30 hours).   
Bt cells survive and multiply within Manduca sexta haemocytes 
At 0hrs (within 45 mins of injection) barely any bacteria were visibly extracellular, having 
been internalised by HCs. It is not known whether this internalisation occurred by 
phagocytosis or by active entry by the bacteria. For example Inglis et al observed that Bp 
uses flagellum-mediated endocytosis to enter Acanthamoeba amoebae (Inglis et al. 2000; 
Inglis et al. 2003). It could be a combination of both.  
Bt cells were seen surviving in high numbers inside HCs. For the first 12 hours most 
bacteria were intracellular. After that the balance shifted with increasing proportions of Bt 
cells being located extracellularly. At first the majority of HCs did not contain bacteria but 
those that did often contained numerous bacterial cells. Certain HC subtypes more 
commonly contained bacteria, primarily plasmatocytes and HP cells. Later, a greater 
proportion of HCs including granulocytes had intracellular or attached bacteria.  
The total numbers of Bt bacteria increased throughout the time-course: approximately 30-
fold from 0-12 hours and approximately a further six-fold from 12-30 hours. When also 
considering that the proportions of Bt cells that were intracellular increased to a peak at 12 
hours post-injection, these results indicate that Bt cells multiplied within the M. sexta 
haemocytes. 
In late infection many Bt cells were extracellular  
From 12 hours post-injection Bt cells were visible in increasing numbers in the 
extracellular medium; by 24 hours and particularly at 30 hours there were large numbers, 
with more than 109 CFU per ml (average 90 bacteria per view) and less than 7% of those 
remaining intracellular at 30 hours post-injection. Bacteria probably ended up in the 
extracellular medium due to apoptosis or lysis of HCs they were inside (many HCs were 
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seen to be packed full of bacteria) and potentially due to actin-based propulsion out of 
HCs. 
Haemocyte numbers peaked at twelve hours post-injection, followed by 
evidence of cell death 
HC numbers were also assessed during the time-course, as an easily measurable aspect 
of the host response. Elevated haemocyte number is a response to – or a symptom of – 
bacterial infection (Auld et al. 2012). The number of free M. sexta HCs temporarily 
increases after injection of non-pathogenic E. coli (Au et al. 2004). Conversely, the insect 
pathogen Photorhabdus luminescens causes a dramatic decrease in HC number in 
infected larvae and the bacteria are able to avoid phagocytosis (Au et al. 2004).  
Using the ‘per field of view’ measure, HC cell numbers increased from zero hours to a 
peak at 12 hours post-injection. This was true for both Bt E264 GFP and Ec100 GFP 
samples and fits well with published observations that a peak in HC number was seen at 8 
hours after M. sexta infection with 105 E. coli (Au et al. 2004). 
The increase in HC numbers is likely to be a response to the bacterial infection with a time 
lag of a few hours. The subsequent drop in HC numbers is possibly due to different 
reasons in the E. coli  and Bt infections: E. coli Ec100 GFP cells were phagocytosed and 
killed by HCs such that very few remained in the haemolymph at 12 hours post-injection, 
so ‘extra’ recruited HCs may have been destroyed once no longer required. Conversely, 
Bt E264 GFP infection led to the death of many HCs, as evidenced by cellular debris and 
released bacteria. 
Signs of apoptosis were observed. In Bt-infected samples condensed nuclei were seen 
from 6 hours post injection, more so at 18 hours, and were quiet extensive by 24 hours 
post injection. By 30 hours few HCs remained per field of view, and many of them were 
apoptotic. Condensed nuclei were also observed in the E. coli Ec100 GFP infection; these 
were mostly at the 24-30 hour time-points, but importantly there were also many healthy 
HCs in those instances. Therefore some apoptotic changes may be due to destruction of 
older HCs but Bt induced a noticeably greater incidence of HC death than was observed 
in the E. coli control. 
Statistical significance of quantitative data 
Calculating the significance of differences between Ec100 GFP and Bt E264 GFP showed 
that bacteria-related values (total number, proportion intracellular, proportion extracellular 
excluding attached) were significantly different at all time-points with the exception of total 
number at 6 hours post-injection. This was the point at which the decreasing E. coli Ec100 
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numbers matched the increasing Bt E264 numbers. Haemocyte numbers had larger p-
values at most time-points indicating they were less divergent, although the differences 
were still significant in all but two cases: zero hours and 12 hours post-infection. It could 
be expected that there was no significant difference at zero hours as there has been 
insufficient time for a difference to emerge between the two infections. At 12 hours there 
was larger variation in replicate values which led to overlapping error bars. The reason 
why Bt E264 HC numbers were consistently lower than E. coli Ec100 HC numbers is not 
clear; it could be that both bacteria elicit an increase in HC numbers but Bt also kills a 
proportion of those, or that Bt stimulates less of an increase in HCs due to factors which 
aid immune evasion. As Bt is actually successful at surviving and apparently multiplying 
within HCs, the former explanation might be more plausible. 
Further evidence of actin remodelling was limited 
In the initial microscopy experiment actin tails were clearly apparent at 24 and 36 hours 
post-injection. In the time-course however, classic comet-tail structures were not seen. 
This could be due to: less detailed resolution of actin structures with the new TRITC-
phalloidin stock; damage to delicate cellular structures during the slide preparation; or 
variation in the bacterial pathogenesis (i.e. the structures may not have been made in 
every Bt infection). The most convincing example resembled an actin bridge linking two 
bacteria-containing HCs at 12 hours post-infection with Bt E264 GFP. 
Inconclusive evidence of MNGCs  
Published images of Burkholderia-induced MNGCs in mammalian cells or cockroach HCs 
show distinct giant cells with rounded or branched shapes, one cell membrane and 
multiple nuclei (Suparak et al. 2005; Burtnick et al. 2011; Fisher et al. 2012; Galyov et al. 
2010; Hasselbring et al. 2011). Upon 3D-imaging, formations that had looked like multi-
nucleated cells were usually discovered to resemble multiple separate cells clustered 
together. Some cases could neither be dismissed as clusters nor conclusively accepted 
as true MNGCs, such as the images pictured in Figure 4.15 from 12 and 18 hours post-
injection. In the 12 hours image the apparent ‘squashing’ of one nucleus may indicate that 
one HC is on top of another. The cell cluster pictured in Panel C of Figure 4.15 does look 
similar to MNGCs pictured in RAW 264.7 macrophages (Burtnick et al. 2011), showing 
multiple nuclei and bacteria around a large cellular mass. Unfortunately a Z-stack was not 
available for that image as it was taken in addition to the designated time-course images. 
Therefore it was not possible to study this structure in 3D detail and it cannot be 
confidently said that MNGCs were observed in this M. sexta time-course.  
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Bt E264 is reported to form fewer MNGCs than some other Bt strains (Wand et al. 2011). 
If MNGC numbers were low to begin with, the likelihood of capturing them in the time-
course images is further reduced.  
Other researchers have generally observed MNGCs in tissues of melioidosis patients and 
in monolayers in cell culture, i.e. where cells are relatively fixed in contact with or close to 
one another. Fisher et al reported seeing Bp MNGCs formed from cockroach haemocytes 
which implies that they can be formed from un-attached cells circulating in the 
haemolymph (Fisher et al. 2012). Further attention – perhaps with a different Bt strain – 
would be required to determine whether this process does also occur in M. sexta. 
 
4.4.4. ViaCount quantification of haemocytes and their 
viability 
The number of HCs counted from the confocal microscopy cannot be used to reliably 
calculate cell concentrations per volume of haemolymph because they show only the cells 
which adhered to the cover-slip (hence using ‘per view’ measures). Therefore, a cytometry 
method for assessing M. sexta HC number and viability was tested with a view to 
correlating our observations from microscopy with a semi-automated quantitative assay. 
Further work will be required to fully establish this assay but the initial results are 
promising. 
Haemocyte concentration 
The data were taken from duplicate experimental set-ups each with multiple readings. The 
fact that the standard error bars were tight supports the reliability of the cell concentration 
readings. At the time-point the readings were taken (24 hours post-injection) the Ec100 
and Ec100 GFP samples show similar HC concentrations to the un-injected control. This 
reflects the Ec100 GFP data from the microscopy time-course where HC numbers at 24 
hours had already returned (after a peak at 12 hours) to match the numbers at zero hours. 
This indicates that the E. coli infection has already been cleared and HC numbers have 
returned to normal. Injection with saline (NaCl) appears to have increased HC numbers; 
the reason for this is not clear.  
Injection with Bt E264 and especially with Bt E264 GFP resulted in significantly higher HC 
concentrations. This is in contrast to the Bt E264 GFP data from the microscopy time-
course, where HC numbers at 24 hours were lower than at zero hours.  
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This might be an erroneous reading effect explained by the clusters of cell debris which 
were observed by microscopy at that time-point. Debris is usually distinguished in the 
ViaCount assay by a lack of staining with the nuclear dye, and bacteria are too small to 
generate enough forward scatter. It is conceivable that clusters of debris may be large 
enough and may have enough attached (live-stained) bacteria to be recorded by the 
ViaCount program as HCs.  
It is not clear why Bt E264 GFP – the strain used for the microscopy time-course – was 
associated with a greater HC concentration than the wild-type Bt E264 strain. The dose 
response experiments indicated that the GFP strain was slightly less virulent, so perhaps 
more HCs were still remaining intact or more debris clusters still had bacteria attached.  
Haemocyte viability 
Based on observations from the microscopy it was expected that HC viability at 24 hours 
post-injection would be lower with Bt than with E. coli, but cells from larvae injected with 
wild-type Bt E264 showed a statistically similar viability to those from Ec100 GFP-injected 
samples (78.6%). Another unexpected result was that cells from Bt E264 GFP-injected 
samples recorded a greatly reduced viability compared to wild-type Bt E264 (44.7%, p < 
0.001). 50.3% of cells were designated as mid-apoptotic.  
One reason for testing both GFP-labelled and wild-type strains of each bacterium was so 
that any effects attributable to GFP expression (including altered virulence or fluorescence 
artefacts) could be detected. No difference in HC viability readings was observed between 
Ec100 wild-type and GFP samples, as hoped. But, as the Ec100 bacteria were virtually all 
destroyed by 24 hours according to the microscopy and CFU counts, this does not help to 
reveal whether their GFP fluorescence affects the ViaCount readings. 
According to correspondence with Millipore, bright GFP fluorescence (e.g. from bacteria 
within or upon a haemocyte) could potentially bleed into the wavelengths for the dead-cell 
dye, resulting in more apoptotic readings. This could account for the observed differences 
in viability readings between the Bt E264 strains. Alternatively, the result could be 
accurate – that over half of the HCs are indeed dead or dying – and the inaccuracy lies 
with the wild-type Bt E264 results. However, it was unexpected that the Bt E264-induced 
HC viability was not significantly lower than that for HCs which had encountered harmless 
Ec100 cells. Clearly more characterisation will be required for reliably informative data to 
be generated from this assay.  
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4.4.5. Potential directions for further work 
The confocal microscopy visualisation of bacteria-haemocyte interactions allowed detailed 
monitoring of the progression of Bt infection in M. sexta. It was discovered that Bt survives 
and multiplies within M. sexta haemocytes, that extensive haemocyte death occurs at late 
infection, and Burkholderia actin tails were observed in invertebrate cells for the first time. 
These results fit well with observations from mammalian studies and lend support to the 
validity of the M. sexta surrogate model of Burkholderia infection. 
Following our discovery in Chapter 3 that B. oklahomensis is unusually virulent in M. 
sexta, it would be fascinating to perform a similar time-course study with Bo strains. 
Equally, if it was practicable it would be interesting to use this technique towards 
understanding why Bp shows relatively low virulence in M. sexta.  
If actin staining could be restored to the high level of detail seen in the initial images, it 
would be useful to repeat a Bt time-course and look once more for cellular pathologies 
including actin tails and MNGC formation. With electron microscopy it should also be 
possible to detect at what time-points bacteria were inside and escaping from phagocytic 
vacuoles. 
With further characterisation and optimisation the ViaCount assay for infected M. sexta 
haemolymph could be a useful tool. If GFP-bacteria are to be used then GFP interference 
must be removed from the readings by running positive GFP controls and performing 
‘colour compensation’. Non-GFP bacteria should be fine to use, but in either case 
bacteria-only samples should be run to determine where they appear on the plot. More 
controls will be required to: (i) characterise the populations of healthy HCs (accounting for 
their heterogenous nature); (ii) characterise populations of HCs which are dead or dying 
as a result of abiotic means (controls); (iii) confirm that the gates for viability dye readings 
are set correctly; and (iv) ensure reproducibility. Once performing reliably, the assay could 
be used to generate quantitative data at more time-points during infections. As well as 
Burkholderia, this method could be applied to evaluate M. sexta health and immunity in 
response to other pathogens or toxic factors or treatments. Potentially, sub-regions of the 
cytometry plot could be defined to distinguish HC cell types, e.g. granulocytes from 
hyperphagocytes. 
It was hoped that RT-PCR would also be used to analyse the transcription of specific 
virulence-related genes throughout the time-course study. Potential targets include bimA 
for actin-based motility or T3SS effector genes. RNA samples were obtained and 
processed for each time-point. However, the RT-PCR results showed problems of DNA 
contamination which could not be overcome within the limited time available. Therefore no 
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data are presented. Transcriptomic or proteomic analyses of bacteria during an M. sexta 
infection would tie in well with data regarding the numbers and health of bacteria and 
haemocytes. From the host response point of view, host gene expression has been 
probed in C. elegans and murine models of Bp infection (Ooi et al. 2012; Chin et al. 2010). 
With the M. sexta genome and transcriptomes now available, a similar approach could 
conceivably be used with M. sexta.   
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Chapter 5. Rapid Virulence 
Annotation of Burkholderia 
pseudomallei 
5.1. Chapter summary 
A genome-wide screen for Bp virulence-related genes was undertaken using multiple 
invertebrate infection hosts and a large expression library of E. coli fosmid clones with Bp 
genomic inserts. This chapter describes the outcomes of that approach. A statistical 
method was devised which enables quantitative analysis of Rapid Virulence Annotation 
(RVA) results and overcomes problems with reproducibility of biologically active clones. 
The calculated observed-to-expected hit ratio for genes allows the identification of a 
refined subset of the most convincing positive hits. The hits included many known and 
putative Bp virulence factors, and work was begun to create a deletion mutant in kdpD, a 
locus of particular interest. Ultimately, the lack of reproducibility from positive clones cast 
doubt on the appropriateness of the fosmid system for expressing Bp genes in E. coli. 
Preliminary RT-PCR analyses of the expression of candidate virulence factors are 
reported. Overall, the outcome highlights the importance of a thorough assessment of 
recombinant library expression capability when embarking on RVA-style screening. 
Nonetheless, the statistical method described here represents a useful tool for the 
analysis of past or future RVA data sets. 
5.2. Introduction 
As discussed in the main introductory chapter, Rapid Virulence Annotation (RVA) is a 
technique for the rapid identification of putative virulence factors of bacterial pathogens. 
The method employs an expression library – several thousand E. coli clones expressing 
fosmid-based inserts from the genomic DNA of the pathogen of interest. In this case, RVA 
was applied to Bp strain K96243.  
While several factors have already been identified as playing a role in Bp virulence, much 
remains to be understood. Therefore the rapid generation, using an assumption-free 
approach, of a shortlist of putative factors for further investigation could be highly useful 
for the study of Bp, as it was for the study of P. asymbiotica (Waterfield et al, 2008). The 
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ability to investigate the genome of this CL3 pathogen under CL2 laboratory conditions is 
also a major benefit. 
Bp K96423 was confirmed in Chapter 3 to be virulent to M. sexta larvae. Bp K96423 can 
also be predicted to evade predation by amoebae and nematodes based on high genetic 
similarity with Bt E264 which was shown in Chapter 3 to evade predation by A. polyphaga 
and C. elegans, and also based on the observations by Inglis et al (2000; 2003) of Bp 
interactions with Acanthamoebae. The E. coli fosmid expression strain Epi300 is not 
harmful to M. sexta larvae and is readily consumed by the bacteriovore species. Therefore 
any ‘Gain of Toxicity’ (GOT) of some clones would be attributed to the presence of the Bp 
DNA. GOT is indicated by signs of mortality or morbidity in the insect larvae, or by a lack 
of predation by the bacteriovores. In this chapter the Bp K96423 fosmid library was 
screened in each of the three invertebrate models.   
This RVA of Bp differs from the original P. asymbiotica RVA in two respects. Firstly, only 
the three invertebrate assays were performed in parallel. An mGOT macrophage assay 
was performed in collaboration with another research group but the experimental work 
was not coordinated, and the macrophage assays used a combination of the fosmid 
library and an additional BAC library. The macrophage data was published (Dowling et al. 
2010) and will be referred to in the results and discussion sections for comparison with the 
invertebrate RVA results. Secondly, the Bp RVA used a different expression system: 
fosmids as opposed to cosmids, and Epi300 E. coli as opposed to the EP1305 E. coli host 
(both from Epicentre). Fosmids are low-copy number cosmids based on the bacterial 
fertility plasmid (F-plasmid). They allow cloning of large DNA fragments and are 
considered to be more stable than high-copy number cosmids (Kim et al. 1992). The 
pCC1FOS fosmids used in this study are single-copy, but can be temporarily induced to a 
higher copy number by addition of CopyControl™ AutoInduction solution. However, this 
short-term up-regulation is optimal between 16-20 hours after addition to a starter culture, 
after which the suppliers report there may be problems with stability and toxicity of clones. 
Therefore the GOT assays were performed without addition of induction solution. 
Aim: To use RVA to identify putative virulence-related genomic loci of Bp K96423 
The primary aim was to use RVA – with the insect, amoeba and nematode host models – 
to identify ‘hit’ fosmid clones from the Bp K96423 fosmid library. If RVA led to a 
reproducible shortlist of fosmids with putative virulence-related activity the aim would then 
be to further pin-point the precise loci responsible, using transposon mutagenesis for 
example. It would also be possible to draw conclusions about the extent of overlap of Bp 
virulence factors relevant for the different invertebrate hosts. 
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Aim: To develop a new statistical approach for analysis of the RVA results and to 
assess quantitatively which regions, if any, were the most likely true RVA ‘hits’ 
Unexpectedly, the shortlist fosmids with putative virulence-related effects seen in the first 
round of RVA screening was not reproducible, and there was little distinctive ‘clustering’ of 
multiple hit fosmids around genomic loci. Therefore, the secondary aim was to develop a 
more rigorous and quantitative method to statistically assess the hit results for clustering, 
and to look for evidence as to whether the ‘hits’ from the first round of screening did 
indeed include true hits or simply resembled a random sample. 
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5.3. Results 
5.3.1. Analysis of the BPF library 
First the genomic fosmid library itself was assessed for completeness of coverage and for 
evidence of Bp protein expression. 
Coverage 
The library end-sequences were batch-BLASTed and manually curated,  which identified 
the coordinates of 2,396 fosmid inserts (67.45% of the library). The mean insert size was 
35,323 bp. 3,552 clones x 35,323 bp = approximately 125.5 Mb of sequence. This 
equates to more than 17x coverage of the 7.2 Mb Bp K96423 genome. However, the end-
sequences of many clones did not have good BLAST matches and therefore could not be 
located. Figure 5.1 shows the coverage of located clones. 
Figure 5.1. Coverage of the Bp K96423 genome within the BPF fosmid library. The lengths of chromosome 1 
(top) and 2 (bottom) are represented along the x-axes. Located inserts are spaced along the y-axes simply for 
ease of viewing. 
 
 Rapid Virulence Annotation of Burkholderia pseudomallei pg. 196 
The library coverage was over 99.9% complete with one 8kb gap near the terminus of 
chromosome 1. Chromosome 1 also showed a heavily over-represented area around 
base pairs 17,900-20,000. 
Protein expression from BPF clones 
To look for evidence of protein expression, fosmids encoding the MprA metalloprotease 
were plated on mil agar plates. If successfully expressing, translating and exporting the 
protein this would result in proteolytic clearing of the milk agar. Table 5.1 shows the 
degree of proteolysis observed on 3% milk agar plates. 
Table 5.1. Degree of proteolysis of milk agar exhibited by BPF fosmid clones and controls 
Organism or BPF clones 
Proteolysis 
No extra regulation With auto-induction solution 
Bt E264 ++++ NT 
Epi300 E. coli 0 0 
16b11 / 28f02 / 15b05 / 
34f05 / 05b11 / 32b11 / 
01a03 
+ ++ 
Plates were incubated at 37 °C and assessed after 72 hours. The degree of proteolysis is 
represented on a scale from 0 (no effect) to ++++ (extensive effect). NT = not tested 
 
As shown in Figure 5.2 the Bt control plate showed extensive proteolysis of the milk agar. 
The mode of regulation of extracellular enzymes often differs between Bt and Bp (Vial et 
al., 2007), and additionally, the proteolytic effect may have resulted from the action of 
multiple enzymes as opposed to MprA alone. However, the effect serves as a clear 
indication of a positive proteolytic effect. On the other hand, the Epi300 E. coli background 
strain showed no clearing of the milk agar. 
All of the BPF clones tested showed a slight proteolytic effect: a selection is shown in 
Figure 5.3 panel A. The effect took 48-72 hours to become apparent, unlike the Bt control 
which took less than 24 hours’ incubation to show clearing. As shown in Figure 5.3 panel 
B, it was also evident that addition of the CopyControl™ solution increased the proteolytic 
ability of each clone but, importantly, some limited activity was still seen in areas of thick 
growth from clones grown without it. 
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 Figure 5.2. Protease expression from Bt E264 and Epi300 E. coli. After 72hrs incubation at 37°C: (A) the milk 
agar was cleared by the Bt E264 positive control; (B) the Epi300 E. coli negative control plate remained 
opaque. 
 
Figure 5.3. Metalloprotease expression from BPF clones. Following 72hrs’ incubation at 37°C, BPF clones 
bearing a metalloprotease gene (BPSS1993) were able to lyse the milk in the areas of thickest bacterial 
growth. (A) Two representative MprA-bearing BPF clones. (B) Proteolysis was more pronounced when clones 
were grown with CopyControl™ Auto-Induction solution (left) than without (right), although limited clearing was 
still evident in the un-treated clones. 
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The evidence of proteolysis meant that Bp proteins could be successfully expressed and 
secreted in the recombinant system and therefore indicated that the system would be 
sufficient for RVA. 
5.3.2. Initial RVA results and re-testing 
Initially the RVA results were assessed by plotting their fosmid insert locations relative to 
the Bp K96423 genome and looking for evidence of clustered hits. 
Numbers and different types of hits  
The gain-of-toxicity (GOT) assays yielded semi-qualitative results. aGOT (amoeba-GOT) 
and nGOT (nematode-GOT) results were classed as either ‘best’ or ‘possible’ positives 
based on how clear-cut the result had been. Similarly, iGOT (insect-GOT) results were 
classed as ‘best’, ‘possible higher’, ‘possible lower’, or ‘interesting phenotype’ hits. 
Interesting phenotype hits were those which did not appear to have detrimental effects on 
larval development but the larvae showed a pink tinge which anecdotally may be immune 
system-related. ‘Best’ iGOT hits from the first round were those with which the injected 
larva had died (n = 33). Full details of the results are listed in DVD e-Appendix 5a. 
Numbers of each type of hit are summarised in Table 5.2.  
Table 5.2. Qualitative classification of hits from GOT screens 












aGOT 202 107 - - 309 202 
nGOT 147 53 - - 200 147 
iGOT 33 20 73 32 158 158 
 
Mapping of positive fosmids to the Bp genome 
The entire BPF library consisted of 3,552 clones. Of these, approximately 74% could be 
revived from -80 °C stocks and were tested in GOT screens (Table 5.3). RVA screening 
was conducted before Batch-BLAST results of end-sequences were available. Due to 
poor sequence data or poor BLAST results approximately 25-35% of positive clones could 
not be mapped. The rest were assigned to chromosome 1 or 2 as shown in Table 5.3. 
Positive GOT results were mapped to their corresponding locations along the Bp genome, 
as shown in Figure 5.4. 
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Table 5.3. Numbers and locations of positive hit results from BPF invertebrate GOT assays 
 
No. clones 
grown and  
tested (% of 
library) 
Total 
positive hits  
(% of clones 
tested) 
Locations of hit regions 
(% of total positive hits)  
Un-mapped  Chromosome 1 Chromosome 2 
aGOT 2632 (74.1%) 202 (7.7%) 58 (28.7%) 91 (45.0%) 53 (26.2%) 
nGOT 2634 (74.2%) 147 (5.6%) 38 (25.8%) 70 (47.6%) 39 (26.5%) 
iGOT 2630 (74.0%) 158 (6.0%) 56 (35.4%) 65 (41.1%) 37 (23.4%) 
Average 74.1% 6.4% 30.0% 44.6% 25.4% 
‘% of library’ values are based on 3552 BPF clones. Hits ‘% of clones tested’ values are based on only those 
clones that grew and could be tested. The distribution of hits is shown - chromosome 1 or 2 or un-located 
due to poor sequence or BLAST data. 
 
Figure 5.4. Positive fosmid distribution maps. Bp K96423 genome maps showing the locations of inserts from 
positive hit clones along chromosome 1 (top) and chromosome 2 (bottom). aGOT hits are shown in red, nGOT 
in blue, and iGOT in green. 
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The positive hits were spread across the majority of the genome. Apart from a clustering 
of hits in the region which was heavily over-represented in the library itself (chromosome 
1, base pairs 17,900-20,000), there were no particularly obvious clusters.  
Retests of positive hits  
When it came to re-testing the fosmids identified as hits in the first round of screening, it 
became apparent that there was little to no reproducibility. When the first 20 positive 
clones from aGOT and nGOT screens were re-tested using 10 replicate wells the results 
were not consistently reproducible (data not shown). Therefore it was decided that re-
testing all the aGOT and nGOT positives would not be worthwhile.  
Positive hits from iGOT were re-tested with 10 larvae each. Of the 33 clones which were 
lethal in the first round (i.e. scored 4 based on the original 0-4 scoring system), none 
reproduced the lethal effect. The average retest score was just 0.66 with a range of 0-
0.70. These scores corresponded to only a very slight effect. Similarly, clones from the 
‘possible’ or ‘interesting phenotype’ categories re-tested with an average score of 0.20 
and a range of 0-0.70. A score of 1 was considered a small effect, so these re-test scores 
did not represent a great degree of morbidity. The re-tests suggested that either the 
original high scores may have been anomalous, or the virulence-related activity of the 
fosmids may have been lost or degraded over time. 
5.3.3. Statistical analysis of RVA results 
Which hits to consider in further analyses 
As the re-testing was not appropriate for aGOT and nGOT and was not reproducible for 
iGOT it was not possible to refine a shortlist of fosmids for further study. Therefore it was 
decided which hits would be considered in the further (statistical) analyses. From the first 
screening round the aGOT and nGOT screens yielded a large number of positive hits, so 
only the ‘best’ hits were considered in all subsequent analyses (202 and 147 hits, 
respectively). iGOT had produced far fewer ‘best’ hits and fewer hits overall, so all iGOT 
hits (158 in total) were considered in analyses.  
Descriptive statistics and correlations of coverage and hit distributions  
BPF library Coverage values and Observed Hit values were determined as described in 
the methods section. Fosmids contained an average of 31.65 CDSs with standard 
deviation of 7.83 CDSs. 76,352 CDS representations were identified by the script output, 
with coverage across the Bp genome as shown in Figure 5.5.  
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Figure 5.5. BPF library coverage maps for chromosome 1 (top) and chromosome 2 (bottom). Chromosome 1 
is also represented on a different scale (upper, inset) to illustrate the extent of coverage of the over-
represented region.   
 
CDS by CDS, coverage varied considerably across each chromosome, with a few distinct 
peaks of higher coverage. If a random sample of fosmids was picked, it would be 
expected by chance to see more hits (i.e. clusters) at regions with higher coverage.  
When excluding clones which did not grow and therefore could not be tested in the 
screens, the following coverage numbers were tested: aGOT = 57,228 CDS 
representations; nGOT = 57,228 CDS representations; iGOT = 57,170 CDS 
representations. This means that across the 5,855 CDSs present in the Bp genome the 
average coverage was between 9.77-9.78 fosmids per CDS. Further statistical 
calculations were based on that tested portion of the library only. 
One-Sample Kolmogorov-Smirnov tests revealed that for all three GOT screens the 
Coverage and Observed Hit data did not fit the normal distribution (p < 0.000) and 
therefore further test statistics would need to be non-parametric. Full SPSS statistics 
reports are included in DVD e-Appendix 5b.  
Scatterplots of each screen’s Coverage and Observed Hits (Figure 5.6) show a positive 
correlation; CDSs which are represented more are generally hit more, as would be 
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expected. A portion of the data points in each case have very high coverage - these 
correspond to the heavily over-represented region of chromosome 1.  
Figure 5.6. Scatterplot graphs for Observed Hits and Coverage data from aGOT, nGOT and all iGOT hits  (top 
left, clockwise). If coverage alone was an accurate predictor of observed hits (Obs), the data points would fit a 
linear positive correlation, i.e. would align close to an imaginary diagonal line from the bottom left to top right 
corner. The presence of the data points on the far right gives the impression of that trend, but they represent 
the heavily over-represented region of chromosome 1. The majority of hits (in the range of up to 30x 






Correlation coefficients for CDS coverage and observed hits were calculated using the 
Spearman’s rho statistic suitable for non-parametric data (Table 5.4). 
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0.221**   
nGOT Observed 
Hits 
 0.268**  
iGOT Observed 
Hits (all) 
  0.304** 
** Correlation is significant at the 0.01 level (2-tailed). 
 
With a perfect positive correlation having a coefficient of 1.0, the calculated coefficients 
(0.221 – 0.304) showed a weak-to-moderate but significant correlation between CDS 
Coverage and Observed Hit data. This indicates that the degree to which a CDS is hit is 
not solely determined by its Coverage; other factors are at play, e.g. random effects or 
true-positive GOT effects. 
Correlation between observed and expected hit values   
Table 5.5 shows the Spearman’s rho correlation coefficients for Observed hits and 
Expected hits. As the Expected hits are calculated based on CDS coverage, it would be 
expected that this would produce a similarly weak-to-moderate correlation. 










0.204**   
nGOT Observed 
Hits 
 0.331**  
iGOT Observed 
Hits (all) 
  0.331** 
** Correlation is significant at the 0.01 level (2-tailed). 
 
A weak-to-moderate but significant correlation was indeed seen between Expected Hits 
and Observed Hits (0.204 – 0.331). If the hits had been distributed exactly as expected 
according to the Coverage alone this would have yielded a perfect correlation of 1.0. 
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Descriptive statistics for Obs/Exp ratio data 
Ratios of Observed/Expected hits were calculated for each hit CDS, as described in the 
methods section. Descriptive statistics for the Ratios use median rather than mean values 
because the data was non-normal.  
When considering the aGOT hits, nGOT hits and all iGOT hit types, the median Ratio was 
2.0. This means the median trend for hit CDSs was to be hit twice as often as expected. 
Excluding the iGOT ‘phenotype’ hits did not affect this result. Excluding the ‘lower 
possible’ hits, and subsequently the ‘higher possible’ hits too, did affect the result; the 
median trend was for CDSs to be hit six- and ten-times as often as expected. This 
indicates that hit clones that were qualitatively categorised as ‘best’ or ‘higher possible’ 
actually did cluster around particular CDSs more, supporting the theory that, despite a 
lack of reproducibility, true GOT effects did occur during screening.  
Confidence intervals (CIs) for the medians were constructed without any distribution 
assumptions and values for the upper limit were noted (Table 5.6). These values enable 
average or below-average Ratios to be disregarded, leaving a sub-set of hits with high 
ratios. Ratio values above those upper limits are at least as great as the true median 
value, with at least 95% or 99.9% confidence. 
Table 5.6. Descriptive statistics for the GOT screens’ Obs/Exp Ratio data. n = number of hit CDSs. Median = 
median average observed/expected (Obs/Exp) ratio. Upper bounds of Confidence Interval for the medians 
(CI) are shown (95% and 99.9% confidence that the median is less than or equal to the figure shown).  
Obs/Exp Ratio n 
Upper confidence interval of the median 
95% 99.9% 
aGOT 3021 2.0 2.0 
nGOT 2064 2.0 2.0 
iGOT 
(all hits) 
2181 2.0 2.0 
iGOT 
(excl. phenotype hits) 
1206 3.0 3.0 
iGOT 
(best & higher possible hits) 
778 6.0 6.0 
iGOT 
(only best hits) 
442 10.0 12.0 
 
In most cases the 99.9% upper confidence interval level is the same as for the 95% upper 
confidence level, with the exception of for the iGOT best hits. This simply indicates that 
the iGOT best hits had greater variability among high Obs/Exp Ratio values. 
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Refining the GOT hits 
The upper median CI values were used to eliminate CDSs which were not hit more than 
the average, leaving the numbers of CDSs shown in Table 5.7. DVD e-Appendix 5c lists 
all the CDSs in the refined subset with their Obs/Exp Ratios, genome coordinates, gene 
ontology (GO) information and other published annotations. 
Table 5.7. Refined numbers of hit CDSs based on Obs/Exp ratios 
 
Original number of hit 
CDSs 
Number of refined hit 
CDSs 
Percentage of original 
number  
aGOT 3021 1190 39.4 % 
nGOT 2064 1209 58.6 % 
iGOT 
(all hits) 
2181 1174 53.8 % 
 
All the refined hit CDS Obs/Exp Ratios were plotted on genome maps (Figures 5.7-5.9). 
This allows the visualisation of regions with Obs/Exp Ratios higher than the upper CIs for 
the medians, i.e. those which were hit particularly more than expected by chance.  
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Figure 5.7. Graphs showing Obs/Exp Ratios for aGOT hit CDSs. Hit CDSs are aligned to the genome 
(chromosome 1, top; chromosome 2, bottom). The average (median) Ratio is 2.0 or below. Ratios greater than 
2.0 are highlighted in bright red. Some CDSs were hit up to 13 times more than expected. 
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Figure 5.8. Graphs showing Obs/Exp Ratios for nGOT hit CDSs. Hit CDSs are aligned to the genome 
(chromosome 1, top; chromosome 2, bottom). The average (median) Ratio is 2.0 or below. Ratios greater than 
2.0 are highlighted in bright blue. Some CDSs were hit up to 6.5 times more than expected 
 
  
 Rapid Virulence Annotation of Burkholderia pseudomallei pg. 208 
Figure 5.9. Graphs showing Obs/Exp Ratios for all iGOT hit CDSs. Hit CDSs are aligned to the genome 
(chromosome 1, top; chromosome 2, bottom). The average (median) Ratio for all hits is 2.0 or below. Ratios 
greater than 2.0 are highlighted in bright green. Some CDSs were hit up to 11 times more than expected. 
 
Having taken into account variations in the coverage of the tested fosmid library to 
generate Obs/Exp Ratios, it was apparent that some regions were ‘hit’ considerably more 
than average. These represent the loci most likely to have shown true GOT effects in the 
first round of scrrening, despite the lack of reproducibility in re-testing.   
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Comparing hits between invertebrate GOT screens 
The refined hits (those with Ratios greater than or equal to the upper CI for the median) 
were analysed to see how much overlap there was between hits from the three different 
invertebrate screens. CDSs from the refined hits were hit in one or more screens as 
shown in Figure 5.10. 
Figure 5.10. Number of CDSs unique to or shared by different GOT screens (total 2,756 CDSs) 
 
CDSs hit in one model only =  73.4 % 
CDSs hit in two models =   23.5 % 
CDSs hit in all three models =  3.1 % 
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Mapping refined hit ‘regions’ from all screens 
Refined hit regions were defined as those containing one or more CDSs with Obs/Exp hit 
ratios at least equal to the median ratio, as described in the methods section. DVD e-
Appendices 5d and 5e contain complete details about the GOT Regions in terms of 
genomic coordinates and the average and maximum Obs/Exp Ratio of the CDSs within 
each region. 
Table 5.8 shows the numbers of hit regions from aGOT, nGOT and iGOT (‘all hits’ and 
‘best hits’). 
Table 5.8. Numbers of GOT Regions, by GOT assay type and by chromosome. CI = confidence interval  
 Number of GOT Regions 
 Chromosome 1 Chromosome 2 Total 
aGOT 37 29 66 
nGOT 34 27 61 
iGOT (all hits) 30 27 57 
iGOT (only best hits, 95% CI) 6 5 11 
 
The refined hit regions were used in order to plot the new results from all three screens 
onto the same map; in Figure 5.11 the different GOT screens (plus an iGOT subset) are 
arranged and labelled on horizontal tracks.  
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Figure 5.11. Refined hit regions of the Bp K96423 genome according to iGOT, nGOT and aGOT. These regions all show observed-to-expected hit ratios equal to or higher than the 
median ratio for hit CDSs. For most data the 95% and 99.9% confidence intervals (CI) are the same. iGOT best hits are shown using the 95% CI. Horizontal tracks for each data 
subset are labelled at the right. There is a mixture of overlapping refined hit loci and loci which were refined hits in only one screen.  
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Out of interest to see whether the different subjective scores of different iGOT hit types 
corresponds to any interesting variation in refined hit regions, Table 5.9 and Figure 5.12 
show the refined regions based on the different subsets of iGOT hits.  
Table 5.9. Numbers of GOT Regions, by iGOT hit type and by chromosome. CI = confidence interval  
 Number of GOT Regions 
 Chromosome 1 Chromosome 2 Total 
iGOT (all hits) 30 27 57 
iGOT (excl. phenotype hits) 7 13 20 
iGOT (best & higher possible 
hits) 
24 15 39 
iGOT (only best hits, 95% CI) 6 5 11 
iGOT (only best hits, 99.9% CI) 4 6 10 
 
In Figure 5.12 the lowest track shows the refined regions from the analysis of all iGOT hits 
(ratios at least equal to 2). The highest track shows results from only the best hits with the 
most stringent upper CI cut-off (ratios at least equal to 12). It seems that there is little 
difference in the overall pattern between ‘all hits’ and ‘best & higher possible’ hits (which 
excluded both ‘lower possible’ and ‘phenotype’ hits). This implies that the ‘best & higher 
possible hits’ results strongly contribute to the regions defined for ‘all hits’. Similarly, most 
regions that are identified from ‘best hits’ are present in all the sub-sets, suggesting that 
they truly were the most reliable hits; not only were their original GOT scores higher but 
they were also hit more times. 
For most subsets of data the 95% and 99.9% CIs of the median gave the same value but 
for the iGOT best hits two different values were given. In this figure both were used as cut-
off values for the ratios. The 95% and 99.9% confidence intervals gave very similar results 
in terms of the locations of hits because most best hit ratios were equal to at least 12.  
As there were not major differences between most subsets of iGOT data (or between the 
two confidence intervals for the best hits), all further analyses of iGOT will continue to 
concentrate only on the results from ‘all hits’ and ‘best hits’ (95% CI). 
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Figure 5.12. Refined hit regions of the Bp K96423 genome according to iGOT with different analyses of the data. These regions all show observed-to-expected hit ratios equal to or 
higher than the median ratio for hit CDSs. For most data the 95% and 99.9% confidence intervals (CI) are the same. Two tracks are shown for iGOT best hits to reflect the different 
CI values. Horizontal tracks for each data subset are labelled at the right. 
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Functional annotations of hits 
Thanks to the availability of annotations for the Bp K96423 genome it was possible to look 
for patterns in the annotated functions of hi CDSs. The JCVI database was used to find 
gene ontology (GO) data (http://pathema.jcvi.org).  
Pie charts in Figures 5.13 – 5.15 show the frequencies of different GO annotations which 
occurred two or more times.  
Table 5.10 summarises the same GO annotations for all three GOT screens. The vast 
majority of CDSs stated “no GO annotation on JCVI”. For those that did have GO 
accession numbers, many corresponded to “biological process unknown”.  
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Figure 5.13. Pie chart showing frequency of GO annotations among refined hit aGOT CDSs. Annotations which occurred only once were combined into the ‘individual GO terms’ 
category. The ‘Other’ portion of the pie chart is expanded for ease of viewing. 
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Figure 5.14. Pie chart showing frequency of GO annotations among refined hit nGOT CDSs. Annotations which occurred only once were combined into the ‘individual GO terms’ 
category. The ‘Other’ portion of the pie chart is expanded for ease of viewing. 
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Figure 5.15. Pie chart showing frequency of GO annotations among all refined hit iGOT CDSs. Annotations which occurred only once were combined into the ‘individual GO terms’ 
category. The ‘Other’ portion of the pie chart is expanded for ease of viewing. 
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Table 5.10. Summary of common GO annotations from refined hits of the three GOT screens 
GO Annotations aGOT nGOT iGOT 
>3 mentions 
Undefined metabolic processes Ciliary or flagellar motility DNA-dependent transcriptional regulation 
Transport functions Undefined metabolic processes Undefined metabolic processes 
Riboflavin biosynthesis Cobalamin biosynthesis Transport functions 
DNA-dependent transcriptional regulation ATP-coupled proton transport Fatty acid biosynthesis 
DNA repair DNA-dependent transcriptional regulation Glycolysis 
Iron-sulfur cluster assembly Riboflavin biosynthesis Deoxyribonucleotide biosynthesis 
 Chemotaxis (Purine) Ribonucleotide biosynthesis 
  Chemotaxis 
  Translation 
3 mentions 
Biotin biosynthesis Fatty acid biosynthesis Protein secretion 
Arginine biosynthesis DNA repair Gluconeogenesis 
Potassium ion transport tRNA modification DNA replication 
Phenylacetate-catabolic process Transport functions (Pyrimidine) Ribonucleotide biosynthesis 
Glycine decarboxylation (Pyrimidine) Ribonucleotide biosynthesis Ciliary or flagellar motility 
Porphyrin compound biosynthesis DNA recombination ATP-coupled proton transport 
  Iron-sulfur cluster assembly 
  Glycine decarboxylation 
  Histidine-catabolic process 
2 mentions 
Arginine deiminase Arginine deiminase tRNA modification 
Transcriptional regulation Gluconeogenesis, glycolysis Cytokinesis 
DNA replication, topology, recombination DNA replication (Purine) Ribonucleoside salvage 
rRNA modification Translation DNA repair, recombination 
 Protein secretion Arginine deiminase pathway 
Biosynthesis of: IMP, UMP, fatty acids, 
ribonucleosides, deoxyribonucleotides, 
NAD 
Biosynthesis of: arginine, UDP-glucoronate, 
cysteine, porphyrin compounds, tryptophan, 
(purine) ribonucleotides 
Biosynthesis of: IMP, tryptophan, arginine, 
cobalamin, porphyrin compounds, lipid A, 
peptidoglycan, histidine, pantothenate 
Metabolism of: cysteine, ethanolamine Metabolism of: glycine, valine, ethanolamine Metabolism of: cysteine, ethanolamine 
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Tables 5.11 – 5.13 summarise other annotations collated from the ‘Artemis’ information; 
Table 5.11 shows annotations common to all three GOT screens, Table 5.12 shows those 
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Table 5.11. ‘Artemis’ annotations: CDSs hit by all three GOT screens. *Asterisks denote cases where the iGOT hits were from the ‘best’ hits 
CDSs hit by all three GOT screens   
Artemis annotations of hits 




Regulatory proteins, transcription repressors, sigma factors, H-NS-like * 
K+ transport proteins, glutathione-regulated K+ efflux KefB or TrkB, Kup or TrkD, homologue of human K+ channel * 
ABC transporters (e.g. for polyamines, glutamate, proline, betaine, phosphate, D-methionine, choline, arginine, ornithine, sulphate, 
sugars, branched amino acids, iron, histidine, taurine, oligopeptides)  
* 
Histidine binding/transport * 
Multi-drug efflux transporters, antibiotic/polymixin/arsenite resistance or synthesis * 
Iron scavenging, heme/porphyrin/bacterioferritin functions, ferredoxin proteins * 
Cytochrome C precursors/signal peptides/subunits * 
Fimbrial proteins/chaperones, TadB/TadC, type IV pilus * 
Electron transfer flavoproteins * 
Starvation response proteins * 
Hypothetical proteins * 
Prophage integrase proteins, transposases, insertion elements, recombinases  
Arginine biosynthesis/ binding, ornithine metabolism  
Copper transport/homeostasis, heavy metal binding  
Biotin biosynthesis  
Redox functions, glutaredoxin, TrxA/ TrxB, glutathione transferase  
Mg
2+
 and cobalt efflux  
Major Facilitator Superfamily (MFS) transporters  
TCS signal transduction systems  
Proline and betaine transport/ binding  
Conjugal transfer proteins  
Ethanolamine operon regulatory protein EutR  
Cadmium/lead/zinc cation efflux and response  
Polyketide synthases (PKSs), non-ribosomal peptide synthetases (NRPSs)  
Osmotic response lipoprotein OsmE  
Arabinose/proton symporter  
Polyamine transport/acetyltransferase  
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Table 5.12. Additional Artemis annotations: CDSs hit by two out of three GOT screens. *Asterisks denote cases where the iGOT hits were from the ‘best’ hits 
CDSs hit by two out of three GOT screens     
Artemis annotations of hits from n & 
iGOT 
Porin protein precursors  
Stress response proteins  
Outer membrane proteins/lipoproteins/precursors/receptors * 
DNA repair * 
RNA polymerase sigma-54 * 
Homoserine lactone (HSL) efflux protein * 
Ribonucleotide biosynthesis * 
Putative exported proteins  
DNA competence  
Dehydratase/racemase enzymes  
Similar to Bordetella pertussis Vgr-6  
Alginate biosynthesis  
Capsule synthesis genes  
Artemis annotations of hits from a & 
iGOT 
Similar to QseB/C TCS  
Activator of quorum sensing auto-inducer (AI) transcription  * 
Xanthine dehydrogenase * 
Sodium ion/ proton exchange  
Nutrient depletion / cold-shock response proteins * 
Secretion proteins / toxin transporter * 
Clp-protease associated stress response * 
Type VI secretion-related genes SciB, SciC * 
Artemis annotations of hits from a & 
nGOT 
Chromate transport 
Syr-P-like (syringomycin) genes 
Rhamnolipids (rhlA, rhlB)  
Spa/Bop/Inv/mxi type 3 secretion system (T3SS) 
Hpa/Sct T3SS 
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Table 5.13. Additional Artemis annotations: CDSs hit in only one GOT screen. *Asterisks denote cases where the iGOT hits were from the ‘best’ hits 
CDSs hit in only one GOT screen  





Osmolarity sensing proteins EnvZ/OmpB-like 
Hydrogen peroxide-induced gene 
Artemis annotations of hits from 
nGOT only 
Flagella synthesis operons 
Manganese ion transport 
Mannose/ cell wall synthesis 
SurA survival protein 
Heat shock proteins 
Malonate transporter and decarboxylase 
Pyoverdine synthesis, ornithine/ cobalamin 
Similar to E. coli shiga toxin subunit 
Salmonella invasion protein IagB 
Artemis annotations of hits from 
iGOT only 
Nitrate/nitrous oxide reductase * 
Amino acid metabolism and biosythesis * 
Cell division proteins * 
ABC transport of arginine/ glycine/ betaine/ L-proline * 
Haemagglutinin / cell wall anchor protein * 
GTPase  
O-antigen transporter  
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5.3.4. Relation to known and putative Bp virulence factors 
As described in the methods section, details of known or putative Bp virulence factors were collated. Tables 5.14 – 5.16 list the known or putative 
virulence factors that were identified as refined hits in aGOT, nGOT and iGOT respectively. 
Table 5.14. aGOT refined hit CDSs with known or putative roles in Burkholderia virulence 
CDS number Gene Name Function Role In Virulence, Other Details References 
TYPE VI SECRETION 
BPSL3096 - 111 
 
T6SS-6 Type VI Secretion  
Burtnick et al 2011; Schell et 
al 2007; Shalom et al 2007 
BPSS0515 - 33 
 
T6SS-2 Type VI Secretion  
Burtnick et al 2011; Schell et 
al 2007; Shalom et al 2007 
BPSS1493 - 511 
including virG, virA, 
hcp1/tssD, tssE, 
clpV1, vgrG1, tagB, 
tssJ, icmF1  
T6SS-1 
Type VI Secretion: Actin Modelling And MNGC Formation. 
T6SS-1 Is Flanked By BimA and Bsa T3SS. Mutants Caused 
Some Actin Modelling Defects And MNGC Defects 
Burtnick et al 2011; Schell et 
al 2007; Shalom et al 2007; 
Sun et al 2010; Chieng et al 
2012  
BPSS1512 TssM   Host Ubiquitination Interference, Immune Evasion Tan et al 2010 
BPSS1514 - 5 including folE  Up-Regulated By VirAG (TCS Within T6SS-1 Locus) Burtnick et al 2011 
BPSS2103 - 09  T6SS-3 Type VI Secretion  
Burtnick et al 2011; Schell et 
al 2007; Shalom et al 2007 
TYPE III SECRETION 
BPSL1105 bspR Extended Regulation Of T3SS-3   Sun et al 2011 
BPSS1516 - 7 including  BopC T3SS-3-Related BopC Effector And Chaperone Of BopC Muangman et al 2011 
BPSS1520-2 including  bprC T3SS-3-Related Extended T3SS-3 Regulon/Cluster Sun et al 2011 
BPSS1535 - 9 including bsaU T3SS-3 Type III Secretion (Bsa System); BsaU Involved In 
Phagosomal Escape 
Pilatz et al 2006 
BPSS1607 - 30  T3SS-2 Type III Secretion Hrp-Like   
SECONDARY METABOLISM 
BPSL1779  Secondary Metabolism, 
Hydroxamate Siderophore 
Biosynthesis 
Fourteen Clusters Encoding Possible Antibiotic, Surfactant, 
And Siderophore Biosynthesis Pathways 
Holden et al 2004 
BPSS1199   Unknown Molecule, NRPS NRPS/PKSs Biggins et al 2012 
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CDS number Gene Name Function Role In Virulence, Other Details References 
EXOPROTEINS     
BPSL0338    Phospholipase C Exoproteins  Holden et al 2004 
BPSS0666   Putative Collagenase Exoproteins  Holden et al 2004 
QUORUM SENSING 
BPSL2347 luxR Quorum Sensing   Ulrich et al 2004 
BPSS0481 - 7 hmqABDEFG Quorum Sensing - Hmaq 
Signalling 
  Diggle et al 2006; Vial et al 
2008 
BPSS1180 luxI Quorum Sensing   Ulrich et al 2004 
ADHESINS     
BPSL2063   Adhesin; Autotransporter Autosecreted, Attachment Holden et al 2004; Adler et al 
2011 
BPSS0908   Adhesin; Autotransporter Autosecreted, Attachment Holden et al 2004; Adler et al 
2011 
BPSL1075 boaB Adhesin; Autotransporter Autosecreted, Attachment Balder et al 2010 
OTHER      
BPSS1492 BimA Autotransporter Autosecreted Protein Required For Actin-Based Motility 
Adler et al 2011; Stevens et al 
2005b 
BPSL0776 recA  Homologous Recombination, SOS Response Cuccui et al 2007 
BPSL1060   Putative Hypothetical 
Bacteriophage Protein 
 Cuccui et al 2007 
BPSL1103 nth Putative Endonuclease III DNA Replication, Recombination, And Repair Cuccui et al 2007 
BPSL3168 aroB Dehydroquinate Synthase Chorismate Biosynthesis Cuccui et al 2007 
BPSL1505 rpoS Sigma Factor MNGC Formation, Transcriptional Regulation   
BPSL0395   Cytidylyltransferase   Pilatz et al 2006 
BPSL1174 - 5 kdpD, kdpE KdpD/KdpE TCS Roles In Homeostasis And Virulence; Intracellular 
Persistence, Stress Resistance 
Xue at al 2011; Alegado et al 
2011; Hughes et al 2010 
BPSL0349   Hypothetical Protein Differential Regulation in Primary versus Relapsing 
Melioidosis 
Velapatino et al 2012 
BPSL1743 - 5 arcA, arcB, arcC Arginine Deiminase, 
Ornithine Carbamoyltransferase, 
Carbamate Kinase; Anaerobic 
Growth, Acid-Resistance 
Differential Regulation in Primary versus Relapsing 
Melioidosis 
Velapatino et al 2012 
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CDS number Gene Name Function Role In Virulence, Other Details References 
BPSS1562   Kumamolysin; Post-Translational 
Modification, Chaperones 
Differential Regulation in Primary versus Relapsing 
Melioidosis 
Velapatino et al 2012 
BPSL1067    Up-Regulated In Macrophages Chieng et al 2012 
BPSL3354   Putative Cytochrome Up-Regulated In Macrophages  Chieng et al 2012 
BPSL3428  Set Domain Protein Mutation of Homologue Attenuated Bt Virulence To 
Dictyostelium  
Hasselbring et al 2011 
BPSS1722  Malate Dehydrogenase  Mutation of Homologue Attenuated Bt Virulence To 
Dictyostelium 
Hasselbring et al 2011 
BPSL0558 -9   Toxin-Antitoxin Module Toxin-Antitoxin Module, On GI Butt et al 2012 
BPSL3260 - 1   Toxin-Antitoxin Module Toxin-Antitoxin Module, On GI Butt et al 2012 
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Table 5.15. nGOT refined hit CDSs with known or putative roles in Burkholderia virulence 
CDS number Gene name Function Role In Virulence, Other Details References 
TYPE VI SECRETION 
BPSS0525 - 0533  T6SS-2 Type VI Secretion; BPSS0529 Up-Regulated In 
Macrophages  
Burtnick et al 2011; Schell et 
al 2007; Shalom et al 2007; 
Chieng et al 2012 
BPSS0166, BPSS0177 
- 82 
 T6SS-4 Type VI Secretion  Burtnick et al 2011; Schell et 
al 2007; Shalom et al 2007 
TYPE III SECRETION     
BPSS1525 bopE T3SS-3-Related  Effector Protein. Guanine-Nucleotide Exchange For Rho-
GTPases That Regulate Actin Network; Invasion Role 
Evident In Cell Model But Not Mammalian Infection 
Models 
  
BPSS1529 bipD T3SS-3-Related Translocator Protein; Needle Tip, Expressed In Vivo. 
Invasion of Non-Phagocytic Cells, Phagosomal Escape 
  
BPSS1532 bipB T3SS-3-Related MNGC Formation   
BPSS1534 BsaZ T3SS-3 Structural Protein; Mutants Delayed In Phagosomal 
Escape 
Pilatz et al 2006 
BPSS1535 - 54 including bsaU, bsaQ, 
bprP, bprQ 
T3SS-3 Type III Secretion; BsaU Involved In Phagosomal Escape. 
BsaQ Required For Secretion Of BopE And BipD Effectors  
Pilatz et al 2006; Sun et al 
2011 
BPSS1603, BPSS1607, 
BPSS1612 - 30 
 T3SS-2 Type III Secretion, Hrp-Like    
SECONDARY 
METABOLISM 
    
BPSL1774 - 9   Secondary Metabolism, 
Malleobactin NRPS 
Hydroxamate Siderophore Biosynthesis. Fourteen Clusters 
Encoding Possible Antibiotic, Surfactant, And Siderophore 
Biosynthesis Pathways 
Holden et al 2004; Biggins et 
al 2012 
BPSL2233   Unknown Molecule, NRPS NRPS/PKSs Biggins et al 2012 
BPSS0160   Secondary Metabolism: Isonitrile NRPS/PKSs Biggins et al 2012 
BPSS0311   Secondary Metabolism: 
Malleilactone, PKS 
NRPS/PKSs Biggins et al 2012 
BPSS2329   Unknown Molecule, PKS NRPS/PKSs Biggins et al 2012 
EXOPROTEINS     
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CDS number Gene name Function Role In Virulence, Other Details References 
BPSL2403   Phospholipase C Exoproteins  Holden et al 2004 
BPSS0067 plc-3 Phospholipase C Exoproteins Korbsrisate et al 2007; Holden 
et al 2004 
BPSS1993 mprA Serine Peptidase, 
Metalloprotease A 
Exoproteins; KO Attenuates Virulence to Dictostelium  Hasselbring et al 2011; 
Holden et al 2004 
QUORUM SENSING     
BPSS1569 - 70 luxR, luxI Quorum Sensing   Ulrich et al 2004 
ADHESINS     
BPSL0782 pilA Type IV Pilin Subunit Attachment   
FLAGELLIN 
BPSL3319 fliC Flagellin; Flagellar Component Invasion Of Acanthamoebae, Immune Stimulation Inglis et al 2003; Chua et al 
2003; DeShazer et al 1997 
CAPSULAR 
POLYSACCHARIDE 
    
BPSL2769 - 82   CPS Cluster IV Capsular Polysaccharide  Reckseidler-Zenteno et al 
2005 
BPSS1828 - 35 including hepB, wabG, 
cheA, cap1E, BceG, 
Wzc, wza, wzb, rkpK, 
wcaJ, manC 
CPS Cluster III  Capsular Polysaccharide  Lazar-Adler et al 2009; Sarkar-
Tyson et al 2007; Reckseidler-
Zenteno et al 2005 
OTHER     
BPSL0776 recA   Homologous Recombination, SOS Response Cuccui et al 2007 
BPSL1060   Putative Hypothetical 
Bacteriophage Protein 
 Cuccui et al 2007 
BPSS0993   Superoxide Catalase Intracellular Stress Holden et al 2004 
BPSS1997  Oxacillinase Beta-Lactamase Drug Resistance  Holden et al 2004 
BPSS1701  tRNA Pseudouridine Synthase A  Mutation of Homologue Attenuated Bt Virulence To 
Dictyostelium 
Hasselbring et al 2011 
BPSL0659 surA FKBPs And Parvulins FKBPs And Parvulins Norville 2011 thesis 
BPSL2254   FKBPs And Parvulins FKBPs And Parvulins Norville 2011 thesis 
BPSL0886 
 
Hypothetical Protein  Up-Regulated In Macrophages  Chieng et al 2012 
BPSL1067 
 
Hypothetical Protein Up-Regulated In Macrophages  Chieng et al 2012 
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CDS number Gene name Function Role In Virulence, Other Details References 





Up-Regulated In Macrophages   Chieng et al 2012 
BPSS0142 
 
Sugar ABC Transport System, 
ATP-Binding Protein 
Up-Regulated In Macrophages   Chieng et al 2012 
BPSS0143 
 
ROK Family Transcriptional 
Regulator 
Up-Regulated In Macrophages   Chieng et al 2012 
BPSS1279 
 
Threonine Dehydratase  Up-Regulated In Macrophages   Chieng et al 2012 
BPSS1892 - 3 catA, catC Catechol 1,2-Dioxygenase Up-Regulated In Macrophages   Chieng et al 2012 
BPSL1743 - 5 arcA, arcB, arcC Arginine Deiminase, 
Ornithine Carbamoyltransferase, 
Carbamate Kinase; Anaerobic 
Growth, Acid-Resistance 
Differential Regulation in Primary versus Relapsing 
Melioidosis 
Velapatino et al 2012 
BPSS1562   Kumamolysin; Post-Translational 
Modification, Chaperones 
Differential Regulation in Primary versus Relapsing 
Melioidosis 
Velapatino et al 2012 
BPSS1888   Aromatic Oxygenase; Inorganic 
Ion Transport, Metabolism 
Differential Regulation in Primary versus Relapsing 
Melioidosis 
Velapatino et al 2012 
BPSL0558 - 9   Toxin-Antitoxin Module Toxin-Antitoxin Module, On GI Butt et al 2012 
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Table 5.16. iGOT refined hit CDSs with known or putative roles in Burkholderia virulence 
CDS number Gene name Function Role In Virulence, Other Details References 
TYPE VI SECRETION 
BPSL3096 - 111  T6SS-6 Type VI Secretion  Burtnick et al 2011; Schell et 
al 2007; Shalom et al 2007 
BPSS0098  T6SS-5 Single Gene Of Type VI Secretion Cluster Burtnick et al 2011; Schell et 
al 2007; Shalom et al 2007 
BPSS0177 - 85  T6SS-4 Type VI Secretion  Burtnick et al 2011; Schell et 
al 2007; Shalom et al 2007 
BPSS1493  T6SS-1 Single Gene Of Type VI Secretion: T6SS-1 Is Flanked By 
BimA And Bsa T3SS. Mutants Caused Some Actin 
Modelling Defects And MNGC Defects 
Burtnick et al 2011; Schell et 
al 2007; Shalom et al 2007 
TYPE III SECRETION     
BPSS1385  CHBP Cyclomodulin T3SS Effector: Similar To Cycle Inhibiting Factor (Cif) Of 
EPEC/EHEC.  Cytopathic And Actin Reorganisation Effects. 
Inhibits Eukaryotic Ubiquitination Pathway 
Jubelin et al, 2009; Yao et al 
2009; Cui et al 2010; Felgner 
et al 2009 
SECONDARY 
METABOLISM 
    
BPSS0130 - 2   Secondary Metabolism: 
Terphenyl, NRPS 
NRPS/PKSs Biggins et al 2012; Biggins et 
al 2011 
BPSS0584 - 5  Secondary Metabolism: 
Pyochelin Siderophore 
Biosynthesis 
Fourteen Clusters Encoding Possible Antibiotic, Surfactant, 
And Siderophore Biosynthesis Pathways 
Holden et al 2004 
EXOPROTEINS     
BPSL0808   MucD Ser Protease Homologue  Exoproteins Holden et al 2004 
BPSS0067 plc-3 Phospholipase C Exoproteins Korbsrisate et al 2007; Holden 
et al 2004 
QUORUM SENSING     
BPSL2347 luxR Quorum Sensing   Ulrich et al 2004 
ADHESINS     
BPSL0782 pilA Type IV Pilin Subunit Attachment   
BPSS1434 BpaA Adhesin; Autotransporter Autosecreted, Attachment Adler et al 2011; Holden et al 
2004 
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CDS number Gene name Function Role In Virulence, Other Details References 
OTHER     
BPSL2140 ppsA Putative Phosphoenol Pyruvate 
Synthase 
Carbohydrate Transport And Metabolism Cuccui et al 2007 
BPSL2519 serC Phosphoserine Aminotransferase Serine Biosynthesis Cuccui et al 2007 
BPSS0993   Superoxide Catalase Intracellular Stress Holden et al 2004 
BPSS1383   FKBPs And Parvulins FKBPs And Parvulins Norville 2011 thesis 
BPSL1528   Putative Exported Protein Unknown Mechanisms But Important For Intracellular 
Replication And Survival  
Pilatz et al 2006 
BPSL1001 sodC Superoxide Dismutase Intracellular Stress Vanaporn et al 2011; Holden 
et al 2004 
BPSS1039 - 40 irlS, irlR Invasion Related Locus TCS Invasion Of Cells But Not Mammalian Virulence    
BPSL1817 
 
Putative Lipoprotein    Chieng et al 2012 
BPSL3354 
 
Putative Cytochrome    Chieng et al 2012 
BPSS0140 
 
Sugar ABC Transport System, 
Lipoprotein 
Up-Regulated In Macrophages  Chieng et al 2012 
BPSS0433 
 
Hypothetical Protein Up-Regulated In Macrophages   Chieng et al 2012 
BPSS1279 
 
Threonine Dehydratase  Up-Regulated In Macrophages   Chieng et al 2012 
BPSS1701  tRNA Pseudouridine Synthase A  Mutation of Homologue Attenuated Bt Virulence To 
Dictyostelium 
Hasselbring et al 2011 
BPSL1743 - 5 arcA, arcB, arcC Arginine Deiminase, 
Ornithine Carbamoyltransferase, 
Carbamate Kinase; Anaerobic 
Growth, Acid-Resistance 
Differential Regulation in Primary versus Relapsing 
Melioidosis 
Velapatino et al 2012 
BPSL0558 - 9   Toxin-Antitoxin Module Toxin-Antitoxin Module, On GI Butt et al 2012 
BPSL2333 - 4   Toxin-Antitoxin Module Toxin-Antitoxin Module Butt et al 2012 
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Table 5.17 summarises the two genomic regions which are known or putative virulence 
loci and were common to all three invertebrate GOT screens.   
Table 5.17. CDSs hit in all three GOT screens with known or putative roles in Bp virulence 
CDS number Gene name Function 
Role in virulence, 
other details 
References 
BPSL0558 - 9   Toxin-Antitoxin Module 
Toxin-Antitoxin 
Module, on GI 
Butt et al 
2012 















These are discussed further in the following discussion section. 
Table 5.18 briefly summarises the occurrence of several key virulence determinant 
categories among the hits from the three screens, based on GO annotations, Artemis 
annotations and known or putative virulence factors. 
Table 5.18. Occurrence of hits in a selection of virulence-related functional categories, by GOT type. X 
denotes occurrence.  
 aGOT nGOT iGOT (all hits) 
TYPE VI SECRETION X X X 
TYPE III SECRETION X X X 
SECONDARY METABOLISM X X X 
EXOPROTEINS X X X 
QUORUM SENSING X X X 
ADHESINS X X X 
FLAGELLIN  X  
CAPSULAR POLYSACCHARIDE  X  
OTHER:    
Toxin-Antitoxin Module X X X 
arcABC Arginine / Ornithine 
Metabolism Genes 
X X X 
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Hits in ‘mGOT’-style macrophage assay 
As discussed in the introduction, Dowling et al (2010) screened the Bp K96423 fosmid 
library and a BAC library against a macrophage cell line. Results from that study were 
compared to the results from the three invertebrate GOT screens. Full lists of invertebrate 
GOT hits in common with the macrophage results from Dowling et al. (2010) can be found 
in DVD e-Appendix 5f. They are summarised in Table 5.19. 
Table 5.19. Numbers and functions of CDSs which were hits in invertebrate GOT screens and a macrophage 
assay performed by Dowling et al. (2011) 
Assay/s: 
No. of CDS hits in 
common with 
macrophage assay  
(% of refined hits) 
Including: 
aGOT 286 (24.0%) 
Type VI secretion: T6SS-6, T6SS-2 
BimA (actin motility) 
Malate dehydrogenase (Bt homologue hit in 
Dictyostelium assay; Hasselbring et al. 2011) 
Hypothetical proteins up-regulated in 
macrophages 
Hypothetical bacteriophage protein 
nGOT 267 (22.1%) 




Sugar ABC transporter 
Transcriptional regulator 
tRNA pseudouridine synthase A 
Hypothetical proteins up-regulated in 
macrophages 
Hypothetical bacteriophage protein 
iGOT (all hits) 224 (19.1%) 
Type VI secretion: T6SS-6, T6SS-5, T6SS-4 
Toxin-Antitoxin module 
Phospholipase C 
tRNA pseudouridine synthase A 
FKBP/parvulin 
All 3 invertebrate 
GOT screens 
20 (23.5%) 
2 genomic regions: 
BPSL2629-30 (probable aminotransferase), 
BPSL3362-80 (glycine decarboxylation / 
gluconeogenesis / ethanolamine metabolism) 
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Using the refined hit data to test whether the ‘hits’ resemble a random 
sample from the Bp K96423 genome 
Assuming RVA-style screening is effective, certain regions of a pathogen’s genome would 
be considered more likely to be identified as hits, including known or putative virulence-
related factors and perhaps genomic islands (GIs; which are known to often include 
virulence-related factors). If the Bp RVA was successful in identifying virulence-related 
regions it would be expected that the proportions of known virulence determinants or GIs 
would be enriched in the portion of RVA hits compared to in the genome overall. 
Proportions of virulence determinants 
Table 5.20 summarises the proportion of GOT hits that were annotated virulence-related 
CDSs, compared to the overall genomic proportion. 




CDSs in genome 
Proportion of 
virulence-annotated 
CDSs in GOT hits 
Significant?  
(Using Z-test for 
proportions, p = 
0.05) 
aGOT 
418 / 5855 = 7.1% 
128 / 1190 = 10.8% No 
nGOT 118 / 1209 = 9.8% No 
iGOT (all hits) 59 / 1174 = 5.0% No 
 
The proportion was slightly higher among the aGOT and nGOT hits compared to the 
genome overall and slightly lower in the iGOT hits. However, the differences were not 
significant. 
Proportions of genomic islands 
Bp K96423 has 16 GIs containing 450 CDSs (7.7% of the genome). The numbers and 
percentages of GOT hit CDSs which are located within GIs are shown in Table 5.21. 
Table 5.21. Numbers and proportions of CDSs hit in GOT screens which are located in genomic islands (GIs) 
 GI numbers: 
Number of CDS hits in GIs  
(% of hits) 
aGOT 3, 4, 7, 10, 11, 12, 14 48 / 1190 = (4.0%) 
nGOT 1, 3, 4, 11, 16b 48 / 1209 = (4.0%) 
iGOT (all hits) 1, 3, 4, 5, 10, 11, 12, 13, 15, 16b 97 / 1174 = (8.3%) 
All 3 GOT screens 3 10 / 85 = (11.8%) 
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The proportion of GI-located CDSs was slightly higher among the iGOT hits and among 
hits common to all three screens compared to the overall genomic proportion. The 
proportion was slightly lower for the aGOT and nGOT hits. However, once again the 
differences were not significant; GIs were not represented in the GOT hits significantly 
higher than in the genome as a whole (Z-test for proportions, independent groups, p = 
0.05). 
Comparing virulence determinant and GI representation among the GOT hits versus the 
overall genome did not reveal significant enrichment in either. This may suggest that the 
GOT screens did not successfully identify virulence-relatd regions. However, it should be 
remembered that most annotated virulence determinants are identified relating to activity 
in mammalian systems; it could be the case that invertebrate-relevant factors share little 
overlap with those relevant to mammals.   
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5.3.5. Follow-up 1: Final re-resting of key positive hits 
After analysing the GOT results for the presence of known or putative virulence factors, a 
small selection was re-tested in M. sexta larvae (as it was considered the easiest model to 
assess). The results are shown in Table 5.22.  








Number surviving at 96 hours post-injection  
(out of 10) 




- 10 10 




- 10 10 





- 10 10 
+ 10 10 
02e09 T6SS-6 
- 10 10 




- 10 10 
+ 10 10 
 
By 96 hours post-injection one G. mellonella larva had died but the rest remained healthy. 
From the M. sexta larvae no insects died, with just one remaining slightly smaller. 
None of the injected fosmids appeared to reproduce any virulent or immunogenic effects 
on the larvae, as was the case in the original re-testing of iGOT hits. 
 
 Rapid Virulence Annotation of Burkholderia pseudomallei pg. 236 
5.3.6. Follow-up 2: Preliminary fosmid RT-PCR results 
It was considered that despite seeing evidence of metalloprotease expression, the fosmid 
library may be poor at expressing Bp proteins. RT-PCR would provide a means to test for 
RNA transcripts of selected genes. Figure 5.16 and Table 5.23 show the results of 
attempts to assess expression of virulence-related genes using RT-PCR. 
Figure 5.16. RT-PCR results from BPF fosmid clones.  Panel A: complete RT-PCR reactions. Panel B: 
equivalent reactions lacking reverse transcriptase, as a control for DNA contamination. 100bp # denotes 100 
bp DNA ladder; the position of the 200 bp band is indicated. Expected product sizes were 150-247bp (see 
Table 89). Upwards arrow (↑ relative to text) denotes the addition of Auto-Induction solution during overnight 
growth. 
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Table 5.23. Initial RT-PCR results from six BPF fosmid clones 




Result Effect of Auto-Induction 
mprA bpss1993 173 
Correct band but DNA 
contamination 
Results identical 
bylA bpss1269 150 
Band < 100bp due to non-
specific priming or primer 
dimerisation 
Results identical 
bimA bpss1492 234 
Non-specific priming: 
unexpected bands at 400 and 
500 bp 
Bands slightly fainter in 
auto-induced sample. 
No DNA contamination 
in auto-induced sample. 
NRPS bpsl1777 247 
Band < 100bp due to non-
specific priming or primer 
dimerisation 
Bands absent from 
auto-induced sample. 
Identical result in RTase-
free control 
kdpD bpsl1174 188 
Correct band is present but 
non-specific priming too. DNA 
contamination 
Results identical 
bipD bpss1529 201 




It was apparent that despite having performed an on-column DNase digestion many of the 
RNA samples were still contaminated with DNA. The prepared RNA samples were re-
digested with DNase (off-column) and re-purified as described in the methods section.  
Addition of AutoInduction solution did not appear to affect band presence or increase 
intensity of the bands compared to non-induced samples.  
A further round of reactions was performed for more RT-PCR targets, with templates 
which had been treated with DNase both on- and off-column. As the Autoinduction 
solution did not appear to affect banding patterns in Figure 5.16, the new RT-PCRs used 
non-induced templates only. The results are shown in Figure 5.17 and Table 5.24. 
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Figure 5.17. Repeat RT-PCR results from BPF fosmid clones. 100bp # denotes 100 bp DNA ladder; the 
position of the 200 bp band is indicated. Expected product sizes were 150-247bp (see Table 90). No cultures 
were treated with AutoInduction solution. Complete reactions and equivalent reactions lacking reverse 
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Table 5.24. RT-PCR results from eight BPF fosmid clones 
Target Bp CDS 
Expected PCR 
product size (bp) 
Result 
bipD bpss1529 201 
Correct band present, slight DNA 
contamination remaining 
mprA bpss1993 173 
Correct band present, DNA contamination 
remaining 
TC toxin bpsl0590 240 
Correct band plus one non-specific product. 
No DNA contamination 
bylA bpss1269 150 No band present 
bimA bpss1492 234 No band present 
NRPS bpsl1777 247 No band present 
CHBP  bpss1385 183 





Correct band present, plus faint non-specific 
bands. DNA contamination 
 
DNA contamination or lack of RT-PCR product was again a problem. For one target (the 
TC toxin gene) the expected band was seen and there was no evidence of DNA 
contamination, which suggests that the Bp K96423 gene bpsl0590 was at least 
transcribed in the recombinant E. coli system. Howeer, further evidence would be needed 
to conclusively assess the success and extent of Bp gene expression in this recombinant 
system. 
5.3.7. Follow-up 3: Investigating Bp kdpD 
As discussed in the introduction, the kdpD/kdpE two-component system (TCS) was a 
GOT hit of particular interest and one major aim was to generate a knock-out (KO) mutant 
in the Bp-related CL2 organism Bt.  
Included in Appendix A is the transcript of a paper published in PLoS Pathogens 
(Freeman et al. 2013) which reviews a significant body of evidence regarding a role for 
kdpDE in bacterial virulence and survival.  
Attempts to delete or over-express Bt kdpD 
Unfortunately, attempts to construct a KO vector all failed despite multiple attempts and 
modifications to the methods and primers used. Approach #1 resulted in a non-specific 
product in greater quantity than the desired product, and gradient PCR did not help the 
specificity. The strategy switched to approach #2 which was a simplified method, and a 
more efficient polymerase was used. The new approach used a different cloning vector, 
so primers needed to be re-designed. Initially PCR of the left flank was successful but 
later failed. DMSO concentration was optimised for the reaction but satisfactory PCR 
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products were not produced for the right flank. New primers (approach #2.1) for the right 
flank attempted to lower the annealing temperature, which was very high (the same as the 
extension temperature). Eventually both flanks were successfully amplified and gel-
extracted and were used as template for the cross-over PCR: the desired product was 
very faint and an unwanted band was very strong. Pooling the reactions and gel-extracting 
the correct band did not yield sufficient DNA. Approach #2.2 used primers picked from a 
less constrained region around kdpD, following advice that considerably longer flanks 
would be needed for chromosomal deletion of kdpD (based on previous kdpD KO 
attempts in other species; I. Vlisidou, unpublished). This also meant that primers could be 
designed with lower annealing temperatures. In that attempt the right flank PCR was 
successful but the left flank PCR produced multiple extra products, one of which was too 
close in size to the expected product to allow gel extraction. 
The attempt to clone kdpDE into an over-expression vector was promising; a correctly 
sized PCR product was generated and both the insert and plasmid were digested giving 
the correct plasmid fragments. But each time ligation and transformation was attempted 
the vector-only control produced a lawn of colonies, indicating that there was uncut vector 
still present. The colonies on the ligation mix transformation plate were therefore not 
reliable. The process was repeated from restriction digestions to transformation, but the 
same result was seen and time limitations halted further attempts. 
 
kdpD transgenic transcription in response to host  
The kdpD gene was also investigated in terms of its expression by Bp fosmid library 
clones. Figure 5.18 and Table 5.25 show the results of attempts to assess expression of 
kdpD using RT-PCR, from fosmids before injection into M. sexta and from M. sexta 
haemolymph 30 minutes post-injection. One fosmid encoded complete Kdp structural 
genes as well as KdpDE, and another fosmid lacked two structural genes. 
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Figure 5.18. RT-PCR results from fosmids bearing the kdpD gene, before and after injection into Manduca 
host. Panel A: complete RT-PCR reactions. Panel B: equivalent reactions lacking reverse transcriptase, as a 
control for DNA contamination. 100bp # denotes 100 bp DNA ladder; the position of the 200 bp band is 
indicated. Fosmid 29d10 contains the complete kdp operons (both kdpD/kdpE TCS and kdpFABC structural 
genes). Fosmid 32e10 lacks kdpF and kdpA but the KdpD/KdpE TCS is intact. Lanes are labelled as either 
‘in.’ or ‘30’’, denoting whether the template RNA was derived from inoculum or from haemolymph extracted 
from the larva 30 minutes post-injection. 
 















Correct band is present, as well as 




Smear likely due to (poor 
purification of template?). Non-
specific bands. 188 bp product not 
apparent. No DNA contamination? 
32e10 
Inoculum 




Smear likely due to (poor 
purification of template?). Non-
specific bands. 188 bp product is 
faint. No DNA contamination? 
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kdpD was detected in both sets of inoculum, although there was DNA contamination in the 
fosmid 29d10 sample. When RNA purified from haemolymph extracts was used as a 
template, the reactions produced a smeared assortment of non-specific bands. A band 
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5.4. Discussion  
5.4.1. Initial assessments of the BPF library 
The BPF library was found to have good coverage of the Bp K96423 genome. There was 
only a single 8 kb gap and based on the average fosmid insert size the estimated 
coverage was over 17-fold. However, nearly one-third of the fosmid inserts either lacked 
end-sequence data or the data was insufficient to find a reliable BLAST match. Based on 
the available end-sequences, a coverage map was plotted which revealed a highly-over-
represented region towards the start of chromosome 1 (bpsl0126 – 0209). This was most 
likely an artefact caused either during library construction (e.g. that region contains an 
element which predisposes it to be cloned) or from incorrect BLAST assignment.  
When checking for protein expression from the library the MprA metalloprotease was 
chosen on the basis that an obvious phenotype would be visible on skimmed milk plates. 
The plates did indeed clear – not to the extent of the Bt control plate, but the Bt example is 
a complete organism and the other shows the effects of a cloned 35kb region only. 
Nonetheless the metalloprotease gene must have been successfully transcribed and 
translated in the E. coli system, because the protein was secreted and effective. 
The proteolysis effect was evident without the addition of auto-induction solution, but was 
clearly greater when the fosmid copy number had been increased. Due to an oversight, 
RVA testing of the BPF library had already begun in all three invertebrate screens before 
the effect of auto-induction solution was observed. The effect of auto-induction solution 
peaks at around 20 hours after addition to the culture, after which the manufacturers warn 
there are issues with clone stability and toxicity in the E. coli culture. This information, 
together with the fact that MprA-mediated proteolysis did occur in the single-copy fosmids 
and a number of positive results had already been obtained from the GOT assays, led to 
the decision to continue RVA without up-regulating copy number. 
5.4.2. RVA screening results 
A reasonable number of hit fosmids were identified in the first round of screening in each 
of the GOT assays. With the exception of the region which was over-represented in the 
library itself, plotting the hit inserts to their corresponding genomic locations did not reveal 
particularly obvious clusters of hits, unlike in previous RVA studies (Waterfield et al. 2008; 
F. Dorati, personal communication). 
In 33 cases M. sexta larvae had died but unfortunately the re-testing of positive clones 
revealed that the lethal effect was not reproducible for any of those clones. Whereas 
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previous RVA studies had shown clear GOT positives, the BPF positives were not 
consistently reproducible during re-testing; iGOT results were consistent within a batch of 
replicates but had lower average scores than the original test, and aGOT or nGOT results 
were inconsistent within a batch of replicates (data not shown). Re-testing was completed 
for all the iGOT positive clones. For the aGOT and nGOT positives re-testing was not 
completed due to the inconsistency seen in the replicates. 
According to previous experience in our laboratory, some Photorhabdus cosmid clones 
have been known to be very unstable and sequencing has revealed that internal portions 
have deleted out. For example, some NRPS secondary metabolite cosmids (which 
contain many repeat sequences) have ceased to have their originally-observed effects, 
perhaps due to internal deletions. It is possible that the BPF fosmids were subject to 
similar degradation, although fosmids are reportedly more stable than cosmids (Kim et al. 
1992). 
The uneven coverage of the library meant that many positives were located at the over-
represented region. This inspired a new approach to analysing the positive hits: to assess 
whether there was any clustering of hits relative to the actual library coverage. The fact 
that the BPF hits did not have strong reproducible phenotypes cast doubt on their validity 
and it was hoped that this new analysis approach would identify the most likely true-
positive hits. If the positives were all false and were simply a random selection from the 
library then the number of times a CDS was hit would correlate strongly with the number 
of times it was represented in the library. 
5.4.3. Insights from statistical analyses of RVA hits 
By transforming the fosmid coordinates to correspond to CDSs, a much more detailed 
assessment could be made of the library coverage (Figure 5.5). For example, the average 
coverage for a CDS was found to be just below ten-fold, as opposed to the 17-fold figure 
which was based on average insert size. Fosmid clones which did not grow and therefore 
were not tested were also excluded from this new coverage analysis. For each GOT 
screen the CDSs’ coverage and observed hits did show a significant positive correlation 
but the coefficient values were only 0.221-0.304, indicating that coverage-level alone was 
not a particularly strong predictor of observed hits. Other factors at play could be random 
effects or could be true gain-of-toxicity effects. ‘Expected’ hits values were calculated by 
re-distributing the total number of CDS hits throughout the genome as would be expected 
according to the actual coverage levels. Comparing the expected and observed hits for 
CDSs showed another significant moderate positive correlation (maximum 0.331). If the 
hits had been distributed exactly as expected according to the coverage alone this would 
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yield a perfect correlation of 1.0; as before, other factors are influencing the correlation. 
The median observed-to-expected ratio values were calculated for the screens and 
confidence limits were calculated for the spread of data points around the median; the cut-
off value was usually the median value itself. Hits with ratios below that value (up to 
60.6% of cases) were eliminated as background noise and hits with ratios above the 
upper confidence limit were plotted on new maps. Using these observed-to-expected 
ratios allowed the relative ‘strength’ of hits to be visualised. Refined hit regions from the 
different GOT screens were also plotted on the same axes for comparison; as illustrated 
in a pie chart of hit-CDS overlap between the screens, nearly three-quarters of CDS hits 
were only hit in one model and just 3% of CDS hits were common to all three models. 
The new maps showed that refined hit regions were still quite dispersed throughout the 
genome, so functional annotations were used to help investigate the results further.  
Before discussing the functional roles of the GOT hits it should be noted that there is 
evidence both for and against their validity. Supporting evidence includes the fact that Bp 
gene expression was seen from the mprA-bearing fosmids, that some CDSs had very 
high observed-to-expected hit ratios, and that many known or putative virulence-related 
genes were among the GOT hits. Comparing the refined hit CDSs to a comprehensive list 
of known and putative Bp virulence factors revealed a lot of overlap. However, a 
considerable proportion of Bp genes (7.1%) are annotated as having some link to 
virulence, so to discover whether virulence-annotated CDSs were particularly highly 
represented in the GOT results, the proportions were compared. The proportion was 
actually slightly lower in iGOT hits than in the whole genome, and slightly higher in aGOT 
and nGOT hits, but none of the values were significantly different from the genomic 
proportion. According to this result the ‘positive’ hits could just resemble a random sample 
of the genome, i.e. they could be false-positives. On the other hand, the majority of 
virulence-related information for Bp genes so far comes from mammalian models, and 
only a minority of the CDSs are linked specifically to invertebrate infection. So it could be 
the case that the refined hits are true-positives and that the only known virulence factors 
identified were those which are relevant to multiple host taxa or where annotated evidence 
comes from invertebrate models: there could also be totally novel virulence factors among 
the other hits. A similar analysis looked at whether GI-encoded genes were enriched in 
the hits, as GIs often encode virulence-related factors. Bp K96243 contains 16 GIs across 
its two chromosomes. Due to Bp’s usual environmental lifestyle it can be reasoned that its 
horizontally acquired GIs are likely to contain some genes involved in virulence against 
insects and bacteriovores. Yet statistically, proportions of CDSs located on GIs were 
again the same in the GOT hits as in the genome overall, indicating again that the GOT 
hits resemble a random sample. 
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Annotations 
The number and diversity of functional annotations among the hit genes is considerable, 
so some interesting highlights and recurring themes will be discussed. The initial 
approach was to use GO annotations of biological processes but the vast majority of 
CDSs had no GO annotations, and many were simply annotated as ‘biological process 
unknown’. The next most highly occurring annotations included: undefined metabolic 
processes, DNA transcription regulation, transport, riboflavin biosynthesis and 
ribonucleotide or deoxyribonucleotide biosynthesis. It is possible that fosmid expression of 
transcriptional regulators (including activators, repressors and sigma factors) could have 
detrimental effects on the invertebrate host if, for example, products of the regulatory 
targets are virulence factors or increase the rate of bacterial growth. This could occur 
either through regulating other Bp genes within the same fosmid or through aberrant 
regulatory effects on E. coli genes. Similarly, transport functions could facilitate the import 
of nutrients and cofactors away from the host or the export of virulence factors or 
immunogenic factors from the bacterium. Riboflavin biosynthesis is required for a wide 
variety of cellular processes, redox reactions and energy metabolism. There are no 
obvious direct links to virulence. Initially the same might be said of ribonucleotide or 
deoxyribonucleotide biosynthesis but pathways for purine synthesis have been explicitly 
linked to virulence of many pathogens including Bp (Schwager et al. 2012). Genes for 
these pathways have been demonstrated to be up-regulated during host infection by 
Vibrio vulnificus and Listeria monocytogenes (Kim et al. 2003; Klarsfeld et al. 1994). The 
de novo purine biosynthesis pathway is required for the Bp intracellular lifecycle such that 
mutants are harmless and rapidly cleared from immunocompetent mice and are still 
avirulent even in immunodeficient mice (Pilatz et al. 2006; Propst et al. 2010). A 
transposon mutant screen of Bcc against invertebrates showed that mutations in the 
purine and pyrimidine biosynthesis pathways are attenuating in C. elegans, Drosophila 
melanogaster and G. mellonella models (Schwager et al. 2012). This was not simply due 
to a complete inability to survive without those pathways (auxotrophy) as the bacteria 
could persist in low numbers inside the G. mellonella host. Schwager et al (2012) 
hypothesised that the host environment supplies enough nutrients for survival of the 
mutant but not enough for energetically expensive proliferation or virulence factor 
production. By extension, the over-expression of genes in those pathways could have 
given greater potential for growth (and/or virulence) of BPF clones. 
 To supplement the GO data, information was also taken from the annotations which 
accompany the published Bp K96423 genome sequence (referred to as ‘Artemis’ 
annotations, after the genome browser). Much of this information is based on similarity to 
orthologous genes. K+ transport genes were hits in all screens, as were many ABC 
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transporters, genes for iron scavenging and the EutR regulatory protein for ethanolamine 
utilisation. The Kdp K+ transport-related genes will be expanded upon later in the 
discussion. ABC (ATP-Binding Cassette) systems transport a diverse range of 
substances. In prokaryotes, ABC systems function for both import (e.g. of iron-
siderophore complexes or oligopeptides) and for export (e.g. of haemolysin, 
polysaccharides or antibiotics) (Harland et al. 2007). The targets of the ABC systems hit in 
the GOT screens include polyamines (putrescine and spermidine), amino acids (namely 
L-proline, D-methionine, choline, arginine, taurine, histidine, ornithine and branched amino 
acids), oligopeptides, sugars, glutamate, betaine, phosphate, sulphate and iron. 
Iron scavenging both aids the bacterium’s survival and is detrimental to the host, as both 
organisms compete for a limited supply of iron. Iron is vital for many cellular enzymes and 
processes including DNA synthesis and electron transport (Lieu et al. 2001). Siderophore 
production genes are negatively regulated by the fur (ferric uptake regulator) repressor, 
and become de-repressed when iron is limited. Siderophores scavenge ferric iron from the 
proteins it is bound to, such as haemoglobin and ferritin. Genes for porphyrin compound 
biosynthesis and iron-sulphur cluster assembly were also hits. Iron-sulphur clusters are 
required for critical biochemical pathways, including respiration, photosynthesis, and 
nitrogen fixation (Ayala-Castro et al. 2008).  
Regarding the EutR regulator, a study of P. luminescens using a promoter-trap library and 
a G. mellonella host model revealed that the ethanolamine utilisation genes were up-
regulated during insect infection, which likely reflects a metabolic shift to use nutrients that 
are enriched in the host; ethanolamine can be derived from cell membranes (Münch et al. 
2008; Garsin 2010). More recently it was reported that ethanolamine utilisation is involved 
in the proliferation of Salmonella typhimurium in a C. elegans host (Srikumar & Fuchs 
2011). Utilisation of ethanolamine requires cobalamin, and indeed cobalamin synthesis 
genes were also hits in the nGOT and iGOT screens.  
Interestingly, many annotations referred to biosynthesis, transport or metabolism of 
arginine and polyamines including ornithine, spermidine and spermine. For bacteria, 
polyamines help to maintain cell growth and viability by influencing gene expression and 
protecting cells from oxidative damage (Chan & Chua 2010). In Bp, spermidine regulates 
expression of multi-drug efflux pumps which export antibiotic compounds and quorum 
sensing molecules. In mammalian hosts, polyamines are used to regulate the cytokine 
pro- inflammatory response (Das et al. 2010). Therefore an interesting bacteria-host 
competition exists for these substances. Transporting or metabolising the polyamines 
could help Bp; (a) because spermidine affects quorum sensing, swimming motility and 
biofilm formation in strain KHW (Chan & Chua 2010), and (b) by hijacking the host 
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response, as spermine is used by H. pylori to inhibit the host pro-inflammatory cytokine 
response (Bussière et al. 2005). In terms of the fosmid expression system, polyamines 
normally affect translation of several E. coli transcription factors, so changes to polyamine 
levels in BPF clones (due to encoded transport or metabolic genes) could result in 
aberrant changes to E. coli gene expression (Chan & Chua 2010). Alternatively, increased 
polyamines may help the clones to resist oxidative stress in the hosts.    
Known or putative virulence factors 
There was evidence to support the proof of principle - that the RVA had successfully 
identified putative virulence factors of Bp K96423. As summarised in Tables 5.14 – 5.16, 
hits from all three screens corresponded to many known or putative virulence factors. 
These included secreted exoproteins (particularly phospholipase C) and genes for quorum 
sensing including the luxI and luxR genes and a cluster for HMAQ (4-hydroxy-3-methyl-2-
alkylquinoline) signalling. Interestingly, the immunogenic factors flagellin and capsular 
polysaccharide (CPS) were only hit in the nematode screen. The SurA survival protein (a 
Bt mutant of which was tested in M. sexta in Chapter 3) was a hit in nGOT. SurA is a 
periplasmic chaperone and peptidyl-prolyl isomerase (PPIase) involved in maintaining the 
cell envelope. As discussed in the introduction for chapter 3 SurA is implicated in the 
virulence of several pathogens (Behrens-Kneip 2010), and the Bt E264 mutant is 
attenuated (probably due to pleiotropic effects) in cell-based assays and in G. mellonella 
(Norville 2011), as well as in M. sexta. Four virulence determinant types that featured 
heavily in hits from all the screens were T6SSs, T3SS components, adhesins and 
secondary metabolites. 
T6SSs 
T6SSs are widespread in Gram-negative bacteria and appear to have quite diverse 
functions which can aid environmental survival as well as virulence inside hosts (Bingle et 
al. 2008). Bp has six T6SSs and there is a large body of evidence for the role of T6SS-1 in 
Bp virulence. T6SS-1 is important for virulence in hamster models, intracellular growth in 
macrophages, and for actin motility and MNGC formation (Schell et al. 2007; Burtnick et 
al. 2011; Shalom et al. 2007). Recently the system was found to be regulated by distinct 
mechanisms when in macrophages as opposed to on medium; intracellular expression is 
depended on the VirAG two-component system (TCS) and growth on medium was 
dependent on the regulator BprC (Chen et al. 2011). The two regulators initiate 
transcription at different start sites within the T6SS, and both are critical for T6SS-1 
function in macrophages and for full virulence in mouse models. Bp T6SS-1 has been 
suggested to target the innate immune system, based on the observation that its mutation 
is attenuating in insects (specifically cockroaches) as well as rodents (Fisher et al. 2012). 
 Rapid Virulence Annotation of Burkholderia pseudomallei pg. 249 
The full T6SS-1 system was hit in the amoeba GOT screen, and one CDS was hit in the 
insect screen (surrounding genes were also hit but did had below-average ratios). Each of 
the other five T6SSs was also hit in at least one screen, with full clusters hit for T6SS-2 
(aGOT and nGOT), T6SS-4 (iGOT) and T6SS-6 (aGOT and iGOT). Chieng et al found 
that one gene of the T6SS-2 was differentially regulated inside macrophages, but so far 
there is little published data regarding the activity of the other Bp T6SS systems. 
T3SSs 
Bp has three T3SSs, and T3SS-3 in particular has been well studied. Also known as the 
Bsa (Burkholderia secretion apparatus) system, T3SS-3 is integral to the ability of Bp to 
invade cells and escape vacuoles, and multiple effectors have been identified (Stevens et 
al. 2002; Stevens et al. 2003; Muangman et al. 2011; Pilatz et al. 2006). Parts of the 
T3SS-3 cluster were hit in aGOT and nGOT, as was the T3SS-2 cluster. In iGOT only a 
single T3SS-related gene was hit: CHBP (‘Cif Homologue from B. pseudomallei’), a 
cyclomodulin which is suspected to be an effector of T3SS-3 (Galyov et al. 2010). 
Cyclomodulins allow bacteria to manipulate eukaryotic host cellular processes (such as 
actin remodelling and ubiquitination), and transcription of this particular Bp gene was 
identified as up-regulated in a macrophage model (Chieng et al. 2012; Yao et al. 2009; 
Cui et al. 2010).CHBP is actually encoded some distance from the T3SS-3 cluster which 
explains why this gene was hit in iGOT and other T3SS-3 genes were not. Perhaps 
fosmid expression of CHBP interfered with the normal cell-cycle of insect host cells. 
Although whole T3SS operons were not recovered in the GOT screens, evidence from 
previous RVA work does suggest that the presence of certain effector genes alone can 
have a negative effect on the host, independent of the normal delivery mechanism 
(Waterfield lab; unpublished data) 
Adhesins 
Adhesins were also hits in all three screens. The pilA gene encodes a structural type IVA 
pilin subunit. It has been demonstrated to be involved in adherence to eukaryotic cells and 
a Bp pilA mutant has been shown to have reduced virulence in nematode and mouse 
infection models (Essex-Lopresti et al. 2005). Interestingly in the insect pathogen 
Xenorhabdus, a fimbrial structural subunit has also been shown to act as a pore forming 
toxin (Banerjee et al. 2006). The other four adhesins are autotransporters. Lazar Adler et 
al (2011) reviewed the current state of knowledge about the role of autotransporters in Bp 
and Bm virulence, as autotransporters play key virulence roles in other bacterial 
pathogens. So far, the information is limited but the adhesins hit in the GOT screens have 
been described as immunogenic or serodiagnostic, and one (BoaB) has been implicated 
in adhesion to epithelial cells (Lazar Adler et al. 2011; Balder et al. 2010). 
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NRPS/PKS secondary metabolites 
Polyketide synthases (PKSs) and non-ribosomal polypeptide synthetases (NRPSs) 
produce a diverse range of low molecular weight organic compounds, which sometimes 
have roles in virulence. The P. asymbiotica RVA analysis identified many PKS/NRPS loci 
as virulence factors and similarly, seven distinct PKS/NRPS loci were highlighted in the 
Bp screens. Biggins et al (2011) recently identified several novel compounds produced by 
Bp NRPS/PKSs (Biggins et al. 2011) and found that the PKS malleilactone is a cytotoxic 
siderophore; the Bt homologue is involved in full virulence against C. elegans (Biggins et 
al. 2012). The malleilactone PKS was indeed hit in the nGOT screen, along with 
malleobactin NRPS and two NRPS/PKSs with unknown products. Interestingly the 
nematode GOT screen identified a CDS which had some homology to pyoverdine, a 
fluoresecent iron-binding NRPS from Pseudomonas spp., but this CDS was not classified 
as a PKS/NRPS locus in the study by Biggins et al (2011) and was therefore absent from 
the list of known and putative virulence factors. Another PKS/NRPS absent from the list of 
virulence factors is homologous to the syrP product syringomycin of Pseudomonas 
syringae (Zhang et al. 1997), and this operon was hit in the aGOT and nGOT screens. 
The remaining aGOT hits were another uncharacterised NRPS and a siderophore gene of 
the malleobactin cluster. In iGOT different loci again were hit: one unknown NRPS and the 
pyochelin siderophore. Generally, different secondary metabolites were hit in the various 
GOT screens, which could reflect partitioning of functions which are relevant to different 
host or predator encounters.   
Other virulence factors which were hit in all screens were toxin-antitoxin (TA) modules 
(one particular module was hit in all screens) and arcABC, a cluster of genes for the 
arginine deiminase pathway. TA modules are typically a pair of genes in the same operon, 
coding for a toxin which induces a bacteriostatic or bactericidal effect on the bacterium 
itself, and a cognate antitoxin which blocks that activity. In E. coli TA modules have been 
shown to contribute to the formation of persister cells, so it has been suggested that they 
may contribute to the ability of Bp to persist as a chronic dormant infection. In a recent 
study, transgenic over-expression of Bp K96423’s eight TA toxins in E. coli did decrease 
bacterial growth rate in three cases, and also in one more case when an E. coli 
homologue of the antitoxin was deleted (Butt et al. 2012). The two TA modules which 
were hit in the GOT screens (BPSL0558-9 in all screens, BPSL2333-4 in iGOT) were 
among those which caused no effect in the study by Butt et al., but they were unable to 
identify antitoxin homologues to delete in their E. coli host strain MG1655. For TA 
modules to be hit in the GOT screens either the toxin must be expressed more greatly 
than any corresponding antitoxins (allowing the clone to persist through host responses) 
or, perhaps more fittingly for the timescale of these screens, the antitoxin was expressed 
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highly enough to block the toxin (thereby removing fine control of bacterial growth and 
giving rapid proliferation).  
The arginine deiminase pathway allows anaerobic growth using arginine as a substrate 
(Maghnouj et al. 1998). In species including the Streptococci this pathway is important for 
survival in acidic environments, as ammonia produced from the arginine neutralises acid 
(Gruening et al. 2006; Casiano-Colón & Marquis 1988). This could lend a survival 
advantage to fosmid clones encountering acid killing mechanisms in the model hosts. 
Additionally the arginine deiminase system can also be a major provider of ATP which 
enables greater bacterial growth, and in some organisms the carbamate kinase can work 
in the reverse reaction direction to contribute to pyrimidine synthesis (Casiano-Colón & 
Marquis 1988), which is relevant to Bp virulence as already discussed. An analysis of 
proteins from patients with primary versus relapsing melioidosis revealed that the arcABC 
genes were highly expressed in the relapse isolate, presumably enabling anaerobic 
growth and/or acid resistance (Velapatiño et al. 2012).  
mGOT 
As described earlier, a recent publication reported the results of a macrophage assay 
using this same Bp fosmid library in combination with a Bp BAC library (Dowling 2011). 
The results of the mGOT screen were therefore compared with our invertebrate assays. 
The proportion of hits in common was (slightly) greatest for aGOT (fitting the observation 
that amoebae and macrophages have many mechanistic similarities), and lowest for 
iGOT. Just 85 CDSs were hit in all three invertebrate screens and, of those, 20 were also 
hit in the macrophage results. They correspond to two genomic regions: two genes 
including a probable aminotransferase, and a cluster of eighteen CDSs including genes 
for glycine decarboxylation, gluconeogenesis and ethanolamine metabolism. 
Ethanolamine metabolism has already been discussed in terms of its links to virulence. 
Glycine is a precursor for ethanolamine, and glycine decarboxylation is also linked to the 
biosynthesis of purines and pyrimidines (Bauwe & Kolukisaoglu 2003). Aminotransferases 
are important for the production of amino acids, but have not been directly linked to 
virulence.    
5.4.4. Problems with the BPF expression system 
The Bp hits were spread throughout the genome rather than clustered (even when only 
the refined subset was plotted) and unlike previous RVAs they had only weak or non-
reproducible effects in the GOT screens. The same was true for all three screens, 
regardless of host. Known virulence factors and GIs were not enriched in the hits 
compared to the genome as a whole. Although the mprA gene product was being 
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expressed, it seemed likely that there was some problem with the expression of Bp fosmid 
inserts. 
Dowling et al (2010) reported anti-macrophage activity of some genomic loci but it is 
unclear whether these results came from the fosmids or the BAC clones they 
supplemented the library with. The list of positive hit CDSs reported from their assays 
accounts for 1474 CDSs (25.2%) of the genome, a similar number to the invertebrate 
GOT screens (1190, 1209, and 1174 CDSs in aGOT, nGOT and iGOT). Notably they also 
used crude lysates of the bacterial cells which would circumvent any problems with 
transportation of gene products, assuming translation and folding were successful. 
Correspondence with a research group based at the Genome Institute of Singapore (GIS) 
revealed that they had also constructed a similar Bp fosmid library using genomic DNA 
collected from 39 clinical strains of Bp. They used their own custom microarrays to 
analyse the coverage of Bp genes within their library (based on transcripts), and 
discovered that unlike normal Bp transcription patterns there was extensive anti-sense 
transcription in the fosmid library (J. Kreisberg, unpublished data). Transcription start sites 
were preserved but there appeared to be ‘run-on’ transcription past the usual termination 
sites. Efficient expression in a recombinant system (or following horizontal gene transfer) 
requires compatibility with the host strain’s machinery for transcription termination as well 
as initiation. Antisense RNA can cause gene silencing (Kleinjan & Van Heyningen 2003) 
and it is possible that this is a previously unappreciated obstacle towards the expression 
of foreign genetic material in constructed systems like the fosmid library. Coincidentally, 
the CDS which was the single most highly transcribed gene in the GIS’s library was the 
mprA gene. If a similar phenomenon was occurring in our own library, it is possible that 
one of relatively few properly-transcribed genes was inadvertently selected when fosmid 
expression was assessed early on.    
A small selection of fosmids was re-tested once more in M. sexta, and also in G. 
mellonella (as it is generally a more susceptible model). Two of the fosmids encoded the 
kdpDE genes, which were hit in aGOT and are discussed in more detail in the following 
section. The remaining three were iGOT hits which encoded some of the known or 
putative Bp virulence factors: one for immune evasion which also encoded a 
phospholipase; one for a complete T6SS operon; and one with a virulence-related TCS 
and an ABC sugar transport operon up-regulated in macrophages. The fosmids were 
tested with and without auto-induction solution to enhance copy number, but none of the 
clones showed toxic effects in either model. 
Preliminary attempts were made to use RT-PCR to determine if transcription was 
occurring in the BPF fosmids. The targets were mprA, bimA, bipD, an NRPS gene, the 
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CHBP cyclomodulin, bylA and a TC toxin.  mprA was selected because the fosmids were 
known to be capable of its expression. BimA and BipD are well-known Bp virulence 
determinants and were hits in aGOT and nGOT respectively. The NRPS gene was an 
nGOT hit. The CHBP cyclomodulin was an iGOT hit. BylA and the TC toxin were hits in 
the macrophage/crude lysate assay by Dowling et al. (2010); it was of interest to see if loci 
which were hits in that screen were expressed in our fosmid clones. Toxin Complex (TC) 
toxins are potent against invertebrates (Hares et al. 2008; Yang et al. 2012). bylA is an 
orthologue of the Ps. syringae NRPS/PKS sylA. Its product (syringolin A) inactivates the 
eukaryotic proteasome (Ramel et al. 2012). Due to time limitations only preliminary 
experiments could be performed; without optimisation most of the samples showed either 
DNA contamination (whereby the presence of a band does not necessarily indicate RNA 
transcripts) or no PCR products. Where no products were seen no conclusions can be 
drawn, as there were no true-positive controls in this set-up. However, in one case a band 
was present at the expected size and no DNA contamination was evident: the TC toxin 
gene bpsl0590 does appear to be transcribed in the fosmid system. Beyond that these 
preliminary RT-PCR results remain inconclusive.  
5.4.5. Attempts to investigate kdpDE in Burkholderia 
The fact that the kdpD and kdpE genes (bpsl1174 and bpsl1175) were hit in the aGOT 
screen was of particular interest because the P. asymbiotica RVA had identified that 
particular TCS, which regulates Kdp, a potassium ion transport ATPase (Waterfield et al. 
2008). When the P. asymbiotica kdp genes were expressed in E. coli they were found to 
confer the ability to persist within M. sexta haemocytes (Vlisidou et al. 2010). In fact, 
although the regulation of the Kdp K+ pump serves an important homeostasis role in low-
K+ environments, the kdpDE TCS is increasingly being identified as a pleiotropic virulence 
factor (as reviewed in Appendix A). In diverse bacterial species KdpDE uses mechanisms 
distinct from K+ regulation to play a direct or indirect role in virulence. In several cases the 
TCS is linked to oxidative, osmotic and antimicrobial stress responses, which aid the 
persistence of pathogens within the host and in the intracellular environment (Alegado et 
al. 2011; Moule et al. 2010; O’Loughlin et al. 2010). In Salmonella typhimurium the KdpDE 
TCS was essential for colonisation of C. elegans (Alegado et al. 2011). In Staphylococcus 
aureus kdpDE transcription is up-regulated in response to macrophages and even 
responds to quorum signalling, and KdpE is able to directly bind to the promoter 
sequences of multiple virulence genes and up- or down-regulate their transcription (Xue et 
al. 2011; Zhao et al. 2010). Genes up-regulated by KdpE include colonisation factors spa 
(Staphylococcal protein A) and cap (for capsule synthesis). A negative regulatory effect is 
elicited upon local invasion enzymes and toxin genes (Xue et al. 2011). In 
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Enterohaemorrhagic E. coli (EHEC) H7:O157 KdpE can act as a non-cognate response 
regulator for the histidine kinase QseC, which responds to mammalian host adrenergic 
signals (Hughes et al. 2009). This allows EHEC to efficiently regulate gene expression in 
response to the host. Via KdpE, QseC can regulate not only the Kdp ATPase but also 
over 80 genes including the regulator ler. ler is the master regulator of the Locus of 
Enterocyte Effacement (LEE) genes, which are required for creating the intestinal lesions 
characteristic of EHEC pathogenesis. 
For these reasons it was of great interest to investigate the KdpDE TCS further in 
Burkholderia. Rather than use the Bp fosmid system, attempts were made to knock-out 
(KO) or over-express the genes directly in Bt. It was envisaged that a KO strain and 
complemented KO strain would be tested for attenuation in invertebrate and cellular 
virulence assays. Failing a KO mutant, over-expression of the genes might be technically 
easier to accomplish and – although the effects would not be as clear-cut as the effects of 
a non-polar KO – could still offer insights into the role of KdpDE in Bt. Unfortunately 
despite several attempts, the KO or over-expression constructs were not successfully 
completed within time limitations. Difficulties in creating Kdp KOs have been experienced 
for other bacterial species (I. Vlisidou, personal correspondence).  
RT-PCR was also used to investigate transcription of kdpD in response to injection into 
the M. sexta larva. The KdpD sensor kinase is thought to respond to stimuli associated 
with virulence (e.g. phagocytosis) and stress (e.g. oxidative and antimicrobial stress) 
(Voyich et al. 2005; Hou et al. 2002; Alegado et al. 2011; Moule et al. 2010; O’Loughlin et 
al. 2010). Based on the observation that kdpD is up-regulated in macrophages (Zhao et 
al. 2010; Hou et al. 2002) it would be interesting to see if the same result occurs in the 
insect host, when the bacteria are exposed to haemocytes. Two fosmids were used, one 
which bore all the genes for the ATPase structure as well as the KdpDE TCS and another 
which lacked some structural genes (kdpA which is integral and kdpF which is 
expendable). Again only preliminary results were obtained. The method had not been 
optimised and RT-PCR from the haemolymph extracts produced unclear smeared 
patterns on electrophoresis gels. One fosmid sample was DNA contaminated, but the 
other was not and indicated that kdpD was transcribed in the inoculum prior to injection. 
Overall the results were inconclusive and the method requires further optimisation.   
5.4.6. Lessons from Bp RVA and the new statistical analysis 
approach 
RVA is intended to be used as a rapid and preliminary way to highlight genomic regions 
with a putative role in virulence, so that a shortlist of interesting regions can then be more 
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thoroughly investigated to confirm the effects and pinpoint the exact loci responsible. This 
RVA of Bp encountered problems which are suspected to be due to the Bp-fosmid 
expression system. Bp K96423 has a GC content of 68.0% compared to 50.8% in E. coli 
K12. Expression libraries of organisms with difficult codon biases are often made in 
‘universal translation’ strains of E. coli such as Rosetta but the original purpose of the BPF 
library was for sequencing rather than expression.   A clear lesson learned from this study 
is the need for a more comprehensive assessment of whether a genomic library is fit for 
purpose before embarking on GOT screening.  RT-PCR or microarray should be used to 
assess transcription and more importantly protein translation should be confirmed, e.g. by 
western blot with specific antibodies to a range of targets. Analysing different cellular 
fractions or supernatants would also help to reveal whether proteins were being 
expressed in the appropriate locations.   
It is still not clear what proportion of the Bp GOT hits were true-positives. Did some have 
true GOT effects in the first round of screening but later failed to work due to deletions and 
recombination, as was observed in some P. asymbiotica cosmids? Did some have true 
effects that were subtle or inconsistent and therefore were not reproduced in the re-tests? 
Or were there never any toxicity effects, and variation in scores was simply due to the 
nature of the GOT scoring system (i.e. qualitative, somewhat subjective despite efforts to 
maintain consistency, and n = 1 in the first round)? The use of positive and negative 
controls, and the fact that the invertebrate models themselves have been successfully 
used previously, should suggest that this was not the case.  
The development of a quantitative analysis for this RVA has resulted in a useful approach 
which can also be applied to previous or future results. The approach entails the use of a 
bioinformatics script to automatically calculate the coverage level of each CDS, a 
database to store relevant information about CDSs or GOT results, and statistics to 
eliminate CDSs with observed-to-expected hit ratios below a threshold. Providing the 
positive results are reliable, this new analysis approach allows statistically meaningful 
summaries to be made with relative ease. It also enables quantitative values to be used 
instead of qualitative results, and takes into account any discrepancies in library coverage. 
When applying this analysis some caution and common sense are necessary to avoid 
finding significance where it may not actually exist; if the library is known to express the 
transgenic proteins and positive results are reproducible then there is a sound basis for 
accepting the findings of the analyses. Unfortunately in the case of this Bp RVA, it is not 
appropriate to draw firm conclusions with the evidence available so far.  
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5.4.7. Recently published invertebrate models for Bp 
virulence factor discovery  
Since the Bp RVA screening was conducted, several more publications have described 
the use of invertebrate models to investigate Burkholderia virulence. Some studies served 
to validate the infection models, i.e. the G. mellonella model for Bp, Bt and Bo isolates 
(Wand et al. 2011) and the cockroach insect model for Bp which also confirmed that 
T6SS-1 (but not T6SS-2 – T6SS-6) was important for full virulence in both cockroach and 
mouse models (Fisher et al. 2012). The Bp / C. elegans host-pathogen interaction has 
recently been studied in some detail, as discussed in earlier chapters. Particular host 
genes were seen to be repressed and induced during Bp infection which gave a survival 
advantage to the bacterium, and it has been postulated that Bp may use a chemorepellent 
to ward off nematode predators, but the identity of the Bp factors responsible for these 
effects is not yet known (Ooi et al. 2012).  
At the same time of the RVA screening one study reported the use of multiple infection 
hosts to study bacteria of the Bcc species – the Burkholderia cepacia complex mentioned 
in the main introductory chapter. Mutants of published virulence genes were screened in 
parallel in hosts from several different taxa to uncover the overlap between virulence 
mechanisms: C. elegans nematodes, G. mellonella insect larvae, the alfalfa plant, and 
mice or rats (Uehlinger et al. 2009). A few conserved mechanisms of pathogenicity were 
uncovered: N-Acyl homoserine lactone (AHL)-dependent QS was highly conserved as a 
regulatory mechanism for virulence gene expression. Siderophores and LPS were 
important for virulence in all the animal models. However, most mechanisms were host-
specific with little correlation even between the invertebrate models, which serves as a 
warning that caution ought to be used when extrapolating findings from non-mammalian 
infection models to mammalian pathogenesis and vice versa, at least for Bcc species. 
This investigation only tested targeted mutants and did not aim to identify novel virulence 
factors. 
A particularly relevant study used a high-throughput assay to test 1,500 Bt transposon 
mutants against the amoeba Dictyostelium discoideum (Hasselbring et al. 2011). First, the 
assay was validated by confirming that mutation of a known virulence factor (T3SS-3) 
decreased Bt resistance to predation by D. discoideum, and that published levels of 
virulence of Bp strains correlated with the observed plaque assay results. 13 transposon 
library mutants were more susceptible to predation. Two of those mutants did not show a 
reproducible effect, and one was an auxotroph. The remaining ten were identified by 
sequencing. Six mutants were studied further in quantitative assays and their survival in 
macrophages correlated with their resistance to amoeba predation. Those mutants bore 
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mutations in three hypothetical proteins, a sensor kinase, a SET domain protein and a 
serine peptidase. Orthologues of four of those mutated genes were disrupted in Bp strain 
DD503; quantitative assays confirmed that the Bp mutants were also more susceptible to 
predation by the amoebae. In macrophages one Bp mutant (the sensor kinase bpsl0127) 
showed reduced replication during early stages of infection. That mutant was confirmed 
as attenuated in a mouse model. Some of the other Bp mutants had altered abilities to 
lyse macrophage cells and form MNGCs. Four of the ten sequenced mutants from that 
study were hits in the GOT assays but two of those were not tested further by Hasselbring 
et al (2011) because they were in metabolic genes (malate dehydrogenase and a tRNA 
pseudouridine synthase A). The SET domain protein was hit in nGOT. SET domain 
proteins are eukaryotic-like and are proposed to function in host-pathogen interactions 
(Alvarez-Venegas et al. 2007). The serine peptidase mutant was actually in the mprA 
metalloprotease gene; clearing of milk agar plates showed that this gene was expressed 
in BPF fosmids and it was actually a hit in aGOT.  
Another transposon library for Burkholderia virulence factor discovery was in a species of 
the B. cepacia complex (Bcc), B. cenocepacia H111 (Schwager et al. 2012). Around 5,500 
transposon mutants were tested in C. elegans and 23 showed attenuated virulence. 
Those mutants were then tested in a Drosophila melanogaster model (six were 
attenuated), and positive results from that model were also tested in G. mellonella (five 
were attenuated). The five mutations that were attenuating in all the invertebrate screens 
were in three purine biosynthesis genes, one pyrimidine biosynthesis gene and one 
aromatic amino acid (shikimate) biosynthesis gene (Schwager et al. 2012). As already 
discussed the purine and pyrimidine biosynthesis pathways were refined hits in all of the 
GOT screens. The Bcc species are less closely related to Bp than Bt, Bm and Bo are. But 
like Bp they live environmental saprophytic lifestyles and are opportunistic pathogens (of 
the lungs of immunocompromised humans) so results from this similar invertebrate screen 
for virulence factors may be very informative. 
5.4.8. Future directions 
If work was to continue it would be a priority to confirm the expression status of the BPF 
library, and therefore the validity of the RVA results. Use of a Bp genome-wide microarray 
like that used by the GIS research group would give a comprehensive understanding of 
the transcription patterns in the fosmids, and might reveal similar examples of terminator 
read-through and anti-sense transcription. As that resource was not available, some 
preliminary RT-PCR analysis was used. The RT-PCR technique requires optimisation in 
terms of product specificity and DNA elimination from the RNA samples. Identification of a 
target which is reliably expressed and detected by RT-PCR would be useful as a positive 
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control, which is currently lacking. Proving that proteins are expressed is preferable to 
confirming transcription alone. It would be highly unlikely that all Bp proteins would be 
expressed in this type of transgenic system (for example, where successful expression is 
dependent on additional factors that are not included in the same fosmid insert) so a 
considerable range of targets might need to be assessed. Protein gels could be analysed 
in terms of banding patterns relative to controls, or Western blotting could be used to 
probe targets for which specific antibodies are available. Cellular fractions and 
supernatants could be probed to confirm the location of the proteins and to discover if 
proteins which are normally secreted in Bp were successfully secreted in the transgenic 
system. If not, it might be appropriate to use a combination of cellular lysates and whole 
cells in GOT assays.  
It would be interesting to apply the statistical analysis approach to previous RVA studies 
to see how well the refined observed-to-expected ratios correspond to the known and 
newly-identified virulence factors. Regions which did not appear to have hit-clusters could 
still have had high hit rates relative to their coverage, and may yet be harbouring 
unidentified virulence determinants.     
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Chapter 6. General Discussion 
The work described in this thesis was conducted with two main aims: (i) to evaluate and 
begin to characterise the Manduca sexta larva as a model host for Bp-group infections 
(Chapters 3 and 4); and (ii) to use M. sexta and other invertebrate hosts in parallel to 
screen a recombinant Bp library for the identification of putative virulence-related loci 
(Rapid Virulence Annotation; Chapter 5). 
6.1. Manduca sexta as a model host for Bp-group 
infections 
Summary 
Based on a combination of infection assays by direct injection, oral toxicity / infectivity 
assays, and analyses of haemolymph and HCs post-injection, the M. sexta larva appears 
to be an interesting and potentially useful host for the study of Bp-group pathogens. 
M. sexta does not reflect the relative virulence of different Bp-group species in humans as 
well as the G. mellonella larva does (Wand et al. 2011; Schell et al. 2008). However, there 
are certainly some conserved hallmarks of virulence which may be due to the same 
molecular mechanisms: intra-phagocyte survival and multiplication, actin remodelling, 
host-cell death and acute sepsis were all observed. Therefore although M. sexta would 
not be an ideal model to test the relative human-virulence of novel Bp-group strains, these 
aspects of the infection process could potentially be studied in this larva, e.g. by testing 
mutants or inhibitors of those pathways. Insect hosts remain attractive complementary 
models to supply data while reducing the overall amount of mammalian experimentation 
required. Additionally, whether mutants are similarly attenuated in both M. sexta and other 
models (e.g. mice) may tell the researcher whether the factor in question targets the 
innate branch of the immune system.  
The fact that haemolymph and HCs can be obtained easily and in relatively large 
quantities from this host mean that the infection can be allowed to occur in vivo in the 
whole organism, before samples are quite rapidly extracted and analysed. The process 
from extraction to fixing for microscopy takes less than one hour and from extraction to 
ViaCount reading takes ten minutes. G. mellonella larvae produce considerably less 
haemolymph and HCs per larva, and researchers have reportedly experienced difficulty 
imaging their HCs due to problematic auto-fluorescence (M. Bokori-Brown; personal 
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correspondence); no detailed analyses of pathogenesis within the G. mellonella host have 
been published.  
On another level, the virulence of the Bp-group in M. sexta opens up interesting questions 
about the natural ecology of Bp-group Burkholderia and invertebrates. The discovery that 
Bo is highly virulent to M. sexta is exciting. Only four Bo isolates (comprising the two strain 
sequence-types tested in this study) have been obtained so far. Due to their virtual lack of 
virulence in humans or other tested mammals they have not been a priority for 
melioidosis-centric research. In this study it was discovered that most of the tested Bt 
strains are also highly virulent in M. sexta. The majority of Burkholderia publications 
describe Bt as ‘avirulent’ or ‘non-pathogenic’; some qualify these classifications as ‘to 
mammals’ (despite the fact that a high dose of Bt is lethal to hamsters), but others do not. 
It seems clear that the overall virulence of Bo and Bt has been unknown or understated, 
probably due to the focus on human melioidosis. From an entomological (or broader 
invertebrate zoology) point of view these are interesting and virulent pathogens. Bt is 
highly pathogenic for insects and nematodes, as shown by an increasing number of 
studies (Schell et al. 2008; Wand et al. 2011; Fisher et al. 2012; Pilátová & Dionne 2012; 
Ooi et al. 2012; O’Quinn et al. 2001; Day & Sifri 2012) and it now also appears that Bo is 
highly pathogenic for M. sexta. It will be interesting to learn what other species Bo is 
virulent to – likely to other invertebrates and perhaps more taxa. Pilátová & Dionne (2012) 
suggested that the high virulence of Bt in the fly suggests that Bt may be a natural 
pathogen of invertebrates. On that same basis the conclusion could be extended to Bo; 
the rapidity of M. sexta death with injected Bo and the toxicity of Bo supernatant to 
neonates suggest that the organism is well-equipped as a pathogen of insects, or at least 
to avoid predation by them via the use of paralytic agents. 
The fact that Bo and Bt were toxic or infectious to M. sexta neonates via the oral route is 
important as this represents the most likely route of natural infection. In one experiment Bt 
killed most larvae before day 8, and the survivors were of weights comparable to controls. 
In subsequent experiments only a minority of larvae died, but the majority of survivors 
were significantly underweight. It is likely that they were not feeding, either by choice to 
avoid the Bt or Bo (implying they can sense it), or due to an inability (e.g. caused by a 
paralytic agent). Bo cell-free supernatant was as harmful to the larvae (in terms of weight 
gain) as complete culture, which adds to the evidence from C. elegans and D. 
melanogaster studies that Bp-group pathogens release a soluble toxic factor which is 
active against invertebrates (O’Quinn et al. 2001; Ooi et al. 2012; Lee et al. 2011; Day & 
Sifri 2012). Bt cell-free supernatant was not shown to have the same effect, although 
interestingly, ‘cell-reduced’ un-filtered supernatant was more harmful (in terms of weight 
gain) than complete Bt culture. These experiments will need to be repeated in a 
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systematic manner to reliably confirm the observations made so far. It will be important to 
discern whether infection or intoxication (or a combination) is the primary means of the 
harmful effect caused by Bo and Bt to M. sexta neonates. Paralysis is also observed in 
mammalian models of melioidosis (Brett et al. 2007); it would be interesting to know to 
what extent the paralytic effect in vertebrate and invertebrate hosts is mediated by the 
same factors. 
Bt and Bo virulence 
Although Bt and Bo are considered avirulent to humans both have been isolated more 
than once from human clinical infections. These were associated with traumatic injuries 
which allowed extensive contact between bacteria and host without the usual first-line 
defence barriers (e.g. intact skin for cutaneous infection or digestive enzymes for 
ingestion). Once inside the host, Bt and Bo infections managed to persist for several 
weeks in some cases (Glass, Gee, et al. 2006; Glass, Steigerwalt, et al. 2006; Nussbaum 
et al. 1980). The adaptability of B. cepacia complex (Bcc) species – which include 
saprophytes, plant symbionts, plant pathogens and opportunistic human pathogens – is 
such that no Bcc species are permitted for use in biotechnological applications (Vial et al. 
2011). Bp-group species have a similar propensity to reorganise their DNA (Holden et al. 
2004; Sim et al. 2010). Considering the close genetic relatedness of Bt and Bo to human-
pathogenic Bp and Bm it is not surprising that occasional human infections with Bt and Bo 
have been reported. The Bo strains were isolated in the 1970s and no incidences of Bo 
clinical infection have been reported since then (McCormick et al. 1977; Nussbaum et al. 
1980), although it is possible that asymptomatic or undiagnosed human infections have 
occurred. It would be interesting to learn if more natural and/or clinical Bo isolates can be 
identified, and to assess their prevalence, diversity and virulence. 
The M. sexta findings agreed with results from mammalian models in one respect which 
those from G. mellonella did not: Bt CDC 272 exhibited low virulence in M. sexta. This 
strain has low or no virulence in mammals, but Wand et al reported that it was virulent to 
G. mellonella (Wand et al. 2011). Taken together with the fact that Bo is highly pathogenic 
to M. sexta but dramatically less so in G. mellonella (and that the reverse is true for Bp), 
this discrepancy between the two lepidopteran insects is intriguing and warrants in-depth 
investigation. There may be a fundamental difference in the immune response of the two 
hosts, or perhaps the hosts carry different cues (e.g. hormones or cellular markers) to 
which the bacteria respond. Elucidating the causes of this difference would be informative 
for the understanding of Burkholderia pathogenicity and for the wider field of bacteria-
insect interactions in general. 
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Burkholderia variability within experiments 
One general observation from the experiments described in Chapters 3 and 4 was that the 
outcome of infections was variable, even when using the same strain in the same 
conditions, or even within the same experiment. For example, M. sexta injected with Bp 
K96423 did not all die, and those that survived appeared to be in good general health. 
The presence of melanocytic spots on some larvae showed that they had exhibited an 
immune response. Therefore the Bp infection was either lethal or was apparently cleared, 
presumably determined by the particular host-pathogen relationship in each case. In one 
set of experiments Bt CDC 272 did not kill any larvae, yet in a repeat experiment it did kill 
all larvae, albeit at a slow rate. In the first feeding experiment Bt E264 killed 70% of 
neonates and the survivors were a normal weight, whereas in subsequent experiments it 
killed less than 22% of larvae yet the survivors were significantly reduced in weight. 
Burkholderia exhibit a high degree of variability, as discussed in the main introduction, 
including within-strain variability. Bm and Bp have been reported to change genetically 
within the course of a single infection (Price et al. 2010; Hayden et al. 2012). There is 
evidence to suggest that phase variation is one mechanism contributing to within-species 
differences (Vial et al. 2010; Song et al. 2009; Arnold et al. 2007), and toxin-antitoxin (TA) 
systems appear to allow the formation of dormant ‘persister’ phenotypes (Butt et al. 2012).  
It is plausible that differing proportions of variant sub-populations could lead to the 
variable outcomes of infection observed in this study. Further work could repeat infections 
and feeding assays a sufficient number of times in order to characterise the range of 
‘typical’ results with each strain. Numerous other Bp and Bt strains exist which could also 
be investigated. 
Further directions 
One key experiment would be to systematically repeat the M. sexta Bt and Bo feeding 
assay using whole culture, washed cells, cell-free supernatant and the heat-treated 
equivalent of each of those. In addition to feeding, each component should also be 
injected into fifth-instar larvae; aside from the Bp K96423 infection, no injection assays 
used heat-killed cells as a control and it would be interesting to discover more about the 
immunogenicity (or heat-labile toxicity) versus the infectivity of the strains. To obtain 
supernatant in this study the cultures were centrifuged. It is possible that the toxic factor in 
the Bo supernatant may have originally been cell-attached rather than secreted into the 
medium, and that centrifugation was at a great enough speed to shear the factor from the 
cells. To investigate this it would be useful to test and optimise the centrifugation speed.  
Another key priority would be to determine to what extent temperature affects the outcome 
of invertebrate-Burkholderia interactions, particularly with reference to the differences in 
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relative virulence of Bp-group strains in M. sexta (maintained at 25 °C) and G. mellonella 
(maintained at 37 °C). For comparison with the results of the D. melanogaster Bt 
infections, 18 °C could also be tested. M. sexta larvae could be injected and maintained at 
18 °C and 25 °C, and also at 37 °C if a suitably large cohort of un-injected and saline-
injected controls was included to account for the reduced overall health of M. sexta at that 
temperature. G. mellonella larvae could also be injected and maintained at all three 
temperatures. Median times to death could be calculated as before; it would also be 
interesting to calculate bacterial load or 50% lethal doses at a particular end-point. 
6.2. Rapid Virulence Annotation of Bp K96423 
Summary 
As discussed in Chapter 5, Rapid Virulence Annotation (RVA) – a genome-wide screen 
for virulence-related genes using three invertebrate hosts – produced less clear-cut 
results for Bp than it had done for Photorhabdus species (Waterfield et al. 2008). There 
was less obvious ‘clustering’ of hit fosmids around genomic loci. This could be related to 
the Bp pathogen itself, as its large and flexible genome encodes numerous and variable 
virulence factors, most likely with considerable redundancy (Wiersinga et al. 2012; Holden 
et al. 2004). However, there was also a problem with a lack of reproducibility from hit 
fosmids. Both the lack of ‘clustering’ and the perceived loss of biological activity could 
relate to the fosmid-based expression system. A multiple-strain Bp library constructed by 
another research group, using the same fosmid expression system, was discovered by 
them to yield low transcription with erratic read-through beyond stop codons, producing 
extensive anti-sense transcripts (J. Kreisberg, personal communication). From the Bp 
K96423 fosmid library used in this study, metalloprotease activity from fosmid clones was 
an early indication of successful expression from the system. Unfortunately no further 
characterisation of fosmid expression was undertaken prior to completion of RVA 
screening, and later attempts to analyse gene transcription by RT-PCR were halted by 
time limitations. 
It remains unclear to what extent Bp genes were expressed in the fosmid system, and 
what proportion of hits were due to real effects in the RVA screens. The metalloprotease 
gene was indeed hit in the amoeba bioassay. The most compelling support for the validity 
of the original hits is that iGOT hits that were classed as ‘best’ or ‘higher’ (based on 
qualitative assessment of larva health) actually did also have higher observed-to-expected 
ratios than ‘lower’ hits. The median ratio for all iGOT hits was 2 (i.e. they were hit two-
times the calculated expected rate) but the median ratio for best hits was 10. This means 
that the genomic regions which were associated with the strongest iGOT effects in the first 
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round of screening really were hit considerably more often than expected. It should be 
noted that the scoring of any fosmid as a hit was independent of other fosmids’ scores – 
the contents of each fosmid was not known at the time of screening and fosmids were 
arrayed randomly in 96-well plates, not in any meaningful order. In re-testing however, the 
effects were not reproduced. It is unknown whether this loss of biological activity was due 
to fosmid instability, recombination within the Bp insert DNA, variation in levels of normal 
or antisense transcription, or another factor. 
The newly devised statistical approach allowed the identification of the most likely true-
positive RVA hits. Hits with an observed-to-expected hit ratio below the median ratio value 
(for hits) were removed from the dataset. For future work this threshold could easily be 
adjusted, to find the top 5% of ratios for example. Whether any of the hit genes are true 
virulence determinants would need verification, as would be the case with any RVA 
results regardless of problems with expression and reproducibility. The refined subset of 
hits from the RVA bioassays included known Bp virulence factors such as T3SS, T6SS, 
iron scavenging molecules, and secondary metabolites. It also included unexpected 
factors such as genes annotated for potassium ion (K+) transport.  
The fact that the Kdp operons were identified in aGOT screening was of particular interest 
because KdpD/KdpE was previously a bioassay hit for Photorhabdus asymbiotica, for 
which it has been shown to play an important role in intracellular survival (Vlisidou et al. 
2010). The Kdp operons encode a K+-ATPase (KdpFABC) and a two-component 
regulatory system (KdpD/KdpE) respectively. Although it has widely been known for its 
role in K+ homeostasis, the KdpD/KdpE two-component system (TCS) has increasingly 
been linked to the virulence and survival of bacterial pathogens. This topic is extensively 
reviewed in Appendix A: ‘The KdpD/KdpE Two-Component System: Integrating K+ 
Homeostasis and Virulence’. Considerable efforts were made to construct a Bt 
KdpD/KdpE mutant, or to over-express the TCS, in order to investigate its role in Bp-group 
virulence. Unfortunately no cloning constructs were completed within the available time. 
This remains an area of great interest which warrants further investigation. 
Further directions 
A recombinant expression system was useful for the study of Bp genes because of the 
containment requirements for Bp. Having discovered that Bt and Bo are highly virulent in 
M. sexta it would be interesting and feasible to perform a genome-wide screen with one or 
both of those species. The fact that they can be handled at CL2 means that a random 
transposon mutant library or transposon directed insertion-site sequencing (TraDIS) could 
be used instead of a fosmid expression system (Langridge et al. 2009). The analysis 
would then look for loss-of-function (longer larval survival compared to the wild-type 
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strain) as opposed to gain-of-function. Redundant factors could therefore be missed, but 
potential problems with transgenic expression would be avoided. Similarly, sequence-
tagged mutagenesis (STM) could be used to identify genes required for survival inside the 
M. sexta host by bleeding the haemolymph and assessing which tags are absent (and 
therefore which genes are essential) (Saenz & Dehio 2005). Mutants of interest could be 
GFP-labelled and analysed by fluorescent confocal microscopy to compare their infection 
progression in M. sexta compared to non-mutant strains.    
An important lesson from this RVA study was the need to thoroughly test that expression 
libraries are fit for purpose before embarking on similar approaches. One positive 
outcome is that the statistical method devised to analyse these results could easily be 
applied to past or future RVA data. By quantifying the true best hits accounting for 
variations in actual genome coverage, some different results may become apparent. 
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The two-component system (TCS) KdpD/KdpE, extensively studied for its 
regulatory role in potassium (K+) transport, has more recently been identified as an 
adaptive regulator involved in the virulence and intracellular survival of pathogenic 
bacteria, including Staphylococcus aureus, entero-haemorrhagic Escherichia coli, 
Salmonella typhimurium, Yersinia pestis, Francisella species, Photorhabdus 
asymbiotica and mycobacteria. Key homeostasis requirements monitored by 
KdpD/KdpE and other TCSs such as PhoP/PhoQ are critical to survival in the 
stressful conditions encountered by pathogens during host interactions. It follows 
these TCSs may therefore acquire adaptive roles in response to selective pressures 
associated with adopting a pathogenic lifestyle. Given the central role of K+ in 
virulence, we propose that KdpD/KdpE, as a regulator of a high-affinity K+ pump, 
has evolved virulence-related regulatory functions. In support of this hypothesis, 
we review the role of KdpD/KdpE in bacterial infection, and summarize evidence 
that: i) KdpD/KdpE production is correlated with enhanced virulence and survival, 
ii) KdpE regulates a range of virulence loci through direct promoter binding, and iii) 
KdpD/KdpE regulation responds to virulence-related conditions including 
phagocytosis, exposure to microbicides, quorum sensing signals and host 
hormones. Furthermore, antimicrobial stress, osmotic stress and oxidative stress 
are associated with KdpD/KdpE activity, and the system’s accessory components 
(which allow TCS fine-tuning or crosstalk) provide links to stress response 
pathways. KdpD/KdpE therefore appears to be an important adaptive TCS 
employed during host infection, promoting bacterial virulence and survival through 
mechanisms both related to and distinct from its conserved role in K+ regulation.  
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Introduction 
Two-component systems (TCSs) are widespread regulatory systems which enable 
microbes to control their cellular functions and respond appropriately to a diverse range of 
stimuli such as pH, osmolarity, quorum signals or nutrient availability. The two components 
are a histidine kinase (HK) which senses an environmental signal and a response 
regulator (RR) which mediates a cellular response, typically by altering expression of 
target genes. The genes kdpD and kdpE together encode the KdpD/KdpE TCS, which is 
well-studied for its regulation of the Kdp-ATPase potassium ion (K+) pump operon 
kdpFABC. Although best studied in Escherichia coli, highly homologous genes are found 
in most other bacteria, and are assumed to function similarly in K+ homeostasis.  
However, the signalling networks regulating basic bacterial physiology and bacterial 
virulence are sometimes intricately linked [1], and TCSs are no exception. A classic 
example of a TCS with pleiotropic roles in homeostasis and virulence is PhoP/PhoQ, 
whose regulon both mediates responses to Mg2+-limited environments and governs 
virulence and intra-macrophage survival in a range of Gram negative species [2,3]. More 
recently, the GraS/GraR TCS of Staphylococcus aureus has also been shown to possess 
functional diversity – it was best known for controlling resistance to antimicrobial peptides 
but further investigation has revealed links to quorum sensing, stress response, cell wall 
metabolism, and regulation of haemolytic and fibrinogen-binding proteins [4]. Here, we 
review evidence from diverse and clinically-relevant bacterial species, indicating that the 
KdpD/KdpE TCS responds to pathogenesis-related signals, directly regulates virulence 
genes, and mediates stress resistance.   
KdpD/KdpE and the regulation of K+ homeostasis during 
pathogenesis 
Regulation of K+ homeostasis by KdpD/KdpE 
K+ uptake in bacteria occurs via different combinations of non-specific channels and 
specialised transport systems [5]. Constitutively-expressed systems, such as Trk, satisfy 
general K+ requirements, but the Kdp-ATPase is a specialised, inducible higher-affinity K+ 
pump [6]. The Kdp-ATPase itself is encoded by the structural operon kdpFABC. The Kdp-
ATPase is widespread throughout the prokaryotes and the KdpD/KdpE TCS is found in 
over 1,082 bacterial and archaeal species [7]. Expression of the operon is triggered by 
three stimuli perceived and integrated by the HK KdpD: K+ concentration, osmolarity, and 
ATP concentration [8]. Turgor pressure has also been suggested as a stimulus for 
KdpD/KdpE activation, although this has been a subject of debate [8]. Mutation analysis 
suggests that an activating stimulus causes the inhibition of the phospho-KdpE-specific 
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phosphatase activity of KdpD, leading to an accumulation of phospho-KdpE. This  in turn 
binds to an operator sequence in the promoter DNA to activate transcription of kdpFABC 
[9]. Its regulation by a TCS makes Kdp the only known bacterial K+ transport system 
whose expression is strongly controlled at the level of transcription [5]. 
Regulation of K+ homeostasis during pathogenesis 
K+ is the single most abundant ion in the intracellular environment and its regulation is 
crucial for maintenance of cell turgor and for diverse processes contributing to normal 
homeostasis [5]. Many studies have shown that K+ regulation is critical for bacterial 
virulence [10-13]. Similarly, it is an intricate aspect of host response to pathogens; in 
neutrophils the active transport of K+ across the phagosomal membrane releases 
antimicrobial peptides, activating proteases and enabling Reactive Oxygen Species 
(ROS)-mediated killing of engulfed bacteria [14]. Thus, K+ sequestration from a common 
limited supply may be critical to the competition between the bacterium and host. 
Considering the importance of K+ regulation in virulence, it may not be surprising that 
genes involved in K+ regulation and transport are critical to the survival of pathogenic 
bacteria. Transcriptomic evidence reveals that transcription of the kdpD gene is repressed 
at least 3-fold and in some cases up to 20-fold in Staphylococcus aureus in response to 
phagocytosis by human neutrophils (after 3 hours interaction) [15], and up-regulated in 
Mycobacterium avium during early growth in human macrophages (at 48 hours after 
infection) [16]. 
Role of KdpD/KdpE for virulence and pathogen survival 
KdpD/KdpE aids bacterial survival by increasing K+ uptake 
Although the precise mechanisms of action are yet to be determined, infection models 
suggest that KdpD/KdpE increases the ability of some bacteria to cause disease or to 
survive within a host cell or animal (Table 1). For example, increased transcription of 
kdpD/kdpE was concurrent with increased survival of S. aureus in macrophages and 
deletion of the TCS resulted in attenuated survival [17,18]. In human neutrophils a Y. 
pestis kdpD/kdpE mutant was more readily killed compared to the wild-type strain [3]. A 
study which aimed to identify genes involved in persistent infection of the Caenorhabditis 
elegans intestine highlighted the impact of Salmonella typhimurium kdpD [19]. Further 
characterisation revealed that kdpD was in fact required for S. typhimurium infection of the 
nematode and also for survival in macrophage cell lines. In the nematode feeding assays, 
worms which had grazed on the kdpD mutant strain lived significantly longer than those 
fed on the wild-type bacteria, and in macrophages intracellular growth and cytotoxicity 
were reduced [19]. These observations from intracellular models are generally consistent 
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with the importance of K+ scavenging in K+ limited environments, as would be found in a 
phagosomal vacuole. 
Table 1. Evidence supporting the role of KdpD/KdpE in bacterial virulence and survival in 
cell or animal models 




Knock-out (KO) decreases survival 
Xue et al., 




Increased transcription of kdpD/kdpE is 
concurrent with increased survival in 
blood. KO is attenuated 
Zhao et al., 
2010 [18]  
 Macrophage KO decreases survival 
Xue et al., 
2011 [17]  
 Macrophage 
Increased transcription of kdpD/kdpE is 
concurrent with increased survival in 
blood. KO is attenuated 
Zhao et al., 
2010 [18]  
 Neutrophil 
kdpD is differentially transcribed during 
phagocytosis 
Voyich et al., 




KpdD/KdpE is required for colonisation 
of the worm. KO is attenuated 
Alegado et 
al., 2011 [19]  
 Macrophage KO decreases survival 
Alegado et 
al., 2011 [19]  
Mycobacterium 
tuberculosis 
Mouse KO increases virulence 
Parish et al., 
2003 [20]  
Mycobacterium avium Macrophage 
kdpD is differentially transcribed during 
phagocytosis 
Hou et al., 
2002 [16]  
Yersinia pestis Neutrophil KO decreases survival 
O’Loughlin et 





Transgenic expression of P. asymbiotica 
KdpD/KdpE in Escherichia coli increases 
intracellular survival 
Vlisidou et 
al., 2010 [21]  
Francisella novicida Fruit fly 
Mutation of kdpD, kdpE, kdpA, or kdpC is 
attenuating in a competitive index assay 
Moule et al., 
2010 [22]  
Francisella tularensis Mouse 
Mutation of KdpD is attenuating for 
growth and survival  
Weiss et al., 
2007 [23]  
Enterohaemorrhagic 
Escherichia coli (EHEC) 
HeLa cells 
Deletion of kdpE resulted in slightly 
fewer lesion ‘pedestals’ in infected cells. 
Double deletion of kdpE and cra 
prevented pedestal formation 
Njoroge et 
al., 2012 [24]  
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Other KdpD/KdpE mechanisms influence bacterial virulence and survival  
There are, however, several observations that don’t fully fit with the K+ requirement 
models. Evidence from S. aureus suggests that K+ availability has little to do with 
KdpD/KdpE activity. Despite the fact that human blood is K+ rich, S. aureus kdpD/kdpE is 
still up-regulated and its deletion results in attenuated survival in that environment [18]. 
Additionally, S. aureus kdpD/kdpE transcription is altered not just during phagocytosis 
(when it is repressed); it is enhanced during biofilm formation and in response to 
microbicidal neutrophil extracts [25,26], situations in which K+ is not necessarily limited. 
Although, it is important to remember that it is the KdpD/KdpE phosphorylation status that 
is ultimately important for activity rather than the transcription level of the genes 
themselves. Lastly, it has been suggested that the S. aureus Kdp-ATPase does not even 
function as a predominant K+ transporter [17]. It should be noted however that this 
suggestion was based on results from the deletion of only one KdpD/KdpE system when 
in fact some S. aureus strains possess two systems, with one located on the Type II 
SCCmec mobile genetic element [27]. Therefore, clarification of whether the strain used 
by Xue et al (NCTC 8325) carries one or more functional Kdp operons would be pertinent. 
KdpE is a regulator of diverse virulence loci  
As well as a regulator of the Kdp-ATPase, recent evidence supports the role of KdpE as a 
direct regulator of S. aureus virulence factors [17,18]. KdpE has been shown to bind 
directly to the DNA promoters of a range of virulence genes and it has been demonstrated 
that deletion of kdpD/kdpE altered the level of transcription of over 100 genes, including:  
(i) the surface protein gene spa (Staphylococcal protein A), (ii) the capsule synthesis gene 
cap, (iii) the alpha-toxin gene hla, (iv) the metalloproteinase aureolysin (aur), (v) the lipase 
gene geh, and (vi) the gamma-haemolysin gene hlgB [18].  Figure 1(B) depicts virulence-
related regulatory targets of KdpD/KdpE in S. aureus. A positive regulatory effect was 
elicited upon the colonisation genes (spa and cap), and a negative regulatory effect was 
elicited upon the local invasion enzymes and toxin genes (hla, aur, geh and hlgB) [17]. S. 
aureus kdpD is most highly transcribed at low external K+.  This means that colonisation is 
enabled in response to low K+ (in the external environment, for example), and once in 
higher K+ conditions (in blood or cytoplasm) local pathogenesis is enabled. The spa gene 
has previously been shown to enhance virulence in mouse and macrophage models due 
to its anti-phagocytic role [28].  
Activation of virulence genes via KdpE has also been reported for Enterohaemorrhagic E. 
coli (EHEC) strain O157:H7 [29]. The adrenergic receptor QseC enables EHEC to sense 
host adrenaline and noradrenaline, as well as sensing bacterial signalling molecules 
(Figure 1(C)). This means EHEC can exploit host signals to regulate its metabolic, 
virulence and stress response genes via a complex signalling cascade. In addition to its 
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cognate RR the QseC HK activates two additional RRs, one of which is KdpE [29]. In an 
in vitro system employing liposomes and purified proteins over 80 QseC-regulated genes 
were found to be activated via KdpE. Amongst its targets were the type 3 secretion 
system (T3SS) and its effectors (via regulation of ler), which are necessary genes for 
‘attachment and effacement’ lesions of the intestinal epithelia (see Figure 1) [29]. These 
results show that KdpE has at least the potential to regulate critical virulence genes during 
infection. Further in vitro research has shown that KdpE directly interacts with a second 
transcription factor, the catabolite repressor/activator protein Cra, to regulate ler in a 
glucose-dependent manner [24]. Visualisation of infected HeLa cells revealed that 
deletion of kdpE resulted in slightly fewer lesion pedestals than wild-type, though the 
effect was more pronounced for the equivalent cra mutation. Importantly however, in a 
double mutant full complementation was achieved only when both proteins were 
expressed, indicating that both transcription factors are co-involved in regulating that 
aspect of EHEC virulence. Additional in vivo studies using a non-complemented kdpE 
knock-out strain and whole organism infection models would further help to dissect to 
what extent KdpE plays a direct role in EHEC virulence.  
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Figure 1. Schematic diagram of the varied inputs, accessory proteins, and regulatory effects 
of KdpD/KdpE. (A) The conventional model is that KdpD/KdpE stimulates transcription of the Kdp-
ATPase in response to cytoplasmic ionic and ATP concentrations and possibly also turgor pressure 
[9]. (B) In S. aureus KdpD is affected directly or indirectly by QS systems, and KdpE regulates 
many downstream genes including virulence factors by directly binding to their promoters [17,18]. 
(C) In EHEC, KdpE can also be activated by the QseC histidine kinase which senses host 
adrenergic signals as well as bacterial quorum sensing (QS) signals [29]. In vitro its regulatory 
targets include the ler gene which controls the ‘locus of enterocyte effacement’ (LEE) genes. Under 
gluconeogenic conditions KdpE interacts with Cra to optimally regulate ler; both proteins bind to the 
promoter, perhaps through bending of the DNA [24]. The downstream regulatory cascade is 
integral to lesion formation in the host gut [24,29]. (D) Recently identified accessory components in 
non-pathogenic E. coli link the pathway to additional input stimuli or modulate KdpD activity [30-32].  
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Signal integration via the sensor kinase KdpD and the relevance 
for host infection 
Rather than representing two distinct concepts, bacterial virulence and survival may be 
considered “two sides of the same coin”. Genes which promote the survival of a pathogen 
in its host – whether via stress response or by direct regulation of virulence genes – may 
be classed as virulence factors. While EHEC and S. aureus provide examples for the 
direct regulation of virulence genes by KdpE, there remains a more general implication of 
the importance of KdpD/KdpE in virulence mediated by stress resistance. 
Stress sensing and resistance 
There is a significant body of evidence supporting a link between KdpD/KdpE and the 
bacterial stress response, which in itself has clear relevance to survival within a host. With 
K+ concentration being an activating stimulus for Kdp-ATPase expression, it is 
understandable that osmotic stress (salt shock) can be linked to activity of KdpD/KdpE. 
However, studies in several bacteria also link kdpD/kdpE to resistance to oxidative and 
antimicrobial stresses specifically. Importantly, these bacteria are all either obligate or 
facultative intracellular pathogens. All have been reported in some instance to be able to 
resist host killing [33-35] and the majority are known to spend at least part of their lifecycle 
in the harsh phagosomal compartment – an acidic environment containing a barrage of 
hydrolytic enzymes, microbicidal agents, and reactive oxygen species (ROS) including 
hydrogen peroxide (H2O2). If KdpD/KdpE does mediate the sensing of such stresses 
encountered in the host then the effect of knocking-out them out in those infection models 
would be explained. Table 2 summarises the experimental evidence where KdpD/KdpE 
has been implicated in stress resistance. 
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Table 2. Evidence that KdpD/KdpE plays a role in resisting stresses 
Bacterium Link to stress resistance References 
Salmonella 
typhimurium 
kdpD KO increases sensitivity to antimicrobial 
stress (polymyxin B), osmotic stress (NaCl), and 
oxidative stress (H2O2). The KO mutant elicits a 
three-fold greater host response (production of 
nitric oxide) from macrophages 
Alegado et al., 
2011 [19]  
Francisella novicida 
Transposon insertion mutants in kdpD and kdpE, as 
well as kdpA and kdpC, are more sensitive than the 
wild-type strain to oxidative stress (H2O2 and 
paraquat) 
Moule et al., 
2010 [22]  
Yersinia pestis 
KdpD/KdpE KO results in hypersensitivity to crude 
neutrophil granule extracts and to five individual 
neutrophil microbicides. Amongst a panel of 
deletion mutants the effect on antimicrobial 
peptide resistance is second only to that of 
PhoP/PhoQ 
O’Loughlin et al., 
2010 [3]  
Photorhabdus 
asymbiotica 
P. asymbiotica KdpD/KdpE enables E. coli to persist 
in phagocytes whereas the native KdpDE does not; 
the greatest amino acid divergence is in KdpD’s 
Universal Stress Protein (Usp) domain, thought to 
be involved in stress sensing 
Vlisidou et al., 
2010; Heerman 
and Fuchs, 2008 
[21,36]  
Enterohaemorrhagic 
Escherichia coli (EHEC) 
KdpE is activated by the sensor kinase QseC, a 
receptor for adrenergic signals. Adrenergic 
regulation of bacterial gene expression is an 
underlying mechanism of stress response and 
cellular survival 
Hughes et al., 
2009 [29]  
 
Further evidence that KdpD can sense host-derived signals – including evidence for a role 
in stress response – was seen in Bacillus cereus, in which exposure to chitosan led to up-
regulation of the kdpABC and kdpD genes [37]. Chitosan is an antibacterial 
polysaccharide, thought to induce loss of ions and cellular turgor by forming pores in 
bacterial membranes. This might suggest that the Kdp-ATPase was up-regulated in order 
to recover lost K+. Yet two observations suggest otherwise. One is that a deletion mutant 
of the Kdp-ATPase structural genes actually showed no impairment of growth in 
conditions of either K+-limitation or salt-stress, bringing into question the importance of 
Kdp for K+ regulation in B. cereus. The other is that exposure to benzalkonium chloride (a 
disinfectant which generates leakage of intracellular ions in much the same way as 
chitosan) did not have the same effect of up-regulating the B. cereus kdp genes [38]. 
Taken together this suggests that ion loss alone was not being sensed, rather some other 
form of “antimicrobial stress” may have been. Indeed there is precedence for a TCS being 
directly activated by host-elicited antimicrobial peptides (AMPs) in the case of PhoP/PhoQ 
(Bader et al. 2005). It is therefore tempting to speculate that the biologically-derived 
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antimicrobial chitosan may be sensed by KdpD in a manner akin to the sensing of small 
innate immune molecules by PhoP. 
Quorum sensing 
As discussed earlier, in various bacteria KdpD can integrate multiple stimuli including: K+ 
concentration, osmolarity, possibly turgor pressure and even host adrenergic signals. 
Importantly, in S. aureus KdpD/KdpE can also respond to population density. The two 
studies which showed direct regulation of S. aureus virulence factors also reported that 
KdpD/KdpE can integrate signals from two quorum sensing (QS) systems – the luxS/AI-2 
system [18] and the Agr system [17]. Therefore KdpE-regulated S. aureus virulence genes 
are expressed appropriately according to both K+ concentration (an indication of whether 
the bacterium is extra- or intracellular), and population density (indicating whether there 
are enough bacteria present to make a particular response appropriate, e.g. toxin 
production) [17].  As such, S. aureus uses KdpD/KdpE in an adaptive manner, utilizing its 
"traditional" sensor activity in an integrated fashion with input from QS systems. 
Accessory components of KdpD 
Accessory proteins (also known as auxiliary factors) are known to affect TCSs by: i) fine-
tuning the ratio of the HK’s kinase- to phosphatase-activity, ii) linking the system to other 
regulatory networks,  or iii) enabling the sensing of additional stimuli [40,41]. Table 3 
summarises accessory proteins that have been identified for KdpD and E. coli accessory 
factors are also shown in Figure 1(D). It is not clear if there is any one specific region of 
the KdpD protein structure that is responsible for fine-tuning sensor kinase activity through 
accessory protein interactions. For example, it has been suggested that the IIANtr [41] 
protein (see below) interacts with the C-terminal transmitter domain of KdpD [45]. On the 
other hand, the N-terminus includes a conserved "KdpD" sub-domain with a regulatory 
ATP-binding site [42,43], and a universal stress protein (KdpD-Usp) sub-domain, which is 
highly variable between species.  The E. coli universal stress protein UspC protein is 
known to interact with the N-terminal Usp-domain thus altering its activity [32], although 
not through an influence on KdpD kinase activity.  
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Table 3. Identification of KdpD accessory components in E. coli and M. tuberculosis 
Bacterium Component Details References 
Escherichia coli 
IIA Ntr (enzyme 




Interacts with KdpD, stimulates auto-
kinase activity and therefore Kdp 
pump expression. This activity is 
linked to glycolytic growth 
Lüttman et al., 2009; 








Thioredoxins control the bacterial 
stress response by maintaining a 
reducing environment in the cell, 
preventing ROS damage, and 
signalling osmotic stress and low pH. 
These genes exert effects upstream 
of KdpD, though the precise nature 
of the interaction is not known. KO 
of either gene results in reduced 
expression of the Kdp pump 
Sardesai and 
Gowrishankar, 2001; 
Kumar et al., 2004; 
Zeller and Klug, 







Exerts effects upstream of KdpD, 
though the precise mechanism of the 
interaction is not known. KO results 









Binds to the Usp sub-domain of 
KdpD under osmotic stress 
conditions, scaffolding the active 
KdpD/phospho-KdpE/DNA complex 
and stimulating expression of Kdp 
pump structural genes 







Either protein can interact 
specifically with KdpD (solely with 
the C-terminal region or while also 
forming a ternary complex with the 
N-terminal region). Appear to be 
involved in the phospho-relay 
process. Likely act as sensors or 
ligand-binding proteins for as-yet-
unknown signals/ligands 
Steyn et at., 2003; 
Buelow and Raivio, 
2010 [41,47]  
 
Is the Usp domain of KdpD involved in stress sensing?  
A fundamental feature of Usp proteins is that they accumulate under stress conditions, 
and indeed UspC binds to the KdpD-Usp domain in response to osmotic stress, 
stimulating kdpFABC expression by acting as a scaffold between the active 
KdpD/phospho-KdpE/DNA complex [32]. This enables Kdp-ATPase expression at K+ 
levels at which it would normally be repressed. It has previously been suggested that the 
KdpD-Usp domain might be pivotal in the sensing of additional stimuli (Alegado et al. 
2011; Vlisidou et al. 2010). UspA proteins protect E. coli against superoxide stress and the 
UspA proteins of Photorhabdus species and Yersinia enterocolitica are thought to play a 
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role in stress sensing when invading insect hosts [32,36,48]. Photorhabdus asymbiotica is 
a facultative intracellular pathogen of insects and humans. Interestingly, when P. 
asymbiotica kdpD/kdpE was expressed in a non-pathogenic E. coli strain, the presence of 
the transgenic TCS conferred an ability to the E. coli strain to persist within insect 
phagocytic cells [21]. Although further molecular experiments would be required in order 
to identify the precise mechanism behind the phenomenon, this observation does show 
that there are differences in the functioning of the KdpD/KdpE TCSs between the two 
species. The greatest evolutionary divergence of the kdpD and kdpE genes from P. 
asymbiotica, E. coli and other bacterial species does indeed reside within the KdpD-Usp 
domain. Interestingly, domain swapping experiments revealed that this domain is also 
crucial for activation of KdpD. While the Usp-domain has a net-positive charged surface, 
integration of a net-negative charged surface was shown to block the activity of the 
protein. Therefore this domain can not only act as an interaction surface for other proteins, 
but also appears important for internal (de)activation of KdpD [49]. It has been suggested 
that binding of other Usp proteins might either alter the secondary structure of the protein 
or perhaps facilitate activation by shaping a more positive surface at this position. The 
ability of KdpD/KdpE to sense and respond to stress may thus be mediated via this Usp-
binding domain, and the variability of that domain between species might contribute to 
differences in bacterial virulence and lifestyle.  
Overview 
A study of the TCSs of M. tuberculosis in 2003 found that deletion of kdpD/kdpE 
unexpectedly resulted in hyper-virulence in mice [20]. Although no targets of KdpD/KdpE 
other than the Kdp-ATPase itself had been identified at the time, the result prompted the 
suggestion that KdpD/KdpE deletion had de-repressed virulence genes. It is possible that 
several mycobacterial lipoproteins identified in a study by Steyn et al [47] might be targets 
of KdpD/KdpE regulation. Since then, a diverse set of observations in a range of species 
supports the role of KdpD/KdpE in promoting survival and virulence through various 
mechanisms distinct from K+ regulation. In most cases it is not yet clear exactly how 
KdpD/KdpE impacts on virulence – it is likely that the link to stress response aids bacterial 
persistence within host cells. KdpD/KdpE’s role in virulence is likely to be highly variable 
across species and may ultimately be an indicator of species-specific adaptation.  
In both Gram positive and Gram negative pathogens, KdpD/KdpE functions as a 
previously unrecognised adaptive TCS of stimuli during host infection, integrating cues 
from the host (phagocytosis, host-derived antimicrobials, and adrenergic hormones) in 
addition to bacterial quorum sensing signals and the outside ionic concentrations. A 
recent review of "moonlighting" bacterial proteins focused upon glycolytic enzymes and 
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molecular chaperones in a range of pathogens. Just as the evidence suggests for 
KdpD/KdpE, this review emphasized that key metabolic proteins and molecular 
chaperones, essential for dealing with the bacterium’s response to stress, also have 
unexpected functions in virulence [50]. Like key metabolic enzymes and molecular 
chaperones, the KdpD/KdpE TCS usually plays a conserved role in in maintaining normal 
cellular function. It seems that the conserved TCS KdpD/KdpE provides a further example 
of bacterial protein “moonlighting”. It is suggested that proteins can display multi-
functionality due to "biochemical" or "geographical" conditions: either through possessing 
additional biochemical reactions or by being located in a different cellular location (such as 
the pole of an asymmetric cell), or both [50]. There appear to be no reports of KdpE or 
KdpD being located anywhere other than the cytoplasm and cytoplasmic membrane, but 
evidence does suggest that the Usp domain is a prime candidate as an additional 
“biochemical” site. Data regarding the effects of KdpD/KdpE in pathogenesis are 
somewhat limited to date but come from a range of bacterial genera and experimental 
approaches. The evidence reveals a spectrum of Kdp function from a clearly 
homeostasis-based role to a highly pleiotropic one. Given its function in K+ homeostasis, 
the KdpD/KdpE TCS is extremely important for bacteria in challenging environments. We 
argue that it is therefore likely to be a focal point for selection in relation to survival during 
infection. It should be noted that no additional functions have yet been ascribed to 
KdpD/KdpE in non-pathogenic E. coli; accessory components have been identified which 
interact with E. coli KdpD but these can be reasonably linked to K+ homeostasis. 
Examples include: thioredoxins, which are integral in stress response pathways involving 
osmotic stress, the H-NS nucleoid protein which is a transcriptional repressor that can 
respond to K+ concentration [51], and the IIANtr enzyme. This enzyme has been shown to 
connect K+ homeostasis with carbon starvation through direct interaction of non-
phosphorylated IIANtr with KdpD activating the kinase activity [52]. Non-pathogenic E. coli 
are not typically capable of surviving phagocytosis, and yet when expressing the 
KdpD/KdpE TCS from P. asymbiotica, E. coli cells did persist intracellularly [21] implying a 
fundamental difference between the abilities of the two systems to sense or respond to 
the phagocytic environment. The evidence from F. novicida can be adequately explained 
by a role in K+ regulation; mutants in the kdpFABC operon (as well as those in regulatory 
genes) were attenuated in the fruit fly model which indicates that the Kdp-ATPase itself is 
important in this species [22]. Yet in F. tularensis, only the kdpD gene mutant was 
identified as attenuated in the mouse model; kdpFABC operon genes were apparently 
less critical than within the gene encoding the sensor kinase [23]. In EHEC, KdpE 
regulates K+ uptake and osmolarity alongside important virulence genes; the EHEC QseC 
HK which activates KdpE has even been investigated as a potential target for novel ‘anti-
virulence’ drugs [29,53]. KdpE interacts with Cra, which itself coordinates the E. coli 
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response to sugar availability, thereby linking metabolism to pathogenesis. It has been 
suggested that during its evolution EHEC has co-opted “established mechanisms for 
sensing the metabolites and stress cues in the environment, to induce virulence factors in 
a temporal and energy-efficient manner, culminating in disease” [24]. The clearest K+ 
independent role in virulence so far is in S. aureus, in which KdpD responds to population 
density and KdpE actually regulates over 100 genes.  
Concluding remarks and future directions 
In these cases where KdpD/KdpE has been shown to regulate additional virulence genes, 
it is not yet clear how this has evolved. For example, did the promiscuous regulation by 
KdpE evolve through changes in the KdpE DNA-binding domain or has there been 
widespread selection for the evolution of KdpE operator sequence sites across a range of 
virulence loci? Furthermore, how taxonomically widespread is the expanded regulatory 
capacity of KdpE, and has the same mechanism occurred in each case? If specific 
virulence genes have evolved KdpE-responsive promoters then we may expect to see 
similar virulence genes under the control of KdpD/KdpE in different pathogens by virtue of 
horizontal gene transfer. EHEC’s T3SS and lesion-causing genes were acquired on a 
mobile genetic element and it has been suggested that Cra and KdpE (originally 
regulators of non-pathogenic functions) have been “co-opted by a pathogen to regulate 
virulence factors encoded within a horizontally acquired [pathogenicity island]” [24].  
KdpD/KdpE is positioned at a molecular hub which is fundamentally relevant to 
homeostasis during infection. This central position within regulatory networks controlling 
homeostasis, in conjunction with the radical stress associated with pathogenic host 
interactions is likely to explain how KdpD/KdpE has evolved a role in pathogenicity in 
some taxa. As such, KdpD/KdpE is likely subjected to strong selection to acquire novel 
functions in mediating virulence pathways. We might expect that the selection pressures, 
or the novel functions that result from them, would be variable across different bacteria 
with different hosts and infection- parameters. This taxa-specific evolutionary novelty is 
reflected in the phylogenetically diverse yet discontinuous nature of the data available so 
far. Figure 2 depicts the phylogenetic relationship between bacterial taxa where evidence 
supports a pleiotropic role of KdpD/KdpE. The majority of cases come from the well-
studied gamma-Proteobacteria clade but there is also evidence from the more distantly 
related Firmicutes and Actinobacteria.  The common association of KdpD/KdpE within an 
operon containing the structural genes KdpABC suggests that a role in K+ homeostasis is 
ancestral and that KdpD/KdpE’s adaptation for virulence or survival has arisen more 
recently and possibly multiple times.  Whether K+ regulation by KdpD/KdpE pre-dates 
more specific host-responsive activities or whether these evolved in parallel is a key 
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question with broad implications on the evolution of virulence. Ultimately, a detailed 
understanding (across a range of pathogenic and non-pathogenic bacteria) of 
KdpD/KdpE's connectivity within homeostatic response, stress response and virulence 
pathways will be needed to address this question.  
 
Figure 2. KdpD/KdpE virulence-related roles across bacterial taxa.   Evidence supporting the 
role of KdpD/KdpE in virulence (V) or survival (S) is indicated across diverse bacterial species, all 
of which are capable of intracellular replication to some extent. The relevant references are also 
indicated. Phylogenetic relationships are as suggested by Battistuzzi et al. (2004) (not drawn to 
scale) [54]. 
 
The perception that Kdp serves a general homeostatic function alone means that the Kdp 
regulatory network has not been specifically targeted in virulence studies. The studies 
discussed in this review however point to a clear need for more detailed experiments, with 
a systematic approach across multiple taxa. Specifically, useful tools would include (i) 
genetic knock-outs (plus/minus complementation) of KdpD and KdpE (individually and 
together) and the structural genes kdpFABC, or (ii) combinations of transgenic and/or 
native TCSs and Kdp-ATPases from species observed to show different effects of 
KdpD/KdpE. These genetic tools could be used for transcriptomic analyses and in vivo 
studies. Transcriptomic analyses could identify networks of genes co-regulated in 
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response to different challenges (K+ limitation, AMPs, oxidative or osmotic stress) or 
during infection of cells and whole organisms. In vivo studies in host organisms could 
examine the effects on acute virulence (measuring LD50, time to death, or host weight 
gain) or chronic persistence (how long bacteria can be retrieved). Ideally, it would be 
informative to re-investigate the species discussed in this review – and new species – 
using a coordinated and comparable experimental approach. To contrast with the data 
available so far it would be interesting to investigate species that cannot replicate 
intracellularly such as Pseudomonas spp. (gamma-Proteobacteria) or B. cereus 
(Firmicutes). Studies involving closely related species with diverse lifestyles – such as the 
Burkholderia which range from environmental organisms to obligate and opportunistic 
pathogens with varied host ranges – might be useful for dissecting the effects of host and 
lifestyle on KdpD/KdpE function. 
We predict that KdpD/KdpE will continue to be demonstrated to function in K+ 
homeostasis and virulence (directly or via stress response etc.) to different extents in 
different species. These differences are likely to correlate with whether the species in 
question leads a predominantly pathogenic or more environmentally-based lifestyle. In the 
former case, the type of host response a species encounters is also likely to be important.  
Finally, studies of TCSs such as PhoP/PhoQ, Cra and KdpD/KdpE suggest that other 
central homeostasis bacterial regulators will also prove to have various adaptive roles in 
virulence. The application of sophisticated systems-level studies across diverse bacterial 
pathogens may help to clarify this phenomenon and take us closer to understanding the 
regulatory breadth and complexity of pathogenesis. 
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